0000741815-16-000129.txt : 20160815 0000741815-16-000129.hdr.sgml : 20160815 20160815172131 ACCESSION NUMBER: 0000741815-16-000129 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 64 CONFORMED PERIOD OF REPORT: 20160630 FILED AS OF DATE: 20160815 DATE AS OF CHANGE: 20160815 FILER: COMPANY DATA: COMPANY CONFORMED NAME: HOOPER HOLMES INC CENTRAL INDEX KEY: 0000741815 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090] IRS NUMBER: 221659359 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-09972 FILM NUMBER: 161833997 BUSINESS ADDRESS: STREET 1: 560 N. ROGERS ROAD CITY: OLATHE STATE: KS ZIP: 66062 BUSINESS PHONE: 9137641045 MAIL ADDRESS: STREET 1: 560 N. ROGERS ROAD CITY: OLATHE STATE: KS ZIP: 66062 10-Q 1 hh0630201610q.htm 10-Q Document


 
 
 
 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 10-Q
 
x        Quarterly Report Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
 
For the quarterly period ended June 30, 2016
 
or
 
o        Transition Report pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
 
For the transition period from         to         
__________________
 
Commission File Number: 001-09972
 
HOOPER HOLMES, INC.
(Exact name of registrant as specified in its charter)

 
New York
 
22-1659359
 
 
(State or other jurisdiction of incorporation or organization)
 
(I.R.S. Employer Identification No.)
 
 
 
 
 
 
 
560 N. Rogers Road, Olathe, KS
 
66062
 
 
(Address of principal executive offices)
 
(Zip code)
 
 
Registrant's telephone number, including area code:   (913) 764-1045
 
Former name, former address and former fiscal year, if changed since last report
 
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
 
Yes x
 
No o
 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (sec. 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).
 
Yes x
 
No o
 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated
filer or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

Large Accelerated Filer o
 
Accelerated Filer o 
 
Non-accelerated Filer o
 
Smaller Reporting Company x

 Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
 
Yes o
 
No x
 

The number of shares outstanding of the Registrant's common stock as of July 31, 2016, was:
Common Stock, $.04 par value - 8,714,636 shares

1



HOOPER HOLMES, INC. AND SUBSIDIARIES
INDEX


 
 
 
Page No.
PART I –
Financial Information
 
 
 
 
 
 
ITEM 1 –
Financial Statements
 
 
 
 
 
 
 
Condensed Consolidated Balance Sheets as of June 30, 2016 (unaudited) and December 31, 2015
 
 
 
 
 
 
Condensed Consolidated Statements of Operations for the Three and Six Months Ended June 30, 2016 and 2015 (unaudited)
 
 
 
 
 
 
Condensed Consolidated Statement of Stockholders' (Deficit) Equity for the Six Months Ended June 30, 2016 (unaudited)
 
 
 
 
 
 
Condensed Consolidated Statements of Cash Flows for the Six Months Ended June 30, 2016 and 2015 (unaudited)
 
 
 
 
 
 
Notes to Unaudited Condensed Consolidated Financial Statements
 
 
 
 
 
ITEM 2 –
Management's Discussion and Analysis of Financial Condition and Results of Operations
 
 
 
 
 
ITEM 3 –
Quantitative and Qualitative Disclosures About Market Risk
 
 
 
 
 
ITEM 4 –
Controls and Procedures
 
 
 
 
PART II –
Other Information
 
 
 
 
 
ITEM 1 –
Legal Proceedings
 
 
 
 
 
ITEM 1A –
Risk Factors
 
 
 
 
 
ITEM 2 –
Unregistered Sales of Equity Securities and Use of Proceeds
 
 
 
 
 
ITEM 3 –
Defaults Upon Senior Securities
 
 
 
 
 
ITEM 4 –
Mine Safety Disclosures
 
 
 
 
 
ITEM 5 –
Other Information
 
 
 
 
 
ITEM 6 –
Exhibits
 
 
 
 
 
 
Signatures



2


PART I - Financial Information

Item 1. Financial Statements (unaudited)

Hooper Holmes, Inc. and Subsidiaries
Condensed Consolidated Balance Sheets
(in thousands, except share and per share data)
 
 
June 30, 2016
 
December 31, 2015
ASSETS
 
(unaudited)
 
 
Current assets:
 
 
 
 
Cash and cash equivalents
 
$
102

 
$
2,035

Accounts receivable, net of allowance for doubtful accounts of $169 and $112 at June 30, 2016 and December 31, 2015, respectively
 
5,376

 
5,565

Inventories
 
981

 
567

Other current assets
 
319

 
331

Total current assets 
 
6,778

 
8,498

 
 
 
 
 
Property, plant and equipment
 
8,549

 
8,427

Less: Accumulated depreciation and amortization
 
6,415

 
5,656

Property, plant and equipment, net
 
2,134

 
2,771

 
 
 
 
 
Intangible assets, net
 
4,681

 
5,331

Goodwill
 
633

 
633

Other assets
 
402

 
450

Total assets  
 
$
14,628

 
$
17,683

 
 
 
 
 
LIABILITIES AND STOCKHOLDERS' (DEFICIT) EQUITY
 
 
 
 
Current liabilities:
 
 
 
 
Accounts payable
 
$
4,734

 
$
5,339

Accrued expenses
 
4,685

 
5,186

Short-term debt
 
5,142

 
5,330

Total current liabilities 
 
14,561

 
15,855

Other long-term liabilities
 
544

 
1,611

Commitments and contingencies (Note 10)
 

 

 
 
 
 
 
Stockholders' (deficit) equity:
 
 
 
 
Common stock, par value $.04 per share; Authorized: 240,000,000 shares; Issued: 8,714,636 shares at June 30, 2016, and 5,201,733 shares at December 31, 2015; Outstanding: 8,714,636 shares at June 30, 2016, and 5,201,107 shares at December 31, 2015
 
349

 
3,121

Additional paid-in capital
 
164,089

 
156,195

Accumulated deficit 
 
(164,915
)
 
(159,028
)
 
 
(477
)
 
288

Less: Treasury stock, at cost; 0 and 626 shares at June 30, 2016, and December 31, 2015
 
—

 
(71
)
Total stockholders' (deficit) equity
 
(477
)
 
217

Total liabilities and stockholders' (deficit) equity
 
$
14,628

 
$
17,683

 
 
 
 
 
See accompanying notes to condensed consolidated financial statements.
 
 
 
 

1


Hooper Holmes, Inc. and Subsidiaries
Condensed Consolidated Statements of Operations
(unaudited)
(in thousands, except share and per share data)

 
 
Three Months Ended
 
Six Months Ended
 
 
June 30,
 
June 30,
 
 
2016
 
2015
 
2016
 
2015
Revenues
 
$
7,643

 
$
7,662

 
$
14,884

 
$
13,343

Cost of operations
 
5,878

 
5,969

 
11,659

 
10,918

 Gross profit
 
1,765

 
1,693

 
3,225

 
2,425

Selling, general and administrative expenses
 
3,724

 
3,811

 
7,551

 
6,471

Transaction costs
 
221

 
593

 
329

 
679

Operating loss from continuing operations
 
(2,180
)
 
(2,711
)
 
(4,655
)
 
(4,725
)
Interest expense, net
 
1,011

 
626

 
1,800

 
709

Other income
 
(887
)
 
—

 
(887
)
 
—

Loss from continuing operations before taxes
 
(2,304
)
 
(3,337
)
 
(5,568
)
 
(5,434
)
Income tax expense
 
5

 
5

 
10

 
10

Loss from continuing operations
 
(2,309
)
 
(3,342
)
 
(5,578
)
 
(5,444
)
 
 
 
 
 
 
 
 
 
Discontinued operations:
 
 
 
 
 
 
 
 
     Loss from discontinued operations
 
(150
)
 
(21
)
 
(309
)
 
(25
)
Net loss
 
$
(2,459
)
 
$
(3,363
)
 
$
(5,887
)
 
$
(5,469
)
 
 
 
 
 
 
 
 
 
Basic and diluted loss per share:
 
 
 
 
 
 
 
 
Continuing operations
 
 
 
 
 
 
 
 
Basic
 
$
(0.27
)
 
$
(0.65
)
 
$
(0.67
)
 
$
(1.10
)
Diluted
 
$
(0.27
)
 
$
(0.65
)
 
$
(0.67
)
 
$
(1.10
)
Discontinued operations
 
 
 
 
 
 
 
 
Basic
 
$
(0.02
)
 
$
—

 
$
(0.04
)
 
$
(0.01
)
Diluted
 
$
(0.02
)
 
$
—

 
$
(0.04
)
 
$
(0.01
)
Net loss
 
 
 
 
 
 
 
 
Basic
 
$
(0.29
)
 
$
(0.65
)
 
$
(0.71
)
 
$
(1.11
)
Diluted
 
$
(0.29
)
 
$
(0.65
)
 
$
(0.71
)
 
$
(1.11
)
 
 
 
 
 
 
 
 
 
Weighted average number of shares - Basic
 
8,602,590

 
5,162,786

 
8,329,568

 
4,944,824

Weighted average number of shares - Diluted
 
8,602,590

 
5,162,786

 
8,329,568

 
4,944,824

 
 
 
 
 
 
 
 
 
See accompanying notes to condensed consolidated financial statements.
 
 
 
 



2


 Hooper Holmes, Inc.
Condensed Consolidated Statements of Stockholders’ (Deficit) Equity
(unaudited)
 (in thousands, except share data)

 
 
Common Stock
 
 
 
 
 
Treasury Stock
 
 
 
 
Number
of Shares
 
Amount
 
Additional Paid-in
Capital
 
Accumulated
Deficit
 
Number of
Shares
 
Amount
 
Total Stockholders' (Deficit) Equity
Balance, December 31, 2015
 
5,201,733

 
$
3,121

 
$
156,195

 
$
(159,028
)
 
626

 
$
(71
)
 
$
217

Net loss
 
—

 
—

 
—

 
(5,887
)
 
—

 
—

 
(5,887
)
Issuance of common stock, net of issuance costs
 
3,346,378

 
2,008

 
2,715

 
—

 
—

 
—

 
4,723

Share-based compensation
 
166,665

 
100

 
370

 
—

 
—

 
—

 
470

Reverse stock split re-allocation
 
—

 
(4,880
)
 
4,880

 
—

 
—

 
—

 
—

Other adjustments due to reverse stock split
 
486

 
—

 
—

 
—

 
—

 
—

 
—

Retirement of treasury stock
 
(626
)
 
—

 
(71
)
 
$
—

 
(626
)
 
71

 
—

Balance, June 30, 2016
 
8,714,636

 
$
349

 
$
164,089

 
$
(164,915
)
 
—

 
$
—

 
$
(477
)
See accompanying notes to condensed consolidated financial statements.


3


Hooper Holmes, Inc. and Subsidiaries
Condensed Consolidated Statements of Cash Flows
(unaudited, in thousands)
 
Six Months Ended June 30,
 
2016
 
2015
Cash flows from operating activities:
 
 
 
Net loss
$
(5,887
)
 
$
(5,469
)
Adjustments to reconcile net loss to net cash used in operating activities:
 
 
 
Depreciation and amortization
1,409

 
873

Amortization of debt discount
807

 
244

Amortization of debt issuance costs
123

 
280

Write-off of debt issuance costs
282

 
—

Accretion of termination fees
91

 
—

Mark to market of Additional Warrant
59

 
—

Termination fees included in payoff of 2013 Loan and Security Agreement
277

 
—

Provision for bad debt expense
117

 
26

Share-based compensation expense
470

 
193

Issuance of common stock in connection with First Amendment to Credit Agreement
50

 
—

Write-off of Additional Warrant
(887
)
 
—

Change in assets and liabilities:
 
 
 
Accounts receivable
72

 
(1,667
)
Inventories
(414
)
 
247

Other assets
(52
)
 
(340
)
Accounts payable, accrued expenses and other liabilities
(1,365
)
 
514

Net cash used in operating activities
(4,848
)
 
(5,099
)
Cash flows from investing activities:
 
 
 
Capital expenditures
(191
)
 
(355
)
Acquisition of Accountable Health Solutions
—

 
(4,000
)
Net cash used in investing activities
(191
)
 
(4,355
)
Cash flows from financing activities:
 
 
 
Borrowings under credit facility
16,566

 
1,000

Payments under credit facility
(17,044
)
 
(151
)
Principal payments on term loan
(954
)
 
—

Proceeds from issuance of Term Loan
—

 
5,000

Issuance of common stock, net of issuance costs
4,574

 
—

Proceeds related to the exercise of stock options
—

 
23

Debt issuance costs
(36
)
 
(377
)
Net cash provided by financing activities
3,106

 
5,495

 
 
 
 
Net decrease in cash and cash equivalents
(1,933
)
 
(3,959
)
Cash and cash equivalents at beginning of period
2,035

 
5,201

Cash and cash equivalents at end of period
$
102

 
$
1,242

 
 
 
 
Supplemental disclosure of non-cash investing activities:
 
 
 
Fixed assets vouchered but not paid
$
28

 
$
76

Supplemental disclosure of non-cash financing activities:
 
 
 
     Issuance of common stock in connection with the Acquisition
$
—

 
$
3,000

     Issuance of common stock in connection with Second Amendment to Credit Agreement
$
100

 
$
—

     Debt issuance costs vouchered but not paid
$
—

 
$
500

     Payoff of 2013 Loan and Security Agreement by SCM
$
(2,552
)
 
$
—

     Opening outstanding borrowings under 2016 Credit and Security Agreement
$
3,028

 
$
—

     Debt issuance costs incurred for 2016 Credit and Security Agreement
$
236

 
$
—

Supplemental disclosure of cash paid during period for:
 
 
 
Income taxes
$
31

 
$
—

Interest
$
466

 
$
—

See accompanying notes to condensed consolidated financial statements.
 
 
 

4


Hooper Holmes, Inc. and Subsidiaries

Notes to Unaudited Condensed Consolidated Financial Statements
June 30, 2016
(unaudited)

Note 1: Basis of Presentation

Hooper Holmes, Inc. and its subsidiaries (“Hooper Holmes” or the "Company”) provides on-site screenings, laboratory testing, risk assessment, and sample collection services to individuals as part of comprehensive health and wellness programs offered through corporate and government employers.  The acquisition of Accountable Health Services, Inc. ("AHS") ("the Acquisition"), which is discussed further in Note 3 to the condensed consolidated financial statements, allows Hooper Holmes to also deliver telephonic health coaching, a wellness portal, data analytics, and reporting services. Hooper Holmes is engaged by the organizations sponsoring such programs, including health and care management companies, broker and wellness companies, disease management organizations, reward administrators, third party administrators, clinical research organizations, and health plans.  Hooper Holmes provides these services through a national network of health professionals.
    
The Company's screening business is subject to some seasonality, with the second quarter sales typically dropping below other quarters and the third and fourth quarter sales typically the strongest quarters due to increased demand for screenings from mid-August through November related to annual benefit renewal cycles. The Company's wellness services business is more constant, though there are some variations due to the timing of the health coaching programs, which are billed per participant and typically start soon after the conclusion of onsite screening events. In addition to its Screening and Health and Wellness Service operations, the Company generates ancillary revenue through the assembly of medical kits for sale to third parties.

The unaudited condensed consolidated financial statements of the Company have been prepared in accordance with instructions for Form 10-Q and the rules and regulations of the Securities and Exchange Commission ("SEC"). Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP") have been condensed or omitted pursuant to such rules and regulations. The unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto included in the Company's 2015 Annual Report on Form 10-K, filed with the SEC on March 30, 2016.

Financial statements prepared in accordance with U.S. GAAP require management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities, revenues and expenses and other disclosures. The financial information included herein is unaudited; however, such information reflects all adjustments that are, in the opinion of the Company's management, necessary for a fair statement of results for the interim periods presented.

The results of operations for the three and six month periods ended June 30, 2016 and 2015, are not necessarily indicative of the results to be expected for any other interim period or the full year. See “Management's Discussion and Analysis of Financial Condition and Results of Operations” for additional information.

On September 30, 2013, the Company completed the sale of certain assets comprising its Portamedic service line. During 2014, the Company sold certain assets comprising the Heritage Labs and Hooper Holmes Services businesses. The operating results of these businesses have been segregated and reported as discontinued operations for all periods presented in this Quarterly Report on Form 10-Q.

On June 15, 2016, the Company completed a one-for-fifteen reverse stock split. As a result, the share and per share information for all periods presented in these unaudited condensed consolidated financial statements have been adjusted to reflect the impact of the reverse stock split. The reverse stock split did not affect the total number of authorized shares of common stock of 240,000,000 shares or the par value of the Company’s common stock at $0.04. Accordingly, an adjustment was made between additional paid-in-capital and common stock in the condensed consolidated balance sheet to reflect the new values after the reverse stock split.

During the second quarter of 2016, it was determined that costs that had been expensed in the first quarter of 2016 related to the modification of the Credit Agreement (as defined in Note 9 to the condensed consolidated financial statements) and the equity issuances. Costs associated with the modification of the Credit Agreement should have been capitalized and amortized to interest expense over the remaining life of the Credit Agreement, while costs associated with the equity issuances should have been recorded as a reduction to equity. The Company recorded these correcting entries during the second quarter of 2016. The net impact of the correcting adjustments decreased reported pretax loss in the second quarter of 2016 by approximately $0.2 million. Management

5


does not believe the impact of these out of period adjustments materially impacts the fair presentation of the Company’s operating results or financial condition for the periods impacted.

New Accounting Pronouncements

In May 2014, the Financial Accounting Standards Board ("FASB") issued Accounting Standard Update ("ASU") 2014-09, "Revenue from Contracts with Customers (Topic 606)", which requires an entity to recognize the amount of revenue to which it expects to be entitled for the transfer of promised goods or services to customers. ASU 2014-09 will replace most existing revenue recognition guidance in U.S. GAAP when it becomes effective. This new guidance is effective for the Company in the first quarter of 2018, with early adoption permitted as of the original effective date or first quarter of 2017. The Company is currently evaluating the impact the adoption of ASU 2014-09 will have on the consolidated financial statements and related disclosures.

In August 2014, the FASB issued ASU No. 2014-15, "Presentation of Financial Statements - Going Concern (Subtopic 205-40): Disclosure of Uncertainties about an Entity's Ability to Continue as a Going Concern". This ASU requires management to assess and evaluate whether conditions or events exist, considered in the aggregate, that raise substantial doubt about the entity's ability to continue as a going concern within one year after the financial statements issue date. This standard will be effective for annual periods beginning after December 15, 2016, and for annual and interim periods thereafter; early adoption is permitted. The Company is currently evaluating the impact the adoption of ASU 2014-15 will have on the disclosures in Note 2 of the condensed consolidated financial statements.

In April 2015, the FASB issued ASU 2015-03, "Interest - Imputation of Interest (Subtopic 835-30): Simplifying the Presentation of Debt Issuance Costs", which requires that debt issuance costs be presented in the balance sheet as a direct deduction from the carrying value of the debt liability. The Company adopted the provisions of ASU 2015-03 in the first quarter of 2016. The retrospective application of the new standard resulted in a $0.2 million reduction to both noncurrent assets and current liabilities as of December 31, 2015. The debt issuance costs associated with the revolving credit facilities remain classified in noncurrent assets in accordance with ASU 2015-15.

In February 2016, the FASB issued ASU No. 2016-02, "Leases (Topic 842)", which is intended to improve financial reporting about leasing transactions. This standard requires a lessee to record on the balance sheet the assets and liabilities for the rights and obligations created by lease terms of more than 12 months. This standard will be effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. The Company is currently evaluating the impact the adoption of ASU 2016-02 will have on its consolidated financial position, results of operations or cash flows.

In March 2016, the FASB issued ASU No. 2016-09, "Improvements to Employee Share-Based Payment Accounting (Topic 718)", which is intended to simplify the accounting for share-based compensation. This standard simplifies the accounting for income taxes in relation to share-based compensation, modifies the accounting for forfeitures, and modifies the statutory tax withholding requirements. This standard will be effective for fiscal years beginning after December 15, 2016, including interim periods within those fiscal years. The Company is currently evaluating the impact the adoption of ASU 2016-09 will have on its consolidated financial position, results of operations or cash flows.

Note 2: Liquidity

The accompanying financial statements have been prepared assuming that the Company will continue as a going concern, which contemplates the realization of assets and discharge of liabilities in the normal course of business for the foreseeable future. The uncertainty regarding the Company's ability to generate sufficient cash flows and liquidity to fund operations raises substantial doubt about its ability to continue as a going concern. These financial statements do not include any adjustments that might result from the outcome of this uncertainty.

The Company has taken the following actions toward alleviating the substantial doubt that exists with regard to the Company's ability to continue as a going concern:

•
On January 25, 2016, the Company received $3.4 million, net of issuance costs, in additional equity by issuing 2,601,789 shares of its common stock, $0.04 par value, through a rights offering to current shareholders which is being used to fund working capital;

•
On March 28, 2016, the Company received $1.2 million, net of issuance costs, in additional equity by issuing 666,667 shares of its common stock, $0.04 par value, to 200 NNH, LLC, which is being used to fund working capital;


6


•
On March 28, 2016, the Company renegotiated its financial covenants in the Credit Agreement (as defined below) to requirements based on its forecast models; and

•
On April 29, 2016, the Company entered into a new Credit and Security Agreement with SCM Specialty Finance Opportunities Fund, L.P. (as defined below) replacing the 2013 Loan and Security Agreement (as defined below). Refer to Note 9 to the condensed consolidated financial statements for additional discussion.

The Company expects to continue to monitor its liquidity carefully, work to reduce this uncertainty, and address its cash needs through a combination of one or more of the following actions:

•
The Company will continue to aggressively seek new and return business from its existing customers and expand its presence in the Health and Wellness marketplace;

•
The Company will continue to implement further cost actions and efficiency improvements;

•
The Company expects to continue to carefully manage receipts and disbursements, including amounts and timing, focusing on reducing days receivables outstanding and managing days payables outstanding.
    
The Company's primary sources of liquidity are cash and cash equivalents as well as availability under a Credit and Security Agreement (the "2016 Credit and Security Agreement") with SCM Specialty Finance Opportunities Fund, L.P. ("SCM"). At June 30, 2016, the Company had $0.1 million in cash and cash equivalents and had $3.3 million outstanding under the 2016 Credit and Security Agreement, with available borrowing capacity of $0.3 million. As of August 9, 2016, the Company had $2.4 million outstanding with estimated available borrowing capacity of $0.8 million. As of June 30, 2016, the Company also owed approximately $4.0 million under an existing term loan ("the Term Loan"), which is governed by the terms of a credit agreement ("the Credit Agreement") with SWK Funding LLC ("SWK") and was used to fund the cash component of the Acquisition. Each of these agreements contain certain financial covenants, including various affirmative and negative covenants including minimum aggregate revenue, EBITDA, and consolidated unencumbered liquid assets requirements, which the Company did not comply with as of June 30, 2016. For additional information regarding the 2016 Credit and Security Agreement, Credit Agreement, and the related covenants, see Note 9 to the condensed consolidated financial statements.

The Company incurred a loss from continuing operations of $5.6 million during the six month period ended June 30, 2016. The Company’s net cash used in operating activities for the six month period ended June 30, 2016, was $4.8 million. The Company has managed its liquidity through availability under a revolving credit facility, raising additional equity, and a series of cost reduction initiatives.

The Company has historically used availability under a revolving credit facility to fund operations. The Company experiences a timing difference between the operating expenses and cash collection of the associated revenue based on Health and Wellness customer payment terms. To conduct successful screenings, the Company must expend cash to deliver the equipment and supplies required for the screenings and pay its health professionals and site management, all of which is done in advance of the customer invoicing process and ultimate cash receipts for services performed. Given the seasonal nature of the Company's operations, which are largely dependent on second half volumes, management expects to continue using a revolving credit facility in 2016 and beyond.

Other Considerations

The Health and Wellness business sells services directly to end customers and also through wellness, disease management, benefit brokers, and insurance companies (referred to as channel partners) who ultimately have the relationship with the end customer. Sales to direct customers offer the full suite of our services while sales of our screenings through channel partners are often aggregated with other offerings from these channel partners to provide a total solution to the end-user. As such, the Company's success is largely dependent on that of its partners.

Additionally, the Acquisition provides new offerings including the wellness portal and telephonic coaching, along with new staff, new systems, and new customers. During the six month period ended June 30, 2016, the Company incurred under $0.1 million of costs associated with the ongoing integration of AHS, which are recorded in selling, general and administrative expenses. Transition costs incurred during the three month period ended June 30, 2016, were immaterial. These costs relate primarily to transition services purchased from AHS and the ongoing transition of information technology infrastructure. The Company does not expect to continue to incur material transition costs going forward.


7


In addition, the Company has contractual obligations related to operating leases and employment contracts which could adversely affect liquidity.

The Company’s ability to satisfy its liquidity needs and meet future covenants is dependent on growing revenues, improving profitability, and raising additional equity. These profitability improvements primarily include expansion of the Company’s presence in the Health and Wellness marketplace through new sales to direct customers, retaining existing customers, and capitalizing on the opportunities presented by its channel partners. The Company must increase screening, telephonic health coaching, and wellness portal volumes in order to cover its fixed cost structure and improve gross profits. These improvements may be outside of management’s control. If the Company is unable to increase volumes or control operating costs, liquidity may be adversely affected.

There can be no assurance that cash flows from operations, combined with any additional borrowings available to the Company, will be obtainable in an amount sufficient to enable the Company to repay its indebtedness, or to fund other liquidity needs. If the Company is unable to comply with financial covenants in 2016 and in the event that the Company were unable to modify the covenants, find new or additional lenders, or raise additional equity, the Company would be considered in default, which would then enable the lenders to accelerate the repayment of all amounts outstanding and exercise remedies with respect to collateral, which would have a material adverse impact on the Company's business.

Note 3: Acquisition

The Company entered into and consummated the Purchase Agreement on April 17, 2015, among the Company and certain of its subsidiaries, Accountable Health Solutions, Inc. (the "Seller" or "AHS") and Accountable Health, Inc. (the "Shareholder"). Pursuant to the Purchase Agreement, the Company acquired the assets and certain liabilities representing the health and wellness business of the Seller for approximately $7.0 million - $4.0 million in cash and up to 433,333 shares of the Company’s common stock, $0.04 par value, with a value of $3.0 million, which was subject to a working capital adjustment as described in the Purchase Agreement. At the closing of the Purchase Agreement, the Company issued and delivered 371,739 shares of Common Stock to the Shareholder at closing and issued and held back 21,739 shares of Common Stock for the working capital adjustment, which were subsequently released on October 9, 2015, and 39,855 shares of Common Stock for indemnification purposes. No additional shares will be issued under the terms of the Purchase Agreement. The shares were issued pursuant to an exemption from registration under Section 4(a)(2) of the Securities Act of 1933, which provides an exemption for private offerings of securities.

In order to fund the Acquisition, the Company entered into and consummated the Credit Agreement with SWK on April 17, 2015. Refer to Note 9 of the condensed consolidated financial statements for discussion of the Credit Agreement and related warrants.

The Acquisition was treated as a purchase in accordance with Accounting Standards Codification (ASC) 805, Business Combinations, which requires allocation of the purchase price to the estimated fair values of the assets acquired and liabilities assumed in the transaction. The allocation of purchase price is based on management’s judgment after evaluating several factors, including a valuation assessment.

The allocation of the purchase price was finalized in the first quarter of 2016 and is as follows:
(in thousands)
 
 
Accounts receivable, net of allowance of $2
 
$
918

Inventory and other current assets
 
117

Fixed assets
 
123

Customer portal (existing technologies)
 
4,151

Customer relationships
 
2,097

Goodwill
 
633

Accounts payable and accrued expenses
 
(743
)
Deferred revenue
 
(296
)
           Purchase Price
 
$
7,000


Intangible assets acquired include existing technology in the form of a customer-facing wellness portal and customer relationships. The fair value of the customer relationships acquired was determined using the excess earnings method under the income approach for customer relationships; and the fair value of the wellness portal software was determined using the replacement

8


cost method. The estimated useful life for the wellness portal and customer relationships is 4 years and 8 years, respectively. Amortization is recorded on a straight-line basis over the estimated useful life of the asset. The Company recorded amortization expense as a component of cost of operations of $0.3 million and $0.5 million, respectively, and amortization expense as a component of selling, general and administrative expenses of $0.1 million and $0.1 million, respectively, during the three and six month periods ended June 30, 2016. The Company recorded amortization expense of $0.2 million as a component of cost of operations and $0.1 million as a component of selling, general and administrative expenses for the three and six month periods ended June 30, 2015. The goodwill of $0.6 million was recorded in one reporting unit, the Health and Wellness operations, and is deductible for tax purposes.

The consolidated statement of operations for the three and six month periods ended June 30, 2016, includes revenue of $2.7 million and $5.2 million, respectively, attributable to AHS. Disclosure of the earnings contribution from the AHS business is not practicable, as the Company has already integrated operations.

The following table provides unaudited pro forma results of operations for the three and six month periods ended June 30, 2015, as if AHS was part of operations on the first day of the 2014 fiscal year.

(in thousands)
 
Three Months Ended
 
Six Months Ended
 
 
June 30,
 
June 30,
 
 
2015
 
2015
Pro forma revenues
 
$
7,662

 
$
15,750

 
 
 
 
 
Pro forma net loss from continuing operations
 
$
(2,749
)
 
$
(5,856
)

These pro forma results are based on estimates and assumptions, which the Company believes are reasonable. They are not the results that would have been realized had the Company been a combined company during the periods presented, nor are they indicative of the consolidated results of operations in future periods. The pro forma results for the six month period ended June 30, 2015, include pre-tax adjustments for amortization of intangible assets of $0.3 million. Pro forma results for the three and six month periods ended June 30, 2015, include pre-tax adjustments for the elimination of acquisition costs of $0.6 million and $0.7 million, respectively.
Note 4:
Loss Per Share

Basic loss per share equals net loss divided by the weighted average common shares outstanding during the period.  Diluted loss per share equals net loss divided by the sum of the weighted average common shares outstanding during the period plus dilutive common stock equivalents. The calculation of loss per common share on a basic and diluted basis was the same for the three and six month periods ended June 30, 2016 and 2015, because the inclusion of dilutive common stock equivalents and the Warrant issued in connection with the Acquisition would have been anti-dilutive for all periods presented. The Company has granted options to purchase shares of the Company's common stock through employee stock plans with the weighted average options outstanding as of June 30, 2016 and 2015, being 355,092 and 274,460, respectively, and a warrant to purchase 543,478 shares issued to SWK was outstanding as of June 30, 2016, but are anti-dilutive because the Company is in a net loss position.

Note 5: Share-Based Compensation

Employee Share-Based Compensation Plans - On May 29, 2008, the Company's shareholders approved the 2008 Omnibus Employee Incentive Plan (the "2008 Plan") providing for the grant of stock options, stock appreciation rights, non-vested stock, and performance shares. During the three and six month periods ended June 30, 2016, the Company granted 100,000 and 153,332 options, respectively, for the purchase of shares under the 2008 Plan. During the three and six month periods ended June 30, 2015, the Company granted 667 and 40,000 options, respectively. As of June 30, 2016, 31,659 shares remain available for grant under the 2008 Plan.
    
On May 24, 2011, the Company's shareholders approved the 2011 Omnibus Employee Incentive Plan, as subsequently amended and restated, (the "2011 Plan") providing for the grant of stock options and non-vested stock awards. During the three and six month periods ended June 30, 2016, there were no options for the purchase of shares granted under the 2011 Plan. During the three month period ended June 30, 2015, there were 30,000 options for the purchase of shares granted under the 2011 Plan. During the six month periods ended June 30, 2016 and 2015, the Company also granted a total of 166,665 and 2,778 stock awards,

9


respectively, to non-employee members of the Board of Directors that immediately vested. As of June 30, 2016, 243,693 shares remain available for grant under the 2011 Plan.

The fair value of the stock options granted during the three and six month periods ended June 30, 2016, was estimated on the date of grant using the Black-Scholes option pricing model with the following weighted average assumptions:

 
Three Months Ended June 30,
 
Six Months Ended June 30,
 
2016
 
2016
Expected life (years)
5.3
 
5.1
Expected volatility
80.0%
 
81.0%
Expected dividend yield
—%
 
—%
Risk-free interest rate
1.3%
 
1.4%
Weighted average fair value of options granted during the period
$1.27
 
$1.33

The following table summarizes stock option activity for the six month period ended June 30, 2016:
 
 
Number of Options
 
Weighted Average Exercise Price Per Option
 
Weighted Average remaining Contractual Life (years)
 
Aggregate Intrinsic Value (in thousands)
Outstanding balance at December 31, 2015
 
286,568

 
$
6.46

 
 
 
 
Granted
 
153,332

 
2.05

 
 
 
 
Exercised
 
—

 
—

 
 
 
 
Forfeited and Expired
 
(34,560
)
 
3.23

 
 
 
 
Outstanding balance at June 30, 2016
 
405,340

 
5.07

 
8.45
 
$0
Options exercisable at June 30, 2016
 
147,113

 
$
7.65

 
7.25
 
$0

There were no options exercised during the six month period ended June 30, 2016. There were 50,000 options with a weighted average exercise price of $0.45 exercised during the six month period ended June 30, 2015. Options for the purchase of an aggregate of 30,768 shares of common stock vested during the six month period ended June 30, 2016, and the aggregate fair value at grant date of these options was $0.1 million. As of June 30, 2016, there was approximately $0.4 million of total unrecognized compensation cost related to stock options. The cost is expected to be recognized over a weighted average period of 1.74 years.
The Company recorded $0.4 million and $0.5 million, respectively, of share-based compensation expense in selling, general and administrative expenses for the three and six month periods ended June 30, 2016. The Company recorded $0.1 million and $0.2 million, respectively, of share-based compensation expense in selling, general and administrative expenses for the three and six month periods ended June 30, 2015.

Note 6: Inventories

Included in inventories at June 30, 2016, and December 31, 2015, are $0.4 million and $0.3 million, respectively, of finished goods and $0.6 million and $0.3 million, respectively, of components.

Note 7: Goodwill and Other Intangible Assets

The Company recorded Goodwill of $0.6 million as of June 30, 2016, and December 31, 2015.

Intangible assets subject to amortization are amortized on a straight-line basis and are summarized in the table below.


10


 
June 30, 2016
 
December 31, 2015
(in thousands)
Gross Carrying Amount

Accumulated Amortization
 
Intangibles Assets, net
 
Gross Carrying Amount
 
Accumulated Amortization
 
Intangibles Assets, net
Portal
$
4,151

 
$
1,251

 
$
2,900

 
$
4,151

 
$
732

 
$
3,419

Customer relationships
2,097

 
316

 
1,781

 
2,097

 
185

 
1,912

        Total
$
6,248

 
$
1,567

 
$
4,681

 
$
6,248

 
$
917

 
$
5,331


Amortization expense for the three and six month periods ended June 30, 2016, was $0.3 million and $0.7 million, respectively. Amortization expense for each of the three and six month periods ended June 30, 2015, was $0.3 million.

Based on the Company's recent financial performance and negative equity, management determined a review of impairment of long-lived assets and goodwill was necessary as of June 30, 2016. The analysis indicated no impairment charges for long-lived assets or goodwill was required at June 30, 2016.

Note 8: Restructuring Charges

At June 30, 2016, there was a $0.6 million liability related to Portamedic branch closure costs, which is recorded in accrued expenses and other long-term liabilities in the accompanying condensed consolidated balance sheet. Charges recorded during the three and six month periods ended June 30, 2016, were recorded as a component of discontinued operations. The following table provides a summary of the activity in the restructure accrual for the six month period ended June 30, 2016:

(in thousands)
December 31, 2015
 
Adjustments
 
Payments
 
June 30, 2016
Facility closure obligation
$
657

 
$
134

 
$
(201
)
 
$
590

  
Note 9: Debt

As of June 30, 2016, the Company maintained the 2016 Credit and Security Agreement and the Term Loan provided by the Credit Agreement. The following table summarizes the Company's outstanding borrowings:

(in thousands)
 
June 30, 2016
 
December 31, 2015
 
 
 
 
 
2016 Credit and Security Agreement (2013 Loan and Security Agreement as of December 31, 2015)
 
$
3,277

 
$
3,278

Term Loan
 
4,046

 
5,000

Discount on Term Loan
 
(1,977
)
 
(2,785
)
Unamortized debt issuance costs related to Term Loan
 
(204
)
 
(163
)
Total debt
 
5,142

 
5,330

Short-term portion
 
(5,142
)
 
(5,330
)
Total long-term debt, net
 
$
—

 
$
—


The following table summarizes the components of interest expense for the three and six month periods ended June 30, 2016 and 2015:


11


(in thousands)
 
Three Months Ended
 
Six Months Ended
 
 
June 30,
 
June 30,
 
 
2016
 
2015
 
2016
 
2015
Interest expense on Term Loan (interest at LIBOR, plus 14%)
 
$
161

 
$
154

 
$
341

 
154

Interest expense on 2013 Loan and Security Agreement
 
16

 
4

 
49

 
4

Interest expense on 2016 Credit and Security Agreement
 
48

 
—

 
48

 
—

Accretion of termination fees (over term of Term Loan at rate of 8%)
 
45

 
27

 
91

 
27

Amortization of debt issuance costs
 
62

 
197

 
123

 
280

Write-off of debt issuance costs related to 2013 Loan and Security Agreement
 
282

 
—

 
282

 
—

Amortization of debt discount associated with the warrants
 
397

 
244

 
807

 
244

Mark to market of the Additional Warrant
 
—

 
—

 
59

 
—

Total
 
$
1,011

 
$
626

 
$
1,800

 
$
709


2016 Credit and Security Agreement

On April 29, 2016, the Company entered into the 2016 Credit and Security Agreement with SCM. The 2016 Credit and Security Agreement provides the Company with a revolving credit facility, the proceeds of which are to be used for general working capital purposes and capital expenditures. The 2016 Credit and Security Agreement replaced the 2013 Loan and Security Agreement, eliminating the requirement of the Company to issue the Additional Warrant for the purchase of common stock valued at $1.25 million to SWK, the holder of the Company’s Credit Agreement (see below for further information about the Additional Warrant). An early termination fee of $140,000, approximately $30,000 of legal fees, and approximately $107,000 of other ordinary course fees were accelerated due to the termination of the 2013 Loan and Security Agreement and were rolled into the opening outstanding borrowings under the 2016 Credit and Security Agreement with SCM and are reflected in transaction costs in the condensed consolidated statement of operations during the three month period ended June 30, 2016, and approximately $0.3 million of unamortized debt issuance costs related to the 2013 Loan and Security Agreement were written off and recorded in interest expense in the condensed consolidated statement of operations during the three month period ended June 30, 2016

Under the terms of the 2016 Credit and Security Agreement, SCM makes cash advances to the Company in an aggregate principal at any one time outstanding not to exceed $7 million, subject to certain loan balance limits based on the value of the Company’s eligible collateral (the “Revolving Loan Commitment Amount”). The 2016 Credit and Security Agreement has a term of three years, expiring on April 29, 2019. As of June 30, 2016, the Company had $3.3 million outstanding under the 2016 Credit and Security Agreement with available borrowing capacity of $0.3 million. As of August 9, 2016, the Company had $2.4 million outstanding, with estimated available borrowing capacity of $0.8 million.

Borrowings will bear interest at a fluctuating rate that when annualized is equal to the Prime Rate plus 5.5%, subject to increase in the event of a default. The Company paid SCM a $140,000 facility fee, and monthly, SCM will receive an unused line fee equal to one-half of one percent (0.5%) per annum of the difference derived by subtracting (i) the greater of (x) the average daily outstanding balance under the Revolving Facility during the preceding month and (y) the Minimum Balance, from (ii) the Revolving Loan Commitment Amount and also a collateral management fee equal to one-half of one percent (0.5%) per annum of the Revolving Loan Commitment Amount. As of June 30, 2016, the remaining balance in debt issuance costs recorded in Other Assets on the condensed consolidated balance sheet was $0.3 million.

The 2016 Credit and Security Agreement contains customary representations and warranties and various affirmative and negative covenants including minimum aggregate revenue, EBITDA, and consolidated unencumbered liquid assets requirements. Minimum aggregate revenue must not be less than $34.0 million for the twelve months ending June 30, 2016, $37.0 million for the twelve months ending September 30, 2016, $40.0 million for the twelve months ending December 31, 2016, and $45.0 million for the twelve months ending each fiscal quarter thereafter. Adjusted EBITDA must not be less than negative $2.0 million for the six months ending June 30, 2016, negative $1.1 million for the nine months ending September 30, 2016, $0.8 million for the twelve months ending December 31, 2016, $0.5 million for the twelve months ending March 31, 2017, $0.9 million for the twelve months ending June 30, 2017, and $2.5 million for the twelve months ending September 30, 2017. In addition, consolidated unencumbered liquid assets must not be less than $0.75 million on the last day of any quarter. The Company was not in compliance with the covenants under the 2016 Credit and Security Agreement as of June 30, 2016, and has entered into a First Amendment to Credit and Security Agreement and Limited Waiver and Forbearance (“First Amendment”), which provides a waiver related to the

12


measurement period ended June 30, 2016. If certain conditions set forth in the First Amendment are satisfied as of September 30, 2016, the waiver and an amendment to the 2016 Credit and Security Agreement providing for revised financial covenants will become permanent.  If the Company is unable to fulfill the conditions in the First Amendment by September 30, 2016, or fails to comply with, or obtain further waivers to, the financial covenants in the First Amendment in the future, then the lenders would have the option to accelerate the repayment of all amounts outstanding and exercise remedies with respect to collateral, which would have a material adverse impact on the Company's business. The foregoing description of the First Amendment is only a summary and is qualified in its entirety by the full text of the First Amendment, which is attached as an exhibit to this Quarterly Report on Form 10-Q.

Borrowings under the Agreement are secured by a security interest in all existing and after-acquired property of the Company, including, but not limited to, its receivables (which are subject to a lockbox account arrangement), inventory and equipment.

Credit Agreement

In order to fund the Acquisition, the Company entered into the Credit Agreement with SWK on April 17, 2015, as amended on February 25, 2016, and March 28, 2016. The Credit Agreement provides the Company with a $5.0 million Term Loan. The proceeds of the Term Loan were used to pay certain fees and expenses related to the negotiation and consummation of the Purchase Agreement and the Acquisition described in Note 3 and general corporate purposes. The Company paid SWK an origination fee of $0.1 million. The Term Loan is due and payable on April 17, 2018. The Company is also required to make quarterly revenue-based payments in an amount equal to eight and one-half percent (8.5%) of yearly aggregate revenue up to and including $20 million, seven percent (7%) of yearly aggregate revenue greater than $20 million up to and including $30 million, and five percent (5%) of yearly aggregate revenue greater than $30 million. The revenue-based payment will be applied to fees and interest, and any excess to the principal of the Term Loan. Revenue-based payments commenced in February 2016, and the maximum principal portion of the aggregate revenue-based payment is capped at $600,000 per quarter. During the six month period ended June 30, 2016, the Company made principal payments to SWK of $1.0 million, in addition to $0.4 million of interest paid.
  
The outstanding principal balance under the Credit Agreement bears interest at an adjustable rate per annum equal to the LIBOR Rate (subject to a minimum amount of one percent (1.0%)) plus fourteen percent (14.0%) and is due and payable quarterly, in arrears, which commenced on August 14, 2015. Upon the earlier of (a) the maturity date on April 17, 2018, or (b) full repayment of the Term Loan, whether by acceleration or otherwise, the Company is required to pay an exit fee equal to eight percent (8%) of the aggregate principal amount of all term loans advanced under the Credit Agreement. The Company is recognizing the exit fee over the term of the Term Loan through an accretion accrual to interest expense using the effective interest method.

The Credit Agreement also contains certain financial covenants including minimum aggregate revenue, adjusted EBITDA, and consolidated unencumbered liquid assets requirements. On March 28, 2016, the Company obtained a Second Amendment to the Credit Agreement (the "Second Amendment") in which the lender modified the existing covenants and replaced them with minimum aggregate revenue covenants of $34.0 million for the twelve months ending June 30, 2016, $37.0 million for the twelve months ending September 30, 2016, $40.0 million for the twelve months ending December 31, 2016, and $45.0 million for the twelve months ending each fiscal quarter thereafter. The Second Amendment also modified the minimum adjusted EBITDA covenants for 2016 and replaced them with minimum adjusted EBITDA covenants of negative $2.0 million for the six months ending June 30, 2016, negative $1.1 million for the nine months ending September 30, 2016, $0.8 million for the twelve months ending December 31, 2016, $0.5 million for the twelve months ending March 31, 2017, $0.9 million for the twelve months ending June 30, 2017, and $2.5 million for the twelve months ending September 30, 2017, and each twelve consecutive calendar month period ending on the last day of each fiscal quarter thereafter. In addition, the Company was required to obtain new equity contributions in an aggregate amount of not less than $0.5 million between March 23, 2016 and June 30, 2016, which requirement the Company has satisfied through the private offering to 200 NNH, LLC, which is described further in Note 2 to the condensed consolidated financial statements. The Second Amendment also required the Company to issue shares of its common stock, $0.04 par value, with a value of $100,000 to SWK, which the Company issued during the first quarter of 2016 and recorded as debt issuance costs as a direct deduction to short-term debt on the condensed consolidated balance sheet as of June 30, 2016. The Company was not in compliance with the covenants under the Credit Agreement, as amended, as of June 30, 2016, and has entered into a Third Amendment to Credit Agreement and Limited Waiver and Forbearance (“Third Amendment”), which provides a waiver related to the measurement period ended June 30, 2016. If certain conditions set forth in the Third Amendment are satisfied as of September 30, 2016, the waiver and an amendment to the Credit Agreement providing for revised financial covenants and an extended period of time to make required principal payments will become permanent. If the Company is unable to fulfill the conditions in the Third Amendment by September 30, 2016, or fails to comply with, or obtain further waivers to, the financial covenants in the Third Amendment in the future, then the lenders would have the option to accelerate the repayment of all amounts outstanding and exercise remedies with respect to collateral, which would have a material adverse impact on the Company's business. The foregoing description of the Third Amendment is only a summary and is qualified in its entirety by the full text of the Third Amendment, which is attached as an exhibit to this Quarterly Report on Form 10-Q.

13


    
The Credit Agreement contains a cross-default provision that can be triggered if the Company has more than $0.25 million in debt outstanding under the 2016 Credit and Security Agreement and the Company fails to make payments to SCM when due or if SCM is entitled to accelerate the maturity of debt in response to a default situation under the 2016 Credit and Security Agreement, which may include violation of any financial covenants.

As of June 30, 2016, as security for payment and other obligations under the 2016 Credit and Security Agreement, SCM held a security interest in all of the Company's, and its subsidiary guarantors', existing and after-acquired property, including receivables (which are subject to a lockbox account arrangement), inventory and equipment. Additionally, SWK holds a security interest for final and indefeasible payment. The security interest held by SWK is in substantially all of the Company's assets and the Company's subsidiaries.

In connection with the execution of the Credit Agreement, the Company issued SWK a warrant (the "Warrant") to purchase 543,478 shares of the Company’s common stock. The Warrant is exercisable after October 17, 2015, and up to and including April 17, 2022, at an exercise price of $6.90 per share. The Warrant is exercisable on a cashless basis. The exercise price of the Warrant is subject to customary adjustment provisions for stock splits, stock dividends, recapitalizations and the like. The Warrant grants the holder certain piggyback registration rights. The Warrant was considered equity classified, and as such, the Company allocated the proceeds from the Term Loan to the Warrant using the Relative Fair Value Method. Further, pursuant to the Credit Agreement, if the 2013 Loan and Security Agreement was not repaid in full and terminated, and all liens securing the 2013 Loan and Security Agreement were not released, on or prior to April 30, 2016, as amended in the First Amendment to the Credit Agreement dated February 25, 2016, the Company agreed to issue an additional warrant (the “Additional Warrant”) to SWK to purchase common stock valued at $1.25 million, with an exercise price of the closing price on April 30, 2016. In accordance with the relevant accounting guidance, the Additional Warrant was determined to be an embedded derivative. The fair value of these warrants at the inception of the Credit Agreement of approximately $3.6 million was recorded as a debt discount, and is being amortized through interest expense over the term of the Credit Agreement using the effective interest method. The Company valued both warrants using the Black-Scholes pricing model, which utilizes Level 3 Inputs. For the Warrant, the Company utilized volatility of 85.0%, a risk-free rate of 1.4%, dividend rate of zero, and term of 7 years, which is consistent with the exercise period of the Warrant. For the Additional Warrant, the Company utilized volatility of 80.0%, a risk-free rate of 2.1%, dividend rate of zero, and term of 7 years, which is consistent with the exercise period of the Additional Warrant.

As noted above, on April 29, 2016, the Company entered into the 2016 Credit and Security Agreement with SCM, which eliminated the requirement of the Company to issue the Additional Warrant. Accordingly, during the three month period ended June 30, 2016, the Company recorded $0.9 million in other income in the condensed consolidated statement of operations related to the write-off of the derivative liability associated with the Additional Warrant.
  
Note 10: Commitments and Contingencies

The Company leases its corporate headquarters in Olathe, Kansas, which includes the Health and Wellness operations center, under an operating lease which expires in 2018. The Company leases its AHS operations centers in Des Moines, Iowa and Indianapolis, IN, under operating leases which expire in 2018. The Company also leases copiers and other miscellaneous equipment. These leases expire at various times through 2017.

The Company is obligated under a lease related to the discontinued Hooper Holmes Services operations center through 2018 and has ceased use of this facility. The Company is still the primary lessee under operating leases for two Portamedic branch offices and has recorded a facility closure obligation related to the above mentioned leases for future rent payments not utilized for continuing operations and such related costs are recorded in the reporting for discontinued operations. The Company has recorded a facility closure obligation of $0.6 million as of June 30, 2016, related to the above mentioned leases.

The Company has employment agreements with certain executive employees that provide for payment of base salary for up to a one year period in the event their employment with the Company is terminated in certain circumstances, including following a change in control, as further defined in the agreements.

From time to time, the Company is subject to federal and state tax audits and related governmental inquiries into matters such as income tax returns, sales and use tax returns, employment classification of its workers, and wage and hour law compliance. The Company is currently under examination by the Internal Revenue Service (the “IRS”) for the calendar years 2013, 2014, and 2015 with respect to its classification of certain of its health professionals as independent contractors rather than employees. This examination could lead to proposed adjustments to its federal employment taxes for the periods in question, but the IRS has not yet issued an assessment. The Company believes that it has properly classified these workers as independent contractors, but there

14


can be no assurances of a favorable outcome for the Company and given the ongoing status of the examination, we are unable at this time to provide an estimate of the range of loss, if any.

Note 11: Litigation

The Company, in the normal course of business, is a party to various claims and other legal proceedings. In the opinion of management, the Company has substantial legal defenses and/or insurance coverage (subject to deductibles) with respect to all of its pending legal actions. If management believes that a material loss not covered by insurance arising from these actions is probable and can reasonably be estimated, the Company may record the amount of the estimated loss or, if a loss cannot be estimated but the minimum liability may be estimated using a range and no point is more probable than another, the Company may record the minimum estimated liability. As additional information becomes available, any potential liability related to these actions is assessed and the estimates are revised, if necessary. Management believes that the ultimate outcome of all pending legal actions, individually and in the aggregate, will not have a material adverse effect on the Company's financial position that is inconsistent with its loss reserves or on its overall trends in results of operations. However, litigation and claims are subject to inherent uncertainties and unfavorable outcomes can occur that exceed any amounts reserved for such losses. If an unfavorable outcome were to occur, there exists the possibility of a material adverse impact on the results of operations in the period in which the outcome occurs or in future periods.

On May 24, 2012, a complaint was filed against the Company in the United States District Court for the District of New Jersey alleging, among other things, that the Company failed to pay overtime compensation to a purported class of certain independent contractor examiners who, the complaint alleges, should be treated as employees for purposes of federal law. The complaint seeks award of an unspecified amount of allegedly unpaid overtime wages to certain examiners. The Company filed an answer denying the substantive allegations therein. On August 1, 2014, the Magistrate Judge issued a Report and Recommendation to conditionally certify the class of all contract examiners from August 16, 2010, to the present. On August 29, 2014, the Company submitted its objections to the Report and Recommendation of the Magistrate Judge. The Magistrate has suspended ruling concerning those objections while the parties pursue the possibility of a settlement. On April 29, 2016, the Company reached a preliminary understanding with the plaintiffs with respect to a settlement of the lawsuit involving a release of all claims by the plaintiffs and the Company's establishment of a settlement fund of $0.45 million. Accordingly, as of June 30, 2016, the Company had accrued $0.45 million related to this matter versus $0.3 million as of December 31, 2015.  The litigation accrual for all periods was included in the Accrued expenses line item on the condensed consolidated balance sheet.  The additional expense of $0.15 million recorded during the six month period ended June 30, 2016, is included in the discontinued operations line item on the condensed consolidated statements of operations.  This preliminary understanding is subject to approval by the Magistrate and the parties' entry into a definitive settlement agreement. The claim is not covered by insurance, and the Company is incurring legal costs to defend the litigation which are recorded in discontinued operations. This matter relates to the former Portamedic service line for which the Company retained liability.

Note 12: Income Taxes

The Company's income tax expense was not material for any period presented in the condensed consolidated statement of operations. No amounts were recorded for unrecognized tax benefits or for the payment of interest and penalties during the three and six month periods ended June 30, 2016 and 2015. No federal or state tax benefits were recorded relating to the current year loss. The Company continues to believe that a full valuation allowance is required on its net deferred tax assets, with the exception of deferred income tax on the liabilities of certain indefinite-lived intangibles.
The tax years 2012 through 2015 may be subject to federal examination and assessment. Tax years from 2007 through 2011 remain open solely for purposes of federal and certain state examination of net operating loss and credit carryforwards. State income tax returns may be subject to examination for tax years 2011 through 2015, depending on state tax statute of limitations.

As of December 31, 2015, the Company had U.S. federal and state net operating loss carryforwards of $167.2 million and $149.8 million, respectively. There has been no significant change in these balances as of June 30, 2016. The net operating loss carryforwards, if not utilized, will expire in the years 2016 through 2035.

Since the Company had changes in ownership during 2015 and continuing into the first quarter of 2016, additional limitations under IRC Section 382 of the Internal Revenue Code of 1986 may apply to the future utilization of certain tax attributes including net operating loss (“NOL”) carryforwards, other tax carryforwards, and certain built-in losses. The Company has not yet completed its analysis of any impact of these ownership changes. No tax benefit has been reported since a full valuation allowance offsets these tax attributes. However, limitations could apply even if the valuation allowance was released.

Note 13: Fair Value Measurements

15



The Company determines the fair value measurements used in our consolidated financial statements based upon the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The fair value hierarchy distinguishes between (1) market participant assumptions developed based on market data obtained from independent sources (observable inputs) and (2) an entity’s own assumptions about market participant assumptions developed based on the best information available in the circumstances (unobservable inputs). The fair value hierarchy consists of three broad levels, which gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). The three levels of the fair value hierarchy are described below:

•
Level 1 - Valuations based on quoted prices in active markets for identical assets or liabilities that the entity has the ability to access.

•
Level 2 - Valuations based on quoted prices for similar assets or liabilities, quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable data for substantially the full term of the assets or liabilities.

•
Level 3 - Valuations based on inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.

The Company estimated the fair value of the Term Loan and derivative liability using the Black-Scholes valuation model, which is a Level 3 valuation technique.
 
 
June 30, 2016
 
December 31, 2015
(in thousands)
 
Face Value

Fair Value

Carrying Amount
 
Face Value
 
Fair Value
 
Carrying Amount
Term Loan
 
$
5,000

 
$
3,590

 
$
1,953

 
$
5,000

 
$
3,837

 
$
2,052

Derivative liability
 
$
—

 
$
—

 
$
—

 
$
1,250

 
$
828

 
$
828


ITEM 2
Management's Discussion and Analysis of Financial Condition and Results of Operations

In this Quarterly Report on Form 10-Q (this "Report"), the terms "Hooper Holmes," "Company," "we," "us" and "our" refer to Hooper Holmes, Inc. and its subsidiaries.

Cautionary Statement Regarding Forward-Looking Statements

This Report contains forward-looking statements, as that term is defined in the Private Securities Litigation Reform Act of 1995, concerning the Company’s plans, objectives, goals, strategies, future events or performances, which are not statements of historical fact and can be identified by words such as:  "expect," "continue," "should," "may," "will," "project," "anticipate," "believe," "plan," "goal," and similar references to future periods.  The forward-looking statements contained in this Report reflect our current beliefs and expectations.  Actual results or performance may differ materially from what is expressed in the forward looking statements. 

Forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from those expected. These risks and uncertainties include, but are not limited to, risks related to customer concerns about our financial health, our liquidity, uncertainty as to our working capital requirements over the next 12 to 24 months, our ability to maintain compliance with the financial covenants contained in our credit facility and term loan, declines in our business, our competition, and our ability to retain and grow our customer base and its related impact on revenue, our ability to recognize operational efficiencies and reduce costs, our ability to realize the expected benefits from the acquisition of Accountable Health Solutions, and such other factors as discussed in Part I, Item 1A, Risk Factors, and Part II, Item 7, Management’s Discussion and Analysis of Financial Conditions and Results of Operations of our Annual Report on Form 10-K for the year ended December 31, 2015, Part II, Item 1A, Risk Factors, of this Report, and similar discussions in our other filings with the Securities and Exchange Commission ("SEC"). 

Investors should consider these factors before deciding to make or maintain an investment in our securities. The forward-looking statements included in this Report are based on information available to us as of the date of this Report. We expressly

16


disclaim any intent or obligation to update or release any revisions to these forward-looking statements to reflect events or circumstances, or to reflect the occurrence of unanticipated events, after the date of this Report, except as required by law. 

Overview

Our Company was founded in 1899. We are a publicly-traded New York corporation whose shares of common stock are listed on the NYSE MKT.  Our corporate headquarters are located in Olathe, Kansas, where our health and wellness operating center is located. Over the last 40 years, our business focus has been on providing health risk assessment services. With the acquisition of Accountable Health Solutions, Inc. ("AHS") ("the Acquisition"), we now also provide wellness and health improvement services. This expansion uniquely positions Hooper Holmes to transform and capitalize on the large and growing health and wellness market as one of the only publicly traded, end-to-end health and wellness companies.

We provide on-site screenings, laboratory testing, risk assessment and sample collection services to individuals as part of comprehensive health and wellness programs offered through corporate and government employers as well as to clinical research organizations.  Through our subsidiary AHS, we expanded our capabilities to also include telephonic health coaching, a wellness portal, data analytics, and reporting services. We are engaged by the organizations sponsoring such programs, including corporate and government employers, health plans, hospital systems, health care management companies, wellness companies, brokers and consultants, disease management organizations, reward administrators, third party administrators, clinical research organizations and academic institutions.  We provide these services through a national network of health professionals, trained and certified to deliver quality service.
The majority of large employers that offer health benefits today also offer at least some wellness programs in an effort to promote employee health and productivity and reduce health related costs.  Through screenings, plan sponsors help employees learn of existing and/or potential health risks. Through corporate wellness, they provide education and health improvement tools and gain the ability to systematically reward employees for good, healthy behaviors and for actual health enhancement metrics. Some common examples of these rewards include reductions in annual medical premiums and contributions to an employee’s Health Savings Account (HSA). By combining both the screening and corporate wellness services under a single organization, Hooper Holmes creates a seamless, end-to-end experience for members and drives improved engagement and outcomes for our clients.
Today, we service more than 200 direct clients representing nearly 3,000 employers and up to 1,000,000 participants. In the past year, we delivered over 500,000 screenings and are on track to continue year-over-year growth through a combination of our direct, channel partner, and clinical research organization partners as well as through the addition of new customers.
    
Our screening business is subject to some seasonality, with the second quarter sales typically dropping below other quarters and the third and fourth quarter sales typically the strongest quarters due to increased demand for screenings from mid-August through November related to annual benefit renewal cycles. Our wellness services business is more constant, though there are some variations due to the timing of the health coaching programs which are billed per participant, and typically start soon after the conclusion of onsite screening events. In addition to our Screening and Health and Wellness Service operations, we generate ancillary revenue through the assembly of medical kits for sale to third parties.

We believe that the overall market for our health and wellness services is growing and we expect it will continue to grow with the increased nationwide focus on healthcare, cost-containment and well-being/productivity initiatives.

Acquisition

We entered into and consummated the Purchase Agreement on April 17, 2015, among us and certain of our subsidiaries, Accountable Health Solutions, Inc. (the "Seller" or "AHS") and Accountable Health, Inc. (the "Shareholder"). Pursuant to the Purchase Agreement, we acquired the assets and certain liabilities representing the health and wellness business of the Seller for approximately $7.0 million - $4.0 million in cash and 433,333 shares of our common stock, $0.04 par value, with a value of $3.0 million, which was subject to a working capital adjustment as described in the Purchase Agreement. Refer to Note 3 of the condensed consolidated financial statements for additional discussion regarding the Acquisition and Note 9 for discussion of the Credit Agreement.

Rights Offering

On January 25, 2016, we received $3.4 million, net of issuance costs, in additional equity by issuing 2,601,789 shares of our common stock, $0.04 par value, through a rights offering to current shareholders which is being used to fund working capital.


17


Additional Equity Contributions

On March 28, 2016, we received $1.2 million, net of issuance costs, in additional equity by issuing 666,667 shares of our common stock, $0.04 par value, to 200 NNH, LLC, (the "Investor") a new private investor, which will be used to fund working capital. Pursuant to the Stock Purchase Agreement, there is a lock-up period of 18 months, during which time the Investor cannot sell the shares acquired. The Investor also has the right to send a representative to meetings of our Board of Directors as a non-voting observer for so long as the Investor owns at least 5% of our outstanding shares.

Reverse Stock Split

On June 15, 2016, we completed a one-for-fifteen reverse stock split. As a result, the share and per share information for all periods presented in these unaudited condensed consolidated financial statements have been adjusted to reflect the impact of the reverse stock split. The reverse stock split did not affect the total number of authorized shares of common stock of 240,000,000 shares or the par value of our common stock at $0.04. Accordingly, an adjustment was made between additional paid-in-capital and common stock in the condensed consolidated balance sheet to reflect the new values after the reverse stock split.

Liquidity

The accompanying financial statements have been prepared assuming that we will continue as a going concern (which contemplates the realization of assets and discharge of liabilities in the normal course of business for the foreseeable future). The uncertainty regarding our ability to generate sufficient cash flows and liquidity to fund operations raises substantial doubt about our ability to continue as a going concern. These financial statements do not include any adjustments that might result from the outcome of this uncertainty. As discussed further in Note 2 and within the Liquidity and Capital Resources section below, we expect to continue to monitor our liquidity carefully, work to reduce this uncertainty, and address our cash needs by raising additional equity, as noted above, renegotiating our financial covenants, reducing costs, and increasing revenues.
    
Business Outlook for 2016

With our growth in the second half of 2015 and continued sales momentum in the first half of 2016, we believe there are significant growth opportunities for our health and wellness operations. Health and wellness services include event scheduling, provision and fulfillment of all supplies (e.g., examination kits, blood pressure cuffs, stadiometers, scales, centrifuges, lab coats, bandages, etc.) at screening events, event management, biometric screenings (e.g., height, weight, body mass index, hip, waist, neck, pulse, blood pressure), blood draws via venipuncture or finger stick, procuring lab testing, participant and aggregate reporting, data processing and data transmission. We have expanded our capabilities to allow us to deliver telephonic health coaching, a wellness portal, data analytics, and reporting services. During 2016, we expanded our capabilities further to include administration of flu shots and are exploring other offerings for delivery through our health professionals networks.

The United States spends more on healthcare than any other country, with more than 80% of healthcare costs due to chronic conditions. With the focus on health care cost management and the risk of reduced productivity in the workplace from health issues arising among the employee population, we believe employers of all sizes will adopt health and wellness programs at an increasing rate. We expect the market for health and wellness to grow over the next three to five years, and we believe that we are well positioned to increase revenues from our screening and other related services given our unique set of assets, including our proprietary Health and Wellness technology platform and our national network of health professionals. However, the success of Health and Wellness will also depend in part upon the success of our channel partners and their health and care management initiatives to employers.

A key corporate strength is our extensive network of health professionals, providing coverage in every zip code nationwide and allowing us to offer screenings for smaller sites. We also have national agreements with retail clinics and local lab offices, and offer physician form and at-home-kit services, providing our customers more robust, convenient options to maximize member participation with annual screenings. We also have logistical expertise in staffing and supply chain capabilities that allow us to stock, calibrate, pack, and ship the materials our health professionals need to collect accurate health information. This centralized fulfillment model allows us to deliver a reliable, consistent experience for our customers nationwide, regardless of location, as well as consistent and reliable equipment to provide a strong degree of accuracy and quality.

We monitor our operational performance and are constantly refining metrics to improve operational performance. We believe our attention to the details of a Health and Wellness event, from the set-up, staffing, and post event follow-up, contributes to making our services efficient and effective.


18


We have already gained several new customers in 2016, both through our direct sales efforts and through our channel partners, including a large multi-year clinical research study extension. As previously noted, we also raised $3.4 million, net of issuance costs, in additional equity through our rights offering and another $1.2 million, net of issuance costs, through a private investor. As one of only a few pure-play publicly traded health and wellness companies that offers a fully-integrated end-to-end solution to our customers, we believe we are positioned to capitalize on market need in 2016 and beyond. There are, however, events as noted in Note 2 to the condensed consolidated financial statements, that could negatively affect our financial condition, results of operations, and cash flows.

Key Financial and Other Metrics Monitored by Management

In our periodic reports filed with the SEC, we provide certain financial information and metrics about our businesses, and information that our management uses in evaluating our performance and financial condition.  Our objective in providing this information is to help our shareholders and investors generally understand our overall performance and assess the profitability of and prospects for our business.

We monitor the following key metrics related to our core health and wellness operations:

•
the number of health screenings completed;
•
the number of enrollments in health coaching services;
•
the number of subscribers to the wellness portal services;
•
the quality scores of our Health Professionals;
•
the aggregate of travel expenditures incurred by our Health Professionals; and
•
budget to actual performance for the health and wellness operations.

Certain of the above-cited metrics are discussed in the comparative discussion and analysis of our results of operations that follows.

Adjusted EBITDA

The following table sets forth our reconciliation of Adjusted EBITDA for the three and six month periods ended June 30, 2016 and June 30, 2015:
(in thousands)
 
Three Months Ended
 
Six Months Ended
 
 
June 30,
 
June 30,

 
2016
 
2015
 
2016

2015
Net loss
 
$
(2,459
)
 
$
(3,363
)
 
$
(5,887
)
 
$
(5,469
)
Plus:
 
 
 
 
 
 
 
 
   Interest expense
 
225

 
158

 
438

 
158

   Other debt related costs included in interest expense
 
786

 
468

 
1,362

 
551

   Income tax expense
 
5

 
5

 
10

 
10

   Depreciation and amortization
 
708

 
580

 
1,409

 
873

   Share-based compensation expense
 
390

 
103

 
470

 
193

   Stock payments in connection with debt amendments1
 
(100
)
 
—

 
50

 
—

   Transaction costs
 
221

 
593

 
329

 
679

   Transition costs
 
2

 
258

 
54

 
258

   Portamedic contingent liability
 
—

 
—

 
150

 
—

   Write-off of Additional Warrant
 
(887
)
 
—

 
(887
)
 
—

Adjusted EBITDA
 
$
(1,109
)
 
$
(1,198
)
 
$
(2,502
)
 
$
(2,747
)
1 See Note 1 to the condensed consolidated financial statements regarding out of period corrections.

We present Adjusted EBITDA as a supplemental measure of our performance. We define Adjusted EBITDA as net income (loss) plus (i) interest expense, (ii) net income tax provision (benefit) and (iii) depreciation and amortization, as further adjusted to eliminate the impact of certain non-recurring items that we do not consider indicative of our ongoing operating performance. You are encouraged to evaluate these adjustments and the reasons we consider them appropriate for supplemental analysis. In

19


evaluating Adjusted EBITDA, you should be aware that in the future we may incur expenses that are the same as or similar to some of the adjustments in this presentation. Our presentation of Adjusted EBITDA should not be construed as an inference that our future results will be unaffected by unusual or non-recurring items.

Adjusted EBITDA is a non-GAAP financial measure and should not be construed as an alternative to net earnings (loss) as an indicator of operating performance or as an alternative to cash flow provided by operating activities as a measure of liquidity (as determined in accordance with GAAP). Adjusted EBITDA may not be comparable to similarly titled measures reported by other companies. We have included Adjusted EBITDA because we believe it provides management and investors with additional information to measure our performance and liquidity, estimate our value and evaluate our ability to service debt.

Adjusted EBITDA has important limitations as an analytical tool, and you should not consider it in isolation, or as a substitute for analysis of our results as reported under GAAP. For example, Adjusted EBITDA:
• does not reflect our capital expenditures, future requirements for capital expenditures or contractual commitments;
• does not reflect changes in, or cash requirements for, our working capital needs;
• does not reflect the cash requirements necessary to service interest or principal payments on our debt;
• excludes income tax payments that represent a reduction in cash available to us; and
• does not reflect any cash requirements for the assets being depreciated and amortized that may have to be replaced in the future.

Results of Operations    
    
Comparative Discussion and Analysis of Results of Operations for the three and six month periods ended June 30, 2016 and 2015

Revenue - The table below sets forth our consolidated revenue for the periods indicated:
 
 
Three Months Ended June 30,
 
Six Months Ended June 30,
(dollars in thousands)
 
2016
 
2015
 
% Change
 
2016
 
2015
 
% Change
Revenue
 
$
7,643

 
$
7,662

 
(0.2
)%
 
$
14,884

 
$
13,343

 
11.5
%

Consolidated revenues for the three month period ended June 30, 2016, remained flat at $7.6 million from the prior year period, due primarily to the addition of portal, coaching and screening services with the Acquisition offset by the normal variations in our screening volume.

Consolidated revenues for the six month period ended June 30, 2016, were $14.9 million, an increase of $1.5 million, or 11.5%, from the prior year period, which is primarily due to the addition of portal, coaching and screening services with the Acquisition. The increase in revenue from the Acquisition was partially offset by the normal variations in our screening volume.
      
Consolidated revenues includes third party kit revenue for the three months period ended June 30, 2016 and 2015, of $0.4 million and $0.4 million, respectively, and for the six month periods ended June 30, 2016 and 2015, of $0.8 million and $0.6 million, respectively.

Screening Units - The table below sets forth the approximate number of screening units for the periods indicated:
 
 
Three Months Ended June 30,
 
Six Months Ended June 30,
 
 
2016

2015
 
% Change
 
2016
 
2015
 
% Change
Number of Screenings
 
99,000

 
109,000

 
(9.2
)%
 
203,000

 
216,000

 
(6.0
)%

The Company completed approximately 99,000 screenings during the three month period ended June 30, 2016, for a decrease of 9.2% from the prior year period, and approximately 203,000 screenings during the six month period ended June 30, 2016, for a decrease of 6.0% from the prior year period due to the normal variations in our screening volume.
      
Cost of Operations - The table below sets forth our consolidated cost of operations for the periods indicated:

20



 
 
Three Months Ended June 30,
 
Six Months Ended June 30,
(dollars in thousands)
 
2016
 
% of Revenue
 
2015
 
% of Revenue
 
2016
 
% of
Revenue
 
2015
 
% of
Revenue
Cost of Operations
 
$
5,878

 
76.9
%
 
$
5,969

 
77.9
%
 
$
11,659

 
78.3
%
 
$
10,918

 
81.8
%

Cost of operations, as a percentage of revenue, was 76.9% and 77.9% for the three month periods ended June 30, 2016 and 2015, respectively, and was 78.3% and 81.8% for the six month periods ended June 30, 2016 and 2015, respectively. The increase in gross profit is due to the higher margin offerings acquired through AHS offset by increases in field specialist labor and travel costs compared to the prior year. Additionally, our cost of sales has a certain element of fixed costs that are required to maintain customer service levels and cannot easily be reduced in periods of lower screening volume.

Selling, General and Administrative Expenses - The table below sets forth our consolidated SG&A expenses for the periods indicated:

 
 
Three Months Ended June 30,
 
Six Months Ended June 30,
(dollars in thousands)
 
2016
 
2015
 
% Change
 
2016
 
2015
 
% Change
Selling, general and administrative expenses
 
$
3,724

 
$
3,811

 
(2.3
)%
 
$
7,551

 
$
6,471

 
16.7
%
    
SG&A expenses for the three month period ended June 30, 2016, decreased 2.3% compared to the prior year period due primarily to fewer transition costs than prior year related to the AHS acquisition partially offset by the stock compensation payments made to the Board of Directors. SG&A expenses for the six month period ended June 30, 2016, increased 16.7% from the prior year period primarily due to the addition of AHS expenses and the stock compensation payments made to the Board of Directors, partially offset by fewer transition costs related to the AHS acquisition.

Transaction Costs

Transaction costs represent legal and professional fees incurred for non-recurring transactions. During the three and six month periods ended June 30, 2016, we incurred $0.2 million and $0.3 million, respectively, of transaction costs primarily in connection with the termination of the 2013 Loan and Security Agreement. During the three and six month periods ended June 30, 2015, we incurred $0.6 million and $0.7 million, respectively, of transaction costs in connection with the Acquisition.

Operating Loss from Continuing Operations

Our consolidated operating loss from continuing operations for the three month period ended June 30, 2016, was $2.2 million, compared to $2.7 million in the prior year period. Consolidated operating loss for the six month periods ended June 30, 2016 and 2015, was $4.7 million and $4.7 million, respectively.

Interest Expense, Net

Interest expense, net, for the three month periods ended June 30, 2016 and 2015, was $1.0 million and $0.6 million, respectively. Interest Expense, net, for the six month periods ended June 30, 2016 and 2015, was $1.8 million and $0.7 million, respectively. The increase is due to the financing obtained for the Acquisition, including interest on the Term Loan and accretion of the termination fees and debt discount as well as the write-off of debt issuance costs related to the termination of the 2013 Loan and Security Agreement.

Other Income

Other income for each of the three and six month periods ended June 30, 2016, was $0.9 million which is due to the elimination of the Additional Warrant owed to SWK (see Note 9 to the condensed consolidated financial statements). There was no activity in other income during the three and six month periods ended June 30, 2015.

Loss from Discontinued Operations

21


    
The loss from discontinued operations, net, totaled $0.2 million and $0.3 million for the three and six month periods ended June 30, 2016, which included expenses of $0.15 million for a contingent liability related to the Portamedic service line. The activity in discontinued operations during the three and six month periods ended June 30, 2015, was not significant. Discontinued operations represent the net results of operations and adjustments during the periods presented for the Heritage Labs, Hooper Holmes Services, and Portamedic businesses.

Net Loss
    
Net loss for the three month period ended June 30, 2016, was $2.5 million, or $0.29 per share on both a basic and diluted basis, as compared to a net loss of $3.4 million, or $0.65 per share on both a basic and diluted basis for the three month period ended June 30, 2015. Net loss for the six month period ended June 30, 2016, was $5.9 million, or $0.71 per share on both a basic and diluted basis, as compared to a net loss of $5.5 million, or $1.11 per share on both a basic and diluted basis for the six month period ended June 30, 2015.

Liquidity and Capital Resources

As discussed in Note 2 to the condensed consolidated financial statements, the uncertainty regarding our ability to generate sufficient cash flows and liquidity to fund operations raises substantial doubt about our ability to continue as a going concern.

We have taken the following actions toward alleviating the substantial doubt that exists with regard to our ability to continue as a going concern:

•
On January 25, 2016, we received $3.4 million, net of issuance costs, in additional equity by issuing 2,601,789 shares of our common stock, $0.04 par value, through a rights offering to current shareholders which is being used to fund working capital;

•
On March 28, 2016, we received $1.2 million, net of issuance costs, in additional equity by issuing 666,667 shares of our common stock, $0.04 par value, to 200 NNH, LLC, which is being used to fund working capital;

•
On March 28, 2016, we renegotiated our financial covenants in the Credit Agreement (as defined below) to requirements based on our forecast models; and

•
On April 29, 2016, we entered into a new Credit and Security Agreement with SCM Specialty Finance Opportunities Fund, L.P. (as defined below) replacing the 2013 Loan and Security Agreement (as defined below). Refer to Note 9 to the condensed consolidated financial statements for additional discussion.

We expect to continue to monitor our liquidity carefully, work to reduce this uncertainty, and address our cash needs through a combination of one or more of the following actions:

•
We will continue to aggressively seek new and return business from our existing customers and expand our presence in the Health and Wellness marketplace;

•
We will continue to implement further cost actions and efficiency improvements;

•
We expect to continue to carefully manage receipts and disbursements, including amounts and timing, focusing on reducing days receivables outstanding and managing days payables outstanding.

Our primary sources of liquidity are cash and cash equivalents as well as availability under a Credit and Security Agreement (the "2016 Credit and Security Agreement") with SCM Specialty Finance Opportunities Fund, L.P. ("SCM"). At June 30, 2016, we had $0.1 million in cash and cash equivalents and had $3.3 million outstanding under the 2016 Credit and Security Agreement, with available borrowing capacity of $0.3 million. As of August 9, 2016, we had $2.4 million outstanding with estimated available borrowing capacity of $0.8 million. As of June 30, 2016, the Company also owed approximately $4.0 million under an existing term loan ("the Term Loan"), which is governed by the terms of a credit agreement ("the Credit Agreement") with SWK Funding LLC ("SWK") and was used to fund the cash component of the Acquisition. Each of these agreements contain certain financial covenants, including various affirmative and negative covenants including minimum aggregate revenue, EBITDA, and consolidated unencumbered liquid assets requirements which we did not comply with as of June 30, 2016. For additional information regarding the 2016 Credit and Security Agreement, Credit Agreement, and the related covenants, see Note 9 to the condensed consolidated financial statements.

22



We incurred a loss from continuing operations of $5.6 million during the six month period ended June 30, 2016. Our net cash used in operating activities for the six month period ended June 30, 2016, was $4.8 million. We have managed our liquidity through availability under a revolving credit facility, raising additional equity, and a series of cost reduction initiatives.

We have historically used availability under a revolving credit facility to fund operations. We experience a timing difference between the operating expense and cash collection of the associated revenue based on Health and Wellness customer payment terms. To conduct successful screenings we must expend cash to deliver the equipment and supplies required for the screenings and pay our health professionals and site management, all of which is done in advance of the customer invoicing process and ultimate cash receipts for services performed. Given the seasonal nature of our operations, which are largely dependent on second half volumes, management expects to continue using a revolving credit facility in 2016 and beyond.
    
Other Considerations

The Health and Wellness business sells services directly to end customers and also through wellness, disease management, benefit brokers, and insurance companies (referred to as channel partners) who ultimately have the relationship with the end customer. Sales to direct customers offer the full suite of our services while sales of our screenings through channel partners are often aggregated with other offerings from these channel partners to provide a total solution to the end-user. As such, our success is largely dependent on that of our partners.

Additionally, the Acquisition provides new offerings including the wellness portal and telephonic coaching, along with new staff, new systems, and new customers. During the six month period ended June 30, 2016, we incurred under $0.1 million of costs associated with the ongoing integration of AHS, which are recorded in selling, general and administrative expenses. Transition costs incurred during the three month period ended June 30, 2016, were immaterial. These costs relate primarily to transition services purchased from AHS and the ongoing transition of information technology infrastructure. The Company does not expect to continue to incur material transition costs going forward.

In addition, we have contractual obligations related to operating leases and employment contracts which could adversely affect liquidity.

Our ability to satisfy our liquidity needs and meet future covenants is dependent on growing revenues, improving profitability, and raising additional equity. These profitability improvements primarily include expansion of our presence in the Health and Wellness marketplace through new sales to direct customers, retaining existing customers, and capitalizing on the opportunities presented by our channel partners. We must increase screening, telephonic health coaching, and wellness portal volumes in order to cover our fixed cost structure and improve gross profits. These improvements may be outside of management’s control. If we are unable to increase volumes or control operating costs, liquidity may be adversely affected.

There can be no assurance that cash flows from operations, combined with any additional borrowings available to us, will be obtainable in an amount sufficient to enable us to repay our indebtedness, or to fund other liquidity needs. If we are unable to comply with financial covenants in 2016 and in the event that we were unable to modify the covenants, find new or additional lenders, or raise additional equity, we would be considered in default, which would then enable the lenders to accelerate the repayment of all amounts outstanding and exercise remedies with respect to collateral, which would have a material adverse impact on our business.

Forward-Looking Statements in “Liquidity”

Our beliefs regarding liquidity sufficiency are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21 of the Securities Exchange Act of 1934, as amended.  Forward-looking statements are indicated by words such as “expected”, “will” and other similar words.

Cash Flows from Operating, Investing, and Financing Activities

We believe that as a result of the addition of the offerings acquired in the Acquisition of AHS, cash flow from operations will improve. We have reduced our corporate fixed cost structure and plan to continue to evaluate professional fees and other expenses in 2016. We have ongoing initiatives to increase the flexibility of our cost structure to improve our scalability with changes in screening volumes. We also believe that the Acquisition will allow us to better leverage our capabilities while maintaining a smaller corporate footprint.

Cash Flows used in Operating Activities

23



For the six month period ended June 30, 2016, net cash used in operating activities was $4.8 million, compared to $5.1 million in the prior year period.
    
The net cash used in operating activities for the six month period ended June 30, 2016, reflects a net loss of $5.9 million, which was offset by non-cash charges of $3.0 million in depreciation and amortization expense, amortization of debt discount and debt issuance costs, accretion of termination fees, write-off of debt issuance costs, and termination fees paid on behalf of the Company; and $0.5 million in share-based compensation expense. Changes in working capital included a decrease in accounts receivable of $0.1 million and a decrease in accounts payable and accrued expenses of $1.4 million.

Our consolidated days sales outstanding ("DSO"), measured on a rolling 90-day basis, was 54.5 days at June 30, 2016, compared to 46.0 days at December 31, 2015, and 53.3 days at June 30, 2015, with the change from year end due to timing of large customer receipts. We experience a timing difference between the operating expense and cash collection of the associated revenue based on Health and Wellness customer payment terms. Historically, our accounts receivable balances and our DSO are near their highest point in September and their lowest point in December as many of our customers utilize the remainder of their operating budgets before their year-end budget close-out.
 
Cash Flows used in Investing Activities

We used $0.2 million and $0.4 million, respectively, for the six month periods ended June 30, 2016 and 2015, for capital expenditures. We used $4.0 million for the six month period ended June 30, 2015, to acquire AHS on April 17, 2015.

Cash Flows provided by Financing Activities

For the six month period ended June 30, 2016, we received $4.6 million, net of issuance costs, in connection with the additional equity raised as noted above which was partially offset by the principal payments made of $1.0 million on the Term Loan and net borrowings under the credit facilities of $0.5 million. For the six month period ended June 30, 2015, we received $5.0 million related to the proceeds from the Term Loan which was partially offset by $0.4 million incurred for debt issuance costs and net borrowings under the credit facility of $0.8 million.

Off-Balance Sheet Arrangements

We do not have any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our consolidated financial condition, results of operations, liquidity, capital expenditures or capital resources that are material to investors.

Dividends

No dividends were paid during the six month periods ended June 30, 2016 and 2015. We are precluded from declaring or making any dividend payments or other distributions of assets with respect to any class of our equity securities under the terms of our 2016 Credit and Security Agreement and our Credit Agreement, each as described in Note 9 to the unaudited condensed consolidated financial statements.

Contractual Obligations

There have been no material changes from the contractual obligations previously disclosed in our 2015 Annual Report on Form 10-K except for the following:

On March 14, 2016, the Company entered into an Employment Agreement (the “Employment Agreement”) with Steven R. Balthazor, who was confirmed as the Company’s Chief Financial Officer and whose status has changed from contractor to employee. Pursuant to the Employment Agreement, Mr. Balthazor will be paid a base salary of $250,000 per year. Mr. Balthazor’s annual target bonus opportunity will be equal to 40% of his base salary and is subject to the achievement of annual financial targets and other goals and objectives.

Critical Accounting Policies

There have been no material changes from the critical accounting policies previously disclosed in our 2015 Annual Report on Form 10-K.


24


ITEM 3
Quantitative and Qualitative Disclosures About Market Risk
Not required for smaller reporting companies.

ITEM 4
Controls and Procedures

(a) Evaluation of Disclosure Controls and Procedures

The Company's Chief Executive Officer and Chief Financial Officer, with the assistance of our disclosure committee, have conducted an evaluation of the effectiveness of the Company's disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) as of June 30, 2016. The Company's disclosure controls and procedures are designed to ensure that information required to be disclosed in the reports the Company files under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC's rules and forms and that such information is accumulated and communicated to the Company's management, including the Company's Chief Executive Officer and Chief Financial Officer, to allow for timely decisions regarding required disclosures. In designing and evaluating our disclosure controls and procedures, management recognized that disclosure controls and procedures, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the disclosure controls and procedures are met. Our disclosure controls and procedures have been designed to meet reasonable assurance standards. Additionally, in designing disclosure controls and procedures, our management necessarily was required to apply its judgment in evaluating the cost-benefit relationship of possible disclosure controls and procedures. The design of any disclosure controls and procedures also is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions. Based on this evaluation, the Company's Chief Executive Officer and Chief Financial Officer have concluded that, as of June 30, 2016, the Company's disclosure controls and procedures were not effective as a result of a material weakness in the Company’s internal control over financial reporting related to the ineffective design and operation of internal controls related to the accounting for non-routine transactions.

The Company is in the process of improving its policies and procedures relating to the recognition and measurement of non-routine transactions and designing more effective controls to remediate the material weakness described above. Management has hired a new corporate controller and also plans to enhance its controls related to non-routine transactions by supplementing with additional resources as necessary, enhancing the design and documentation of management review controls, and improving the documentation of internal control procedures.

Notwithstanding this material weakness in accounting for non-routine transactions, management has concluded that the consolidated financial statements included in the Quarterly Report on Form 10-Q present fairly, in all material respects, the consolidated financial position of the Company at June 30, 2016, and December 31, 2015, and the consolidated results of operations and cash flows for each of the three and six month periods ended June 30, 2016 and 2015, in conformity with U.S. generally accepted accounting principles.
 
(b) Changes in Internal Control over Financial Reporting

There has been no change in our internal control over financial reporting during the quarter ended June 30, 2016, that has materially affected, or is reasonably likely to affect, our internal control over financial reporting.

PART II - Other Information

ITEM 1
Legal Proceedings

The Company, in the normal course of business, is a party to various claims and other legal proceedings. In the opinion of management, the Company has substantial legal defenses and/or insurance coverage (subject to deductibles) with respect to all of its pending legal actions. If management believes that a material loss not covered by insurance arising from these actions is probable and can reasonably be estimated, the Company may record the amount of the estimated loss or, if a loss cannot be estimated but the minimum liability may be estimated using a range and no point is more probable than another, the Company may record the minimum estimated liability. As additional information becomes available, any potential liability related to these actions is assessed and the estimates are revised, if necessary. Management believes that the ultimate outcome of all pending legal actions, individually and in the aggregate, will not have a material adverse effect on the Company's financial position that is inconsistent with its loss reserves or on its overall trends in results of operations. However, litigation and claims are subject to inherent uncertainties and unfavorable outcomes can occur that exceed any amounts reserved for such losses. If an unfavorable

25


outcome were to occur, there exists the possibility of a material adverse impact on the results of operations in the period in which the outcome occurs or in future periods.

On May 24, 2012, a complaint was filed against the Company in the United States District Court for the District of New Jersey alleging, among other things, that the Company failed to pay overtime compensation to a purported class of certain independent contractor examiners who, the complaint alleges, should be treated as employees for purposes of federal law. The complaint seeks award of an unspecified amount of allegedly unpaid overtime wages to certain examiners. The Company filed an answer denying the substantive allegations therein. On August 1, 2014, the Magistrate Judge issued a Report and Recommendation to conditionally certify the class of all contract examiners from August 16, 2010, to the present. On August 29, 2014, the Company submitted its objections to the Report and Recommendation of the Magistrate Judge. On April 29, 2016, the Company reached a preliminary understanding with the plaintiffs with respect to a settlement of the lawsuit involving a release of all claims by the plaintiffs and the Company's establishment of a settlement fund of $0.45 million. Accordingly, as of June 30, 2016, the Company had accrued $0.45 million related to this matter versus $0.3 million as of December 31, 2015.  The litigation accrual for all periods was included in the Accrued expenses line item on the condensed consolidated balance sheet.  The additional expense of $0.15 million recorded during the six month period ended June 30, 2016, is included in the discontinued operations line item on the condensed consolidated statements of operations.  This preliminary understanding is subject to approval by the Magistrate and the parties' entry into a definitive settlement agreement. The claim is not covered by insurance, and the Company is incurring legal costs to defend the litigation which are recorded in discontinued operations. This matter relates to the former Portamedic service line for which the Company retained liability.

ITEM 1A
Risk Factors

Readers should carefully consider, in connection with the other information in this Report, the risk factors disclosed in Part I, Item 1A. "Risk Factors" in our 2015 Annual Report on Form 10-K. There have been no material changes from the risk factors previously disclosed in Part I, Item 1A of our 2015 Annual Report on Form 10-K.

ITEM 2
Unregistered Sales of Equity Securities and Use of Proceeds

Share Issuances

As previously reported in our Annual Report on Form 10-K for the year ended December 31, 2015, filed on March 30, 2016, we issued 666,667 shares of our common stock, $0.04 par value, with a value of $1,200,000 to 200 NNH, LLC on March 28, 2016. We also issued 77,922 shares of our common stock, $0.04 par value, with a value of $150,000 to SWK pursuant to the First and Second Amendments to the Credit Agreement. The securities were not registered under the Securities Act of 1933. They were issued in transactions not involving any public offering pursuant to the exemptions from registration set forth in Section 4(a)(2) of the Securities Act and Rule 506 thereunder and are “restricted securities” as that term is defined in Rule 144 of the Securities Act.

Share Repurchases

We did not purchase any shares of our common stock during the six month periods ended June 30, 2016 and 2015.

ITEM 3
Defaults Upon Senior Securities

None.

ITEM 4
Mine Safety Disclosure

None.

ITEM 5
Other Information

None.

26


ITEM 6
Exhibits

Exhibit No.
 
Description of Exhibit
 
 
 
10.1
 
First Amendment dated February 25, 2016, to Credit Agreement dated April 17, 2015, by and between Hooper Holmes, Inc. and SWK Funding LLC. (Incorporated by reference to Exhibit 10.1 of the Company’s Current Report on Form 8-K dated March 2, 2016.)
 
 
 
10.2
 
Second Amendment dated March 28, 2016, to Credit Agreement dated April 17, 2015, by and between Hooper Holmes, Inc. and SWK Funding LLC (Incorporated by reference to Exhibit 10.44 of the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2015.)
 
 
 
10.3
 
Stock Purchase Agreement dated March 28, 2016, between Hooper Holmes, Inc. and 200 NNH, LLC (Incorporated by reference to Exhibit 10.43 of the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2015.)
 
 
 
10.4
 
Employment Agreement by and between Hooper Holmes, Inc. and Steven R. Balthazor (Incorporated by reference to Exhibit 10.13 of the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2015.)**
 
 
 
10.5
 
Credit and Security Agreement dated April 29, 2016, by and between SCM Specialty Finance Opportunities Fund, L.P. and Hooper Holmes, Inc. and subsidiaries. (Incorporated by reference to Exhibit 10.1 of the Company’s Current Report on Form 8-K dated May 3, 2016.)
 
 
 
10.6
 
Third Amendment and Limited Waiver and Forbearance dated August 15, 2016, to Credit Agreement dated April 17, 2015, by and between Hooper Holmes, Inc. and SWK Funding LLC.*
 
 
 
10.7
 
First Amendment and Limited Waiver and Forbearance dated August 15, 2016, to Credit and Security Agreement dated April 29, 2016, by and between SCM Specialty Finance Opportunities Fund, L.P. and Hooper Holmes, Inc. and subsidiaries.*
 
 
 
31.1
 
Certification of Chief Executive Officer pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934.*
 
 
 
31.2
 
Certification of Chief Financial Officer pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934.*
 
 
 
32.1
 
Certification of Chief Executive Officer pursuant to Rule 13a-14(b) under the Securities Exchange Act of 1934 and 18 U.S.C. Section 1350.*
 
 
 
32.2
 
Certification of Chief Financial Officer pursuant to Rule 13a-14(b) under the Securities Exchange Act of 1934 and 18 U.S.C. Section 1350.*
 
 
 
101.INS
 
XBRL Instance Document*
 
 
 
101.SCH
 
XBRL Taxonomy Extension Schema Document*
 
 
 
101.CAL
 
XBRL Taxonomy Extension Calculation Linkbase Document*
 
 
 
101.DEF
 
XBRL Taxonomy Extension Label Linkbase Document*
 
 
 
101.LAB
 
XBRL Taxonomy Extension Label Linkbase Document*
 
 
 
101.PRE
 
XBRL Taxonomy Extension Presentation Linkbase Document*

* Filed herewith.

27


** Denotes a management contract or compensatory plan or arrangement.

28


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned thereunto duly authorized.

Hooper Holmes, Inc.

Dated: August 15, 2016

 
 
By: /s/ Henry E. Dubois
 
 
 
Henry E. Dubois
 
 
 
Chief Executive Officer and President
(Principal Executive Officer)
 
 
 
 
 
 
 
By: /s/ Steven R. Balthazor
 
 
 
Steven R. Balthazor
 
 
 
Chief Financial Officer
(Principal Financial and Accounting Officer)
 


29
 EX-10.6 2 ex106hooperthirdamendmentt.htm EXHIBIT 10.6 Exhibit

Exhibit 10.6

THIRD AMENDMENT TO
CREDIT AGREEMENT AND LIMITED WAIVER AND FORBEARANCE

THIS THIRD AMENDMENT TO CREDIT AGREEMENT AND LIMITED WAIVER AND FORBEARANCE (this “Amendment”), dated as of August 15, 2016, is entered into by and among Hooper Holmes, Inc., a New York Corporation (“Borrower”), each of the undestigned financial institutions (individually each a “Lender” and collectively “Lenders”) and SWK FUNDING LLC, a Delaware limited liability company, in its capacity as administrative agent for the other Lenders (in such capacity, “Agent”).
RECITALS
WHEREAS, Borrower, Agent and Lenders entered into that certain Credit Agreement dated as of April 17, 2015, (as the same may be further amended, modified or restated from time to time, being hereinafter referred to as the “Credit Agreement”; capitalized terms used in this Amendment are defined in the Credit Agreement unless otherwise stated);
WHEREAS, Borrower (a) has failed to maintain Consolidated Unencumbered Liquid Assets of at least $750,000 as measured on June 30, 2016 as required pursuant to Section 7.13.1 of the Credit Agreement, (b) has failed to achieve Aggregate Revenue for the twelve (12) consecutive month period ending June 30, 2016 of at least $34,000,000 as required pursuant to Section 7.13.2 of the Credit Agreement, and (c) has failed to achieve EBITDA, on a consolidated basis, for the six (6) consecutive month period ending June 30, 2016 of at least –($2,000,000) as required pursuant to Section 7.13.3 of the Credit Agreement, each of which failures constitutes an Event of Default under Section 8.1.4(a) of the Credit Agreement (the “Specified Default”);
WHEREAS, by reason of the existence of the Specified Defaults, Agent has full legal right to exercise its rights and remedies under the Credit Agreement and the other Loan Documents upon the occurrence of an Event of Default, and Borrower has no defenses, offsets or counterclaims to the exercise of such rights and remedies;
WHEREAS, Borrower requested that (i) Agent, for the period from the date hereof until September 30, 2016, forbear from exercising its rights and remedies under the Loan Documents solely with respect to the Specified Defaults and (ii) Agent and Lenders enter into this Amendment; and
WHEREAS, Agent and Lenders are willing (i) for the period from the date hereof through the Forbearance Period (as defined below) to forbear from exercising its rights and remedies under the Loan Documents with respect to the Specified Defaults and (ii) subject to the satisfaction or waiver, in Agent’s sole discretion, of each of the conditions precedent set forth herein, to amend the Credit Agreement as set forth below.
AGREEMENT



NOW, THEREFORE, in consideration of the premises herein contained and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties, intending to be legally bound, agree as follows:
ARTICLE I
Agreement to Forbear

1.1    Agreement to Forbear. During the period commencing on the date hereof and ending on the earlier to occur of (i) September 30, 2016 and (ii) the occurrence of any Additional Default (as defined below) (the “Forbearance Period”), and subject to the other terms and conditions of this Amendment, Agent agrees that it will forbear from exercising its rights and remedies under the Loan Documents due to the Specified Defaults. Notwithstanding any provision of this Amendment, nothing contained herein shall limit any rights or remedies of Agent or any Lender under the Credit Agreement or any other Loan Document based on any Default or Event of Default which is not a Specified Default (each an “Additional Default”). Upon the expiration or termination of the Forbearance Period, Agent’s forbearance shall automatically terminate and Agent shall be entitled to exercise any and all of its rights and remedies under this Amendment, the Credit Agreement and the Loan Documents without further notice; provided however, that in the event that, (i) Borrower’s Net Accounts Payable (as defined below) is less than $4,900,000 as measured on September 30, 2016 and (ii) no Additional Default has occurred and is continuing, Agent and Lenders shall waive the Specified Defaults. Borrower hereby agrees that Agent and Lenders shall have no obligation to extend the Forbearance Period. For purposes of this Amendment, “Net Accounts Payable” shall mean, as of any date of determination, an amount equal to (x) the aggregate amount of all accounts payable due and owing by Borrower and its Affiliates minus (y) Borrower’s Consolidated Unencumbered Liquid Assets minus (z) so long as no “Default” or “Event of Default” has occurred and is continuing, the amount of any “Availability” pursuant to that certain Credit and Security Agreement, dated as of April 20, 2016, by and among the Loan Parties and SCM Specialty Finance Opportunities Fund, L.P. (as each such capitalized term used in this clause (z) is defined in such Credit and Security Agreement).
1.2    Limited Waiver and Forbearance. Except as it relates to the forbearance and potential waiver specifically set forth in Section 1.1 above as it relates to the Specified Defaults, nothing contained in this Amendment or any other communication between Agent, any Lender, Borrower or any other Loan Party shall be a waiver of any past, present or future violation, Default or Event of Default of Borrower under the Credit Agreement or any Loan Document. Agent and each Lender hereby expressly reserves any rights, privileges and remedies under the Credit Agreement and each Loan Document that Lender may have with respect to any violation, Default or Event of Default, and any failure by Agent or any Lender to exercise any right, privilege or remedy as a result of the violations set forth above shall not directly or indirectly in any way whatsoever either (i) impair, prejudice or otherwise adversely affect the rights of Agent or any Lender, except as set forth herein, at any time to exercise any right, privilege or remedy in connection with the Credit Agreement or any Loan Document, (ii) amend or alter any provision of the Credit Agreement or any Loan Document or any other contract or instrument or (iii) constitute any course of dealing or other basis for altering any obligation of Borrower or any rights, privilege or remedy




of Agent or any Lender under the Credit Agreement or any Loan Document or any other contract or instrument. Except with respect to the forbearance relating to, and the potential waiver of, the Specified Defaults, nothing in this Amendment shall be construed to be a consent by Agent or any Lender to any prior, existing or future violations of the Credit Agreement or any Loan Document.

1.3    Future Compliance. Borrower is hereby notified that irrespective of (i) any waivers or consents previously granted by Agent or any Lender regarding the Credit Agreement and the Loan Documents, (ii) any previous failures or delays of Agent or any Lender in exercising any right, power or privilege under the Credit Agreement or the Loan Documents or (iii) any previous failures or delays of Agent or any Lender in the monitoring or in the requiring of compliance by Borrower with the duties, obligations and agreements of Borrower in the Credit Agreement and the Loan Documents, Borrower will be expected to comply strictly with its duties, obligations and agreements under the Credit Agreement and the Loan Documents.

ARTICLE II
Amendments to Credit Agreement and Guarantee
2.1Amendment to Section 2.9.1(b) of the Credit Agreement. Effective as of the Third Amendment Effective Date, Section 2.9.1(b)(iv) of the Credit Agreement is amended and restated in its entirety to read as follows:
“(iv) FOURTH, (A) as it relates to the Payment Date occurring in November 2016, to the payment of all principal of the Loans, pro rata based on each Lender’s Pro Rata Term Loan Share, up to an aggregate amount of $300,000 on such Payment Date and (B) as it relates to each Payment Date on or after the Payment Date occurring in February 2017, to the payment of all principal of the Loans, pro rata based on each Lender’s Pro Rata Term Loan Share, up to an aggregate amount of $600,000 on any such Payment Date (for the avoidance of doubt, no principal payment shall be due and owing hereunder on the Payment Date in August 2016);”
2.1    Amendment to Section 7.13 of the Credit Agreement. Effective as of the Third Amendment Effective Date, Section 7.13 of the Credit Agreement is amended and restated in its entirety to read as follows:
“7.13. Financial Covenants
7.13.1    Consolidated Unencumbered Liquid Assets.
Not permit the Consolidated Unencumbered Liquid Assets as of the last day of the Fiscal Quarter ending September, 2016 to be less than $1, as of the last day of the Fiscal Quarter ending December 31, 2016 to be less than $500,000, and as of the end of the last day of any Fiscal Quarter thereafter to be less than $750,000.




7.13.2    Minimum Aggregate Revenue.
Minimum LTM Aggregate Revenue (in millions of Dollars) as of the end of:
Q3 2016
Q4 2016
Q1 2017
Q2 2017 and each Fiscal Quarter thereafter
$34
$38
$41
$42
Not permit the Aggregate Revenue for the twelve (12) consecutive month period ending on the last Business Day of any Fiscal Quarter (designated by “Q” in the table below) to be less than the applicable amount set forth in the table below for such period.
   
7.13.3    Minimum EBITDA.
Not permit the EBITDA of Borrower, on a consolidated basis, for the applicable period of measure set forth below and ending on the last Business Day of any Fiscal Quarter (designated by “Q” in the table below) to be less than the applicable amount set forth in the table below for such period.
Minimum EBITDA as of the end of:
Nine (9) consecutive month period ending Q3 2016
Twelve (12) consecutive month period ending Q4 2016
Twelve (12) consecutive month period ending Q1 2017
Twelve (12) consecutive month period ending Q2 2017
Twelve (12) consecutive month period ending Q3 2017
($2,000,000)
($500,000)
$500,000
$900,000
$2,500,000

ARTICLE III
Conditions Precedent and Post-Closing Obligations




3.1    The effectiveness of the Amendments set forth in Article II above are subject to the satisfaction of the following conditions precedent in a manner satisfactory to Agent, unless specifically waived in writing by Agent in its sole discretion (the date on which all such conditions are satisfied or waived referred to herein as the “Third Amendment Effective Date”):
A.    “Agent shall have received: (i) this Amendment, duly executed by all parties hereto and (ii) an amended and restated Closing Date Warrant providing for an updated “Exercise Price” (as defined therein) equal to the lowest weighted average closing price for any five consecutive day period for Borrower's common stock among the closing prices recorded from and after August 15, 2016 though and including the Third Amendment Effective Date and otherwise in form and substance acceptable to Agent.
B.    Agent shall have received evidence acceptable to Agent in its sole discretion that Borrower’s Net Accounts Payable is less than $4,900,000 as measured on September 30, 2016.
C.    The representations and warranties contained herein and in the Credit Agreement and the other Loan Documents, as each is amended hereby, shall be true and correct as of the date hereof, as if made on the date hereof, except for such representations and warranties as are by their express terms limited to a specific date.
D.    No Specified Default or Additional Default shall have occurred and be continuing, unless (i) any such Additional Default has been otherwise specifically waived in writing by Agent and (ii) such Specified Default shall have been automatically waived in accordance with Article I hereof.
D.    All corporate proceedings taken in connection with the transactions contemplated by this Amendment and all documents, instruments and other legal matters incident thereto shall be satisfactory to Agent.
3.2    On the first Business Day of each month, Borrower shall provide to Agent an updated cash flow forecast for Borrower in form and substance acceptable to Agent (which shall include a cumulative comparison of actual results to prior cash flow projections delivered by Borrower).
ARTICLE IV
Ratifications, Representations and Warranties
4.1    Ratifications. The terms and provisions set forth in this Amendment shall modify and supersede all inconsistent terms and provisions set forth in the Credit Agreement and the other Loan Documents, and, except as expressly modified and superseded by this Amendment, the terms and provisions of the Credit Agreement and the other Loan Documents are ratified and confirmed and shall continue in full force and effect. Borrower, Lenders and Agent agree that the Credit Agreement and the other Loan Documents, as amended hereby, shall continue to be legal, valid, binding and enforceable in accordance with their respective terms. Borrower agrees that this




Amendment is not intended to and shall not cause a novation with respect to any or all of the Obligations.
4.2    Representations and Warranties. Borrower hereby represents and warrants to Agent and Lenders that (a) the execution, delivery and performance of this Amendment, the amended and restated warrant referred to in Section 3.1 above and any and all other Loan Documents executed and/or delivered in connection herewith have been authorized by all requisite action (as applicable) on the part of Borrower and will not violate the organizational documents of Borrower; (b) Borrower’ directors have authorized the execution, delivery and performance of this Amendment, the warrant referred to in Section 3.1 above and any and all other Loan Documents executed and/or delivered in connection herewith; (c) the representations and warranties contained in the Credit Agreement, as amended hereby, and any other Loan Document are true and correct on and as of the date hereof and on and as of the date of execution hereof as though made on and as of each such date (except to the extent such representations and warranties expressly relate to an earlier date); (d) no Default or Event of Default under the Credit Agreement, as amended hereby, has occurred and is continuing; (e) Borrower is in full compliance in all material respects with all covenants and agreements contained in the Credit Agreement and the other Loan Documents, as amended hereby; and (f) except as disclosed to Agent, Borrower has not amended its organizational documents since the date of the Credit Agreement.
ARTICLE V




Miscellaneous Provisions
5.1    Survival of Representations and Warranties. All representations and warranties made in the Credit Agreement or any other Loan Document, including, without limitation, any document furnished in connection with this Amendment, shall survive the execution and delivery of this Amendment and the other Loan Documents, and no investigation by Agent or any Lender or any closing shall affect the representations and warranties or the right of Agent and each Lender to rely upon them.
5.2    Reference to Credit Agreement. Each of the Credit Agreement and the other Loan Documents, and any and all other Loan Documents, documents or instruments now or hereafter executed and delivered pursuant to the terms hereof or pursuant to the terms of the Credit Agreement, as amended hereby, are hereby amended so that any reference in the Credit Agreement and such other Loan Documents to the Credit Agreement shall mean a reference to the Credit Agreement, as amended hereby.
5.3    Expenses of Agent. As provided in the Credit Agreement, Borrower agrees to pay on demand all costs and expenses incurred by Agent, or its Affiliates, in connection with the preparation, negotiation, and execution of this Amendment and the other Loan Documents executed pursuant hereto and any and all amendments, modifications, and supplements thereto, including, without limitation, the reasonable costs and fees of legal counsel, and all costs and expenses incurred by Agent and each Lender in connection with the enforcement or preservation of any rights under the Credit Agreement, as amended hereby, or any other Loan Documents, including, without, limitation, the reasonable costs and fees of legal counsel.
5.4    Severability. Any provision of this Amendment held by a court of competent jurisdiction to be invalid or unenforceable shall not impair or invalidate the remainder of this Amendment and the effect thereof shall be confined to the provision so held to be invalid or unenforceable.
5.5    Successors and Assigns. This Amendment is binding upon and shall inure to the benefit of Agent and each Lender and Borrower and their respective successors and assigns, except that Borrower may not assign or transfer any of its rights or obligations hereunder without the prior written consent of Agent.
5.6    Counterparts. This Amendment may be executed in one or more counterparts, each of which when so executed shall be deemed to be an original, but all of which when taken together shall constitute one and the same instrument. This Amendment may be executed by facsimile or electronic (.pdf) transmission, which facsimile or electronic (.pdf) signatures shall be considered original executed counterparts for purposes of this Section 5.6, and each party to this Amendment agrees that it will be bound by its own facsimile or electronic (.pdf) signature and that it accepts the facsimile or electronic (.pdf) signature of each other party to this Amendment.
5.7    Effect of Waiver. No consent or waiver, express or implied, by Agent to or for any breach of or deviation from any covenant or condition by Borrower shall be deemed a consent to or waiver of any other breach of the same or any other covenant, condition or duty.




5.8    Headings. The headings, captions, and arrangements used in this Amendment are for convenience only and shall not affect the interpretation of this Amendment.
5.9    Applicable Law. THE TERMS AND PROVISIONS OF SECTIONS 10.17 (GOVERNING LAW) AND 10.18 (FORUM SELECTION; CONSENT TO JURISDICTION) OF THE CREDIT AGREEMENT ARE HEREBY INCORPORATED HEREIN BY REFERENCE, AND SHALL APPLY TO THIS AMENDMENT MUTATIS MUTANDIS AS IF FULLY SET FORTH HEREIN.
5.10    Final Agreement. THE CREDIT AGREEMENT AND THE OTHER LOAN DOCUMENTS, EACH AS AMENDED HEREBY, REPRESENT THE ENTIRE EXPRESSION OF THE PARTIES WITH RESPECT TO THE SUBJECT MATTER HEREOF ON THE DATE THIS AMENDMENT IS EXECUTED. THE CREDIT AGREEMENT AND THE OTHER LOAN DOCUMENTS, AS AMENDED HEREBY, MAY NOT BE CONTRADICTED BY EVIDENCE OF PRIOR, CONTEMPORANEOUS OR SUBSEQUENT ORAL AGREEMENTS OF THE PARTIES. THERE ARE NO UNWRITTEN ORAL AGREEMENTS BETWEEN THE PARTIES. NO MODIFICATION, RESCISSION, WAIVER, RELEASE OR AMENDMENT OF ANY PROVISION OF THIS AMENDMENT SHALL BE MADE, EXCEPT BY A WRITTEN AGREEMENT SIGNED BY BORROWER AND AGENT.
[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK]






IN WITNESS WHEREOF, this Amendment has been executed and is effective as of the date first above‑written.
BORROWER:

HOOPER HOLMES, INC.,
a New York corporation


By:    /s/ Henry E. Dubois    
Name: Henry E. Dubois
Title: Chief Executive Officer and President


#47455014








AGENT AND LENDER:

SWK FUNDING LLC,
as Agent and a Lender


By:     SWK Holdings Corporation,
its sole Manager

 

By:     /s/ Winston Black    
Name:    Winston Black    
Title:    CEO    


#47455014



REAFFIRMATION OF GUARANTEE AND COLLATERAL AGREEMENT

The undersigned (the “Guarantor”) each hereby acknowledges and agrees to the amendments of the Credit Agreement contained in this Third Amendment to Credit Agreement dated as of August 15, 2016 (the “Amendment”), and acknowledges and reaffirms its obligations owing to Agent and the Lenders under that certain Guarantee and Collateral Agreement dated as of April 17, 2015 (the “Guarantee Agreement”) and any of the other Loan Documents to which it is a party, and agrees that such Guarantee and Loan Documents are and shall remain in full force and effect. Although Guarantor has been informed of the matters set forth herein and has acknowledged and agreed to same, Guarantor understands that Agent and Lenders have no obligation to inform Guarantor of such matters in the future or to seek Guarantor’s acknowledgement or agreement to future amendments or waivers, and nothing herein shall create such a duty.

HOOPER HOLMES, INC.,
a New York corporation


By:    /s/ Henry E. Dubois    
Name:    Henry E. Dubois
Title:    Chief Executive Officer and President

HOOPER WELLNESS, LLC
a Kansas limited liability company


By:    /s/ Henry E. Dubois    
Name:    Henry E. Dubois
Title:    Chief Executive Officer and President

ACCOUNTABLE HEALTH SOLUTIONS, LLC,
a Kansas limited liability company


By:    /s/ Henry E. Dubois    
Name:    Henry E. Dubois
Title:    Chief Executive Officer and President

HOOPER INFORMATION SERVICES, INC.,
a New Jersey corporation


By:    /s/ Henry E. Dubois    
Name:    Henry E. Dubois
Title:    Chief Executive Officer and President

#47455014




HOOPER DISTRIBUTION SERVICES, LLC,
a New Jersey limited liability company

By: Hooper Homes, Inc.,
its Manager


By:    /s/ Henry E. Dubois    
Name:    Henry E. Dubois
Title:    Chief Executive Officer and President

HOOPER KIT SERVICES, LLC,
a Kansas limited liability company

By: Hooper Homes, Inc.,
its sole Member


By:    /s/ Henry E. Dubois    
Name:    Henry E. Dubois
Title:    Chief Executive Officer and President


#47455014
 EX-10.7 3 ex107firstamendmenttocredi.htm EXHIBIT 10.7 Exhibit

Exhibit 10.7
FIRST AMENDMENT TO CREDIT AND SECURITY AGREEMENT AND LIMITED WAIVER AND FORBEARANCE
THIS FIRST AMENDMENT TO CREDIT AND SECURITY AGREEMENT AND LIMITED WAIVER AND FORBEARANCE (this “Agreement”), entered into as of August 15, 2016, is made and entered into by and among SCM SPECIALTY FINANCE OPPORTUNITIES FUND, L.P., a Delaware limited partnership (“Lender”) and HOOPER HOLMES, INC., a New York corporation (“Hooper Holmes”), HOOPER DISTRIBUTION SERVICES, LLC, a New Jersey limited liability company (“Hooper Distribution”), HOOPER WELLNESS, LLC, a Kansas limited liability company (“Hooper Wellness”), ACCOUNTABLE HEALTH SOLUTIONS, LLC, a Kansas limited liability company (“Accountable Health”), HOOPER INFORMATION SERVICES, INC., a New Jersey corporation (“Hooper Information”), and HOOPER KIT SERVICES, LLC, a Kansas limited liability company (“Hooper Kit”, together with Hooper Holmes, Hooper Distribution, Hooper Wellness, Accountable Health, and Hooper Information, individually as a “Borrower,” and collectively as “Borrowers”).
WHEREAS, Borrowers and Lender are parties to that certain Credit and Security Agreement dated as of April 29, 2016 (as the same may from time to time be amended, restated, supplemented or otherwise modified, collectively, the “Credit Agreement”), pursuant to which, subject to the terms and conditions set forth therein, Lender has made certain credit facilities available to Borrowers. The Credit Agreement and all instruments, documents and agreements executed in connection therewith, or related thereto are referred to herein collectively as the “Existing Loan Documents.”
WHEREAS, Borrower (a) has failed to maintain Consolidated Unencumbered Liquid Assets of at least $750,000 as measured on June 30, 2016 as required pursuant to Section 7.1 of the Credit Agreement, (b) has failed to achieve Aggregate Revenue for the twelve (12) consecutive month period ending June 30, 2016 of at least $34,000,000 as required pursuant to Section 7.1 of the Credit Agreement, (c) has failed to achieve EBITDA, on a consolidated basis, for the six (6) consecutive month period ending June 30, 2016 of at least ($2,000,000) as required pursuant to Section 7.1 of the Credit Agreement, and (d) has failed to comply with Sections 7.13.1, 7.13.2 and 7.13.3 of that certain Credit Agreement dated as of April 17, 2015 by and among Borrowers and Closing Date Subordinated Creditor as amended, as required pursuant to Section 8.1(f) of the Credit Agreement, each of which failures constitutes an Event of Default under Section 8.1 of the Credit Agreement (the “Subject Events of Default”);
WHEREAS, by reason of the existence of the Subject Events of Default, Lender has full legal right to exercise its rights and remedies under the Credit Agreement and the other Loan Documents upon the occurrence of an Event of Default, and Borrowers have no defenses, offsets or counterclaims to the exercise of such rights and remedies;
WHEREAS, Borrowers have requested and Lender has agreed to, among other things, (i) for the period from the date hereof through the Forbearance Period (as defined below) to forbear from exercising its rights and remedies under the Loan Documents with respect to the Subject Events of Default and (ii) subject to the satisfaction or waiver, in Lender’s sole discretion, of each of the



conditions precedent set forth herein, amend the terms and conditions of the Existing Loan Documents pursuant to the terms and conditions of this Agreement.
NOW, THEREFORE, in consideration of the foregoing premises, the mutual covenants and conditions herein contained, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties agree as follows:
1.Defined Terms. Initially capitalized terms used herein and not defined herein that are defined in the Credit Agreement shall have the meanings assigned to them in the Credit Agreement (as amended hereby).
2.    Agreement to Forbear. During the period commencing on the date hereof and ending on the earlier to occur of (i) September 30, 2016 and (ii) the occurrence of any Additional Default (as defined below) (the “Forbearance Period”), and subject to the other terms and conditions of this Agreement, Lender agrees that it will forbear from exercising its rights and remedies under the Loan Documents due to the Subject Events of Default. Notwithstanding any provision of this Agreement, nothing contained herein shall limit any rights or remedies of Lender under the Credit Agreement or any other Loan Document based on any Default or Event of Default which is not a Subject Event of Default (each an “Additional Default”). Upon the expiration or termination of the Forbearance Period, Lender’s forbearance shall automatically terminate and Lender shall be entitled to exercise any and all of its rights and remedies under this Agreement, the Credit Agreement and the Loan Documents without further notice; provided however, that in the event that, (i) Borrowers’ Net Accounts Payable (as defined below) is less than $4,900,000 as measured on September 30, 2016 and (ii) no Additional Default has occurred and is continuing, Lenders shall waive the Subject Events of Default. Borrowers hereby agree that Lender shall have no obligation to extend the Forbearance Period. For purposes of this Agreement, “Net Accounts Payable” shall mean, as of any date of determination, an amount equal to (x) the aggregate amount of all accounts payable due and owing by Borrower and its Affiliates minus (y) Borrower’s Consolidated Unencumbered Liquid Assets minus (z) so long as no Default or Event of Default has occurred and is continuing, the amount of any Availability.
3.    Limited Waiver and Forbearance. Except as it relates to the forbearance and potential waiver specifically set forth in Section 2 above as it relates to the Subject Events of Default, nothing contained in this Agreement or any other communication between Lender, Borrowers or any other loan party shall be a waiver of any past, present or future violation, Default or Event of Default of Borrowers under the Credit Agreement or any Loan Document. Lender hereby expressly reserves any rights, privileges and remedies under the Credit Agreement and each Loan Document that Lender may have with respect to any violation, Default or Event of Default, and any failure by Lender to exercise any right, privilege or remedy as a result of the violations set forth above shall not directly or indirectly in any way whatsoever either (i) impair, prejudice or otherwise adversely affect the rights of Lender, except as set forth herein, at any time to exercise any right, privilege or remedy in connection with the Credit Agreement or any Loan Document, (ii) amend or alter any provision of the Credit Agreement or any Loan Document or any other contract or instrument or (iii) constitute any course of dealing or other basis for altering any obligation of Borrower or any rights, privilege or remedy of Lender under the Credit Agreement or any Loan Document or any

2


other contract or instrument. Except with respect to the forbearance relating to, and the potential waiver of, the Subject Events of Default, nothing in this Agreement shall be construed to be a consent by Lender to any prior, existing or future violations of the Credit Agreement or any Loan Document.
4.    Future Compliance. Borrowers are hereby notified that irrespective of (i) any waivers or consents previously granted by Lender regarding the Credit Agreement and the Loan Documents, (ii) any previous failures or delays of Lender in exercising any right, power or privilege under the Credit Agreement or the Loan Documents or (iii) any previous failures or delays of Lender in the monitoring or in the requiring of compliance by Borrowers with the duties, obligations and agreements of Borrowers in the Credit Agreement and the Loan Documents, Borrowers will be expected to comply strictly with its duties, obligations and agreements under the Credit Agreement and the Loan Documents.
5.    Amendments to Credit Agreement. The Credit Agreement is hereby amended as follows:
(a)    Effective as of the date hereof, Section 6.1(d) of the Credit Agreement is hereby amended by (i) deleting the “and” at the end of subsection (iv) therein, (ii) renumbering subsection (v) therein as subsection (vi) and (iii) inserting a new subsection (v) immediately preceding the new subsection (vi) therein to read as follows:
(v)    Cash Flow Forecast. An updated 13-week cash flow forecast for Borrower in form and substance acceptable to Lender (which shall include a cumulative comparison of actual results to prior cash flow projections delivered by Borrower) certified by an authorized officer of Borrower, on the first Business Day of each month with respect to the 13-week period then beginning.
(b)     Effective as of the Section 5(b) Effective Date (as defined below), Annex I of the Credit Agreement is hereby amended by amending and restating paragraphs 1 through 3 as follows:
1.    Consolidated Unencumbered Liquid Assets.
Not permit the Consolidated Unencumbered Liquid Assets on the last day of the fiscal quarter ending September 30, 2016 to be less than $1, on the last day of the fiscal quarter ending December 31, 2016 to be less than $500,000, and on the last day of any fiscal quarter thereafter to be less than $750,000.
2.    Minimum Aggregate Revenue.
Not permit the Aggregate Revenue for the twelve (12) consecutive month period ending on the last Business Day of any fiscal quarter (designated by “Q” in the table below) to be less than the applicable amount set forth in the table below for such period.

3


Minimum LTM Aggregate Revenue (in millions of Dollars) as of the end of:
 
Q3 2016
Q4 2016
Q1 2017
Q2 2017 and each fiscal quarter thereafter
 
$34
$38
$41
$42
 

3.    Minimum EBITDA.
Not permit the EBITDA of Borrower, on a consolidated basis, for the applicable period of measure set forth below and ending on the last Business Day of any fiscal quarter (designated by “Q” in the table below) to be less than the applicable amount set forth in the table below for such period.
Minimum EBITDA as of the end of:
Nine (9) consecutive month period ending Q3 2016
Twelve (12) consecutive month period ending Q4 2016
($2,000,000)
($500,000)

Minimum EBITDA as of the end of:
Twelve (12) consecutive month period ending Q1 2017
Twelve (12) consecutive month period ending Q2 2017
Twelve (12) consecutive month period ending Q3 2017 and thereafter
$500,000
$900,000
$2,500,000

6.    Representations and Warranties. Borrowers represent and warrant to Lender that, before and after giving effect to this Agreement:
(a)    All warranties and representations made to Lender under the Credit Agreement and the Loan Documents are accurate in all material respects on and as of the date hereof as if made on and as of the date hereof, before and after giving effect to this Agreement.
(b)    The execution, delivery and performance by each Credit Party of this Agreement and any assignment, instrument, document, or agreement executed and delivered in connection herewith and the consummation of the transactions contemplated hereby and thereby (i) have been duly authorized by all requisite action of the appropriate Credit Party and have been duly executed and delivered by or on behalf of such Credit Party; (ii) do not violate any provisions

4


of (A) applicable law, statute, rule, regulation, ordinance or tariff, (B) any order of any Governmental Authority binding on any Credit Party or any of the Credit Parties’ respective properties the effect of which would reasonably be expected to have a Material Adverse Effect, or (C) the certificate of incorporation or bylaws (or any other equivalent governing agreement or document) of each Credit Party, or any agreement between any Credit Party and its shareholders, members, partners or equity owners or among any such shareholders, members, partners or equity owners; (iii) are not in conflict with, and do not result in a breach or default of or constitute an Event of Default, or an event, fact, condition, breach, Default or Event of Default under, any indenture, agreement or other instrument to which any Credit Party is a party, or by which the properties or assets of any Credit Party are bound, the effect of which would reasonably be expected to have a Material Adverse Effect; (iv) except as set forth herein, will not result in the creation or imposition of any Lien of any nature upon any of the properties or assets of any Credit Party, and (v) do not require the consent, approval or authorization of, or filing, registration or qualification with, any Governmental Authority or Credit Party unless otherwise obtained.
(c)    This Agreement and any assignment, instrument, document, or agreement executed and delivered in connection herewith constitutes the legal, valid and binding obligation of each respective Credit Party, enforceable against such Credit Party in accordance with its respective terms.
(d)    Except for the Subject Events of Default, no Default or Event of Default has occurred and is continuing or would exist under the Credit Agreement or any of the Loan Documents, before and after giving effect to this Agreement.
7.    Conditions Precedent. (i) The amendments set forth in Section 5(a) shall be effective on the date hereof upon completion of the following conditions precedent except Section 7(c) and (ii) the amendments set forth in Section 5(b) shall be effective upon completion of the following conditions precedent (the date on which all such conditions are completed or waived referred to herein as the “Section 5(b) Effective Date”) (with all documents to be in form and substance satisfactory to Lender and Lender’s counsel):
(a)    Lender shall have received this Agreement duly executed by Borrowers;
(b)    Lender shall have received that certain Third Amendment to Credit Agreement and Limited Waiver and Forbearance by and among Hooper Holmes and Closing Date Subordinated Creditor dated as of the date hereof, duly executed by all parties thereto;
(c)    Lenders shall have received evidence, in form and substance acceptable to Lender in its sole discretion, that Borrowers’ Net Accounts Payable is less than $4,900,000 as measured on September 30, 2016;
(d)    Payment of all fees, charges and expenses payable to Lender on or prior to the date hereof, if any, and an amendment fee which Borrowers hereby agree Lender has fully earned as of the date hereof in an amount equal to Fifty Thousand and No/100 Dollars ($50,000); and

5


(e)    Borrowers shall have executed and/or delivered such additional documents, instruments and agreements as requested by Lender.
8.    Miscellaneous.
(a)    Reference to the Effect on the Credit Agreement. Upon the effectiveness of this Agreement, each reference in (i) the Credit Agreement to “this Agreement,” “hereunder,” “hereof,” “herein” or words of similar import or (ii) the other Loan Documents to “the Credit Agreement” shall mean and be a reference to the Credit Agreement as amended by this Agreement.
(b)    Ratification. Borrowers hereby restate, ratify and reaffirm each and every term and condition set forth in the Credit Agreement and the Loan Documents effective as of the date hereof.
(c)    Release. By execution of this Agreement, Borrowers acknowledge and confirm that Borrowers do not have any actions, causes of action, damages, claims, obligations, liabilities, costs, expenses and/or demands of any kind whatsoever, at law or in equity, matured or unmatured, vested or contingent arising out of or relating to this Agreement, the Credit Agreement or the other Loan Documents against any Released Party (as defined below), whether asserted or unasserted. Notwithstanding any other provision of any Loan Document, to the extent that such actions, causes of action, damages, claims, obligations, liabilities, costs, expenses and/or demands may exist, Borrowers voluntarily, knowingly, unconditionally and irrevocably, with specific and express intent, for and on behalf of itself, its managers, members, directors, officers, employees, stockholders, Affiliates, agents, representatives, accountants, attorneys, successors and assigns and their respective Affiliates (collectively, the “Releasing Parties”), hereby fully and completely release and forever discharge Lender, its Affiliates and its and their respective managers, members, officers, employee, Affiliates, agents, representatives, successors, assigns, accountants and attorneys (collectively, the “Indemnified Persons”) and any other Person or insurer which may be responsible or liable for the acts or omissions of any of the Indemnified Persons, or who may be liable for the injury or damage resulting therefrom (collectively, with the Indemnified Persons, the “Released Parties”), of and from any and all actions, causes of action, damages, claims, obligations, liabilities, costs, expenses and demands of any kind whatsoever, at law or in equity, matured or unmatured, vested or contingent, that any of the Releasing Parties has against any of the Released Parties, arising out of or relating to this Agreement, the Credit Agreement and the other Loan Documents which Releasing Parties ever had or now have against any Released Party, including, without limitation, any presently existing claim or defense whether or not presently suspected, contemplated or anticipated.
(d)    Security Interest. Borrowers hereby confirm and agree that all security interests and liens granted to Lender continue in full force and effect and shall continue to secure the Obligations. All Collateral remains free and clear of any liens other than liens in favor of Lender and Permitted Liens. Nothing herein contained is intended to in any way impair or limit the validity, priority and extent of Lender’s existing security interest in and liens upon the Collateral.
(e)    Costs and Expenses. Borrowers agree to pay on demand all usual and customary costs and expenses of Lender and/or its Affiliates in connection with the preparation,

6


execution, delivery and enforcement of this Agreement and all other agreements and instruments executed in connection herewith, including, including without limitation reasonable attorneys’ fees and expenses of Lender’s counsel.
(f)    GOVERNING LAW. THIS AGREEMENT SHALL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH THE INTERNAL SUBSTANTIVE LAWS OF THE STATE OF NEW YORK WITHOUT GIVING EFFECT TO ITS CHOICE OF LAW PROVISIONS.
(g)    Counterparts. This Agreement may be executed in any number of counterparts, each of which when so executed shall be deemed to be an original, and such counterparts together shall constitute one and the same respective agreement. Signatures sent by facsimile or electronic mail shall be deemed originals for all purposes and shall bind the parties hereto.
(h)    ALoan Document. This Agreement and any assignment, instrument, document, or agreement executed and delivered in connection with or pursuant to this Agreement shall be deemed to be a “Loan Document” under and as defined in the Credit Agreement for all purposes.
[Signature Pages Follow.]


7

    

IN WITNESS WHEREOF, the parties hereto have duly executed and delivered this Agreement as of the date first hereinabove written.

BORROWERS:
HOOPER HOLMES, INC., a New York corporation
HOOPER WELLNESS, LLC, a Kansas limited liability company
ACCOUNTABLE HEALTH SOLUTIONS, LLC, a Kansas limited liability company
HOOPER INFORMATION SERVICES, INC., a New Jersey corporation
HOOPER KIT SERVICES, LLC, a Kansas limited liability company


By:         /s/ Steven Balthazor
Name: Steven Balthazor
Title: Chief Financial Officer

As Chief Financial Officer of each of the above entities and, in such capacity, intending by this signature to legally bind each of the above entities

 
HOOPER DISTRIBUTION SERVICES, LLC, a New Jersey limited liability company


By:   /s/ Steven Balthazor
Name: Steven Balthazor
Title: Manager


Signature Page to First Amendment to Credit and Security Agreement and Limited Waiver and Forbearance
    

LENDER:
SCM SPECIALTY FINANCE OPPORTUNITIES FUND, L.P., a Delaware limited partnership



By:     /s/ B Kalb    
Name: B. Kalb    
Title: Authorized Signatory    


Signature Page to First Amendment to Credit and Security Agreement and Limited Waiver and Forbearance
 EX-31.1 4 exhibit311q22016.htm EXHIBIT 31.1 Exhibit


EXHIBIT 31.1    CERTIFICATIONS

I, Henry E. Dubois, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Hooper Holmes Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's Board of Directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

/s/ Henry E. Dubois
---------------------------------------------
Henry E. Dubois
Chief Executive Officer and President
August 15, 2016



EX-31.2 5 exhibit312q22016.htm EXHIBIT 31.2 Exhibit


EXHIBIT 31.2     CERTIFICATIONS

I, Steven R. Balthazor, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Hooper Holmes Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's Board of Directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
                    
/s/ Steven R. Balthazor
---------------------------------------------
Steven R. Balthazor
Chief Financial and Accounting Officer
August 15, 2016



EX-32.1 6 exhibit321q22016.htm EXHIBIT 32.1 Exhibit



EXHIBIT 32.1     CERTIFICATIONS

CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

I, Henry E. Dubois, Chief Executive Officer and President of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge, the Quarterly Report of Hooper Holmes, Inc., on Form 10-Q for the quarter ended June 30, 2016, fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that the information contained in such Quarterly Report on Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of Hooper Holmes, Inc.
Dated: August 15, 2016

/s/ Henry E. Dubois
__________________________
Henry E. Dubois
Chief Executive Officer and President
This certification shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liability of Section 18 of the Exchange Act. Such certification shall not be deemed to be incorporated by reference into any filing under the Securities Act of 1933 or the Exchange Act, except to the extent that the Company specifically incorporates it by reference.
A signed original of this written statement required by Section 906 has been provided to Hooper Holmes, Inc. and will be retained by Hooper Holmes, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.



 EX-32.2 7 exhibit322q22016.htm EXHIBIT 32.2 Exhibit


EXHIBIT 32.2     CERTIFICATIONS

CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

I, Steven R. Balthazor, Chief Financial and Accounting Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge, the Quarterly Report of Hooper Holmes, Inc., on Form 10-Q for the quarter ended June 30, 2016, fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that the information contained in such Quarterly Report on Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of Hooper Holmes, Inc.
Dated: August 15, 2016        

/s/ Steven R. Balthazor
__________________________
Steven R. Balthazor
Chief Financial and Accounting Officer
This certification shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liability of Section 18 of the Exchange Act. Such certification shall not be deemed to be incorporated by reference into any filing under the Securities Act of 1933 or the Exchange Act, except to the extent that the Company specifically incorporates it by reference.
A signed original of this written statement required by Section 906 has been provided to Hooper Holmes, Inc. and will be retained by Hooper Holmes, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.



 EX-101.INS 8 hh-20160630.xml XBRL INSTANCE DOCUMENT 0000741815 2016-01-01 2016-06-30 0000741815 2016-07-31 0000741815 2015-12-31 0000741815 2016-06-30 0000741815 2016-04-01 2016-06-30 0000741815 2015-01-01 2015-06-30 0000741815 2015-04-01 2015-06-30 0000741815 us-gaap:TreasuryStockMember 2016-01-01 2016-06-30 0000741815 us-gaap:RetainedEarningsMember 2015-12-31 0000741815 us-gaap:AdditionalPaidInCapitalMember 2016-01-01 2016-06-30 0000741815 us-gaap:CommonStockMember 2016-01-01 2016-06-30 0000741815 us-gaap:CommonStockMember 2015-12-31 0000741815 us-gaap:TreasuryStockMember 2016-06-30 0000741815 us-gaap:TreasuryStockMember 2015-12-31 0000741815 us-gaap:AdditionalPaidInCapitalMember 2015-12-31 0000741815 us-gaap:CommonStockMember 2016-06-30 0000741815 us-gaap:RetainedEarningsMember 2016-06-30 0000741815 us-gaap:AdditionalPaidInCapitalMember 2016-06-30 0000741815 2014-12-31 0000741815 2015-06-30 0000741815 2016-06-15 0000741815 us-gaap:NewAccountingPronouncementMember hh:NoncurrentAssetsMember 2015-12-31 0000741815 hh:AdjustmentofCapitalizedCostsRelatedtoModificationofCreditAgreementMember 2016-04-01 2016-06-30 0000741815 us-gaap:NewAccountingPronouncementMember hh:CurrentLiabilitiesMember 2015-12-31 0000741815 2016-06-15 2016-06-15 0000741815 hh:A2016LoanandSecurityAgreementMember us-gaap:LineOfCreditMember us-gaap:SubsequentEventMember 2016-08-09 0000741815 2016-03-28 0000741815 2016-03-28 2016-03-28 0000741815 hh:A2016LoanandSecurityAgreementMember us-gaap:LineOfCreditMember 2016-06-30 0000741815 2016-01-25 0000741815 2016-01-25 2016-01-25 0000741815 hh:April172015CreditAgreementMember us-gaap:LoansPayableMember 2016-06-30 0000741815 hh:AccountableHealthSolutionsIncAssetPurchaseAgreementMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2016-01-01 2016-06-30 0000741815 hh:AccountableHealthSolutionsIncAssetPurchaseAgreementMember us-gaap:AcquisitionRelatedCostsMember 2015-01-01 2015-06-30 0000741815 hh:AccountableHealthSolutionsIncAssetPurchaseAgreementMember 2015-04-17 2015-04-17 0000741815 hh:AccountableHealthSolutionsIncAssetPurchaseAgreementMember us-gaap:DevelopedTechnologyRightsMember 2016-01-01 2016-06-30 0000741815 hh:AccountableHealthSolutionsIncAssetPurchaseAgreementMember hh:CostOfGoodsAndServicesSoldMember 2016-04-01 2016-06-30 0000741815 hh:AccountableHealthSolutionsIncAssetPurchaseAgreementMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2016-04-01 2016-06-30 0000741815 hh:AccountableHealthSolutionsIncAssetPurchaseAgreementMember 2016-01-01 2016-06-30 0000741815 hh:AccountableHealthSolutionsIncAssetPurchaseAgreementMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2015-04-01 2015-06-30 0000741815 hh:AccountableHealthSolutionsIncAssetPurchaseAgreementMember hh:AmortizationOfIntangibleAssetsMember 2015-01-01 2015-06-30 0000741815 hh:AccountableHealthSolutionsIncAssetPurchaseAgreementMember us-gaap:CustomerRelationshipsMember 2016-01-01 2016-06-30 0000741815 hh:AccountableHealthSolutionsIncAssetPurchaseAgreementMember us-gaap:AcquisitionRelatedCostsMember 2015-04-01 2015-06-30 0000741815 hh:AccountableHealthSolutionsIncAssetPurchaseAgreementMember 2016-03-31 0000741815 hh:AccountableHealthSolutionsIncAssetPurchaseAgreementMember hh:CostOfGoodsAndServicesSoldMember 2016-01-01 2016-06-30 0000741815 hh:AccountableHealthSolutionsIncAssetPurchaseAgreementMember 2015-04-17 0000741815 hh:AccountableHealthSolutionsIncAssetPurchaseAgreementMember 2016-04-01 2016-06-30 0000741815 hh:AccountableHealthSolutionsIncAssetPurchaseAgreementMember hh:CostOfGoodsAndServicesSoldMember 2015-04-01 2015-06-30 0000741815 hh:AccountableHealthSolutionsIncAssetPurchaseAgreementMember 2015-01-01 2015-06-30 0000741815 hh:AccountableHealthSolutionsIncAssetPurchaseAgreementMember 2015-04-01 2015-06-30 0000741815 hh:AccountableHealthSolutionsIncAssetPurchaseAgreementMember us-gaap:DevelopedTechnologyRightsMember 2016-06-30 0000741815 hh:AccountableHealthSolutionsIncAssetPurchaseAgreementMember us-gaap:CustomerRelationshipsMember 2016-06-30 0000741815 hh:AccountableHealthSolutionsIncAssetPurchaseAgreementMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2015-01-01 2015-06-30 0000741815 hh:AccountableHealthSolutionsIncAssetPurchaseAgreementMember hh:CostOfGoodsAndServicesSoldMember 2015-01-01 2015-06-30 0000741815 hh:A2011PlanMember us-gaap:DirectorMember 2016-01-01 2016-06-30 0000741815 hh:A2008PlanMember 2015-04-01 2015-06-30 0000741815 hh:A2008PlanMember 2015-01-01 2015-06-30 0000741815 hh:A2011PlanMember 2016-04-01 2016-06-30 0000741815 hh:A2008PlanMember 2016-06-30 0000741815 hh:A2008PlanMember 2016-01-01 2016-06-30 0000741815 hh:A2011PlanMember 2016-06-30 0000741815 hh:A2008PlanMember 2016-04-01 2016-06-30 0000741815 hh:A2011PlanMember 2015-01-01 2015-06-30 0000741815 hh:A2011PlanMember us-gaap:DirectorMember 2015-01-01 2015-06-30 0000741815 hh:A2011PlanMember 2015-04-01 2015-06-30 0000741815 hh:A2011PlanMember 2016-01-01 2016-06-30 0000741815 us-gaap:DevelopedTechnologyRightsMember 2015-12-31 0000741815 us-gaap:CustomerRelationshipsMember 2015-12-31 0000741815 us-gaap:DevelopedTechnologyRightsMember 2016-06-30 0000741815 us-gaap:CustomerRelationshipsMember 2016-06-30 0000741815 us-gaap:FacilityClosingMember 2016-01-01 2016-06-30 0000741815 us-gaap:FacilityClosingMember 2016-06-30 0000741815 us-gaap:FacilityClosingMember 2015-12-31 0000741815 hh:A2013LoanandSecurityAgreementMember us-gaap:LineOfCreditMember 2015-12-31 0000741815 hh:April172015CreditAgreementMember us-gaap:LoansPayableMember 2015-12-31 0000741815 hh:April172015CreditAgreementMember us-gaap:LoansPayableMember 2016-01-01 2016-06-30 0000741815 hh:April172015CreditAgreementMember us-gaap:LoansPayableMember 2016-03-28 0000741815 hh:April172015CreditAgreementMember us-gaap:LoansPayableMember hh:AnnualAggregateRevenueUpToAndIncluding20millionMember 2015-04-17 2015-04-17 0000741815 hh:ContingentlyIssuableWarrantMember hh:April172015CreditAgreementMember us-gaap:LoansPayableMember 2015-04-17 2015-04-17 0000741815 hh:April172015CreditAgreementMember us-gaap:LoansPayableMember 2015-04-17 2015-04-17 0000741815 hh:A2013LoanandSecurityAgreementMember hh:TransactionCostMember us-gaap:LineOfCreditMember 2016-04-29 2016-04-29 0000741815 hh:April172015CreditAgreementMember us-gaap:LoansPayableMember hh:AnnualAggregateRevenueGreaterThan30millionMember 2015-04-17 2015-04-17 0000741815 hh:A2016LoanandSecurityAgreementMember us-gaap:LineOfCreditMember 2016-04-29 0000741815 hh:A2013LoanandSecurityAgreementMember hh:TransactionCostMember us-gaap:LoansPayableMember 2016-04-29 2016-04-29 0000741815 us-gaap:OtherAssetsMember hh:A2016LoanandSecurityAgreementMember us-gaap:LineOfCreditMember 2016-06-30 0000741815 hh:April172015CreditAgreementMember us-gaap:LoansPayableMember 2016-03-28 2016-03-28 0000741815 hh:April172015CreditAgreementMember us-gaap:LoansPayableMember us-gaap:MinimumMember hh:AnnualAggregateRevenueGreaterThan20MillionUpToAndIncluding30MillionMember 2015-04-17 2015-04-17 0000741815 hh:April172015CreditAgreementMember us-gaap:LoansPayableMember 2015-04-17 0000741815 hh:A2016LoanandSecurityAgreementMember us-gaap:LineOfCreditMember 2016-04-01 2016-06-30 0000741815 hh:April172015CreditAgreementMember us-gaap:LoansPayableMember us-gaap:MaximumMember hh:AnnualAggregateRevenueGreaterThan20MillionUpToAndIncluding30MillionMember 2015-04-17 2015-04-17 0000741815 hh:April172015CreditAgreementMember us-gaap:LoansPayableMember hh:AnnualAggregateRevenueGreaterThan20MillionUpToAndIncluding30MillionMember 2015-04-17 2015-04-17 0000741815 hh:A2013LoanandSecurityAgreementMember hh:TransactionCostMember us-gaap:LineOfCreditMember 2016-04-29 0000741815 hh:ContingentlyIssuableWarrantMember hh:April172015CreditAgreementMember us-gaap:LoansPayableMember 2015-04-17 0000741815 hh:A2016LoanandSecurityAgreementMember us-gaap:LineOfCreditMember us-gaap:PrimeRateMember 2016-04-29 2016-04-29 0000741815 hh:A2016LoanandSecurityAgreementMember us-gaap:LineOfCreditMember 2016-04-29 2016-04-29 0000741815 hh:April172015CreditAgreementMember us-gaap:LoansPayableMember us-gaap:LondonInterbankOfferedRateLIBORMember 2015-04-17 2015-04-17 0000741815 hh:A2013LoanandSecurityAgreementMember us-gaap:InterestExpenseMember 2016-04-01 2016-06-30 0000741815 hh:A2016LoanandSecurityAgreementMember us-gaap:LineOfCreditMember 2015-04-17 2015-04-17 0000741815 hh:ContingentlyIssuableWarrantMember hh:A2013LoanandSecurityAgreementMember us-gaap:LoansPayableMember 2016-03-31 0000741815 hh:A2013LoanandSecurityAgreementMember us-gaap:LineOfCreditMember 2016-04-01 2016-06-30 0000741815 hh:April172015CreditAgreementMember us-gaap:LoansPayableMember 2015-01-01 2015-06-30 0000741815 hh:A2013LoanandSecurityAgreementMember 2016-01-01 2016-06-30 0000741815 hh:April172015CreditAgreementMember us-gaap:LoansPayableMember 2016-04-01 2016-06-30 0000741815 hh:A2013LoanandSecurityAgreementMember us-gaap:LineOfCreditMember 2015-01-01 2015-06-30 0000741815 hh:A2016LoanandSecurityAgreementMember us-gaap:LineOfCreditMember 2016-01-01 2016-06-30 0000741815 hh:A2013LoanandSecurityAgreementMember 2015-04-01 2015-06-30 0000741815 hh:A2013LoanandSecurityAgreementMember 2016-04-01 2016-06-30 0000741815 hh:A2013LoanandSecurityAgreementMember us-gaap:LineOfCreditMember 2015-04-01 2015-06-30 0000741815 hh:April172015CreditAgreementMember us-gaap:LoansPayableMember 2015-04-01 2015-06-30 0000741815 hh:A2016LoanandSecurityAgreementMember us-gaap:LineOfCreditMember 2015-04-01 2015-06-30 0000741815 hh:A2013LoanandSecurityAgreementMember 2015-01-01 2015-06-30 0000741815 hh:A2013LoanandSecurityAgreementMember us-gaap:LineOfCreditMember 2016-01-01 2016-06-30 0000741815 hh:A2016LoanandSecurityAgreementMember us-gaap:LineOfCreditMember 2015-01-01 2015-06-30 0000741815 hh:April172015CreditAgreementMember us-gaap:LoansPayableMember us-gaap:LondonInterbankOfferedRateLIBORMember 2016-01-01 2016-06-30 0000741815 hh:PortamedicServiceLineMember 2016-01-01 2016-06-30 0000741815 2016-04-29 2016-04-29 0000741815 us-gaap:OperatingIncomeLossMember us-gaap:SegmentDiscontinuedOperationsMember 2016-01-01 2016-06-30 0000741815 us-gaap:AccountsPayableAndAccruedLiabilitiesMember 2016-06-30 0000741815 us-gaap:AccountsPayableAndAccruedLiabilitiesMember 2015-12-31 0000741815 us-gaap:InternalRevenueServiceIRSMember 2015-12-31 0000741815 us-gaap:StateAndLocalJurisdictionMember 2015-12-31 0000741815 us-gaap:CarryingReportedAmountFairValueDisclosureMember 2016-06-30 0000741815 us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:LoansPayableMember 2015-12-31 0000741815 us-gaap:LoansPayableMember 2016-06-30 0000741815 us-gaap:FairValueInputsLevel3Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2015-12-31 0000741815 us-gaap:FairValueInputsLevel3Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:LoansPayableMember 2015-12-31 0000741815 us-gaap:FairValueInputsLevel3Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2016-06-30 0000741815 us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:LoansPayableMember 2016-06-30 0000741815 us-gaap:FairValueInputsLevel3Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:LoansPayableMember 2016-06-30 0000741815 us-gaap:CarryingReportedAmountFairValueDisclosureMember 2015-12-31 0000741815 us-gaap:LoansPayableMember 2015-12-31 xbrli:shares iso4217:USD xbrli:pure hh:branch_office iso4217:USD xbrli:shares false --12-31 Q2 2016 2016-06-30 10-Q 0000741815 8714636 Smaller Reporting Company HOOPER HOLMES INC 244000 244000 397000 807000 27000 27000 45000 91000 371739 39855 21739 0 743000 117000 2000 1250000 1250000 750000 600000 30000000 20000000 30000000 20000000 500000.0 250000.00 34000000 34000000 40000000 40000000 37000000 37000000 45000000 45000000 900000 900000 500000 500000 -2000000 2000000 2500000 2500000 800000 800000 -1100000 1100000 0 277000 0.07 0.05 0.085 0.08 0.08 0.01 2 600000 P1Y 0 50000 0.005 0 236000 0 3028000 0 2552000 30768 0 100000 0 887000 5339000 4734000 5565000 5376000 0 91000 5656000 6415000 156195000 164089000 0 -4880000 4880000 100000 200000 400000 500000 112000 169000 244000 807000 197000 280000 62000 123000 300000 200000 100000 300000 200000 100000 300000 300000 100000 700000 500000 100000 0 17683000 14628000 8498000 6778000 3000000 433333 -2749000 -5856000 7662000 15750000 593000 679000 221000 329000 7000000 3000000 0 100000 2700000 5200000 918000 296000 123000 7000000 76000 28000 5201000 1242000 2035000 102000 -3959000 -1933000 6.90 543478 543478 0.04 0.04 0.04 0.04 0.04 0.04 0.04 240000000 240000000 240000000 5201733 8714636 5201107 8714636 3121000 349000 5969000 10918000 5878000 11659000 0 0 0 0 0.14 0.055 0.14 2052000 1953000 5000000 5000000 5000000 3837000 3590000 100000 107000 140000 400000 1000000 2785000 1977000 3600000 500000 0 200000 -200000 163000 300000 204000 167200000 149800000 873000 1409000 828000 828000 0 0 1250000 0 -0.65 -1.11 -0.29 -0.71 -0.65 -1.11 -0.29 -0.71 P1Y8M27D 400000 0 0 0 59000 0 0 P7Y P3Y P7Y 0.8 0.85 0.021 0.014 P8Y P4Y 917000 185000 732000 1567000 316000 1251000 6248000 2097000 4151000 6248000 2097000 4151000 2097000 4151000 5331000 1912000 3419000 4681000 1781000 2900000 600000 633000 633000 633000 600000 1693000 2425000 1765000 3225000 -3342000 -5444000 -2309000 -5578000 -5600000 600000 300000 700000 -3337000 -5434000 -2304000 -200000 -5568000 -0.65 -1.10 -0.27 -0.67 -0.65 -1.10 -0.27 -0.67 -21000 -25000 -150000 -309000 0.00 -0.01 -0.02 -0.04 0.00 -0.01 -0.02 -0.04 0 0 0 0 5000 10000 5000 10000 0 31000 514000 -1365000 1667000 -72000 -247000 414000 340000 52000 5331000 4681000 626000 709000 1011000 1800000 4000 0 154000 4000 0 154000 16000 48000 161000 49000 48000 341000 0 466000 300000 400000 567000 981000 300000 600000 30000 17683000 14628000 15855000 14561000 3300000 2400000 0.005 7000000 300000 800000 450000 4000000 5330000 3278000 5000000 5142000 3277000 4046000 5330000 5142000 0 0 300000 450000 150000 140000 5495000 3106000 -4355000 -191000 -5099000 -4848000 -4800000 -3363000 -5469000 -2459000 -5887000 -626000 -709000 -1011000 -1800000 -2711000 -4725000 -2180000 -4655000 5186000 4685000 331000 319000 450000 402000 1611000 544000 0 0 887000 900000 887000 201000 377000 36000 4000000 4000000 0 355000 191000 3400000 1200000 0 4574000 5000000 0 1000000 16566000 23000 0 8427000 8549000 2771000 2134000 26000 117000 151000 17044000 0 954000 134000 657000 590000 -159028000 -164915000 7662000 13343000 7643000 14884000 3811000 6471000 3724000 7551000 193000 470000 0 0 0.800 0.810 0.013 0.014 31659 243693 147113 7.65 34560 3.23 667 30000 40000 30000 2778 100000 0 153332 153332 0 166665 1.27 1.33 0 286568 405340.00 6.46 5.07 0.45 0.00 2.05 P5Y3M18D P5Y1M6D 0 P7Y2M29D P8Y5M12D 100000 5201733 626 8714636 0 2601789 666667 3346378 486 166665 50000 0 100000 4723000 2715000 2008000 470000 370000 100000 217000 156195000 3121000 -159028000 -71000 -477000 164089000 349000 -164915000 0 288000 -477000 0.0667 0 71000 -71000 626 0 626 626 71000 0 0 0 5162786 4944824 8602590 8329568 274460 355092 5162786 4944824 8602590 8329568 0 0 0 282000 300000 282000 282000 <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Liquidity </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The accompanying financial statements have been prepared assuming that the Company will continue as a going concern, which contemplates the realization of assets and discharge of liabilities in the normal course of business for the foreseeable future. The uncertainty regarding the Company's ability to generate sufficient cash flows and liquidity to fund operations raises substantial doubt about its ability to continue as a going concern. These financial statements do not include any adjustments that might result from the outcome of this uncertainty. </font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company has taken the following actions toward alleviating the substantial doubt that exists with regard to the Company's ability to continue as a going concern: </font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:46px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On January 25, 2016, the Company received </font><font style="font-family:inherit;font-size:10pt;">$3.4 million</font><font style="font-family:inherit;font-size:10pt;">, net of issuance costs, in additional equity by issuing </font><font style="font-family:inherit;font-size:10pt;">2,601,789</font><font style="font-family:inherit;font-size:10pt;"> shares of its common stock, </font><font style="font-family:inherit;font-size:10pt;">$0.04</font><font style="font-family:inherit;font-size:10pt;"> par value, through a rights offering to current shareholders which is being used to fund working capital;</font></div></td></tr></table><div style="line-height:120%;text-align:justify;padding-left:46px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:46px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On March 28, 2016, the Company received </font><font style="font-family:inherit;font-size:10pt;">$1.2 million</font><font style="font-family:inherit;font-size:10pt;">, net of issuance costs, in additional equity by issuing </font><font style="font-family:inherit;font-size:10pt;">666,667</font><font style="font-family:inherit;font-size:10pt;"> shares of its common stock, </font><font style="font-family:inherit;font-size:10pt;">$0.04</font><font style="font-family:inherit;font-size:10pt;"> par value, to 200 NNH, LLC, which is being used to fund working capital; </font></div></td></tr></table><div style="line-height:120%;text-align:justify;padding-left:46px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:46px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On March 28, 2016, the Company renegotiated its financial covenants in the Credit Agreement (as defined below) to requirements based on its forecast models; and</font></div></td></tr></table><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On April 29, 2016, the Company entered into a new Credit and Security Agreement with SCM Specialty Finance Opportunities Fund, L.P. (as defined below) replacing the 2013 Loan and Security Agreement (as defined below). Refer to Note 9 to the condensed consolidated financial statements for additional discussion.</font></div></td></tr></table><div style="line-height:120%;text-align:justify;padding-left:46px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company expects to continue to monitor its liquidity carefully, work to reduce this uncertainty, and address its cash needs through a combination of one or more of the following actions: </font></div><div style="line-height:120%;text-align:justify;padding-left:46px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:46px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company will continue to aggressively seek new and return business from its existing customers and expand its presence in the Health and Wellness marketplace;</font></div></td></tr></table><div style="line-height:120%;text-align:justify;padding-left:46px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:46px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company will continue to implement further cost actions and efficiency improvements;</font></div></td></tr></table><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:46px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company expects to continue to carefully manage receipts and disbursements, including amounts and timing, focusing on reducing days receivables outstanding and managing days payables outstanding.</font></div></td></tr></table><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company's primary sources of liquidity are cash and cash equivalents as well as availability under a Credit and Security Agreement (the "2016 Credit and Security Agreement") with SCM Specialty Finance Opportunities Fund, L.P. ("SCM"). At </font><font style="font-family:inherit;font-size:10pt;">June&#160;30, 2016</font><font style="font-family:inherit;font-size:10pt;">, the Company had </font><font style="font-family:inherit;font-size:10pt;">$0.1 million</font><font style="font-family:inherit;font-size:10pt;"> in cash and cash equivalents and had </font><font style="font-family:inherit;font-size:10pt;">$3.3 million</font><font style="font-family:inherit;font-size:10pt;"> outstanding under the 2016 Credit and Security Agreement, with available borrowing capacity of </font><font style="font-family:inherit;font-size:10pt;">$0.3 million</font><font style="font-family:inherit;font-size:10pt;">. As of </font><font style="font-family:inherit;font-size:10pt;">August&#160;9, 2016</font><font style="font-family:inherit;font-size:10pt;">, the Company had </font><font style="font-family:inherit;font-size:10pt;">$2.4 million</font><font style="font-family:inherit;font-size:10pt;"> outstanding with estimated available borrowing capacity of </font><font style="font-family:inherit;font-size:10pt;">$0.8 million</font><font style="font-family:inherit;font-size:10pt;">. As of </font><font style="font-family:inherit;font-size:10pt;">June&#160;30, 2016</font><font style="font-family:inherit;font-size:10pt;">, the Company also owed approximately </font><font style="font-family:inherit;font-size:10pt;">$4.0 million</font><font style="font-family:inherit;font-size:10pt;"> under an existing term loan ("the Term Loan"), which is governed by the terms of a credit agreement ("the Credit Agreement") with SWK Funding LLC ("SWK") and was used to fund the cash component of the Acquisition. Each of these agreements contain certain financial covenants, including various affirmative and negative covenants including minimum aggregate revenue, EBITDA, and consolidated unencumbered liquid assets requirements, which the Company did not comply with as of </font><font style="font-family:inherit;font-size:10pt;">June&#160;30, 2016</font><font style="font-family:inherit;font-size:10pt;">. For additional information regarding the 2016 Credit and Security Agreement, Credit Agreement, and the related covenants, see Note 9 to the condensed consolidated financial statements.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company incurred a loss from continuing operations of </font><font style="font-family:inherit;font-size:10pt;">$5.6 million</font><font style="font-family:inherit;font-size:10pt;"> during the </font><font style="font-family:inherit;font-size:10pt;">six month period ended</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;">June&#160;30, 2016</font><font style="font-family:inherit;font-size:10pt;">. The Company&#8217;s net cash used in operating activities for the </font><font style="font-family:inherit;font-size:10pt;">six month period ended</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;">June&#160;30, 2016</font><font style="font-family:inherit;font-size:10pt;">, was </font><font style="font-family:inherit;font-size:10pt;">$4.8 million</font><font style="font-family:inherit;font-size:10pt;">. The Company has managed its liquidity through availability under a revolving credit facility, raising additional equity, and a series of cost reduction initiatives.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company has historically used availability under a revolving credit facility to fund operations. The Company experiences a timing difference between the operating expenses and cash collection of the associated revenue based on Health and Wellness customer payment terms. To conduct successful screenings, the Company must expend cash to deliver the equipment and supplies required for the screenings and pay its health professionals and site management, all of which is done in advance of the customer invoicing process and ultimate cash receipts for services performed. Given the seasonal nature of the Company's operations, which are largely dependent on second half volumes, management expects to continue using a revolving credit facility in 2016 and beyond. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Other Considerations</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Health and Wellness business sells services directly to end customers and also through wellness, disease management, benefit brokers, and insurance companies (referred to as channel partners) who ultimately have the relationship with the end customer. Sales to direct customers offer the full suite of our services while sales of our screenings through channel partners are often aggregated with other offerings from these channel partners to provide a total solution to the end-user. As such, the Company's success is largely dependent on that of its partners.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Additionally, the Acquisition provides new offerings including the wellness portal and telephonic coaching, along with new staff, new systems, and new customers. During the </font><font style="font-family:inherit;font-size:10pt;">six month period ended</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;">June&#160;30, 2016</font><font style="font-family:inherit;font-size:10pt;">, the Company incurred under </font><font style="font-family:inherit;font-size:10pt;">$0.1 million</font><font style="font-family:inherit;font-size:10pt;"> of costs associated with the ongoing integration of AHS, which are recorded in selling, general and administrative expenses. Transition costs incurred during the three month period ended </font><font style="font-family:inherit;font-size:10pt;">June&#160;30, 2016</font><font style="font-family:inherit;font-size:10pt;">, were immaterial. These costs relate primarily to transition services purchased from AHS and the ongoing transition of information technology infrastructure. The Company does not expect to continue to incur material transition costs going forward.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In addition, the Company has contractual obligations related to operating leases and employment contracts which could adversely affect liquidity.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company&#8217;s ability to satisfy its liquidity needs and meet future covenants is dependent on growing revenues, improving profitability, and raising additional equity. These profitability improvements primarily include expansion of the Company&#8217;s presence in the Health and Wellness marketplace through new sales to direct customers, retaining existing customers, and capitalizing on the opportunities presented by its channel partners. The Company must increase screening, telephonic health coaching, and wellness portal volumes in order to cover its fixed cost structure and improve gross profits. These improvements may be outside of management&#8217;s control. If the Company is unable to increase volumes or control operating costs, liquidity may be adversely affected.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">There can be no assurance that cash flows from operations, combined with any additional borrowings available to the Company, will be obtainable in an amount sufficient to enable the Company to repay its indebtedness, or to fund other liquidity needs. If the Company is unable to comply with financial covenants in 2016 and in the event that the Company were unable to modify the covenants, find new or additional lenders, or raise additional equity, the Company would be considered in default, which would then enable the lenders to accelerate the repayment of all amounts outstanding and exercise remedies with respect to collateral, which would have a material adverse impact on the Company's business.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The unaudited condensed consolidated financial statements of the Company have been prepared in accordance with instructions for Form 10-Q and the rules and regulations of the Securities and Exchange Commission ("SEC"). Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP") have been condensed or omitted pursuant to such rules and regulations. The unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto included in the Company's 2015 Annual Report on Form 10-K, filed with the SEC on March 30, 2016. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Financial statements prepared in accordance with U.S. GAAP require management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities, revenues and expenses and other disclosures. The financial information included herein is unaudited; however, such information reflects all adjustments that are, in the opinion of the Company's management, necessary for a fair statement of results for the interim periods presented. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The results of operations for the </font><font style="font-family:inherit;font-size:10pt;">three and six month periods ended</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">June&#160;30, 2016</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2015</font><font style="font-family:inherit;font-size:10pt;">, are not necessarily indicative of the results to be expected for any other interim period or the full year. See &#8220;Management's Discussion and Analysis of Financial Condition and Results of Operations&#8221; for additional information.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table provides unaudited pro forma results of operations for the </font><font style="font-family:inherit;font-size:10pt;">three and six month periods ended</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">, </font><font style="font-family:inherit;font-size:10pt;">as if AHS was part of operations on the first day of the 2014 fiscal year.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:98.6328125%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:57%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:18%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:18%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">(in thousands)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Three Months Ended</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Six Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">June 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">June 30,</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2015</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Pro forma revenues</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,662</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15,750</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Pro forma net loss from continuing operations</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2,749</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(5,856</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Acquisition</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company entered into and consummated the Purchase Agreement on April 17, 2015, among the Company and certain of its subsidiaries, Accountable Health Solutions, Inc. (the "Seller" or "AHS") and Accountable Health, Inc. (the "Shareholder"). Pursuant to the Purchase Agreement, the Company acquired the assets and certain liabilities representing the health and wellness business of the Seller for approximately </font><font style="font-family:inherit;font-size:10pt;">$7.0 million</font><font style="font-family:inherit;font-size:10pt;"> - </font><font style="font-family:inherit;font-size:10pt;">$4.0 million</font><font style="font-family:inherit;font-size:10pt;"> in cash and up to </font><font style="font-family:inherit;font-size:10pt;">433,333</font><font style="font-family:inherit;font-size:10pt;"> shares of the Company&#8217;s common stock, </font><font style="font-family:inherit;font-size:10pt;">$0.04</font><font style="font-family:inherit;font-size:10pt;"> par value, with a value of </font><font style="font-family:inherit;font-size:10pt;">$3.0 million</font><font style="font-family:inherit;font-size:10pt;">, which was subject to a working capital adjustment as described in the Purchase Agreement. At the closing of the Purchase Agreement, the Company issued and delivered </font><font style="font-family:inherit;font-size:10pt;">371,739</font><font style="font-family:inherit;font-size:10pt;"> shares of Common Stock to the Shareholder at closing and issued and held back </font><font style="font-family:inherit;font-size:10pt;">21,739</font><font style="font-family:inherit;font-size:10pt;"> shares of Common Stock for the working capital adjustment, which were subsequently released on October 9, 2015, and </font><font style="font-family:inherit;font-size:10pt;">39,855</font><font style="font-family:inherit;font-size:10pt;"> shares of Common Stock for indemnification purposes. </font><font style="font-family:inherit;font-size:10pt;">No</font><font style="font-family:inherit;font-size:10pt;"> additional shares will be issued under the terms of the Purchase Agreement. The shares were issued pursuant to an exemption from registration under Section 4(a)(2) of the Securities Act of 1933, which provides an exemption for private offerings of securities. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In order to fund the Acquisition, the Company entered into and consummated the Credit Agreement with SWK on April 17, 2015. Refer to Note 9 of the condensed consolidated financial statements for discussion of the Credit Agreement and related warrants.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Acquisition was treated as a purchase in accordance with Accounting Standards Codification (ASC) 805, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Business Combinations</font><font style="font-family:inherit;font-size:10pt;">, which requires allocation of the purchase price to the estimated fair values of the assets acquired and liabilities assumed in the transaction. The allocation of purchase price is based on management&#8217;s judgment after evaluating several factors, including a valuation assessment.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The allocation of the purchase price was finalized in the first quarter of 2016 and is as follows:</font></div><div style="line-height:120%;text-align:left;padding-left:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5" rowspan="1"></td></tr><tr><td style="width:78%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:18%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">(in thousands)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accounts receivable, net of allowance of $2</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">918</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Inventory and other current assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">117</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fixed assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">123</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Customer portal (existing technologies)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,151</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Customer relationships</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,097</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Goodwill</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">633</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accounts payable and accrued expenses</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(743</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Deferred revenue</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(296</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Purchase Price</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,000</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Intangible assets acquired include existing technology in the form of a customer-facing wellness portal and customer relationships. The fair value of the customer relationships acquired was determined using the excess earnings method under the income approach for customer relationships; and the fair value of the wellness portal software was determined using the replacement cost method. The estimated useful life for the wellness portal and customer relationships is </font><font style="font-family:inherit;font-size:10pt;">4 years</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">8 years</font><font style="font-family:inherit;font-size:10pt;">, respectively. Amortization is recorded on a straight-line basis over the estimated useful life of the asset. The Company recorded amortization expense as a component of cost of operations of </font><font style="font-family:inherit;font-size:10pt;">$0.3 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$0.5 million</font><font style="font-family:inherit;font-size:10pt;">, respectively, and amortization expense as a component of selling, general and administrative expenses of </font><font style="font-family:inherit;font-size:10pt;">$0.1 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$0.1 million</font><font style="font-family:inherit;font-size:10pt;">, respectively, during the </font><font style="font-family:inherit;font-size:10pt;">three and six month periods ended</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;">June&#160;30, 2016</font><font style="font-family:inherit;font-size:10pt;">. The Company recorded amortization expense of </font><font style="font-family:inherit;font-size:10pt;">$0.2 million</font><font style="font-family:inherit;font-size:10pt;"> as a component of cost of operations and </font><font style="font-family:inherit;font-size:10pt;">$0.1 million</font><font style="font-family:inherit;font-size:10pt;"> as a component of selling, general and administrative expenses for the </font><font style="font-family:inherit;font-size:10pt;">three and six month periods ended</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:inherit;font-size:10pt;">. The goodwill of </font><font style="font-family:inherit;font-size:10pt;">$0.6 million</font><font style="font-family:inherit;font-size:10pt;"> was recorded in one reporting unit, the Health and Wellness operations, and is deductible for tax purposes.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The consolidated statement of operations for the </font><font style="font-family:inherit;font-size:10pt;">three and six month periods ended</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;">June&#160;30, 2016</font><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">, </font><font style="font-family:inherit;font-size:10pt;">includes revenue of </font><font style="font-family:inherit;font-size:10pt;">$2.7 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$5.2 million</font><font style="font-family:inherit;font-size:10pt;">, respectively, attributable to AHS. Disclosure of the earnings contribution from the AHS business is not practicable, as the Company has already integrated operations. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table provides unaudited pro forma results of operations for the </font><font style="font-family:inherit;font-size:10pt;">three and six month periods ended</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">, </font><font style="font-family:inherit;font-size:10pt;">as if AHS was part of operations on the first day of the 2014 fiscal year.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:98.6328125%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:57%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:18%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:18%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">(in thousands)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Three Months Ended</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Six Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">June 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">June 30,</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2015</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Pro forma revenues</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,662</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15,750</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Pro forma net loss from continuing operations</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2,749</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(5,856</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">These pro forma results are based on estimates and assumptions, which the Company believes are reasonable. They are not the results that would have been realized had the Company been a combined company during the periods presented, nor are they indicative of the consolidated results of operations in future periods. The pro forma results for the </font><font style="font-family:inherit;font-size:10pt;">six month period ended</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:inherit;font-size:10pt;">, include pre-tax adjustments for amortization of intangible assets of </font><font style="font-family:inherit;font-size:10pt;">$0.3 million</font><font style="font-family:inherit;font-size:10pt;">. Pro forma results for the </font><font style="font-family:inherit;font-size:10pt;">three and six month periods ended</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:inherit;font-size:10pt;">, include pre-tax adjustments for the elimination of acquisition costs of </font><font style="font-family:inherit;font-size:10pt;">$0.6 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$0.7 million</font><font style="font-family:inherit;font-size:10pt;">, respectively.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Commitments and Contingencies </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company leases its corporate headquarters in Olathe, Kansas, which includes the Health and Wellness operations center, under an operating lease which expires in 2018. The Company leases its AHS operations centers in Des Moines, Iowa and Indianapolis, IN, under operating leases which expire in 2018. The Company also leases copiers and other miscellaneous equipment. These leases expire at various times through 2017. </font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company is obligated under a lease related to the discontinued Hooper Holmes Services operations center through 2018 and has ceased use of this facility. The Company is still the primary lessee under operating leases for </font><font style="font-family:inherit;font-size:10pt;">two</font><font style="font-family:inherit;font-size:10pt;"> Portamedic branch offices and has recorded a facility closure obligation related to the above mentioned leases for future rent payments not utilized for continuing operations and such related costs are recorded in the reporting for discontinued operations. The Company has recorded a facility closure obligation of </font><font style="font-family:inherit;font-size:10pt;">$0.6 million</font><font style="font-family:inherit;font-size:10pt;"> as of </font><font style="font-family:inherit;font-size:10pt;">June&#160;30, 2016</font><font style="font-family:inherit;font-size:10pt;">, related to the above mentioned leases.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company has employment agreements with certain executive employees that provide for payment of base salary for up to a </font><font style="font-family:inherit;font-size:10pt;">one year</font><font style="font-family:inherit;font-size:10pt;"> period in the event their employment with the Company is terminated in certain circumstances, including following a change in control, as further defined in the agreements.</font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">From time to time, the Company is subject to federal and state tax audits and related governmental inquiries into matters such as income tax returns, sales and use tax returns, employment classification of its workers, and wage and hour law compliance. The Company is currently under examination by the Internal Revenue Service (the &#8220;IRS&#8221;) for the calendar years 2013, 2014, and 2015 with respect to its classification of certain of its health professionals as independent contractors rather than employees. This examination could lead to proposed adjustments to its federal employment taxes for the periods in question, but the IRS has not yet issued an assessment. The Company believes that it has properly classified these workers as independent contractors, but there can be no assurances of a favorable outcome for the Company and given the ongoing status of the examination, we are unable at this time to provide an estimate of the range of loss, if any.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Debt</font><font style="font-family:inherit;font-size:8pt;font-weight:bold;"> </font><font style="font-family:inherit;font-size:8pt;color:#ff0000;font-weight:bold;"> </font></div><div style="line-height:120%;text-align:justify;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of </font><font style="font-family:inherit;font-size:10pt;">June&#160;30, 2016</font><font style="font-family:inherit;font-size:10pt;">, the Company maintained the 2016 Credit and Security Agreement and the Term Loan provided by the Credit Agreement. The following table summarizes the Company's outstanding borrowings:</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:62%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:16%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:16%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">(in thousands)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">June&#160;30, 2016</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December&#160;31, 2015</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2016 Credit and Security Agreement (2013 Loan and Security Agreement as of December 31, 2015)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,277</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,278</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Term Loan</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,046</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Discount on Term Loan</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,977</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2,785</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unamortized debt issuance costs related to Term Loan</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(204</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(163</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total debt</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,142</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,330</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Short-term portion</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(5,142</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(5,330</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total long-term debt, net </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes the components of interest expense for the </font><font style="font-family:inherit;font-size:10pt;">three and six month periods ended</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;">June 30, 2016 and 2015</font><font style="font-family:inherit;font-size:10pt;">:</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="17" rowspan="1"></td></tr><tr><td style="width:51%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">(in thousands)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Three Months Ended</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Six Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">June 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">June 30,</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2016</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2016</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2015</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest expense on Term Loan (interest at LIBOR, plus 14%)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">161</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">154</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">341</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">154</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest expense on 2013 Loan and Security Agreement</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">49</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest expense on 2016 Credit and Security Agreement</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">48</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">48</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accretion of termination fees (over term of Term Loan at rate of 8%)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">45</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">27</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">91</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">27</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amortization of debt issuance costs </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">62</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">197</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">123</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">280</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Write-off of debt issuance costs related to 2013 Loan and Security Agreement</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">282</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">282</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amortization of debt discount associated with the warrants</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">397</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">244</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">807</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">244</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Mark to market of the Additional Warrant </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">59</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,011</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">626</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,800</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">709</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">2016 Credit and Security Agreement</font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On April 29, 2016, the Company entered into the 2016 Credit and Security Agreement with SCM. The 2016 Credit and Security Agreement provides the Company with a revolving credit facility, the proceeds of which are to be used for general working capital purposes and capital expenditures. The 2016 Credit and Security Agreement replaced the 2013 Loan and Security Agreement, eliminating the requirement of the Company to issue the Additional Warrant for the purchase of common stock valued at </font><font style="font-family:inherit;font-size:10pt;">$1.25 million</font><font style="font-family:inherit;font-size:10pt;"> to SWK, the holder of the Company&#8217;s Credit Agreement (see below for further information about the Additional Warrant). An early termination fee of </font><font style="font-family:inherit;font-size:10pt;">$140,000</font><font style="font-family:inherit;font-size:10pt;">, approximately </font><font style="font-family:inherit;font-size:10pt;">$30,000</font><font style="font-family:inherit;font-size:10pt;"> of legal fees, and approximately </font><font style="font-family:inherit;font-size:10pt;">$107,000</font><font style="font-family:inherit;font-size:10pt;"> of other ordinary course fees were accelerated due to the termination of the 2013 Loan and Security Agreement and were rolled into the opening outstanding borrowings under the 2016 Credit and Security Agreement with SCM and are reflected in transaction costs in the condensed consolidated statement of operations during the three month period ended </font><font style="font-family:inherit;font-size:10pt;">June&#160;30, 2016</font><font style="font-family:inherit;font-size:10pt;">, and approximately </font><font style="font-family:inherit;font-size:10pt;">$0.3 million</font><font style="font-family:inherit;font-size:10pt;"> of unamortized debt issuance costs related to the 2013 Loan and Security Agreement were written off and recorded in interest expense in the condensed consolidated statement of operations during the three month period ended </font><font style="font-family:inherit;font-size:10pt;">June&#160;30, 2016</font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Under the terms of the 2016 Credit and Security Agreement, SCM makes cash advances to the Company in an aggregate principal at any </font><font style="font-family:inherit;font-size:10pt;">one</font><font style="font-family:inherit;font-size:10pt;"> time outstanding not to exceed </font><font style="font-family:inherit;font-size:10pt;">$7 million</font><font style="font-family:inherit;font-size:10pt;">, subject to certain loan balance limits based on the value of the Company&#8217;s eligible collateral (the &#8220;Revolving Loan Commitment Amount&#8221;). The 2016 Credit and Security Agreement has a term of </font><font style="font-family:inherit;font-size:10pt;">three years</font><font style="font-family:inherit;font-size:10pt;">, expiring on April 29, 2019. As of </font><font style="font-family:inherit;font-size:10pt;">June&#160;30, 2016</font><font style="font-family:inherit;font-size:10pt;">, the Company had </font><font style="font-family:inherit;font-size:10pt;">$3.3 million</font><font style="font-family:inherit;font-size:10pt;"> outstanding under the 2016 Credit and Security Agreement with available borrowing capacity of </font><font style="font-family:inherit;font-size:10pt;">$0.3 million</font><font style="font-family:inherit;font-size:10pt;">. As of </font><font style="font-family:inherit;font-size:10pt;">August&#160;9, 2016</font><font style="font-family:inherit;font-size:10pt;">, the Company had </font><font style="font-family:inherit;font-size:10pt;">$2.4 million</font><font style="font-family:inherit;font-size:10pt;"> outstanding, with estimated available borrowing capacity of </font><font style="font-family:inherit;font-size:10pt;">$0.8 million</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Borrowings will bear interest at a fluctuating rate that when annualized is equal to the Prime Rate plus </font><font style="font-family:inherit;font-size:10pt;">5.5%</font><font style="font-family:inherit;font-size:10pt;">, subject to increase in the event of a default. The Company paid SCM a </font><font style="font-family:inherit;font-size:10pt;">$140,000</font><font style="font-family:inherit;font-size:10pt;"> facility fee, and monthly, SCM will receive an unused line fee equal to one-half of one percent (</font><font style="font-family:inherit;font-size:10pt;">0.5%</font><font style="font-family:inherit;font-size:10pt;">) per annum of the difference derived by subtracting (i) the greater of (x) the average daily outstanding balance under the Revolving Facility during the preceding month and (y) the Minimum Balance, from (ii) the Revolving Loan Commitment Amount and also a collateral management fee equal to one-half of one percent (</font><font style="font-family:inherit;font-size:10pt;">0.5%</font><font style="font-family:inherit;font-size:10pt;">) per annum of the Revolving Loan Commitment Amount. As of </font><font style="font-family:inherit;font-size:10pt;">June&#160;30, 2016</font><font style="font-family:inherit;font-size:10pt;">, the remaining balance in debt issuance costs recorded in Other Assets on the condensed consolidated balance sheet was </font><font style="font-family:inherit;font-size:10pt;">$0.3 million</font><font style="font-family:inherit;font-size:10pt;">. </font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:11pt;"><font style="font-family:inherit;font-size:10pt;">The 2016 Credit and Security Agreement contains customary representations and warranties and various affirmative and negative covenants including minimum aggregate revenue, EBITDA, and consolidated unencumbered liquid assets requirements. Minimum aggregate revenue must not be less than </font><font style="font-family:inherit;font-size:10pt;">$34.0 million</font><font style="font-family:inherit;font-size:10pt;"> for the twelve months ending June 30, 2016, </font><font style="font-family:inherit;font-size:10pt;">$37.0 million</font><font style="font-family:inherit;font-size:10pt;"> for the twelve months ending September 30, 2016, </font><font style="font-family:inherit;font-size:10pt;">$40.0 million</font><font style="font-family:inherit;font-size:10pt;"> for the twelve months ending December 31, 2016, and </font><font style="font-family:inherit;font-size:10pt;">$45.0 million</font><font style="font-family:inherit;font-size:10pt;"> for the twelve months ending each fiscal quarter thereafter. Adjusted EBITDA must not be less than negative </font><font style="font-family:inherit;font-size:10pt;">$2.0 million</font><font style="font-family:inherit;font-size:10pt;"> for the six months ending June 30, 2016, negative </font><font style="font-family:inherit;font-size:10pt;">$1.1 million</font><font style="font-family:inherit;font-size:10pt;"> for the nine months ending September 30, 2016, </font><font style="font-family:inherit;font-size:10pt;">$0.8 million</font><font style="font-family:inherit;font-size:10pt;"> for the twelve months ending December 31, 2016, </font><font style="font-family:inherit;font-size:10pt;">$0.5 million</font><font style="font-family:inherit;font-size:10pt;"> for the twelve months ending March 31, 2017, </font><font style="font-family:inherit;font-size:10pt;">$0.9 million</font><font style="font-family:inherit;font-size:10pt;"> for the twelve months ending June 30, 2017, and </font><font style="font-family:inherit;font-size:10pt;">$2.5 million</font><font style="font-family:inherit;font-size:10pt;"> for the twelve months ending September 30, 2017. In addition, consolidated unencumbered liquid assets must not be less than </font><font style="font-family:inherit;font-size:10pt;">$0.75 million</font><font style="font-family:inherit;font-size:10pt;"> on the last day of any quarter. The Company was not in compliance with the covenants under the 2016 Credit and Security Agreement as of </font><font style="font-family:inherit;font-size:10pt;">June&#160;30, 2016</font><font style="font-family:inherit;font-size:10pt;">,</font><font style="font-family:inherit;font-size:11pt;"> </font><font style="font-family:inherit;font-size:10pt;">and has entered into a First Amendment to Credit and Security Agreement and Limited Waiver and Forbearance (&#8220;First Amendment&#8221;), which provides a waiver related to the measurement period ended June 30, 2016. If certain conditions set forth in the First Amendment are satisfied as of September 30, 2016, the waiver and an amendment to the 2016 Credit and Security Agreement providing for revised financial covenants will become permanent. &#160;If the Company is unable to fulfill the conditions in the First Amendment by September 30, 2016, or fails to comply with, or obtain further waivers to, the financial covenants in the First Amendment in the future, then the lenders would have the option to accelerate the repayment of all amounts outstanding and exercise remedies with respect to collateral, which would have a material adverse impact on the Company's business. The foregoing description of the First Amendment is only a summary and is qualified in its entirety by the full text of the First Amendment, which is attached as an exhibit to this Quarterly Report on Form 10-Q.</font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Borrowings under the Agreement are secured by a security interest in all existing and after-acquired property of the Company, including, but not limited to, its receivables (which are subject to a lockbox account arrangement), inventory and equipment. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Credit Agreement</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In order to fund the Acquisition, the Company entered into the Credit Agreement with SWK on April 17, 2015, as amended on February 25, 2016, and March 28, 2016. The Credit Agreement provides the Company with a </font><font style="font-family:inherit;font-size:10pt;">$5.0 million</font><font style="font-family:inherit;font-size:10pt;"> Term Loan. The proceeds of the Term Loan were used to pay certain fees and expenses related to the negotiation and consummation of the Purchase Agreement and the Acquisition described in Note 3 and general corporate purposes. The Company paid SWK an origination fee of </font><font style="font-family:inherit;font-size:10pt;">$0.1 million</font><font style="font-family:inherit;font-size:10pt;">. The Term Loan is due and payable on April 17, 2018. The Company is also required to make quarterly revenue-based payments in an amount equal to eight and one-half percent (</font><font style="font-family:inherit;font-size:10pt;">8.5%</font><font style="font-family:inherit;font-size:10pt;">) of yearly aggregate revenue up to and including </font><font style="font-family:inherit;font-size:10pt;">$20 million</font><font style="font-family:inherit;font-size:10pt;">, seven percent (</font><font style="font-family:inherit;font-size:10pt;">7%</font><font style="font-family:inherit;font-size:10pt;">) of yearly aggregate revenue greater than </font><font style="font-family:inherit;font-size:10pt;">$20 million</font><font style="font-family:inherit;font-size:10pt;"> up to and including </font><font style="font-family:inherit;font-size:10pt;">$30 million</font><font style="font-family:inherit;font-size:10pt;">, and five percent (</font><font style="font-family:inherit;font-size:10pt;">5%</font><font style="font-family:inherit;font-size:10pt;">) of yearly aggregate revenue greater than </font><font style="font-family:inherit;font-size:10pt;">$30 million</font><font style="font-family:inherit;font-size:10pt;">. The revenue-based payment will be applied to fees and interest, and any excess to the principal of the Term Loan. Revenue-based payments commenced in February 2016, and the maximum principal portion of the aggregate revenue-based payment is capped at </font><font style="font-family:inherit;font-size:10pt;">$600,000</font><font style="font-family:inherit;font-size:10pt;"> per quarter. During the </font><font style="font-family:inherit;font-size:10pt;">six month period ended</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;">June&#160;30, 2016</font><font style="font-family:inherit;font-size:10pt;">, the Company made principal payments to SWK of </font><font style="font-family:inherit;font-size:10pt;">$1.0 million</font><font style="font-family:inherit;font-size:10pt;">, in addition to </font><font style="font-family:inherit;font-size:10pt;">$0.4 million</font><font style="font-family:inherit;font-size:10pt;"> of interest paid.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;</font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The outstanding principal balance under the Credit Agreement bears interest at an adjustable rate per annum equal to the LIBOR Rate (subject to a minimum amount of one percent (</font><font style="font-family:inherit;font-size:10pt;">1.0%</font><font style="font-family:inherit;font-size:10pt;">)) plus fourteen percent (</font><font style="font-family:inherit;font-size:10pt;">14.0%</font><font style="font-family:inherit;font-size:10pt;">) and is due and payable quarterly, in arrears, which commenced on August 14, 2015. Upon the earlier of (a) the maturity date on April 17, 2018, or (b) full repayment of the Term Loan, whether by acceleration or otherwise, the Company is required to pay an exit fee equal to eight percent (</font><font style="font-family:inherit;font-size:10pt;">8%</font><font style="font-family:inherit;font-size:10pt;">) of the aggregate principal amount of all term loans advanced under the Credit Agreement. The Company is recognizing the exit fee over the term of the Term Loan through an accretion accrual to interest expense using the effective interest method. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Credit Agreement also contains certain financial covenants including minimum aggregate revenue, adjusted EBITDA, and consolidated unencumbered liquid assets requirements. On March 28, 2016, the Company obtained a Second Amendment to the Credit Agreement (the "Second Amendment") in which the lender modified the existing covenants and replaced them with minimum aggregate revenue covenants of </font><font style="font-family:inherit;font-size:10pt;">$34.0 million</font><font style="font-family:inherit;font-size:10pt;"> for the twelve months ending June 30, 2016, </font><font style="font-family:inherit;font-size:10pt;">$37.0 million</font><font style="font-family:inherit;font-size:10pt;"> for the twelve months ending September 30, 2016, </font><font style="font-family:inherit;font-size:10pt;">$40.0 million</font><font style="font-family:inherit;font-size:10pt;"> for the twelve months ending December 31, 2016, and </font><font style="font-family:inherit;font-size:10pt;">$45.0 million</font><font style="font-family:inherit;font-size:10pt;"> for the twelve months ending each fiscal quarter thereafter. The Second Amendment also modified the minimum adjusted EBITDA covenants for 2016 and replaced them with minimum adjusted EBITDA covenants of negative </font><font style="font-family:inherit;font-size:10pt;">$2.0 million</font><font style="font-family:inherit;font-size:10pt;"> for the six months ending June 30, 2016, negative </font><font style="font-family:inherit;font-size:10pt;">$1.1 million</font><font style="font-family:inherit;font-size:10pt;"> for the nine months ending September 30, 2016, </font><font style="font-family:inherit;font-size:10pt;">$0.8 million</font><font style="font-family:inherit;font-size:10pt;"> for the twelve months ending December 31, 2016, </font><font style="font-family:inherit;font-size:10pt;">$0.5 million</font><font style="font-family:inherit;font-size:10pt;"> for the twelve months ending March 31, 2017, </font><font style="font-family:inherit;font-size:10pt;">$0.9 million</font><font style="font-family:inherit;font-size:10pt;"> for the twelve months ending June 30, 2017, and </font><font style="font-family:inherit;font-size:10pt;">$2.5 million</font><font style="font-family:inherit;font-size:10pt;"> for the twelve months ending September 30, 2017, and each twelve consecutive calendar month period ending on the last day of each fiscal quarter thereafter. In addition, the Company was required to obtain new equity contributions in an aggregate amount of not less than </font><font style="font-family:inherit;font-size:10pt;">$0.5 million</font><font style="font-family:inherit;font-size:10pt;"> between March 23, 2016 and June 30, 2016, which requirement the Company has satisfied through the private offering to 200 NNH, LLC, which is described further in Note 2 to the condensed consolidated financial statements. The Second Amendment also required the Company to issue shares of its common stock, </font><font style="font-family:inherit;font-size:10pt;">$0.04</font><font style="font-family:inherit;font-size:10pt;"> par value, with a value of </font><font style="font-family:inherit;font-size:10pt;">$100,000</font><font style="font-family:inherit;font-size:10pt;"> to SWK, which the Company issued during the first quarter of 2016 and recorded as debt issuance costs as a direct deduction to short-term debt on the condensed consolidated balance sheet as of </font><font style="font-family:inherit;font-size:10pt;">June&#160;30, 2016</font><font style="font-family:inherit;font-size:10pt;">. The Company was not in compliance with the covenants under the Credit Agreement, as amended, as of </font><font style="font-family:inherit;font-size:10pt;">June&#160;30, 2016</font><font style="font-family:inherit;font-size:10pt;">, and has entered into a Third Amendment to Credit Agreement and Limited Waiver and Forbearance (&#8220;Third Amendment&#8221;), which provides a waiver related to the measurement period ended June 30, 2016. If certain conditions set forth in the Third Amendment are satisfied as of September 30, 2016, the waiver and an amendment to the Credit Agreement providing for revised financial covenants and an extended period of time to make required principal payments will become permanent. If the Company is unable to fulfill the conditions in the Third Amendment by September 30, 2016, or fails to comply with, or obtain further waivers to, the financial covenants in the Third Amendment in the future, then the lenders would have the option to accelerate the repayment of all amounts outstanding and exercise remedies with respect to collateral, which would have a material adverse impact on the Company's business. The foregoing description of the Third Amendment is only a summary and is qualified in its entirety by the full text of the Third Amendment, which is attached as an exhibit to this Quarterly Report on Form 10-Q.</font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Credit Agreement contains a cross-default provision that can be triggered if the Company has more than </font><font style="font-family:inherit;font-size:10pt;">$0.25 million</font><font style="font-family:inherit;font-size:10pt;"> in debt outstanding under the 2016 Credit and Security Agreement and the Company fails to make payments to SCM when due or if SCM is entitled to accelerate the maturity of debt in response to a default situation under the 2016 Credit and Security Agreement, which may include violation of any financial covenants.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> As of June 30, 2016, as security for payment and other obligations under the 2016 Credit and Security Agreement, SCM held a security interest in all of the Company's, and its subsidiary guarantors', existing and after-acquired property, including receivables (which are subject to a lockbox account arrangement), inventory and equipment. Additionally, SWK holds a security interest for final and indefeasible payment. The security interest held by SWK is in substantially all of the Company's assets and the Company's subsidiaries.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In connection with the execution of the Credit Agreement, the Company issued SWK a warrant (the "Warrant") to purchase </font><font style="font-family:inherit;font-size:10pt;">543,478</font><font style="font-family:inherit;font-size:10pt;"> shares of the Company&#8217;s common stock. The Warrant is exercisable after October 17, 2015, and up to and including April 17, 2022, at an exercise price of </font><font style="font-family:inherit;font-size:10pt;">$6.90</font><font style="font-family:inherit;font-size:10pt;"> per share. The Warrant is exercisable on a cashless basis. The exercise price of the Warrant is subject to customary adjustment provisions for stock splits, stock dividends, recapitalizations and the like. The Warrant grants the holder certain piggyback registration rights. The Warrant was considered equity classified, and as such, the Company allocated the proceeds from the Term Loan to the Warrant using the Relative Fair Value Method. Further, pursuant to the Credit Agreement, if the 2013 Loan and Security Agreement was not repaid in full and terminated, and all liens securing the 2013 Loan and Security Agreement were not released, on or prior to April 30, 2016, as amended in the First Amendment to the Credit Agreement dated February 25, 2016, the Company agreed to issue an additional warrant (the &#8220;Additional Warrant&#8221;) to SWK to purchase common stock valued at </font><font style="font-family:inherit;font-size:10pt;">$1.25 million</font><font style="font-family:inherit;font-size:10pt;">, with an exercise price of the closing price on April 30, 2016. In accordance with the relevant accounting guidance, the Additional Warrant was determined to be an embedded derivative. The fair value of these warrants at the inception of the Credit Agreement of approximately </font><font style="font-family:inherit;font-size:10pt;">$3.6 million</font><font style="font-family:inherit;font-size:10pt;"> was recorded as a debt discount, and is being amortized through interest expense over the term of the Credit Agreement using the effective interest method. The Company valued both warrants using the Black-Scholes pricing model, which utilizes Level 3 Inputs. For the Warrant, the Company utilized volatility of </font><font style="font-family:inherit;font-size:10pt;">85.0%</font><font style="font-family:inherit;font-size:10pt;">, a risk-free rate of </font><font style="font-family:inherit;font-size:10pt;">1.4%</font><font style="font-family:inherit;font-size:10pt;">, dividend rate of </font><font style="font-family:inherit;font-size:10pt;">zero</font><font style="font-family:inherit;font-size:10pt;">, and term of </font><font style="font-family:inherit;font-size:10pt;">7</font><font style="font-family:inherit;font-size:10pt;"> years, which is consistent with the exercise period of the Warrant. For the Additional Warrant, the Company utilized volatility of </font><font style="font-family:inherit;font-size:10pt;">80.0%</font><font style="font-family:inherit;font-size:10pt;">, a risk-free rate of </font><font style="font-family:inherit;font-size:10pt;">2.1%</font><font style="font-family:inherit;font-size:10pt;">, dividend rate of </font><font style="font-family:inherit;font-size:10pt;">zero</font><font style="font-family:inherit;font-size:10pt;">, and term of </font><font style="font-family:inherit;font-size:10pt;">7 years</font><font style="font-family:inherit;font-size:10pt;">, which is consistent with the exercise period of the Additional Warrant.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As noted above, on April 29, 2016, the Company entered into the 2016 Credit and Security Agreement with SCM, which eliminated the requirement of the Company to issue the Additional Warrant. Accordingly, during the </font><font style="font-family:inherit;font-size:10pt;">three month period ended</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;">June&#160;30, 2016</font><font style="font-family:inherit;font-size:10pt;">, the Company recorded </font><font style="font-family:inherit;font-size:10pt;">$0.9 million</font><font style="font-family:inherit;font-size:10pt;"> in other income in the condensed consolidated statement of operations related to the write-off of the derivative liability associated with the Additional Warrant.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Share-Based Compensation </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Employee</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Share-Based Compensation Plans</font><font style="font-family:inherit;font-size:10pt;"> - On May 29, 2008, the Company's shareholders approved the 2008 Omnibus Employee Incentive Plan (the "2008 Plan") providing for the grant of stock options, stock appreciation rights, non-vested stock, and performance shares. During the </font><font style="font-family:inherit;font-size:10pt;">three and six month periods ended</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;">June&#160;30, 2016</font><font style="font-family:inherit;font-size:10pt;">, the Company granted </font><font style="font-family:inherit;font-size:10pt;">100,000</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">153,332</font><font style="font-family:inherit;font-size:10pt;"> options, respectively, for the purchase of shares under the 2008 Plan. During the </font><font style="font-family:inherit;font-size:10pt;">three and six month periods ended</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:inherit;font-size:10pt;">, the Company granted </font><font style="font-family:inherit;font-size:10pt;">667</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">40,000</font><font style="font-family:inherit;font-size:10pt;"> options, respectively. As of </font><font style="font-family:inherit;font-size:10pt;">June&#160;30, 2016</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">31,659</font><font style="font-family:inherit;font-size:10pt;"> shares remain available for grant under the 2008 Plan. </font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On May 24, 2011, the Company's shareholders approved the 2011 Omnibus Employee Incentive Plan, as subsequently amended and restated, (the "2011 Plan") providing for the grant of stock options and non-vested stock awards. During the </font><font style="font-family:inherit;font-size:10pt;">three and six month periods ended</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;">June&#160;30, 2016</font><font style="font-family:inherit;font-size:10pt;">, there were </font><font style="font-family:inherit;font-size:10pt;">no</font><font style="font-family:inherit;font-size:10pt;"> options for the purchase of shares granted under the 2011 Plan. During the </font><font style="font-family:inherit;font-size:10pt;">three month period ended</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:inherit;font-size:10pt;">, there were </font><font style="font-family:inherit;font-size:10pt;">30,000</font><font style="font-family:inherit;font-size:10pt;"> options for the purchase of shares granted under the 2011 Plan. During the </font><font style="font-family:inherit;font-size:10pt;">six month periods ended</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;">June 30, 2016 and 2015</font><font style="font-family:inherit;font-size:10pt;">, the Company also granted a total of </font><font style="font-family:inherit;font-size:10pt;">166,665</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2,778</font><font style="font-family:inherit;font-size:10pt;"> stock awards, respectively, to non-employee members of the Board of Directors that immediately vested. As of </font><font style="font-family:inherit;font-size:10pt;">June&#160;30, 2016</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">243,693</font><font style="font-family:inherit;font-size:10pt;"> shares remain available for grant under the 2011 Plan.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The fair value of the stock options granted during the </font><font style="font-family:inherit;font-size:10pt;">three and six month periods ended</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;">June&#160;30, 2016</font><font style="font-family:inherit;font-size:10pt;">, was estimated on the date of grant using the Black-Scholes option pricing model with the following weighted average assumptions:</font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="6" rowspan="1"></td></tr><tr><td style="width:67%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#cceeff;font-weight:bold;">Three Months Ended June 30,</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#cceeff;font-weight:bold;">Six Months Ended June 30,</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2016</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2016</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Expected life (years)</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.1</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Expected volatility</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">80.0%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">81.0%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Expected dividend yield</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Risk-free interest rate</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.3%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.4%</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Weighted average fair value of options granted during the period</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$1.27</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$1.33</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:9px;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes stock option activity for the </font><font style="font-family:inherit;font-size:10pt;">six month period ended</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;">June&#160;30, 2016</font><font style="font-family:inherit;font-size:10pt;">:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:52%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Number of Options</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Weighted Average Exercise Price Per Option</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Weighted Average remaining Contractual Life (years)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Aggregate Intrinsic Value (in thousands)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Outstanding balance at December 31, 2015</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">286,568</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.46</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Granted</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">153,332</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.05</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Exercised</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Forfeited and Expired</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(34,560</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.23</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Outstanding balance at June 30, 2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">405,340</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.07</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8.45</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$0</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Options exercisable at June 30, 2016</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">147,113</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7.65</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7.25</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$0</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:9px;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">There were </font><font style="font-family:inherit;font-size:10pt;">no</font><font style="font-family:inherit;font-size:10pt;"> options exercised during the </font><font style="font-family:inherit;font-size:10pt;">six month period ended</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;">June&#160;30, 2016</font><font style="font-family:inherit;font-size:10pt;">. There were </font><font style="font-family:inherit;font-size:10pt;">50,000</font><font style="font-family:inherit;font-size:10pt;"> options with a weighted average exercise price of </font><font style="font-family:inherit;font-size:10pt;">$0.45</font><font style="font-family:inherit;font-size:10pt;"> exercised during the </font><font style="font-family:inherit;font-size:10pt;">six month period ended</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:inherit;font-size:10pt;">. Options for the purchase of an aggregate of </font><font style="font-family:inherit;font-size:10pt;">30,768</font><font style="font-family:inherit;font-size:10pt;"> shares of common stock vested during the </font><font style="font-family:inherit;font-size:10pt;">six month period ended</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;">June&#160;30, 2016</font><font style="font-family:inherit;font-size:10pt;">, and the aggregate fair value at grant date of these options was </font><font style="font-family:inherit;font-size:10pt;">$0.1 million</font><font style="font-family:inherit;font-size:10pt;">. As of </font><font style="font-family:inherit;font-size:10pt;">June&#160;30, 2016</font><font style="font-family:inherit;font-size:10pt;">, there was approximately </font><font style="font-family:inherit;font-size:10pt;">$0.4 million</font><font style="font-family:inherit;font-size:10pt;"> of total unrecognized compensation cost related to stock options. The cost is expected to be recognized over a weighted average period of </font><font style="font-family:inherit;font-size:10pt;">1.74</font><font style="font-family:inherit;font-size:10pt;"> years.</font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company recorded </font><font style="font-family:inherit;font-size:10pt;">$0.4 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$0.5 million</font><font style="font-family:inherit;font-size:10pt;">, respectively, of share-based compensation expense in selling, general and administrative expenses for the </font><font style="font-family:inherit;font-size:10pt;">three and six month periods ended</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;">June&#160;30, 2016</font><font style="font-family:inherit;font-size:10pt;">. The Company recorded </font><font style="font-family:inherit;font-size:10pt;">$0.1 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$0.2 million</font><font style="font-family:inherit;font-size:10pt;">, respectively, of share-based compensation expense in selling, general and administrative expenses for the </font><font style="font-family:inherit;font-size:10pt;">three and six month periods ended</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:inherit;font-size:10pt;">.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On September 30, 2013, the Company completed the sale of certain assets comprising its Portamedic service line. During 2014, the Company sold certain assets comprising the Heritage Labs and Hooper Holmes Services businesses. The operating results of these businesses have been segregated and reported as discontinued operations for all periods presented in this Quarterly Report on Form 10-Q.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Loss Per Share </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Basic loss per share equals net loss divided by the weighted average common shares outstanding during the period.&#160;&#160;Diluted loss per share equals net loss divided by the sum of the weighted average common shares outstanding during the period plus dilutive common stock equivalents.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Loss Per Share </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Basic loss per share equals net loss divided by the weighted average common shares outstanding during the period.&#160;&#160;Diluted loss per share equals net loss divided by the sum of the weighted average common shares outstanding during the period plus dilutive common stock equivalents. The calculation of loss per common share on a basic and diluted basis was the same for the </font><font style="font-family:inherit;font-size:10pt;">three and six month periods ended</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;">June&#160;30, 2016</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2015</font><font style="font-family:inherit;font-size:10pt;">, because the inclusion of dilutive common stock equivalents and the Warrant issued in connection with the Acquisition would have been anti-dilutive for all periods presented. The Company has granted options to purchase shares of the Company's common stock through employee stock plans with the weighted average options outstanding as of </font><font style="font-family:inherit;font-size:10pt;">June&#160;30, 2016</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2015</font><font style="font-family:inherit;font-size:10pt;">, being </font><font style="font-family:inherit;font-size:10pt;">355,092</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">274,460</font><font style="font-family:inherit;font-size:10pt;">, respectively, and a warrant to purchase </font><font style="font-family:inherit;font-size:10pt;">543,478</font><font style="font-family:inherit;font-size:10pt;"> shares issued to SWK was outstanding as of </font><font style="font-family:inherit;font-size:10pt;">June&#160;30, 2016</font><font style="font-family:inherit;font-size:10pt;">, but are anti-dilutive because the Company is in a net loss position.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company estimated the fair value of the Term Loan and derivative liability using the Black-Scholes valuation model, which is a Level 3 valuation technique. </font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:96.484375%;border-collapse:collapse;text-align:left;"><tr><td colspan="25" rowspan="1"></td></tr><tr><td style="width:29%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">June&#160;30, 2016</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December&#160;31, 2015</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">(in thousands)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Face Value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fair Value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Carrying Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Face Value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fair Value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Carrying Amount</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Term Loan</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,590</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,953</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,837</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,052</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Derivative liability</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,250</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">828</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">828</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"> </font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Fair Value Measurements </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company determines the fair value measurements used in our consolidated financial statements based upon the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The fair value hierarchy distinguishes between (1) market participant assumptions developed based on market data obtained from independent sources (observable inputs) and (2) an entity&#8217;s own assumptions about market participant assumptions developed based on the best information available in the circumstances (unobservable inputs). The fair value hierarchy consists of three broad levels, which gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). The three levels of the fair value hierarchy are described below:</font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:30px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Level 1 - Valuations based on quoted prices in active markets for identical assets or liabilities that the entity has the ability to access.</font></div></td></tr></table><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:30px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Level 2 - Valuations based on quoted prices for similar assets or liabilities, quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable data for substantially the full term of the assets or liabilities.</font></div></td></tr></table><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:30px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Level 3 - Valuations based on inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.</font></div></td></tr></table><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company estimated the fair value of the Term Loan and derivative liability using the Black-Scholes valuation model, which is a Level 3 valuation technique. </font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:96.484375%;border-collapse:collapse;text-align:left;"><tr><td colspan="25" rowspan="1"></td></tr><tr><td style="width:29%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">June&#160;30, 2016</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December&#160;31, 2015</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">(in thousands)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Face Value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fair Value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Carrying Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Face Value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fair Value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Carrying Amount</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Term Loan</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,590</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,953</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,837</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,052</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Derivative liability</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,250</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">828</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">828</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Fair Value Measurements </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company determines the fair value measurements used in our consolidated financial statements based upon the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The fair value hierarchy distinguishes between (1) market participant assumptions developed based on market data obtained from independent sources (observable inputs) and (2) an entity&#8217;s own assumptions about market participant assumptions developed based on the best information available in the circumstances (unobservable inputs). The fair value hierarchy consists of three broad levels, which gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). The three levels of the fair value hierarchy are described below:</font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:30px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Level 1 - Valuations based on quoted prices in active markets for identical assets or liabilities that the entity has the ability to access.</font></div></td></tr></table><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:30px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Level 2 - Valuations based on quoted prices for similar assets or liabilities, quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable data for substantially the full term of the assets or liabilities.</font></div></td></tr></table><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:30px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Level 3 - Valuations based on inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.</font></div></td></tr></table></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Goodwill and Other Intangible Assets</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company recorded Goodwill of </font><font style="font-family:inherit;font-size:10pt;">$0.6 million</font><font style="font-family:inherit;font-size:10pt;"> as of </font><font style="font-family:inherit;font-size:10pt;">June&#160;30, 2016</font><font style="font-family:inherit;font-size:10pt;">, and </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2015</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Intangible assets subject to amortization are amortized on a straight-line basis and are summarized in the table below. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="24" rowspan="1"></td></tr><tr><td style="width:19%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">June&#160;30, 2016</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December&#160;31, 2015</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">(in thousands)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Gross Carrying Amount</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Accumulated Amortization</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Intangibles Assets, net</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Gross Carrying Amount</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Accumulated Amortization</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Intangibles Assets, net</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Portal</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,151</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,251</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,900</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,151</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">732</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,419</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Customer relationships</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,097</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">316</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,781</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,097</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">185</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,912</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,248</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,567</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,681</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,248</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">917</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,331</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amortization expense for the </font><font style="font-family:inherit;font-size:10pt;">three and six month periods ended</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;">June&#160;30, 2016</font><font style="font-family:inherit;font-size:10pt;">, was </font><font style="font-family:inherit;font-size:10pt;">$0.3 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$0.7 million</font><font style="font-family:inherit;font-size:10pt;">, respectively. Amortization expense for each of the </font><font style="font-family:inherit;font-size:10pt;">three and six month periods ended</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:inherit;font-size:10pt;">, was </font><font style="font-family:inherit;font-size:10pt;">$0.3 million</font><font style="font-family:inherit;font-size:10pt;">. </font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Based on the Company's recent financial performance and negative equity, management determined a review of impairment of long-lived assets and goodwill was necessary as of </font><font style="font-family:inherit;font-size:10pt;">June&#160;30, 2016</font><font style="font-family:inherit;font-size:10pt;">. The analysis indicated </font><font style="font-family:inherit;font-size:10pt;">no</font><font style="font-family:inherit;font-size:10pt;"> impairment charges for long-lived assets or goodwill was required at </font><font style="font-family:inherit;font-size:10pt;">June&#160;30, 2016</font><font style="font-family:inherit;font-size:10pt;">.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Income Taxes</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:9px;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company's income tax expense was not material for any period presented in the condensed consolidated statement of operations. No amounts were recorded for unrecognized tax benefits or for the payment of interest and penalties during the </font><font style="font-family:inherit;font-size:10pt;">three and six month periods ended</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;">June&#160;30, 2016</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2015</font><font style="font-family:inherit;font-size:10pt;">. No federal or state tax benefits were recorded relating to the current year loss. The Company continues to believe that a full valuation allowance is required on its net deferred tax assets, with the exception of deferred income tax on the liabilities of certain indefinite-lived intangibles.</font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The tax years 2012 through 2015 may be subject to federal examination and assessment. Tax years from 2007 through 2011 remain open solely for purposes of federal and certain state examination of net operating loss and credit carryforwards. State income tax returns may be subject to examination for tax years 2011 through 2015, depending on state tax statute of limitations.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2015</font><font style="font-family:inherit;font-size:10pt;">, the Company had U.S. federal and state net operating loss carryforwards of </font><font style="font-family:inherit;font-size:10pt;">$167.2 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$149.8 million</font><font style="font-family:inherit;font-size:10pt;">, respectively. There has been no significant change in these balances as of </font><font style="font-family:inherit;font-size:10pt;">June&#160;30, 2016</font><font style="font-family:inherit;font-size:10pt;">. The net operating loss carryforwards, if not utilized, will expire in the years </font><font style="font-family:inherit;font-size:10pt;">2016</font><font style="font-family:inherit;font-size:10pt;"> through </font><font style="font-family:inherit;font-size:10pt;">2035</font><font style="font-family:inherit;font-size:10pt;">. </font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Since the Company had changes in ownership during 2015 and continuing into the first quarter of 2016, additional limitations under IRC Section&#160;382 of the Internal Revenue Code of 1986 may apply to the future utilization of certain tax attributes including net operating loss (&#8220;NOL&#8221;) carryforwards, other tax carryforwards, and certain built-in losses. The Company has not yet completed its analysis of any impact of these ownership changes. No tax benefit has been reported since a full valuation allowance offsets these tax attributes. However, limitations could apply even if the valuation allowance was released.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes the components of interest expense for the </font><font style="font-family:inherit;font-size:10pt;">three and six month periods ended</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;">June 30, 2016 and 2015</font><font style="font-family:inherit;font-size:10pt;">:</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="17" rowspan="1"></td></tr><tr><td style="width:51%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">(in thousands)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Three Months Ended</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Six Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">June 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">June 30,</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2016</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2016</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2015</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest expense on Term Loan (interest at LIBOR, plus 14%)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">161</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">154</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">341</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">154</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest expense on 2013 Loan and Security Agreement</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">49</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest expense on 2016 Credit and Security Agreement</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">48</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">48</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accretion of termination fees (over term of Term Loan at rate of 8%)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">45</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">27</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">91</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">27</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amortization of debt issuance costs </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">62</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">197</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">123</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">280</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Write-off of debt issuance costs related to 2013 Loan and Security Agreement</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">282</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">282</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amortization of debt discount associated with the warrants</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">397</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">244</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">807</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">244</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Mark to market of the Additional Warrant </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">59</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,011</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">626</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,800</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">709</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Inventories</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Included in inventories at </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">June&#160;30, 2016</font><font style="font-family:inherit;font-size:10pt;">, and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December&#160;31, 2015</font><font style="font-family:inherit;font-size:10pt;">, are </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$0.4 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$0.3 million</font><font style="font-family:inherit;font-size:10pt;">, respectively, of finished goods and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$0.6 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$0.3 million</font><font style="font-family:inherit;font-size:10pt;">, respectively, of components.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Litigation </font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company, in the normal course of business, is a party to various claims and other legal proceedings. In the opinion of management, the Company has substantial legal defenses and/or insurance coverage (subject to deductibles) with respect to all of its pending legal actions. If management believes that a material loss not covered by insurance arising from these actions is probable and can reasonably be estimated, the Company may record the amount of the estimated loss or, if a loss cannot be estimated but the minimum liability may be estimated using a range and no point is more probable than another, the Company may record the minimum estimated liability. As additional information becomes available, any potential liability related to these actions is assessed and the estimates are revised, if necessary. Management believes that the ultimate outcome of all pending legal actions, individually and in the aggregate, will not have a material adverse effect on the Company's financial position that is inconsistent with its loss reserves or on its overall trends in results of operations. However, litigation and claims are subject to inherent uncertainties and unfavorable outcomes can occur that exceed any amounts reserved for such losses. If an unfavorable outcome were to occur, there exists the possibility of a material adverse impact on the results of operations in the period in which the outcome occurs or in future periods.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On May 24, 2012, a complaint was filed against the Company in the United States District Court for the District of New Jersey alleging, among other things, that the Company failed to pay overtime compensation to a purported class of certain independent contractor examiners who, the complaint alleges, should be treated as employees for purposes of federal law. The complaint seeks award of an unspecified amount of allegedly unpaid overtime wages to certain examiners. The Company filed an answer denying the substantive allegations therein. On August 1, 2014, the Magistrate Judge issued a Report and Recommendation to conditionally certify the class of all contract examiners from August 16, 2010, to the present. On August 29, 2014, the Company submitted its objections to the Report and Recommendation of the Magistrate Judge. The Magistrate has suspended ruling concerning those objections while the parties pursue the possibility of a settlement. On April 29, 2016, the Company reached a preliminary understanding with the plaintiffs with respect to a settlement of the lawsuit involving a release of all claims by the plaintiffs and the Company's establishment of a settlement fund of </font><font style="font-family:inherit;font-size:10pt;">$0.45 million</font><font style="font-family:inherit;font-size:10pt;">. Accordingly, as of </font><font style="font-family:inherit;font-size:10pt;">June&#160;30, 2016</font><font style="font-family:inherit;font-size:10pt;">, the Company had accrued $</font><font style="font-family:inherit;font-size:10pt;">0.45 million</font><font style="font-family:inherit;font-size:10pt;"> related to this matter versus </font><font style="font-family:inherit;font-size:10pt;">$0.3 million</font><font style="font-family:inherit;font-size:10pt;"> as of December 31, 2015. &#160;The litigation accrual for all periods was included in the Accrued expenses line item on the condensed consolidated balance sheet.&#160; The additional expense of </font><font style="font-family:inherit;font-size:10pt;">$0.15 million</font><font style="font-family:inherit;font-size:10pt;"> recorded during the six month period ended June 30, 2016, is included in the discontinued operations line item on the condensed consolidated statements of operations.&#160; This preliminary understanding is subject to approval by the Magistrate and the parties' entry into a definitive settlement agreement. The claim is not covered by insurance, and the Company is incurring legal costs to defend the litigation which are recorded in discontinued operations. This matter relates to the former Portamedic service line for which the Company retained liability.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">New Accounting Pronouncements</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In May 2014, the Financial Accounting Standards Board ("FASB") issued Accounting Standard Update ("ASU") 2014-09, "Revenue from Contracts with Customers (Topic 606)", which requires an entity to recognize the amount of revenue to which it expects to be entitled for the transfer of promised goods or services to customers. ASU 2014-09 will replace most existing revenue recognition guidance in U.S. GAAP when it becomes effective. This new guidance is effective for the Company in the first quarter of 2018, with early adoption permitted as of the original effective date or first quarter of 2017. The Company is currently evaluating the impact the adoption of ASU 2014-09 will have on the consolidated financial statements and related disclosures.</font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In August 2014, the FASB issued ASU No. 2014-15, "Presentation of Financial Statements - Going Concern (Subtopic 205-40): Disclosure of Uncertainties about an Entity's Ability to Continue as a Going Concern". This ASU requires management to assess and evaluate whether conditions or events exist, considered in the aggregate, that raise substantial doubt about the entity's ability to continue as a going concern within one year after the financial statements issue date. This standard will be effective for annual periods beginning after December 15, 2016, and for annual and interim periods thereafter; early adoption is permitted. The Company is currently evaluating the impact the adoption of ASU 2014-15 will have on the disclosures in Note 2 of the condensed consolidated financial statements.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In April 2015, the FASB issued ASU 2015-03, "Interest - Imputation of Interest (Subtopic 835-30): Simplifying the Presentation of Debt Issuance Costs", which requires that debt issuance costs be presented in the balance sheet as a direct deduction from the carrying value of the debt liability. The Company adopted the provisions of ASU 2015-03 in the first quarter of 2016. The retrospective application of the new standard resulted in a </font><font style="font-family:inherit;font-size:10pt;">$0.2 million</font><font style="font-family:inherit;font-size:10pt;"> reduction to both noncurrent assets and current liabilities as of December 31, 2015. The debt issuance costs associated with the revolving credit facilities remain classified in noncurrent assets in accordance with ASU 2015-15.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In February 2016, the FASB issued ASU No. 2016-02, "Leases (Topic 842)", which is intended to improve financial reporting about leasing transactions. This standard requires a lessee to record on the balance sheet the assets and liabilities for the rights and obligations created by lease terms of more than 12 months. This standard will be effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. The Company is currently evaluating the impact the adoption of ASU 2016-02 will have on its consolidated financial position, results of operations or cash flows.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In March 2016, the FASB issued ASU No. 2016-09, "Improvements to Employee Share-Based Payment Accounting (Topic 718)", which is intended to simplify the accounting for share-based compensation. This standard simplifies the accounting for income taxes in relation to share-based compensation, modifies the accounting for forfeitures, and modifies the statutory tax withholding requirements. This standard will be effective for fiscal years beginning after December 15, 2016, including interim periods within those fiscal years. The Company is currently evaluating the impact the adoption of ASU 2016-09 will have on its consolidated financial position, results of operations or cash flows.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Basis of Presentation</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Hooper Holmes, Inc. and its subsidiaries (&#8220;Hooper Holmes&#8221; or the "Company&#8221;) provides on-site screenings, laboratory testing, risk assessment, and sample collection services to individuals as part of comprehensive health and wellness programs offered through corporate and government employers.&#160; The acquisition of Accountable Health Services, Inc. ("AHS") ("the Acquisition"), which is discussed further in Note 3 to the condensed consolidated financial statements, allows Hooper Holmes to also deliver telephonic health coaching, a wellness portal, data analytics, and reporting services. Hooper Holmes is engaged by the organizations sponsoring such programs, including health and care management companies, broker and wellness companies, disease management organizations, reward administrators, third party administrators, clinical research organizations, and health plans. &#160;Hooper Holmes provides these services through a national network of health professionals.</font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#160;&#160;&#160;&#160;</font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company's screening business is subject to some seasonality, with the second quarter sales typically dropping below other quarters and the third and fourth quarter sales typically the strongest quarters due to increased demand for screenings from mid-August through November related to annual benefit renewal cycles. The Company's wellness services business is more constant, though there are some variations due to the timing of the health coaching programs, which are billed per participant and typically start soon after the conclusion of onsite screening events. In addition to its Screening and Health and Wellness Service operations, the Company generates ancillary revenue through the assembly of medical kits for sale to third parties.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The unaudited condensed consolidated financial statements of the Company have been prepared in accordance with instructions for Form 10-Q and the rules and regulations of the Securities and Exchange Commission ("SEC"). Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP") have been condensed or omitted pursuant to such rules and regulations. The unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto included in the Company's 2015 Annual Report on Form 10-K, filed with the SEC on March 30, 2016. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Financial statements prepared in accordance with U.S. GAAP require management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities, revenues and expenses and other disclosures. The financial information included herein is unaudited; however, such information reflects all adjustments that are, in the opinion of the Company's management, necessary for a fair statement of results for the interim periods presented. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The results of operations for the </font><font style="font-family:inherit;font-size:10pt;">three and six month periods ended</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">June&#160;30, 2016</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2015</font><font style="font-family:inherit;font-size:10pt;">, are not necessarily indicative of the results to be expected for any other interim period or the full year. See &#8220;Management's Discussion and Analysis of Financial Condition and Results of Operations&#8221; for additional information.</font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On September 30, 2013, the Company completed the sale of certain assets comprising its Portamedic service line. During 2014, the Company sold certain assets comprising the Heritage Labs and Hooper Holmes Services businesses. The operating results of these businesses have been segregated and reported as discontinued operations for all periods presented in this Quarterly Report on Form 10-Q. </font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On June 15, 2016, the Company completed a one-for-fifteen reverse stock split. As a result, the share and per share information for all periods presented in these unaudited condensed consolidated financial statements have been adjusted to reflect the impact of the reverse stock split. The reverse stock split did not affect the total number of authorized shares of common stock of </font><font style="font-family:inherit;font-size:10pt;">240,000,000</font><font style="font-family:inherit;font-size:10pt;"> shares or the par value of the Company&#8217;s common stock at </font><font style="font-family:inherit;font-size:10pt;">$0.04</font><font style="font-family:inherit;font-size:10pt;">. Accordingly, an adjustment was made between additional paid-in-capital and common stock in the condensed consolidated balance sheet to reflect the new values after the reverse stock split.</font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During the second quarter of 2016, it was determined that costs that had been expensed in the first quarter of 2016 related to the modification of the Credit Agreement (as defined in Note 9 to the condensed consolidated financial statements) and the equity issuances. Costs associated with the modification of the Credit Agreement should have been capitalized and amortized to interest expense over the remaining life of the Credit Agreement, while costs associated with the equity issuances should have been recorded as a reduction to equity. The Company recorded these correcting entries during the second quarter of 2016. The net impact of the correcting adjustments decreased reported pretax loss in the second quarter of 2016 by approximately </font><font style="font-family:inherit;font-size:10pt;">$0.2 million</font><font style="font-family:inherit;font-size:10pt;">. Management does not believe the impact of these out of period adjustments materially impacts the fair presentation of the Company&#8217;s operating results or financial condition for the periods impacted.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">New Accounting Pronouncements</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In May 2014, the Financial Accounting Standards Board ("FASB") issued Accounting Standard Update ("ASU") 2014-09, "Revenue from Contracts with Customers (Topic 606)", which requires an entity to recognize the amount of revenue to which it expects to be entitled for the transfer of promised goods or services to customers. ASU 2014-09 will replace most existing revenue recognition guidance in U.S. GAAP when it becomes effective. This new guidance is effective for the Company in the first quarter of 2018, with early adoption permitted as of the original effective date or first quarter of 2017. The Company is currently evaluating the impact the adoption of ASU 2014-09 will have on the consolidated financial statements and related disclosures.</font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In August 2014, the FASB issued ASU No. 2014-15, "Presentation of Financial Statements - Going Concern (Subtopic 205-40): Disclosure of Uncertainties about an Entity's Ability to Continue as a Going Concern". This ASU requires management to assess and evaluate whether conditions or events exist, considered in the aggregate, that raise substantial doubt about the entity's ability to continue as a going concern within one year after the financial statements issue date. This standard will be effective for annual periods beginning after December 15, 2016, and for annual and interim periods thereafter; early adoption is permitted. The Company is currently evaluating the impact the adoption of ASU 2014-15 will have on the disclosures in Note 2 of the condensed consolidated financial statements.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In April 2015, the FASB issued ASU 2015-03, "Interest - Imputation of Interest (Subtopic 835-30): Simplifying the Presentation of Debt Issuance Costs", which requires that debt issuance costs be presented in the balance sheet as a direct deduction from the carrying value of the debt liability. The Company adopted the provisions of ASU 2015-03 in the first quarter of 2016. The retrospective application of the new standard resulted in a </font><font style="font-family:inherit;font-size:10pt;">$0.2 million</font><font style="font-family:inherit;font-size:10pt;"> reduction to both noncurrent assets and current liabilities as of December 31, 2015. The debt issuance costs associated with the revolving credit facilities remain classified in noncurrent assets in accordance with ASU 2015-15.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In February 2016, the FASB issued ASU No. 2016-02, "Leases (Topic 842)", which is intended to improve financial reporting about leasing transactions. This standard requires a lessee to record on the balance sheet the assets and liabilities for the rights and obligations created by lease terms of more than 12 months. This standard will be effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. The Company is currently evaluating the impact the adoption of ASU 2016-02 will have on its consolidated financial position, results of operations or cash flows.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In March 2016, the FASB issued ASU No. 2016-09, "Improvements to Employee Share-Based Payment Accounting (Topic 718)", which is intended to simplify the accounting for share-based compensation. This standard simplifies the accounting for income taxes in relation to share-based compensation, modifies the accounting for forfeitures, and modifies the statutory tax withholding requirements. This standard will be effective for fiscal years beginning after December 15, 2016, including interim periods within those fiscal years. The Company is currently evaluating the impact the adoption of ASU 2016-09 will have on its consolidated financial position, results of operations or cash flows.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Restructuring Charges </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At </font><font style="font-family:inherit;font-size:10pt;">June&#160;30, 2016</font><font style="font-family:inherit;font-size:10pt;">, there was a </font><font style="font-family:inherit;font-size:10pt;">$0.6 million</font><font style="font-family:inherit;font-size:10pt;"> liability related to Portamedic branch closure costs, which is recorded in accrued expenses and other long-term liabilities in the accompanying condensed consolidated balance sheet. Charges recorded during the </font><font style="font-family:inherit;font-size:10pt;">three and six month periods ended</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;">June&#160;30, 2016</font><font style="font-family:inherit;font-size:10pt;">, were recorded as a component of discontinued operations. The following table provides a summary of the activity in the restructure accrual for the </font><font style="font-family:inherit;font-size:10pt;">six month period ended</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;">June&#160;30, 2016</font><font style="font-family:inherit;font-size:10pt;">:</font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:677px;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:221px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:119px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:10px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:67px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:10px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:66px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:10px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:119px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">(in thousands)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December 31, 2015</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Adjustments</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Payments</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">June 30, 2016</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Facility closure obligation</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">657</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">134</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(201</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">590</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes the Company's outstanding borrowings:</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:62%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:16%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:16%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">(in thousands)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">June&#160;30, 2016</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December&#160;31, 2015</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2016 Credit and Security Agreement (2013 Loan and Security Agreement as of December 31, 2015)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,277</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,278</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Term Loan</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,046</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Discount on Term Loan</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,977</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2,785</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unamortized debt issuance costs related to Term Loan</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(204</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(163</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total debt</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,142</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,330</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Short-term portion</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(5,142</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(5,330</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total long-term debt, net </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Intangible assets subject to amortization are amortized on a straight-line basis and are summarized in the table below. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="24" rowspan="1"></td></tr><tr><td style="width:19%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">June&#160;30, 2016</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December&#160;31, 2015</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">(in thousands)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Gross Carrying Amount</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Accumulated Amortization</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Intangibles Assets, net</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Gross Carrying Amount</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Accumulated Amortization</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Intangibles Assets, net</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Portal</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,151</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,251</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,900</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,151</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">732</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,419</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Customer relationships</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,097</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">316</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,781</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,097</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">185</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,912</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,248</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,567</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,681</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,248</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">917</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,331</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The allocation of the purchase price was finalized in the first quarter of 2016 and is as follows:</font></div><div style="line-height:120%;text-align:left;padding-left:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5" rowspan="1"></td></tr><tr><td style="width:78%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:18%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">(in thousands)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accounts receivable, net of allowance of $2</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">918</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Inventory and other current assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">117</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fixed assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">123</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Customer portal (existing technologies)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,151</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Customer relationships</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,097</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Goodwill</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">633</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accounts payable and accrued expenses</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(743</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Deferred revenue</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(296</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Purchase Price</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,000</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table provides a summary of the activity in the restructure accrual for the </font><font style="font-family:inherit;font-size:10pt;">six month period ended</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;">June&#160;30, 2016</font><font style="font-family:inherit;font-size:10pt;">:</font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:677px;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:221px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:119px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:10px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:67px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:10px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:66px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:10px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:119px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">(in thousands)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December 31, 2015</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Adjustments</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Payments</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">June 30, 2016</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Facility closure obligation</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">657</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">134</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(201</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">590</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:9px;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes stock option activity for the </font><font style="font-family:inherit;font-size:10pt;">six month period ended</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;">June&#160;30, 2016</font><font style="font-family:inherit;font-size:10pt;">:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:52%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Number of Options</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Weighted Average Exercise Price Per Option</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Weighted Average remaining Contractual Life (years)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Aggregate Intrinsic Value (in thousands)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Outstanding balance at December 31, 2015</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">286,568</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.46</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Granted</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">153,332</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.05</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Exercised</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Forfeited and Expired</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(34,560</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.23</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Outstanding balance at June 30, 2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">405,340</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.07</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8.45</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$0</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Options exercisable at June 30, 2016</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">147,113</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7.65</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7.25</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$0</font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The fair value of the stock options granted during the </font><font style="font-family:inherit;font-size:10pt;">three and six month periods ended</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;">June&#160;30, 2016</font><font style="font-family:inherit;font-size:10pt;">, was estimated on the date of grant using the Black-Scholes option pricing model with the following weighted average assumptions:</font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="6" rowspan="1"></td></tr><tr><td style="width:67%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#cceeff;font-weight:bold;">Three Months Ended June 30,</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#cceeff;font-weight:bold;">Six Months Ended June 30,</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2016</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2016</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Expected life (years)</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.1</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Expected volatility</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">80.0%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">81.0%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Expected dividend yield</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Risk-free interest rate</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.3%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.4%</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Weighted average fair value of options granted during the period</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$1.27</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$1.33</font></div></td></tr></table></div></div></div> EX-101.SCH 9 hh-20160630.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 2110100 - Disclosure - Acquisition link:presentationLink link:calculationLink link:definitionLink 2410402 - Disclosure - Acquisition - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 2410404 - Disclosure - Acquisition - Pro forma results of operations (Details) link:presentationLink link:calculationLink link:definitionLink 2410403 - Disclosure - Acquisition - Purchase price allocation (Details) link:presentationLink link:calculationLink link:definitionLink 2310301 - Disclosure - Acquisition (Tables) link:presentationLink link:calculationLink link:definitionLink 2101100 - Disclosure - Basis of Presentation link:presentationLink link:calculationLink link:definitionLink 2401402 - Disclosure - Basis of Presentation (Details) link:presentationLink link:calculationLink link:definitionLink 2201201 - Disclosure - Basis of Presentation (Policies) link:presentationLink link:calculationLink link:definitionLink 2139100 - Disclosure - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 2439401 - Disclosure - Commitments and Contingencies (Details) link:presentationLink link:calculationLink link:definitionLink 1001000 - Statement - Condensed Consolidated Balance Sheets (unaudited) link:presentationLink link:calculationLink link:definitionLink 1001501 - Statement - Condensed Consolidated Balance Sheets (unaudited) (Parentheticals) link:presentationLink link:calculationLink link:definitionLink 1004000 - Statement - Condensed Consolidated Statements of Cash Flows (unaudited) link:presentationLink link:calculationLink link:definitionLink 1002000 - Statement - Condensed Consolidated Statements of Operations (unaudited) link:presentationLink link:calculationLink link:definitionLink 1003000 - Statement - Condensed Consolidated Statements of Stockholders' (Deficit) Equity (unaudited) link:presentationLink link:calculationLink link:definitionLink 2138100 - Disclosure - Debt link:presentationLink link:calculationLink link:definitionLink 2438404 - Disclosure - Debt (Details) link:presentationLink link:calculationLink link:definitionLink 2438404 - Disclosure - Debt (Details) link:presentationLink link:calculationLink link:definitionLink 2438403 - Disclosure - Debt - Summary of Interest Expense Components (Details) link:presentationLink link:calculationLink link:definitionLink 2438402 - Disclosure - Debt - Summary of Outstanding Borrowings (Details) link:presentationLink link:calculationLink link:definitionLink 2338301 - Disclosure - Debt (Tables) link:presentationLink link:calculationLink link:definitionLink 0001000 - Document - DEI Document link:presentationLink link:calculationLink link:definitionLink 2142100 - Disclosure - Fair Value Measurements link:presentationLink link:calculationLink link:definitionLink 2442402 - Disclosure - Fair Value Measurements (Details) link:presentationLink link:calculationLink link:definitionLink 2342301 - Disclosure - Fair Value Measurements (Tables) link:presentationLink link:calculationLink link:definitionLink 2136100 - Disclosure - Goodwill and Other Intangible Assets link:presentationLink link:calculationLink link:definitionLink 2436402 - Disclosure - Goodwill and Other Intangible Assets (Details) link:presentationLink link:calculationLink link:definitionLink 2336301 - Disclosure - Goodwill and Other Intangible Assets (Tables) link:presentationLink link:calculationLink link:definitionLink 2141100 - Disclosure - Income Taxes link:presentationLink link:calculationLink link:definitionLink 2441401 - Disclosure - Income Taxes (Details) link:presentationLink link:calculationLink link:definitionLink 2135100 - Disclosure - Inventories link:presentationLink link:calculationLink link:definitionLink 2435401 - Disclosure - Inventories (Details) link:presentationLink link:calculationLink link:definitionLink 2107100 - Disclosure - Liquidity link:presentationLink link:calculationLink link:definitionLink 2407401 - Disclosure - Liquidity (Details) link:presentationLink link:calculationLink link:definitionLink 2140100 - Disclosure - Litigation link:presentationLink link:calculationLink link:definitionLink 2440401 - Disclosure - Litigation (Details) link:presentationLink link:calculationLink link:definitionLink 2122100 - Disclosure - Loss Per Share link:presentationLink link:calculationLink link:definitionLink 2422401 - Disclosure - Loss Per Share (Details) link:presentationLink link:calculationLink link:definitionLink 2137100 - Disclosure - Restructuring Charges link:presentationLink link:calculationLink link:definitionLink 2437402 - Disclosure - Restructuring Charges (Details) link:presentationLink link:calculationLink link:definitionLink 2337301 - Disclosure - Restructuring Charges (Tables) link:presentationLink link:calculationLink link:definitionLink 2131100 - Disclosure - Share-Based Compensation link:presentationLink link:calculationLink link:definitionLink 2431405 - Disclosure - Share-Based Compensation - Award Activity (Details) link:presentationLink link:calculationLink link:definitionLink 2431402 - Disclosure - Share-Based Compensation - Employee Share-Based Compensation Plans (Details) link:presentationLink link:calculationLink link:definitionLink 2431404 - Disclosure - Share-Based Compensation - Option Roll-Forward (Details) link:presentationLink link:calculationLink link:definitionLink 2431403 - Disclosure - Share-Based Compensation - Stock Option Valuation Assumptions (Details) link:presentationLink link:calculationLink link:definitionLink 2331301 - Disclosure - Share-Based Compensation (Tables) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 10 hh-20160630_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 11 hh-20160630_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 12 hh-20160630_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Organization, Consolidation and Presentation of Financial Statements [Abstract] Basis of Presentation Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] Business Combinations [Abstract] Schedule of Business Acquisitions, by Acquisition [Table] Schedule of Business Acquisitions, by Acquisition [Table] Business Acquisition [Axis] Business Acquisition [Axis] Business Acquisition, Acquiree [Domain] Business Acquisition, Acquiree [Domain] AHS acquisition Accountable Health Solutions, Inc Asset Purchase Agreement [Member] Accountable Health Solutions, Inc Asset Purchase Agreement [Member] Business Acquisition [Line Items] Business Acquisition [Line Items] Pro forma revenues Business Acquisition, Pro Forma Revenue Pro forma net loss from continuing operations Business Acquisition, Pro Forma Net Income (Loss) Restructuring Charges [Abstract] Activity in the Restructure Accrual Restructuring and Related Costs [Table Text Block] Acquisition Business Combination Disclosure [Text Block] Income Statement [Abstract] Revenues Revenues Cost of operations Cost of Goods and Services Sold Gross profit Gross Profit Selling, general and administrative expenses Selling, General and Administrative Expense Transaction costs Business Combination, Acquisition Related Costs Operating loss from continuing operations Operating Income (Loss) Interest expense, net Nonoperating Income (Expense) Other income Other Operating Income Loss from continuing operations before taxes Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest Income tax expense Income Tax Expense (Benefit) Loss from continuing operations Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent Discontinued operations: Discontinued Operations and Disposal Groups [Abstract] Loss from discontinued operations Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent Net loss Net Income (Loss) Attributable to Parent Basic and diluted loss per share: Earnings Per Share, Basic and Diluted, Other Disclosures [Abstract] Continuing operations Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent [Abstract] Basic (in dollars per share) Income (Loss) from Continuing Operations, Per Basic Share Diluted (in dollars per share) Income (Loss) from Continuing Operations, Per Diluted Share Discontinued operations Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic and Diluted Share [Abstract] Basic (in dollars per share) Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share Diluted (in dollars per share) Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Diluted Share Net loss Earnings Per Share [Abstract] Basic (in dollars per share) Earnings Per Share, Basic Diluted (in dollars per share) Earnings Per Share, Diluted Weighted average number of shares - Basic (in shares) Weighted Average Number of Shares Outstanding, Basic Weighted average number of shares - Diluted (in shares) Weighted Average Number of Shares Outstanding, Diluted Inventory Disclosure [Abstract] Inventories Inventory Disclosure [Text Block] Statement of Financial Position [Abstract] Allowance for doubtful accounts Allowance for Doubtful Accounts Receivable, Current Common stock, par value (in dollars per share) Common Stock, Par or Stated Value Per Share Common stock, shares authorized (in shares) Common Stock, Shares Authorized Common stock, shares issued (in shares) Common Stock, Shares, Issued Common stock, shares outstanding (in shares) Common Stock, Shares, Outstanding Treasury stock (in shares) Treasury Stock, Shares Finished goods Inventory, Finished Goods, Gross Components Inventory, Raw Materials, Gross Debt Disclosure [Abstract] Schedule of Long-term Debt Instruments Schedule of Long-term Debt Instruments [Table Text Block] Summary of Components of Interest Expense Interest Income and Interest Expense Disclosure [Table Text Block] Commitments and Contingencies Disclosure [Abstract] Loss Contingencies [Table] Loss Contingencies [Table] Balance Sheet Location [Axis] Balance Sheet Location [Axis] Balance Sheet Location [Domain] Balance Sheet Location [Domain] Accrued expenses Accounts Payable and Accrued Liabilities [Member] Income Statement Location [Axis] Income Statement Location [Axis] Income Statement Location [Domain] Income Statement Location [Domain] Loss from operations Operating Income (Loss) [Member] Operating Activities [Axis] Operating Activities [Axis] Operating Activities [Domain] Operating Activities [Domain] Discontinued operations Discontinued Operations [Member] Loss Contingencies [Line Items] Loss Contingencies [Line Items] Settlement fund amount Litigation Settlement, Amount Accrual of loss Loss Contingency, Estimate of Possible Loss Loss recognized in period Loss Contingency, Loss in Period Fair Value Disclosures [Abstract] Fair Value of Term Loan and Derivative Liability Fair Value, by Balance Sheet Grouping [Table Text Block] Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets, Major Class Name [Domain] Finite-Lived Intangible Assets, Major Class Name [Domain] Customer portal (existing technologies) Developed Technology Rights [Member] Customer relationships Customer Relationships [Member] Accounts receivable, net of allowance of $2 Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables Inventory and other current assets Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Inventory And Other Current Assets Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Inventory And Other Current Assets Fixed assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment Intangible assets Finite-Lived Intangible Assets, Gross Goodwill Goodwill Accounts payable and accrued expenses Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Current Liabilities, Accounts Payable And Accrued Expenses Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Current Liabilities, Accounts Payable And Accrued Expenses Deferred revenue Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Deferred Revenue Purchase Price Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net Accounts receivable, allowance Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Allowance For Doubtful Accounts Receivable Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Allowance For Doubtful Accounts Receivable Goodwill and Intangible Assets Disclosure [Abstract] Goodwill and Other Intangible Assets Goodwill and Intangible Assets Disclosure [Text Block] Loss Per Share Earnings Per Share [Text Block] Restructuring Charges Restructuring and Related Activities Disclosure [Text Block] Customer relationships Cost of operations Cost Of Goods And Services Sold [Member] Cost Of Goods And Services Sold [Member] Selling, general and administrative expenses Selling, General and Administrative Expenses [Member] Nonrecurring Adjustment [Axis] Nonrecurring Adjustment [Axis] Nonrecurring Adjustment [Domain] Nonrecurring Adjustment [Domain] Amortization of Intangible Assets Amortization Of Intangible Assets [Member] Amortization Of Intangible Assets [Member] Acquisition-related costs Acquisition-related Costs [Member] Acquisition, purchase price Business Combination, Consideration Transferred Acquisition, cash paid Payments to Acquire Businesses, Gross Shared to be issued in acquisition (up to amount) (in shares) Business Acquisition, Equity Interest Issued or Issuable, Number of Shares Value of common stock issued in acquisition Business Acquisition, Equity Interest Issued or Issuable, Value Assigned Acquisition, shares delivered at closing (in shares) Business Acquisition, Equity Interest Issued Or Issuable, Number Of Shares Delivered To Shareholder At Closing Business Acquisition, Equity Interest Issued Or Issuable, Number Of Shares Delivered To Shareholder At Closing Acquisition, shares held back for working capital adjustment (in shares) Business Acquisition, Equity Interest Issued Or Issuable, Number Of Shares Held Back For Working Capital Adjustment Business Acquisition, Equity Interest Issued Or Issuable, Number Of Shares Held Back For Working Capital Adjustment Acquisition, shares held back for indemnification (in shares) Business Acquisition, Equity Interest Issued Or Issuable, Number Of Shares Held Back For Indemnification Business Acquisition, Equity Interest Issued Or Issuable, Number Of Shares Held Back For Indemnification Number of additional shares to be issued (in shares) Business Acquisition, Equity Interest Issued or Issuable, Number of Additional Shares To Be Issued Business Acquisition, Equity Interest Issued or Issuable, Number of Additional Shares To Be Issued Estimated useful life Finite-Lived Intangible Asset, Useful Life Amortization of intangible assets Amortization of Intangible Assets Revenues attributable to AHS since the acquisition Business Combination, Pro Forma Information, Revenue of Acquiree since Acquisition Date, Actual Pro forma amortization of intangible assets Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Disclosure of Compensation Related Costs, Share-based Payments [Abstract] Expected life (years) Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term Expected volatility (as percent) Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate Expected dividend yield (as percent) Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate Risk-free interest rate (as percent) Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Weighted average fair value of options granted during the period Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value Statement of Stockholders' Equity [Abstract] Statement [Table] Statement [Table] Statement, Equity Components [Axis] Equity Components [Axis] Equity Component [Domain] Equity Component [Domain] Common Stock Common Stock [Member] Additional Paid-in Capital Additional Paid-in Capital [Member] Accumulated Deficit Retained Earnings [Member] Treasury Stock Treasury Stock [Member] Statement [Line Items] Statement [Line Items] Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Balance (in shares) Shares, Issued Balance Stockholders' Equity Attributable to Parent Net loss Issuance of common stock, net of issuance costs (in shares) Stock Issued During Period, Shares, New Issues Issuance of common stock, net of issuance costs Stock Issued During Period, Value, New Issues Share-based compensation (in shares) Stock Issued During Period, Shares, Share-based Compensation, Net of Forfeitures Stock Issued During Period, Value, Share-based Compensation, Net of Forfeitures Stock Issued During Period, Value, Share-based Compensation, Net of Forfeitures Reverse stock split re-allocation Adjustments to Additional Paid in Capital, Stock Split Other adjustments due to reverse stock split (in shares) Stock Issued During Period, Shares, Reverse Stock Splits Retirement of treasury stock (in shares) Treasury Stock, Shares, Retired Retirement of treasury stock Treasury Stock, Retired, Cost Method, Amount Balance (in shares) Balance Income Tax Disclosure [Abstract] Income Taxes Income Tax Disclosure [Text Block] Litigation Legal Matters and Contingencies [Text Block] Options exercised (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period Exercised (weighted averaged exercise price) (in dollars per share) Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Options vested in period (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options Vested in Period The number of stock options that vested during the reporting period. Aggregate fair value of options vested in period Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value Unrecognized compensation cost related to stock options Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Stock Options Weighted average period for recognition of compensation cost Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition Share-based compensation expense Allocated Share-based Compensation Expense Commitments and Contingencies Commitments and Contingencies Disclosure [Text Block] Statement of Cash Flows [Abstract] Cash flows from operating activities: Net Cash Provided by (Used in) Operating Activities [Abstract] Adjustments to reconcile net loss to net cash used in operating activities: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Depreciation and amortization Depreciation Amortization of debt discount Amortization of Debt Discount (Premium) Amortization of debt issuance costs Amortization of Debt Issuance Costs Write-off of debt issuance costs Write off of Deferred Debt Issuance Cost Accretion of termination fees Accretion Expense Mark to market of the Additional Warrant Fair Value Adjustment of Warrants Termination fees included in payoff of 2013 Loan and Security Agreement Debt Instrument, Loan Termination Fee Amount Debt Instrument, Loan Termination Fee Amount Provision for bad debt expense Provision for Doubtful Accounts Share-based compensation expense Share-based Compensation Issuance of common stock in connection with First Amendment to Credit Agreement Issuance of Common Stock in Connection with Debt Amendments Issuance of Common Stock in Connection with Debt Amendments Write-off of Additional Warrant Write off Warrants Write off Warrants Change in assets and liabilities: Increase (Decrease) in Operating Assets [Abstract] Accounts receivable Increase (Decrease) in Accounts Receivable Inventories Increase (Decrease) in Inventories Other assets Increase (Decrease) in Other Operating Assets Accounts payable, accrued expenses and other liabilities Increase (Decrease) in Accounts Payable and Other Operating Liabilities Net cash used in operating activities Net Cash Provided by (Used in) Operating Activities, Continuing Operations Cash flows from investing activities: Net Cash Provided by (Used in) Investing Activities [Abstract] Capital expenditures Payments to Acquire Property, Plant, and Equipment Acquisition of Accountable Health Solutions Net cash used in investing activities Net Cash Provided by (Used in) Investing Activities, Continuing Operations Cash flows from financing activities: Net Cash Provided by (Used in) Financing Activities [Abstract] Borrowings under credit facility Proceeds from Lines of Credit Payments under credit facility Repayments of Lines of Credit Principal payments on term loan Repayments of Notes Payable Proceeds from issuance of Term Loan Proceeds from Issuance of Long-term Debt Issuance of common stock, net of issuance costs Proceeds from Issuance of Common Stock Proceeds related to the exercise of stock options Proceeds from Stock Options Exercised Debt issuance costs Payments of Financing Costs Net cash provided by financing activities Net Cash Provided by (Used in) Financing Activities, Continuing Operations Net decrease in cash and cash equivalents Cash and Cash Equivalents, Period Increase (Decrease) Cash and cash equivalents at beginning of period Cash and Cash Equivalents, at Carrying Value Cash and cash equivalents at end of period Supplemental disclosure of non-cash investing activities: Additional Cash Flow Elements, Investing Activities [Abstract] Fixed assets vouchered but not paid Capital Expenditures Incurred but Not yet Paid Supplemental disclosure of non-cash financing activities: Supplemental Cash Flow Elements [Abstract] Issuance of common stock in connection with the Acquisition Business Combination, Consideration Transferred, Equity Interests Issued and Issuable Issuance of common stock in connection with Second Amendment to Credit Agreement Stock Issued, Debt Amendment Stock Issued, Debt Amendment Debt issuance costs vouchered but not paid Debt Issuance Costs Incurred During Noncash or Partial Noncash Transaction Payoff of 2013 Loan and Security Agreement by SCM Line of Credit Facility Payoff Noncash or Partial Noncash Transaction Line of Credit Facility Payoff Noncash or Partial Noncash Transaction Opening outstanding borrowings under 2016 Credit and Security Agreement Line of Credit Facility Opening Outstanding Costs Incurred During Noncash or Partial Noncash Transaction Line of Credit Facility Opening Outstanding Costs Incurred During Noncash or Partial Noncash Transaction Debt issuance costs incurred for 2016 Credit and Security Agreement Line of Credit Facility Costs Incurred During Noncash or Partial Noncash Transaction Line of Credit Facility Costs Incurred During Noncash or Partial Noncash Transaction Supplemental disclosure of cash paid during period for: Supplemental Cash Flow Information [Abstract] Income taxes Income Taxes Paid Interest Interest Paid Unrecognized tax benefits Unrecognized Tax Benefits Interest and penalty payments Income Tax Examination, Penalties and Interest Expense Current federal tax benefit Current Federal Tax Expense (Benefit) Current state tax benefit Current State and Local Tax Expense (Benefit) Income Tax Authority [Axis] Income Tax Authority [Axis] Income Tax Authority [Domain] Income Tax Authority [Domain] U.S. Federal Internal Revenue Service (IRS) [Member] State State and Local Jurisdiction [Member] Operating loss carryforwards, subject to expiration Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration DEI [Abstract] DEI [Abstract] Entity Registrant Name Entity Registrant Name Entity Central Index Key Entity Central Index Key Current Fiscal Year End Date Current Fiscal Year End Date Entity Filer Category Entity Filer Category Document Type Document Type Document Period End Date Document Period End Date Document Fiscal Year Focus Document Fiscal Year Focus Document Fiscal Period Focus Document Fiscal Period Focus Amendment Flag Amendment Flag Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Basis of Presentation Basis of Accounting, Policy [Policy Text Block] Discontinued Operations Discontinued Operations, Policy [Policy Text Block] New Accounting Pronouncements New Accounting Pronouncements, Policy [Policy Text Block] Loss Per Share Earnings Per Share, Policy [Policy Text Block] Fair Value Measurements Fair Value Measurement, Policy [Policy Text Block] Stock Option Activity [Roll Forward] Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward] Outstanding balance at December 31, 2015 (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number Options granted (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross Options exercised (in shares) Options forfeited and expired (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period Outstanding balance at June 30, 2016 (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract] Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract] Outstanding balance (weighted average exercise price) at December 31, 2015 (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price Granted (weighted average exercise price) (in dollars per share) Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Forfeited and Expired (weighted average exercise price) (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price Outstanding balance (weighted average exercise price) at June 30, 2016 (in dollars per share) Weighted Average Remaining Contractual Life, options outstanding Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Aggregate Intrinsic Value of options Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value Number of options exercisable at March 31, 2016 (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number Weighted average exercise price of options exercisable at March 31, 2016 (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price Weighted Average Remaining Contractual Life, options exercisable Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term Aggregate Intrinsic Value of options Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Title of Individual [Axis] Title of Individual [Axis] Relationship to Entity [Domain] Relationship to Entity [Domain] Non-employee Members Board of Directors Director [Member] Plan Name [Axis] Plan Name [Axis] Plan Name [Domain] Plan Name [Domain] 2008 Plan 2008 Plan [Member] 2008 Plan [Member] 2011 Plan 2011 Plan [Member] 2011 Plan [Member] name of equity-based compensation arrangement plan Share-based Compensation Arrangement by Share-based Payment Award Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Remaining shares available for grant under the plan (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant Amortization expense Schedule of Finite-Lived Intangible Assets [Table] Schedule of Finite-Lived Intangible Assets [Table] Portal Finite-Lived Intangible Assets [Line Items] Finite-Lived Intangible Assets [Line Items] Gross Carrying Amount Accumulated Amortization Finite-Lived Intangible Assets, Accumulated Amortization Intangibles Assets, net Finite-Lived Intangible Assets, Net Long-lived assets and goodwill impairment charges Asset Impairment Charges Schedule of Long-term Debt Instruments [Table] Schedule of Long-term Debt Instruments [Table] Long-term Debt, Type [Axis] Long-term Debt, Type [Axis] Long-term Debt, Type [Domain] Long-term Debt, Type [Domain] Loans payable Loans Payable [Member] Line of credit Line of Credit [Member] Debt Instrument [Axis] Debt Instrument [Axis] Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] Credit agreement April 17, 2015 Credit Agreement [Member] April 17, 2015 Credit Agreement [Member] 2013 Loan and Security Agreement 2013 Loan and Security Agreement [Member] 2013 Loan and Security Agreement [Member] 2016 Credit and Security Agreement 2016 Loan and Security Agreement [Member] 2016 Loan and Security Agreement Debt Instrument [Line Items] Debt Instrument [Line Items] Interest expense Interest Expense, Debt Accretion of termination fees (over term of Term Loan at rate of 8%) Accretion Expense, Termination Fees Accretion Expense, Termination Fees Amortization of deferred financing costs Amortization of debt discount associated with the warrants Accretion Expense, Debt Discount Associated With Warrant Accretion Expense, Debt Discount Associated With Warrant Total Interest Expense Spread on variable rate (as percent) Debt Instrument, Basis Spread on Variable Rate Exit fee as a percent of aggregate principal Debt Instrument, Termination Fee As A Percent Of Aggregate Principal Amount Debt Instrument, Termination Fee As A Percent Of Aggregate Principal Amount Schedule of Intangible Assets Subject to Amortization Schedule of Finite-Lived Intangible Assets [Table Text Block] Loan and Security Agreements [Table] Line of Credit Facility [Table] Transaction Cost Transaction Cost [Member] Transaction Costs Interest Expense Interest Expense [Member] Class of Warrant or Right [Axis] Class of Warrant or Right [Axis] Class of Warrant or Right [Domain] Class of Warrant or Right [Domain] Contingently Issuable Warrant Contingently Issuable Warrant [Member] Contingently Issuable Warrant [Member] Subsequent Event Type [Axis] Subsequent Event Type [Axis] Subsequent Event Type [Domain] Subsequent Event Type [Domain] Subsequent event Subsequent Event [Member] Variable Rate [Axis] Variable Rate [Axis] Variable Rate [Domain] Variable Rate [Domain] Prime rate Prime Rate [Member] LIBOR London Interbank Offered Rate (LIBOR) [Member] Other Assets Other Assets [Member] Scenario [Axis] Scenario [Axis] Scenario, Unspecified [Domain] Scenario, Unspecified [Domain] Annual Aggregate Revenue Up To And Including $20 million Annual Aggregate Revenue Up To And Including $20 million [Member] Annual Aggregate Revenue Up To And Including $20 million [Member] Annual Aggregate Revenue Greater Than $20 Million Up To And Including $30 Million Annual Aggregate Revenue Greater Than $20 Million Up To And Including $30 Million [Member] Annual Aggregate Revenue Greater Than $20 Million Up To And Including $30 Million [Member] Annual Aggregate Revenue Greater Than $30 million Annual Aggregate Revenue Greater Than $30 million [Member] Annual Aggregate Revenue Greater Than $30 million [Member] Range [Axis] Range [Axis] Range [Domain] Range [Domain] Minimum Minimum [Member] Maximum Maximum [Member] Loan and Security Agreements [Line Items] Line of Credit Facility [Line Items] Value of warrant to be issued is debt instrument is not paid Class Of Warrant Or Right, Value Of Warrant To Be Issued If Debt Instrument Is Not Paid And Terminated By Cutoff Date Class Of Warrant Or Right, Value Of Warrant To Be Issued If Debt Instrument Is Not Paid And Terminated By Cutoff Date Debt extinguishment costs, early termination fees Loss on Contract Termination Debt extinguishment cost, legal fees Legal Fees Facility fee amount Debt Instrument, Fee Amount Maximum borrowing capacity Line of Credit Facility, Maximum Borrowing Capacity Expected term Fair Value Assumptions, Expected Term Borrowings outstanding Long-term Line of Credit Available borrowing availability Line of Credit Facility, Remaining Borrowing Capacity Commitment fee, percentage (as percent) Line of Credit Facility, Commitment Fee Percentage Collateral fee (as percent) Line of Credit Facility, Collateral Fee, Percentage Line of Credit Facility, Collateral Fee, Percentage Deferred issuance costs, net Debt Issuance Costs, Net Debt covenant, minimum aggregate revenue for twelve month period ending June 30, 2016 Debt Instrument, Covenant, Minimum Aggregate Revenue, Period One Debt Instrument, Covenant, Minimum Aggregate Revenue, Period One Debt covenant, minimum aggregate revenue for twelve month period ending September 30, 2016 Debt Instrument, Covenant, Minimum Aggregate Revenue, Period Two Debt Instrument, Covenant, Minimum Aggregate Revenue, Period Two Debt covenant, minimum aggregate revenue for twelve month period ending December 31, 2016 Debt Instrument, Covenant, Minimum Aggregate Revenue, Period Three Debt Instrument, Covenant, Minimum Aggregate Revenue, Period Three Debt covenant, minimum aggregate revenue for twelve month period ending each fiscal quarter thereafter Debt Instrument, Covenant, Minimum Aggregate Revenue, Thereafter Debt Instrument, Covenant, Minimum Aggregate Revenue, Thereafter Debt covenant, minimum EBITDA amount for the three month period ending June 30, 2016 Debt Instrument, Covenant, Minimum EBITDA Amount, Period One Debt Instrument, Covenant, Minimum EBITDA Amount, Period One Debt covenant, minimum EBITDA amount for the six month period ending September 30, 2016 Debt Instrument, Covenant, Minimum EBITDA Amount, Period Two Debt Instrument, Covenant, Minimum EBITDA Amount, Period Two Debt covenant, minimum EBITDA amount for the nine month period ending December 31, 2016 Debt Instrument, Covenant, Minimum EBITDA Amount, Period Three Debt Instrument, Covenant, Minimum EBITDA Amount, Period Three Debt covenant, minimum EBITDA amount for the twelve month period ending March 31, 2017 Debt Instrument, Covenant, Minimum EBITDA Amount, Period Four Debt Instrument, Covenant, Minimum EBITDA Amount, Period Four Debt covenant, minimum EBITDA amount for the twelve month period ending June 30, 2017 Debt Instrument, Covenant, Minimum EBITDA Amount, Period Five Debt Instrument, Covenant, Minimum EBITDA Amount, Period Five Debt covenant, minimum EBITDA amount for the twelve month period ending September 30, 2017 Debt Instrument, Covenant, Minimum EBITDA Amount, Period Six Debt Instrument, Covenant, Minimum EBITDA Amount, Period Six Amount of consolidated unencumbered liquid assets required (not less than) Debt Covenant, Consolidated Unencumbered Liquid Assets Requirement Debt Covenant, Consolidated Unencumbered Liquid Assets Requirement Amount of term loan Debt Instrument, Face Amount Percent of aggregate revenue for quarterly payments Debt Instrument, Quarterly Revenue-Based Payments As A Percent Of Annual Aggregate Revenue Debt Instrument, Quarterly Revenue-Based Payments As A Percent Of Annual Aggregate Revenue Annual aggregate revenue limit Debt Instrument, Conditions, Annual Aggregate Revenue Debt Instrument, Conditions, Annual Aggregate Revenue Maximum aggregate revenue-based payment Debt Instrument, Conditions, Aggregate Revenue-Based Quarterly Payment Ceiling Debt Instrument, Conditions, Aggregate Revenue-Based Quarterly Payment Ceiling First principal payment Debt Instrument, Periodic Payment, Principal Interest paid Debt Instrument, Periodic Payment, Interest Variable rate floor, percent Debt Instrument, Variable Interest Rate Floor Debt Instrument, Variable Interest Rate Floor Debt covenant, additional equity required (not less than) Debt Instrument, Covenant, Additional Equity Required, Total Debt Instrument, Covenant, Additional Equity Required, Total Stock issued Debt covenant, maximum debt outstanding Debt Instrument, Covenant, Maximum Debt Outstanding Debt Instrument, Covenant, Maximum Debt Outstanding Number of shares to be purchased under warrant (in shares) Class of Warrant or Right, Number of Securities Called by Each Warrant or Right Exercise price of warrant (in dollars per share) Class of Warrant or Right, Exercise Price of Warrants or Rights Term loan, fair value Debt Instrument, Unamortized Discount Expected volatility rate (as percent) Fair Value Assumptions, Expected Volatility Rate Risk free interest rate (as percent) Fair Value Assumptions, Risk Free Interest Rate Dividend rate (as percent) Fair Value Assumptions, Expected Dividend Rate Other Operating Income Share-Based Compensation Disclosure of Compensation Related Costs, Share-based Payments [Text Block] Liquidity [Abstract] Liquidity [Abstract] Liquidity Liquidity [Text Block] The disclosure for the company's management of liquidity. Fair Value Measurements Fair Value Disclosures [Text Block] Total debt Long-term Debt Discount on Term Loan Unamortized debt issuance costs related to Term Loan Short-term portion Long-term Debt, Current Maturities Total long-term debt, net Long-term Debt, Excluding Current Maturities Allocation of Purchase Price Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block] Business Acquisition, Pro Forma Information Business Acquisition, Pro Forma Information [Table Text Block] Disposal Groups, Including Discontinued Operations [Table] Disposal Groups, Including Discontinued Operations [Table] Disposal Group Name [Axis] Disposal Group Name [Axis] Disposal Group Name [Domain] Disposal Group Name [Domain] Portamedic branch Portamedic Service Line [Member] Portamedic Service Line [Member] Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] Number of offices Discontinued Operations, Continuing Involvement, Entity Primary Lessee, Number Of Offices Discontinued Operations, Continuing Involvement, Entity Primary Lessee, Number Of Offices Branch closure obligation Disposal Group, Including Discontinued Operation, Branch Obligation Disposal Group, Including Discontinued Operation, Branch Obligation Employment agreements, contract term employment agreements, contract term Contract term associated with employment agreements Weighted average options outstanding (in shares) Weighted Average Number of Shares Outstanding, Basic and Diluted ASSETS Assets [Abstract] Cash and cash equivalents Accounts receivable, net of allowance for doubtful accounts of $169 and $112 at June 30, 2016 and December 31, 2015, respectively Accounts Receivable, Net, Current Inventories Inventory, Net Other current assets Other Assets, Current Total current assets Assets, Current Property, plant and equipment Property, Plant and Equipment, Gross Less: Accumulated depreciation and amortization Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Property, plant and equipment, net Property, Plant and Equipment, Net Intangible assets, net Intangible Assets, Net (Excluding Goodwill) Other assets Other Assets, Noncurrent Total assets Assets LIABILITIES AND STOCKHOLDERS' (DEFICIT) EQUITY Liabilities and Equity [Abstract] Accounts payable Accounts Payable, Current Accrued expenses Other Accrued Liabilities, Current Short-term debt Total current liabilities Liabilities, Current Other long-term liabilities Other Liabilities, Noncurrent Commitments and contingencies Commitments and Contingencies Stockholders' (deficit) equity: Stockholders' Equity Attributable to Parent [Abstract] Common stock, par value $.04 per share; Authorized: 240,000,000 shares; Issued: 8,714,636 shares at June 30, 2016, and 5,201,733 shares at December 31, 2015; Outstanding: 8,714,636 shares at June 30, 2016, and 5,201,107 shares at December 31, 2015 Common Stock, Value, Issued Additional paid-in capital Additional Paid in Capital, Common Stock Accumulated deficit Retained Earnings (Accumulated Deficit) Stockholders' (deficit) equity Stockholders' Equity before Treasury Stock Less: Treasury stock, at cost; 0 and 626 shares at June 30, 2016, and December 31, 2015 Treasury Stock, Value Total stockholders' (deficit) equity Total liabilities and stockholders' (deficit) equity Liabilities and Equity Debt Debt Disclosure [Text Block] New Accounting Pronouncements or Change in Accounting Principle [Table] New Accounting Pronouncements or Change in Accounting Principle [Table] Adjustments for Error Corrections [Axis] Adjustments for Error Corrections [Axis] Adjustments for Error Correction [Domain] Adjustments for Error Correction [Domain] Adjustment of Capitalized Costs Related to Modification of Credit Agreement Adjustment of Capitalized Costs Related to Modification of Credit Agreement [Member] Adjustment of Capitalized Costs Related to Modification of Credit Agreement Adjustments for New Accounting Pronouncements [Axis] Adjustments for New Accounting Pronouncements [Axis] Type of Adoption [Domain] Type of Adoption [Domain] Adjustments for new accounting pronouncement Adjustments for New Accounting Pronouncement [Member] Noncurrent assets Noncurrent Assets [Member] Noncurrent Assets [Member] Current liabilities Current Liabilities [Member] Current Liabilities [Member] New Accounting Pronouncements or Change in Accounting Principle [Line Items] New Accounting Pronouncements or Change in Accounting Principle [Line Items] Stock split conversion ratio Stockholders' Equity Note, Stock Split, Conversion Ratio Loss from continuing operations before taxes Stock issued (in shares) Outstanding borrowings under term loan Loans Payable Loss from continuing operations Net cash used in operating activities of continuing operations Integration costs Business Combination, Integration Related Costs Fair Value, by Balance Sheet Grouping [Table] Fair Value, by Balance Sheet Grouping [Table] Fair Value, Hierarchy [Axis] Fair Value, Hierarchy [Axis] Fair Value Hierarchy [Domain] Fair Value Hierarchy [Domain] Level 3 Fair Value, Inputs, Level 3 [Member] Measurement Basis [Axis] Measurement Basis [Axis] Fair Value Measurement [Domain] Fair Value Measurement [Domain] Portion at Fair Value Measurement Portion at Fair Value Measurement [Member] Fair Value Estimate of Fair Value Measurement [Member] Carrying Amount Reported Value Measurement [Member] Term Loan Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] Term Loan - Face Value Term Loan, Fair Value Debt Instrument, Fair Value Disclosure Term Loan, Carrying Amount Long-term Debt, Gross Derivative liability - Face Value Derivative Liability, Notional Amount Derivative liability Derivative Liability Schedule of Valuation Assumptions Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Schedule of Stock Option Activity Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block] Schedule of Restructuring and Related Costs [Table] Schedule of Restructuring and Related Costs [Table] Restructuring Type [Axis] Restructuring Type [Axis] Type of Restructuring [Domain] Type of Restructuring [Domain] Facility closure obligation Facility Closing [Member] Restructuring Cost and Reserve [Line Items] Restructuring Cost and Reserve [Line Items] Restructuring Reserve [Roll Forward] Restructuring Reserve [Roll Forward] Restructuring reserve, beginning balance Restructuring Reserve Adjustments Restructuring Charges Payments Payments for Restructuring Restructuring reserve, ending balance EX-101.PRE 13 hh-20160630_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 14 R1.htm IDEA: XBRL DOCUMENT v3.5.0.2
DEI Document - shares
 6 Months Ended
Jun. 30, 2016
Jul. 31, 2016
DEI [Abstract]    
Entity Registrant Name HOOPER HOLMES INC  
Entity Central Index Key 0000741815  
Current Fiscal Year End Date --12-31  
Entity Filer Category Smaller Reporting Company  
Document Type 10-Q  
Document Period End Date Jun. 30, 2016  
Document Fiscal Year Focus 2016  
Document Fiscal Period Focus Q2  
Amendment Flag false  
Entity Common Stock, Shares Outstanding   8,714,636
XML 15 R2.htm IDEA: XBRL DOCUMENT v3.5.0.2
Condensed Consolidated Balance Sheets (unaudited) - USD ($)
$ in Thousands
Jun. 30, 2016
Dec. 31, 2015
ASSETS    
Cash and cash equivalents $ 102 $ 2,035
Accounts receivable, net of allowance for doubtful accounts of $169 and $112 at June 30, 2016 and December 31, 2015, respectively 5,376 5,565
Inventories 981 567
Other current assets 319 331
Total current assets 6,778 8,498
Property, plant and equipment 8,549 8,427
Less: Accumulated depreciation and amortization 6,415 5,656
Property, plant and equipment, net 2,134 2,771
Intangible assets, net 4,681 5,331
Goodwill 633 633
Other assets 402 450
Total assets 14,628 17,683
LIABILITIES AND STOCKHOLDERS' (DEFICIT) EQUITY    
Accounts payable 4,734 5,339
Accrued expenses 4,685 5,186
Short-term debt 5,142 5,330
Total current liabilities 14,561 15,855
Other long-term liabilities 544 1,611
Commitments and contingencies
Stockholders' (deficit) equity:    
Common stock, par value $.04 per share; Authorized: 240,000,000 shares; Issued: 8,714,636 shares at June 30, 2016, and 5,201,733 shares at December 31, 2015; Outstanding: 8,714,636 shares at June 30, 2016, and 5,201,107 shares at December 31, 2015 349 3,121
Additional paid-in capital 164,089 156,195
Accumulated deficit (164,915) (159,028)
Stockholders' (deficit) equity (477) 288
Less: Treasury stock, at cost; 0 and 626 shares at June 30, 2016, and December 31, 2015 0 (71)
Total stockholders' (deficit) equity (477) 217
Total liabilities and stockholders' (deficit) equity $ 14,628 $ 17,683
XML 16 R3.htm IDEA: XBRL DOCUMENT v3.5.0.2
Condensed Consolidated Balance Sheets (unaudited) (Parentheticals) - USD ($)
$ in Thousands
Jun. 30, 2016
Dec. 31, 2015
Statement of Financial Position [Abstract]    
Allowance for doubtful accounts $ 169 $ 112
Common stock, par value (in dollars per share) $ 0.04 $ 0.04
Common stock, shares authorized (in shares) 240,000,000 240,000,000
Common stock, shares issued (in shares) 8,714,636 5,201,733
Common stock, shares outstanding (in shares) 8,714,636 5,201,107
Treasury stock (in shares) 0 626
XML 17 R4.htm IDEA: XBRL DOCUMENT v3.5.0.2
Condensed Consolidated Statements of Operations (unaudited) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2016
Jun. 30, 2015
Jun. 30, 2016
Jun. 30, 2015
Income Statement [Abstract]        
Revenues $ 7,643 $ 7,662 $ 14,884 $ 13,343
Cost of operations 5,878 5,969 11,659 10,918
Gross profit 1,765 1,693 3,225 2,425
Selling, general and administrative expenses 3,724 3,811 7,551 6,471
Transaction costs 221 593 329 679
Operating loss from continuing operations (2,180) (2,711) (4,655) (4,725)
Interest expense, net 1,011 626 1,800 709
Other income (887) 0 (887) 0
Loss from continuing operations before taxes (2,304) (3,337) (5,568) (5,434)
Income tax expense 5 5 10 10
Loss from continuing operations (2,309) (3,342) (5,578) (5,444)
Discontinued operations:        
Loss from discontinued operations (150) (21) (309) (25)
Net loss $ (2,459) $ (3,363) $ (5,887) $ (5,469)
Continuing operations        
Basic (in dollars per share) $ (0.27) $ (0.65) $ (0.67) $ (1.10)
Diluted (in dollars per share) (0.27) (0.65) (0.67) (1.10)
Discontinued operations        
Basic (in dollars per share) (0.02) 0.00 (0.04) (0.01)
Diluted (in dollars per share) (0.02) 0.00 (0.04) (0.01)
Net loss        
Basic (in dollars per share) (0.29) (0.65) (0.71) (1.11)
Diluted (in dollars per share) $ (0.29) $ (0.65) $ (0.71) $ (1.11)
Weighted average number of shares - Basic (in shares) 8,602,590 5,162,786 8,329,568 4,944,824
Weighted average number of shares - Diluted (in shares) 8,602,590 5,162,786 8,329,568 4,944,824
XML 18 R5.htm IDEA: XBRL DOCUMENT v3.5.0.2
Condensed Consolidated Statements of Stockholders' (Deficit) Equity (unaudited) - 6 months ended Jun. 30, 2016 - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Treasury Stock
Balance (in shares) at Dec. 31, 2015   5,201,733     626
Balance at Dec. 31, 2015 $ 217 $ 3,121 $ 156,195 $ (159,028) $ (71)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (5,887)        
Issuance of common stock, net of issuance costs (in shares)   3,346,378      
Issuance of common stock, net of issuance costs 4,723 $ 2,008 2,715    
Share-based compensation (in shares)   166,665      
Stock Issued During Period, Value, Share-based Compensation, Net of Forfeitures 470 $ 100 370    
Reverse stock split re-allocation 0 $ (4,880) 4,880    
Other adjustments due to reverse stock split (in shares)   486      
Retirement of treasury stock (in shares)   (626)     (626)
Retirement of treasury stock 0   (71)   $ 71
Balance (in shares) at Jun. 30, 2016   8,714,636     0
Balance at Jun. 30, 2016 $ (477) $ 349 $ 164,089 $ (164,915) $ 0
XML 19 R6.htm IDEA: XBRL DOCUMENT v3.5.0.2
Condensed Consolidated Statements of Cash Flows (unaudited) - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2016
Jun. 30, 2015
Cash flows from operating activities:    
Net loss $ (5,887) $ (5,469)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 1,409 873
Amortization of debt discount 807 244
Amortization of debt issuance costs 123 280
Write-off of debt issuance costs 282 0
Accretion of termination fees 91 0
Mark to market of the Additional Warrant 59 0
Termination fees included in payoff of 2013 Loan and Security Agreement 277 0
Provision for bad debt expense 117 26
Share-based compensation expense 470 193
Issuance of common stock in connection with First Amendment to Credit Agreement 50 0
Write-off of Additional Warrant (887) 0
Change in assets and liabilities:    
Accounts receivable 72 (1,667)
Inventories (414) 247
Other assets (52) (340)
Accounts payable, accrued expenses and other liabilities (1,365) 514
Net cash used in operating activities (4,848) (5,099)
Cash flows from investing activities:    
Capital expenditures (191) (355)
Acquisition of Accountable Health Solutions 0 (4,000)
Net cash used in investing activities (191) (4,355)
Cash flows from financing activities:    
Borrowings under credit facility 16,566 1,000
Payments under credit facility (17,044) (151)
Principal payments on term loan (954) 0
Proceeds from issuance of Term Loan 0 5,000
Issuance of common stock, net of issuance costs 4,574 0
Proceeds related to the exercise of stock options 0 23
Debt issuance costs (36) (377)
Net cash provided by financing activities 3,106 5,495
Net decrease in cash and cash equivalents (1,933) (3,959)
Cash and cash equivalents at beginning of period 2,035 5,201
Cash and cash equivalents at end of period 102 1,242
Supplemental disclosure of non-cash investing activities:    
Fixed assets vouchered but not paid 28 76
Supplemental disclosure of non-cash financing activities:    
Issuance of common stock in connection with the Acquisition 0 3,000
Issuance of common stock in connection with Second Amendment to Credit Agreement 100 0
Debt issuance costs vouchered but not paid 0 500
Payoff of 2013 Loan and Security Agreement by SCM (2,552) 0
Opening outstanding borrowings under 2016 Credit and Security Agreement 3,028 0
Debt issuance costs incurred for 2016 Credit and Security Agreement 236 0
Supplemental disclosure of cash paid during period for:    
Income taxes 31 0
Interest $ 466 $ 0
XML 20 R7.htm IDEA: XBRL DOCUMENT v3.5.0.2
Basis of Presentation
 6 Months Ended
Jun. 30, 2016
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Basis of Presentation
Basis of Presentation

Hooper Holmes, Inc. and its subsidiaries (“Hooper Holmes” or the "Company”) provides on-site screenings, laboratory testing, risk assessment, and sample collection services to individuals as part of comprehensive health and wellness programs offered through corporate and government employers.  The acquisition of Accountable Health Services, Inc. ("AHS") ("the Acquisition"), which is discussed further in Note 3 to the condensed consolidated financial statements, allows Hooper Holmes to also deliver telephonic health coaching, a wellness portal, data analytics, and reporting services. Hooper Holmes is engaged by the organizations sponsoring such programs, including health and care management companies, broker and wellness companies, disease management organizations, reward administrators, third party administrators, clinical research organizations, and health plans.  Hooper Holmes provides these services through a national network of health professionals.
    
The Company's screening business is subject to some seasonality, with the second quarter sales typically dropping below other quarters and the third and fourth quarter sales typically the strongest quarters due to increased demand for screenings from mid-August through November related to annual benefit renewal cycles. The Company's wellness services business is more constant, though there are some variations due to the timing of the health coaching programs, which are billed per participant and typically start soon after the conclusion of onsite screening events. In addition to its Screening and Health and Wellness Service operations, the Company generates ancillary revenue through the assembly of medical kits for sale to third parties.

The unaudited condensed consolidated financial statements of the Company have been prepared in accordance with instructions for Form 10-Q and the rules and regulations of the Securities and Exchange Commission ("SEC"). Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP") have been condensed or omitted pursuant to such rules and regulations. The unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto included in the Company's 2015 Annual Report on Form 10-K, filed with the SEC on March 30, 2016.

Financial statements prepared in accordance with U.S. GAAP require management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities, revenues and expenses and other disclosures. The financial information included herein is unaudited; however, such information reflects all adjustments that are, in the opinion of the Company's management, necessary for a fair statement of results for the interim periods presented.

The results of operations for the three and six month periods ended June 30, 2016 and 2015, are not necessarily indicative of the results to be expected for any other interim period or the full year. See “Management's Discussion and Analysis of Financial Condition and Results of Operations” for additional information.

On September 30, 2013, the Company completed the sale of certain assets comprising its Portamedic service line. During 2014, the Company sold certain assets comprising the Heritage Labs and Hooper Holmes Services businesses. The operating results of these businesses have been segregated and reported as discontinued operations for all periods presented in this Quarterly Report on Form 10-Q.

On June 15, 2016, the Company completed a one-for-fifteen reverse stock split. As a result, the share and per share information for all periods presented in these unaudited condensed consolidated financial statements have been adjusted to reflect the impact of the reverse stock split. The reverse stock split did not affect the total number of authorized shares of common stock of 240,000,000 shares or the par value of the Company’s common stock at $0.04. Accordingly, an adjustment was made between additional paid-in-capital and common stock in the condensed consolidated balance sheet to reflect the new values after the reverse stock split.

During the second quarter of 2016, it was determined that costs that had been expensed in the first quarter of 2016 related to the modification of the Credit Agreement (as defined in Note 9 to the condensed consolidated financial statements) and the equity issuances. Costs associated with the modification of the Credit Agreement should have been capitalized and amortized to interest expense over the remaining life of the Credit Agreement, while costs associated with the equity issuances should have been recorded as a reduction to equity. The Company recorded these correcting entries during the second quarter of 2016. The net impact of the correcting adjustments decreased reported pretax loss in the second quarter of 2016 by approximately $0.2 million. Management does not believe the impact of these out of period adjustments materially impacts the fair presentation of the Company’s operating results or financial condition for the periods impacted.

New Accounting Pronouncements

In May 2014, the Financial Accounting Standards Board ("FASB") issued Accounting Standard Update ("ASU") 2014-09, "Revenue from Contracts with Customers (Topic 606)", which requires an entity to recognize the amount of revenue to which it expects to be entitled for the transfer of promised goods or services to customers. ASU 2014-09 will replace most existing revenue recognition guidance in U.S. GAAP when it becomes effective. This new guidance is effective for the Company in the first quarter of 2018, with early adoption permitted as of the original effective date or first quarter of 2017. The Company is currently evaluating the impact the adoption of ASU 2014-09 will have on the consolidated financial statements and related disclosures.

In August 2014, the FASB issued ASU No. 2014-15, "Presentation of Financial Statements - Going Concern (Subtopic 205-40): Disclosure of Uncertainties about an Entity's Ability to Continue as a Going Concern". This ASU requires management to assess and evaluate whether conditions or events exist, considered in the aggregate, that raise substantial doubt about the entity's ability to continue as a going concern within one year after the financial statements issue date. This standard will be effective for annual periods beginning after December 15, 2016, and for annual and interim periods thereafter; early adoption is permitted. The Company is currently evaluating the impact the adoption of ASU 2014-15 will have on the disclosures in Note 2 of the condensed consolidated financial statements.

In April 2015, the FASB issued ASU 2015-03, "Interest - Imputation of Interest (Subtopic 835-30): Simplifying the Presentation of Debt Issuance Costs", which requires that debt issuance costs be presented in the balance sheet as a direct deduction from the carrying value of the debt liability. The Company adopted the provisions of ASU 2015-03 in the first quarter of 2016. The retrospective application of the new standard resulted in a $0.2 million reduction to both noncurrent assets and current liabilities as of December 31, 2015. The debt issuance costs associated with the revolving credit facilities remain classified in noncurrent assets in accordance with ASU 2015-15.

In February 2016, the FASB issued ASU No. 2016-02, "Leases (Topic 842)", which is intended to improve financial reporting about leasing transactions. This standard requires a lessee to record on the balance sheet the assets and liabilities for the rights and obligations created by lease terms of more than 12 months. This standard will be effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. The Company is currently evaluating the impact the adoption of ASU 2016-02 will have on its consolidated financial position, results of operations or cash flows.

In March 2016, the FASB issued ASU No. 2016-09, "Improvements to Employee Share-Based Payment Accounting (Topic 718)", which is intended to simplify the accounting for share-based compensation. This standard simplifies the accounting for income taxes in relation to share-based compensation, modifies the accounting for forfeitures, and modifies the statutory tax withholding requirements. This standard will be effective for fiscal years beginning after December 15, 2016, including interim periods within those fiscal years. The Company is currently evaluating the impact the adoption of ASU 2016-09 will have on its consolidated financial position, results of operations or cash flows.
XML 21 R8.htm IDEA: XBRL DOCUMENT v3.5.0.2
Liquidity
 6 Months Ended
Jun. 30, 2016
Liquidity [Abstract]  
Liquidity
Liquidity

The accompanying financial statements have been prepared assuming that the Company will continue as a going concern, which contemplates the realization of assets and discharge of liabilities in the normal course of business for the foreseeable future. The uncertainty regarding the Company's ability to generate sufficient cash flows and liquidity to fund operations raises substantial doubt about its ability to continue as a going concern. These financial statements do not include any adjustments that might result from the outcome of this uncertainty.

The Company has taken the following actions toward alleviating the substantial doubt that exists with regard to the Company's ability to continue as a going concern:

•
On January 25, 2016, the Company received $3.4 million, net of issuance costs, in additional equity by issuing 2,601,789 shares of its common stock, $0.04 par value, through a rights offering to current shareholders which is being used to fund working capital;

•
On March 28, 2016, the Company received $1.2 million, net of issuance costs, in additional equity by issuing 666,667 shares of its common stock, $0.04 par value, to 200 NNH, LLC, which is being used to fund working capital;

•
On March 28, 2016, the Company renegotiated its financial covenants in the Credit Agreement (as defined below) to requirements based on its forecast models; and

•
On April 29, 2016, the Company entered into a new Credit and Security Agreement with SCM Specialty Finance Opportunities Fund, L.P. (as defined below) replacing the 2013 Loan and Security Agreement (as defined below). Refer to Note 9 to the condensed consolidated financial statements for additional discussion.

The Company expects to continue to monitor its liquidity carefully, work to reduce this uncertainty, and address its cash needs through a combination of one or more of the following actions:

•
The Company will continue to aggressively seek new and return business from its existing customers and expand its presence in the Health and Wellness marketplace;

•
The Company will continue to implement further cost actions and efficiency improvements;

•
The Company expects to continue to carefully manage receipts and disbursements, including amounts and timing, focusing on reducing days receivables outstanding and managing days payables outstanding.
    
The Company's primary sources of liquidity are cash and cash equivalents as well as availability under a Credit and Security Agreement (the "2016 Credit and Security Agreement") with SCM Specialty Finance Opportunities Fund, L.P. ("SCM"). At June 30, 2016, the Company had $0.1 million in cash and cash equivalents and had $3.3 million outstanding under the 2016 Credit and Security Agreement, with available borrowing capacity of $0.3 million. As of August 9, 2016, the Company had $2.4 million outstanding with estimated available borrowing capacity of $0.8 million. As of June 30, 2016, the Company also owed approximately $4.0 million under an existing term loan ("the Term Loan"), which is governed by the terms of a credit agreement ("the Credit Agreement") with SWK Funding LLC ("SWK") and was used to fund the cash component of the Acquisition. Each of these agreements contain certain financial covenants, including various affirmative and negative covenants including minimum aggregate revenue, EBITDA, and consolidated unencumbered liquid assets requirements, which the Company did not comply with as of June 30, 2016. For additional information regarding the 2016 Credit and Security Agreement, Credit Agreement, and the related covenants, see Note 9 to the condensed consolidated financial statements.

The Company incurred a loss from continuing operations of $5.6 million during the six month period ended June 30, 2016. The Company’s net cash used in operating activities for the six month period ended June 30, 2016, was $4.8 million. The Company has managed its liquidity through availability under a revolving credit facility, raising additional equity, and a series of cost reduction initiatives.

The Company has historically used availability under a revolving credit facility to fund operations. The Company experiences a timing difference between the operating expenses and cash collection of the associated revenue based on Health and Wellness customer payment terms. To conduct successful screenings, the Company must expend cash to deliver the equipment and supplies required for the screenings and pay its health professionals and site management, all of which is done in advance of the customer invoicing process and ultimate cash receipts for services performed. Given the seasonal nature of the Company's operations, which are largely dependent on second half volumes, management expects to continue using a revolving credit facility in 2016 and beyond.

Other Considerations

The Health and Wellness business sells services directly to end customers and also through wellness, disease management, benefit brokers, and insurance companies (referred to as channel partners) who ultimately have the relationship with the end customer. Sales to direct customers offer the full suite of our services while sales of our screenings through channel partners are often aggregated with other offerings from these channel partners to provide a total solution to the end-user. As such, the Company's success is largely dependent on that of its partners.

Additionally, the Acquisition provides new offerings including the wellness portal and telephonic coaching, along with new staff, new systems, and new customers. During the six month period ended June 30, 2016, the Company incurred under $0.1 million of costs associated with the ongoing integration of AHS, which are recorded in selling, general and administrative expenses. Transition costs incurred during the three month period ended June 30, 2016, were immaterial. These costs relate primarily to transition services purchased from AHS and the ongoing transition of information technology infrastructure. The Company does not expect to continue to incur material transition costs going forward.

In addition, the Company has contractual obligations related to operating leases and employment contracts which could adversely affect liquidity.

The Company’s ability to satisfy its liquidity needs and meet future covenants is dependent on growing revenues, improving profitability, and raising additional equity. These profitability improvements primarily include expansion of the Company’s presence in the Health and Wellness marketplace through new sales to direct customers, retaining existing customers, and capitalizing on the opportunities presented by its channel partners. The Company must increase screening, telephonic health coaching, and wellness portal volumes in order to cover its fixed cost structure and improve gross profits. These improvements may be outside of management’s control. If the Company is unable to increase volumes or control operating costs, liquidity may be adversely affected.

There can be no assurance that cash flows from operations, combined with any additional borrowings available to the Company, will be obtainable in an amount sufficient to enable the Company to repay its indebtedness, or to fund other liquidity needs. If the Company is unable to comply with financial covenants in 2016 and in the event that the Company were unable to modify the covenants, find new or additional lenders, or raise additional equity, the Company would be considered in default, which would then enable the lenders to accelerate the repayment of all amounts outstanding and exercise remedies with respect to collateral, which would have a material adverse impact on the Company's business.
XML 22 R9.htm IDEA: XBRL DOCUMENT v3.5.0.2
Acquisition
 6 Months Ended
Jun. 30, 2016
Business Combinations [Abstract]  
Acquisition
Acquisition

The Company entered into and consummated the Purchase Agreement on April 17, 2015, among the Company and certain of its subsidiaries, Accountable Health Solutions, Inc. (the "Seller" or "AHS") and Accountable Health, Inc. (the "Shareholder"). Pursuant to the Purchase Agreement, the Company acquired the assets and certain liabilities representing the health and wellness business of the Seller for approximately $7.0 million - $4.0 million in cash and up to 433,333 shares of the Company’s common stock, $0.04 par value, with a value of $3.0 million, which was subject to a working capital adjustment as described in the Purchase Agreement. At the closing of the Purchase Agreement, the Company issued and delivered 371,739 shares of Common Stock to the Shareholder at closing and issued and held back 21,739 shares of Common Stock for the working capital adjustment, which were subsequently released on October 9, 2015, and 39,855 shares of Common Stock for indemnification purposes. No additional shares will be issued under the terms of the Purchase Agreement. The shares were issued pursuant to an exemption from registration under Section 4(a)(2) of the Securities Act of 1933, which provides an exemption for private offerings of securities.

In order to fund the Acquisition, the Company entered into and consummated the Credit Agreement with SWK on April 17, 2015. Refer to Note 9 of the condensed consolidated financial statements for discussion of the Credit Agreement and related warrants.

The Acquisition was treated as a purchase in accordance with Accounting Standards Codification (ASC) 805, Business Combinations, which requires allocation of the purchase price to the estimated fair values of the assets acquired and liabilities assumed in the transaction. The allocation of purchase price is based on management’s judgment after evaluating several factors, including a valuation assessment.

The allocation of the purchase price was finalized in the first quarter of 2016 and is as follows:
(in thousands)
 
 
Accounts receivable, net of allowance of $2
 
$
918

Inventory and other current assets
 
117

Fixed assets
 
123

Customer portal (existing technologies)
 
4,151

Customer relationships
 
2,097

Goodwill
 
633

Accounts payable and accrued expenses
 
(743
)
Deferred revenue
 
(296
)
           Purchase Price
 
$
7,000



Intangible assets acquired include existing technology in the form of a customer-facing wellness portal and customer relationships. The fair value of the customer relationships acquired was determined using the excess earnings method under the income approach for customer relationships; and the fair value of the wellness portal software was determined using the replacement cost method. The estimated useful life for the wellness portal and customer relationships is 4 years and 8 years, respectively. Amortization is recorded on a straight-line basis over the estimated useful life of the asset. The Company recorded amortization expense as a component of cost of operations of $0.3 million and $0.5 million, respectively, and amortization expense as a component of selling, general and administrative expenses of $0.1 million and $0.1 million, respectively, during the three and six month periods ended June 30, 2016. The Company recorded amortization expense of $0.2 million as a component of cost of operations and $0.1 million as a component of selling, general and administrative expenses for the three and six month periods ended June 30, 2015. The goodwill of $0.6 million was recorded in one reporting unit, the Health and Wellness operations, and is deductible for tax purposes.

The consolidated statement of operations for the three and six month periods ended June 30, 2016, includes revenue of $2.7 million and $5.2 million, respectively, attributable to AHS. Disclosure of the earnings contribution from the AHS business is not practicable, as the Company has already integrated operations.

The following table provides unaudited pro forma results of operations for the three and six month periods ended June 30, 2015, as if AHS was part of operations on the first day of the 2014 fiscal year.

(in thousands)
 
Three Months Ended
 
Six Months Ended
 
 
June 30,
 
June 30,
 
 
2015
 
2015
Pro forma revenues
 
$
7,662

 
$
15,750

 
 
 
 
 
Pro forma net loss from continuing operations
 
$
(2,749
)
 
$
(5,856
)


These pro forma results are based on estimates and assumptions, which the Company believes are reasonable. They are not the results that would have been realized had the Company been a combined company during the periods presented, nor are they indicative of the consolidated results of operations in future periods. The pro forma results for the six month period ended June 30, 2015, include pre-tax adjustments for amortization of intangible assets of $0.3 million. Pro forma results for the three and six month periods ended June 30, 2015, include pre-tax adjustments for the elimination of acquisition costs of $0.6 million and $0.7 million, respectively.
XML 23 R10.htm IDEA: XBRL DOCUMENT v3.5.0.2
Loss Per Share
 6 Months Ended
Jun. 30, 2016
Earnings Per Share [Abstract]  
Loss Per Share
Loss Per Share

Basic loss per share equals net loss divided by the weighted average common shares outstanding during the period.  Diluted loss per share equals net loss divided by the sum of the weighted average common shares outstanding during the period plus dilutive common stock equivalents. The calculation of loss per common share on a basic and diluted basis was the same for the three and six month periods ended June 30, 2016 and 2015, because the inclusion of dilutive common stock equivalents and the Warrant issued in connection with the Acquisition would have been anti-dilutive for all periods presented. The Company has granted options to purchase shares of the Company's common stock through employee stock plans with the weighted average options outstanding as of June 30, 2016 and 2015, being 355,092 and 274,460, respectively, and a warrant to purchase 543,478 shares issued to SWK was outstanding as of June 30, 2016, but are anti-dilutive because the Company is in a net loss position.
XML 24 R11.htm IDEA: XBRL DOCUMENT v3.5.0.2
Share-Based Compensation
 6 Months Ended
Jun. 30, 2016
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Share-Based Compensation
Share-Based Compensation

Employee Share-Based Compensation Plans - On May 29, 2008, the Company's shareholders approved the 2008 Omnibus Employee Incentive Plan (the "2008 Plan") providing for the grant of stock options, stock appreciation rights, non-vested stock, and performance shares. During the three and six month periods ended June 30, 2016, the Company granted 100,000 and 153,332 options, respectively, for the purchase of shares under the 2008 Plan. During the three and six month periods ended June 30, 2015, the Company granted 667 and 40,000 options, respectively. As of June 30, 2016, 31,659 shares remain available for grant under the 2008 Plan.
    
On May 24, 2011, the Company's shareholders approved the 2011 Omnibus Employee Incentive Plan, as subsequently amended and restated, (the "2011 Plan") providing for the grant of stock options and non-vested stock awards. During the three and six month periods ended June 30, 2016, there were no options for the purchase of shares granted under the 2011 Plan. During the three month period ended June 30, 2015, there were 30,000 options for the purchase of shares granted under the 2011 Plan. During the six month periods ended June 30, 2016 and 2015, the Company also granted a total of 166,665 and 2,778 stock awards, respectively, to non-employee members of the Board of Directors that immediately vested. As of June 30, 2016, 243,693 shares remain available for grant under the 2011 Plan.

The fair value of the stock options granted during the three and six month periods ended June 30, 2016, was estimated on the date of grant using the Black-Scholes option pricing model with the following weighted average assumptions:

 
Three Months Ended June 30,
 
Six Months Ended June 30,
 
2016
 
2016
Expected life (years)
5.3
 
5.1
Expected volatility
80.0%
 
81.0%
Expected dividend yield
—%
 
—%
Risk-free interest rate
1.3%
 
1.4%
Weighted average fair value of options granted during the period
$1.27
 
$1.33


The following table summarizes stock option activity for the six month period ended June 30, 2016:
 
 
Number of Options
 
Weighted Average Exercise Price Per Option
 
Weighted Average remaining Contractual Life (years)
 
Aggregate Intrinsic Value (in thousands)
Outstanding balance at December 31, 2015
 
286,568

 
$
6.46

 
 
 
 
Granted
 
153,332

 
2.05

 
 
 
 
Exercised
 
—

 
—

 
 
 
 
Forfeited and Expired
 
(34,560
)
 
3.23

 
 
 
 
Outstanding balance at June 30, 2016
 
405,340

 
5.07

 
8.45
 
$0
Options exercisable at June 30, 2016
 
147,113

 
$
7.65

 
7.25
 
$0


There were no options exercised during the six month period ended June 30, 2016. There were 50,000 options with a weighted average exercise price of $0.45 exercised during the six month period ended June 30, 2015. Options for the purchase of an aggregate of 30,768 shares of common stock vested during the six month period ended June 30, 2016, and the aggregate fair value at grant date of these options was $0.1 million. As of June 30, 2016, there was approximately $0.4 million of total unrecognized compensation cost related to stock options. The cost is expected to be recognized over a weighted average period of 1.74 years.
The Company recorded $0.4 million and $0.5 million, respectively, of share-based compensation expense in selling, general and administrative expenses for the three and six month periods ended June 30, 2016. The Company recorded $0.1 million and $0.2 million, respectively, of share-based compensation expense in selling, general and administrative expenses for the three and six month periods ended June 30, 2015.
XML 25 R12.htm IDEA: XBRL DOCUMENT v3.5.0.2
Inventories
 6 Months Ended
Jun. 30, 2016
Inventory Disclosure [Abstract]  
Inventories
Inventories

Included in inventories at June 30, 2016, and December 31, 2015, are $0.4 million and $0.3 million, respectively, of finished goods and $0.6 million and $0.3 million, respectively, of components.
XML 26 R13.htm IDEA: XBRL DOCUMENT v3.5.0.2
Goodwill and Other Intangible Assets
 6 Months Ended
Jun. 30, 2016
Goodwill and Intangible Assets Disclosure [Abstract]  
Goodwill and Other Intangible Assets
Goodwill and Other Intangible Assets

The Company recorded Goodwill of $0.6 million as of June 30, 2016, and December 31, 2015.

Intangible assets subject to amortization are amortized on a straight-line basis and are summarized in the table below.

 
June 30, 2016
 
December 31, 2015
(in thousands)
Gross Carrying Amount

Accumulated Amortization
 
Intangibles Assets, net
 
Gross Carrying Amount
 
Accumulated Amortization
 
Intangibles Assets, net
Portal
$
4,151

 
$
1,251

 
$
2,900

 
$
4,151

 
$
732

 
$
3,419

Customer relationships
2,097

 
316

 
1,781

 
2,097

 
185

 
1,912

        Total
$
6,248

 
$
1,567

 
$
4,681

 
$
6,248

 
$
917

 
$
5,331



Amortization expense for the three and six month periods ended June 30, 2016, was $0.3 million and $0.7 million, respectively. Amortization expense for each of the three and six month periods ended June 30, 2015, was $0.3 million.

Based on the Company's recent financial performance and negative equity, management determined a review of impairment of long-lived assets and goodwill was necessary as of June 30, 2016. The analysis indicated no impairment charges for long-lived assets or goodwill was required at June 30, 2016.
XML 27 R14.htm IDEA: XBRL DOCUMENT v3.5.0.2
Restructuring Charges
 6 Months Ended
Jun. 30, 2016
Restructuring Charges [Abstract]  
Restructuring Charges
Restructuring Charges

At June 30, 2016, there was a $0.6 million liability related to Portamedic branch closure costs, which is recorded in accrued expenses and other long-term liabilities in the accompanying condensed consolidated balance sheet. Charges recorded during the three and six month periods ended June 30, 2016, were recorded as a component of discontinued operations. The following table provides a summary of the activity in the restructure accrual for the six month period ended June 30, 2016:

(in thousands)
December 31, 2015
 
Adjustments
 
Payments
 
June 30, 2016
Facility closure obligation
$
657

 
$
134

 
$
(201
)
 
$
590
XML 28 R15.htm IDEA: XBRL DOCUMENT v3.5.0.2
Debt
 6 Months Ended
Jun. 30, 2016
Debt Disclosure [Abstract]  
Debt
Debt

As of June 30, 2016, the Company maintained the 2016 Credit and Security Agreement and the Term Loan provided by the Credit Agreement. The following table summarizes the Company's outstanding borrowings:

(in thousands)
 
June 30, 2016
 
December 31, 2015
 
 
 
 
 
2016 Credit and Security Agreement (2013 Loan and Security Agreement as of December 31, 2015)
 
$
3,277

 
$
3,278

Term Loan
 
4,046

 
5,000

Discount on Term Loan
 
(1,977
)
 
(2,785
)
Unamortized debt issuance costs related to Term Loan
 
(204
)
 
(163
)
Total debt
 
5,142

 
5,330

Short-term portion
 
(5,142
)
 
(5,330
)
Total long-term debt, net
 
$
—

 
$
—



The following table summarizes the components of interest expense for the three and six month periods ended June 30, 2016 and 2015:

(in thousands)
 
Three Months Ended
 
Six Months Ended
 
 
June 30,
 
June 30,
 
 
2016
 
2015
 
2016
 
2015
Interest expense on Term Loan (interest at LIBOR, plus 14%)
 
$
161

 
$
154

 
$
341

 
154

Interest expense on 2013 Loan and Security Agreement
 
16

 
4

 
49

 
4

Interest expense on 2016 Credit and Security Agreement
 
48

 
—

 
48

 
—

Accretion of termination fees (over term of Term Loan at rate of 8%)
 
45

 
27

 
91

 
27

Amortization of debt issuance costs
 
62

 
197

 
123

 
280

Write-off of debt issuance costs related to 2013 Loan and Security Agreement
 
282

 
—

 
282

 
—

Amortization of debt discount associated with the warrants
 
397

 
244

 
807

 
244

Mark to market of the Additional Warrant
 
—

 
—

 
59

 
—

Total
 
$
1,011

 
$
626

 
$
1,800

 
$
709



2016 Credit and Security Agreement

On April 29, 2016, the Company entered into the 2016 Credit and Security Agreement with SCM. The 2016 Credit and Security Agreement provides the Company with a revolving credit facility, the proceeds of which are to be used for general working capital purposes and capital expenditures. The 2016 Credit and Security Agreement replaced the 2013 Loan and Security Agreement, eliminating the requirement of the Company to issue the Additional Warrant for the purchase of common stock valued at $1.25 million to SWK, the holder of the Company’s Credit Agreement (see below for further information about the Additional Warrant). An early termination fee of $140,000, approximately $30,000 of legal fees, and approximately $107,000 of other ordinary course fees were accelerated due to the termination of the 2013 Loan and Security Agreement and were rolled into the opening outstanding borrowings under the 2016 Credit and Security Agreement with SCM and are reflected in transaction costs in the condensed consolidated statement of operations during the three month period ended June 30, 2016, and approximately $0.3 million of unamortized debt issuance costs related to the 2013 Loan and Security Agreement were written off and recorded in interest expense in the condensed consolidated statement of operations during the three month period ended June 30, 2016

Under the terms of the 2016 Credit and Security Agreement, SCM makes cash advances to the Company in an aggregate principal at any one time outstanding not to exceed $7 million, subject to certain loan balance limits based on the value of the Company’s eligible collateral (the “Revolving Loan Commitment Amount”). The 2016 Credit and Security Agreement has a term of three years, expiring on April 29, 2019. As of June 30, 2016, the Company had $3.3 million outstanding under the 2016 Credit and Security Agreement with available borrowing capacity of $0.3 million. As of August 9, 2016, the Company had $2.4 million outstanding, with estimated available borrowing capacity of $0.8 million.

Borrowings will bear interest at a fluctuating rate that when annualized is equal to the Prime Rate plus 5.5%, subject to increase in the event of a default. The Company paid SCM a $140,000 facility fee, and monthly, SCM will receive an unused line fee equal to one-half of one percent (0.5%) per annum of the difference derived by subtracting (i) the greater of (x) the average daily outstanding balance under the Revolving Facility during the preceding month and (y) the Minimum Balance, from (ii) the Revolving Loan Commitment Amount and also a collateral management fee equal to one-half of one percent (0.5%) per annum of the Revolving Loan Commitment Amount. As of June 30, 2016, the remaining balance in debt issuance costs recorded in Other Assets on the condensed consolidated balance sheet was $0.3 million.

The 2016 Credit and Security Agreement contains customary representations and warranties and various affirmative and negative covenants including minimum aggregate revenue, EBITDA, and consolidated unencumbered liquid assets requirements. Minimum aggregate revenue must not be less than $34.0 million for the twelve months ending June 30, 2016, $37.0 million for the twelve months ending September 30, 2016, $40.0 million for the twelve months ending December 31, 2016, and $45.0 million for the twelve months ending each fiscal quarter thereafter. Adjusted EBITDA must not be less than negative $2.0 million for the six months ending June 30, 2016, negative $1.1 million for the nine months ending September 30, 2016, $0.8 million for the twelve months ending December 31, 2016, $0.5 million for the twelve months ending March 31, 2017, $0.9 million for the twelve months ending June 30, 2017, and $2.5 million for the twelve months ending September 30, 2017. In addition, consolidated unencumbered liquid assets must not be less than $0.75 million on the last day of any quarter. The Company was not in compliance with the covenants under the 2016 Credit and Security Agreement as of June 30, 2016, and has entered into a First Amendment to Credit and Security Agreement and Limited Waiver and Forbearance (“First Amendment”), which provides a waiver related to the measurement period ended June 30, 2016. If certain conditions set forth in the First Amendment are satisfied as of September 30, 2016, the waiver and an amendment to the 2016 Credit and Security Agreement providing for revised financial covenants will become permanent.  If the Company is unable to fulfill the conditions in the First Amendment by September 30, 2016, or fails to comply with, or obtain further waivers to, the financial covenants in the First Amendment in the future, then the lenders would have the option to accelerate the repayment of all amounts outstanding and exercise remedies with respect to collateral, which would have a material adverse impact on the Company's business. The foregoing description of the First Amendment is only a summary and is qualified in its entirety by the full text of the First Amendment, which is attached as an exhibit to this Quarterly Report on Form 10-Q.

Borrowings under the Agreement are secured by a security interest in all existing and after-acquired property of the Company, including, but not limited to, its receivables (which are subject to a lockbox account arrangement), inventory and equipment.

Credit Agreement

In order to fund the Acquisition, the Company entered into the Credit Agreement with SWK on April 17, 2015, as amended on February 25, 2016, and March 28, 2016. The Credit Agreement provides the Company with a $5.0 million Term Loan. The proceeds of the Term Loan were used to pay certain fees and expenses related to the negotiation and consummation of the Purchase Agreement and the Acquisition described in Note 3 and general corporate purposes. The Company paid SWK an origination fee of $0.1 million. The Term Loan is due and payable on April 17, 2018. The Company is also required to make quarterly revenue-based payments in an amount equal to eight and one-half percent (8.5%) of yearly aggregate revenue up to and including $20 million, seven percent (7%) of yearly aggregate revenue greater than $20 million up to and including $30 million, and five percent (5%) of yearly aggregate revenue greater than $30 million. The revenue-based payment will be applied to fees and interest, and any excess to the principal of the Term Loan. Revenue-based payments commenced in February 2016, and the maximum principal portion of the aggregate revenue-based payment is capped at $600,000 per quarter. During the six month period ended June 30, 2016, the Company made principal payments to SWK of $1.0 million, in addition to $0.4 million of interest paid.
  
The outstanding principal balance under the Credit Agreement bears interest at an adjustable rate per annum equal to the LIBOR Rate (subject to a minimum amount of one percent (1.0%)) plus fourteen percent (14.0%) and is due and payable quarterly, in arrears, which commenced on August 14, 2015. Upon the earlier of (a) the maturity date on April 17, 2018, or (b) full repayment of the Term Loan, whether by acceleration or otherwise, the Company is required to pay an exit fee equal to eight percent (8%) of the aggregate principal amount of all term loans advanced under the Credit Agreement. The Company is recognizing the exit fee over the term of the Term Loan through an accretion accrual to interest expense using the effective interest method.

The Credit Agreement also contains certain financial covenants including minimum aggregate revenue, adjusted EBITDA, and consolidated unencumbered liquid assets requirements. On March 28, 2016, the Company obtained a Second Amendment to the Credit Agreement (the "Second Amendment") in which the lender modified the existing covenants and replaced them with minimum aggregate revenue covenants of $34.0 million for the twelve months ending June 30, 2016, $37.0 million for the twelve months ending September 30, 2016, $40.0 million for the twelve months ending December 31, 2016, and $45.0 million for the twelve months ending each fiscal quarter thereafter. The Second Amendment also modified the minimum adjusted EBITDA covenants for 2016 and replaced them with minimum adjusted EBITDA covenants of negative $2.0 million for the six months ending June 30, 2016, negative $1.1 million for the nine months ending September 30, 2016, $0.8 million for the twelve months ending December 31, 2016, $0.5 million for the twelve months ending March 31, 2017, $0.9 million for the twelve months ending June 30, 2017, and $2.5 million for the twelve months ending September 30, 2017, and each twelve consecutive calendar month period ending on the last day of each fiscal quarter thereafter. In addition, the Company was required to obtain new equity contributions in an aggregate amount of not less than $0.5 million between March 23, 2016 and June 30, 2016, which requirement the Company has satisfied through the private offering to 200 NNH, LLC, which is described further in Note 2 to the condensed consolidated financial statements. The Second Amendment also required the Company to issue shares of its common stock, $0.04 par value, with a value of $100,000 to SWK, which the Company issued during the first quarter of 2016 and recorded as debt issuance costs as a direct deduction to short-term debt on the condensed consolidated balance sheet as of June 30, 2016. The Company was not in compliance with the covenants under the Credit Agreement, as amended, as of June 30, 2016, and has entered into a Third Amendment to Credit Agreement and Limited Waiver and Forbearance (“Third Amendment”), which provides a waiver related to the measurement period ended June 30, 2016. If certain conditions set forth in the Third Amendment are satisfied as of September 30, 2016, the waiver and an amendment to the Credit Agreement providing for revised financial covenants and an extended period of time to make required principal payments will become permanent. If the Company is unable to fulfill the conditions in the Third Amendment by September 30, 2016, or fails to comply with, or obtain further waivers to, the financial covenants in the Third Amendment in the future, then the lenders would have the option to accelerate the repayment of all amounts outstanding and exercise remedies with respect to collateral, which would have a material adverse impact on the Company's business. The foregoing description of the Third Amendment is only a summary and is qualified in its entirety by the full text of the Third Amendment, which is attached as an exhibit to this Quarterly Report on Form 10-Q.
    
The Credit Agreement contains a cross-default provision that can be triggered if the Company has more than $0.25 million in debt outstanding under the 2016 Credit and Security Agreement and the Company fails to make payments to SCM when due or if SCM is entitled to accelerate the maturity of debt in response to a default situation under the 2016 Credit and Security Agreement, which may include violation of any financial covenants.

As of June 30, 2016, as security for payment and other obligations under the 2016 Credit and Security Agreement, SCM held a security interest in all of the Company's, and its subsidiary guarantors', existing and after-acquired property, including receivables (which are subject to a lockbox account arrangement), inventory and equipment. Additionally, SWK holds a security interest for final and indefeasible payment. The security interest held by SWK is in substantially all of the Company's assets and the Company's subsidiaries.

In connection with the execution of the Credit Agreement, the Company issued SWK a warrant (the "Warrant") to purchase 543,478 shares of the Company’s common stock. The Warrant is exercisable after October 17, 2015, and up to and including April 17, 2022, at an exercise price of $6.90 per share. The Warrant is exercisable on a cashless basis. The exercise price of the Warrant is subject to customary adjustment provisions for stock splits, stock dividends, recapitalizations and the like. The Warrant grants the holder certain piggyback registration rights. The Warrant was considered equity classified, and as such, the Company allocated the proceeds from the Term Loan to the Warrant using the Relative Fair Value Method. Further, pursuant to the Credit Agreement, if the 2013 Loan and Security Agreement was not repaid in full and terminated, and all liens securing the 2013 Loan and Security Agreement were not released, on or prior to April 30, 2016, as amended in the First Amendment to the Credit Agreement dated February 25, 2016, the Company agreed to issue an additional warrant (the “Additional Warrant”) to SWK to purchase common stock valued at $1.25 million, with an exercise price of the closing price on April 30, 2016. In accordance with the relevant accounting guidance, the Additional Warrant was determined to be an embedded derivative. The fair value of these warrants at the inception of the Credit Agreement of approximately $3.6 million was recorded as a debt discount, and is being amortized through interest expense over the term of the Credit Agreement using the effective interest method. The Company valued both warrants using the Black-Scholes pricing model, which utilizes Level 3 Inputs. For the Warrant, the Company utilized volatility of 85.0%, a risk-free rate of 1.4%, dividend rate of zero, and term of 7 years, which is consistent with the exercise period of the Warrant. For the Additional Warrant, the Company utilized volatility of 80.0%, a risk-free rate of 2.1%, dividend rate of zero, and term of 7 years, which is consistent with the exercise period of the Additional Warrant.

As noted above, on April 29, 2016, the Company entered into the 2016 Credit and Security Agreement with SCM, which eliminated the requirement of the Company to issue the Additional Warrant. Accordingly, during the three month period ended June 30, 2016, the Company recorded $0.9 million in other income in the condensed consolidated statement of operations related to the write-off of the derivative liability associated with the Additional Warrant.
XML 29 R16.htm IDEA: XBRL DOCUMENT v3.5.0.2
Commitments and Contingencies
 6 Months Ended
Jun. 30, 2016
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies
Commitments and Contingencies

The Company leases its corporate headquarters in Olathe, Kansas, which includes the Health and Wellness operations center, under an operating lease which expires in 2018. The Company leases its AHS operations centers in Des Moines, Iowa and Indianapolis, IN, under operating leases which expire in 2018. The Company also leases copiers and other miscellaneous equipment. These leases expire at various times through 2017.

The Company is obligated under a lease related to the discontinued Hooper Holmes Services operations center through 2018 and has ceased use of this facility. The Company is still the primary lessee under operating leases for two Portamedic branch offices and has recorded a facility closure obligation related to the above mentioned leases for future rent payments not utilized for continuing operations and such related costs are recorded in the reporting for discontinued operations. The Company has recorded a facility closure obligation of $0.6 million as of June 30, 2016, related to the above mentioned leases.

The Company has employment agreements with certain executive employees that provide for payment of base salary for up to a one year period in the event their employment with the Company is terminated in certain circumstances, including following a change in control, as further defined in the agreements.

From time to time, the Company is subject to federal and state tax audits and related governmental inquiries into matters such as income tax returns, sales and use tax returns, employment classification of its workers, and wage and hour law compliance. The Company is currently under examination by the Internal Revenue Service (the “IRS”) for the calendar years 2013, 2014, and 2015 with respect to its classification of certain of its health professionals as independent contractors rather than employees. This examination could lead to proposed adjustments to its federal employment taxes for the periods in question, but the IRS has not yet issued an assessment. The Company believes that it has properly classified these workers as independent contractors, but there can be no assurances of a favorable outcome for the Company and given the ongoing status of the examination, we are unable at this time to provide an estimate of the range of loss, if any.
XML 30 R17.htm IDEA: XBRL DOCUMENT v3.5.0.2
Litigation
 6 Months Ended
Jun. 30, 2016
Commitments and Contingencies Disclosure [Abstract]  
Litigation
Litigation

The Company, in the normal course of business, is a party to various claims and other legal proceedings. In the opinion of management, the Company has substantial legal defenses and/or insurance coverage (subject to deductibles) with respect to all of its pending legal actions. If management believes that a material loss not covered by insurance arising from these actions is probable and can reasonably be estimated, the Company may record the amount of the estimated loss or, if a loss cannot be estimated but the minimum liability may be estimated using a range and no point is more probable than another, the Company may record the minimum estimated liability. As additional information becomes available, any potential liability related to these actions is assessed and the estimates are revised, if necessary. Management believes that the ultimate outcome of all pending legal actions, individually and in the aggregate, will not have a material adverse effect on the Company's financial position that is inconsistent with its loss reserves or on its overall trends in results of operations. However, litigation and claims are subject to inherent uncertainties and unfavorable outcomes can occur that exceed any amounts reserved for such losses. If an unfavorable outcome were to occur, there exists the possibility of a material adverse impact on the results of operations in the period in which the outcome occurs or in future periods.

On May 24, 2012, a complaint was filed against the Company in the United States District Court for the District of New Jersey alleging, among other things, that the Company failed to pay overtime compensation to a purported class of certain independent contractor examiners who, the complaint alleges, should be treated as employees for purposes of federal law. The complaint seeks award of an unspecified amount of allegedly unpaid overtime wages to certain examiners. The Company filed an answer denying the substantive allegations therein. On August 1, 2014, the Magistrate Judge issued a Report and Recommendation to conditionally certify the class of all contract examiners from August 16, 2010, to the present. On August 29, 2014, the Company submitted its objections to the Report and Recommendation of the Magistrate Judge. The Magistrate has suspended ruling concerning those objections while the parties pursue the possibility of a settlement. On April 29, 2016, the Company reached a preliminary understanding with the plaintiffs with respect to a settlement of the lawsuit involving a release of all claims by the plaintiffs and the Company's establishment of a settlement fund of $0.45 million. Accordingly, as of June 30, 2016, the Company had accrued $0.45 million related to this matter versus $0.3 million as of December 31, 2015.  The litigation accrual for all periods was included in the Accrued expenses line item on the condensed consolidated balance sheet.  The additional expense of $0.15 million recorded during the six month period ended June 30, 2016, is included in the discontinued operations line item on the condensed consolidated statements of operations.  This preliminary understanding is subject to approval by the Magistrate and the parties' entry into a definitive settlement agreement. The claim is not covered by insurance, and the Company is incurring legal costs to defend the litigation which are recorded in discontinued operations. This matter relates to the former Portamedic service line for which the Company retained liability.
XML 31 R18.htm IDEA: XBRL DOCUMENT v3.5.0.2
Income Taxes
 6 Months Ended
Jun. 30, 2016
Income Tax Disclosure [Abstract]  
Income Taxes
Income Taxes

The Company's income tax expense was not material for any period presented in the condensed consolidated statement of operations. No amounts were recorded for unrecognized tax benefits or for the payment of interest and penalties during the three and six month periods ended June 30, 2016 and 2015. No federal or state tax benefits were recorded relating to the current year loss. The Company continues to believe that a full valuation allowance is required on its net deferred tax assets, with the exception of deferred income tax on the liabilities of certain indefinite-lived intangibles.
The tax years 2012 through 2015 may be subject to federal examination and assessment. Tax years from 2007 through 2011 remain open solely for purposes of federal and certain state examination of net operating loss and credit carryforwards. State income tax returns may be subject to examination for tax years 2011 through 2015, depending on state tax statute of limitations.

As of December 31, 2015, the Company had U.S. federal and state net operating loss carryforwards of $167.2 million and $149.8 million, respectively. There has been no significant change in these balances as of June 30, 2016. The net operating loss carryforwards, if not utilized, will expire in the years 2016 through 2035.

Since the Company had changes in ownership during 2015 and continuing into the first quarter of 2016, additional limitations under IRC Section 382 of the Internal Revenue Code of 1986 may apply to the future utilization of certain tax attributes including net operating loss (“NOL”) carryforwards, other tax carryforwards, and certain built-in losses. The Company has not yet completed its analysis of any impact of these ownership changes. No tax benefit has been reported since a full valuation allowance offsets these tax attributes. However, limitations could apply even if the valuation allowance was released.
XML 32 R19.htm IDEA: XBRL DOCUMENT v3.5.0.2
Fair Value Measurements
 6 Months Ended
Jun. 30, 2016
Fair Value Disclosures [Abstract]  
Fair Value Measurements
Fair Value Measurements

The Company determines the fair value measurements used in our consolidated financial statements based upon the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The fair value hierarchy distinguishes between (1) market participant assumptions developed based on market data obtained from independent sources (observable inputs) and (2) an entity’s own assumptions about market participant assumptions developed based on the best information available in the circumstances (unobservable inputs). The fair value hierarchy consists of three broad levels, which gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). The three levels of the fair value hierarchy are described below:

•
Level 1 - Valuations based on quoted prices in active markets for identical assets or liabilities that the entity has the ability to access.

•
Level 2 - Valuations based on quoted prices for similar assets or liabilities, quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable data for substantially the full term of the assets or liabilities.

•
Level 3 - Valuations based on inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.

The Company estimated the fair value of the Term Loan and derivative liability using the Black-Scholes valuation model, which is a Level 3 valuation technique.
 
 
June 30, 2016
 
December 31, 2015
(in thousands)
 
Face Value

Fair Value

Carrying Amount
 
Face Value
 
Fair Value
 
Carrying Amount
Term Loan
 
$
5,000

 
$
3,590

 
$
1,953

 
$
5,000

 
$
3,837

 
$
2,052

Derivative liability
 
$
—

 
$
—

 
$
—

 
$
1,250

 
$
828

 
$
828
XML 33 R20.htm IDEA: XBRL DOCUMENT v3.5.0.2
Basis of Presentation (Policies)
 6 Months Ended
Jun. 30, 2016
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Basis of Presentation
The unaudited condensed consolidated financial statements of the Company have been prepared in accordance with instructions for Form 10-Q and the rules and regulations of the Securities and Exchange Commission ("SEC"). Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP") have been condensed or omitted pursuant to such rules and regulations. The unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto included in the Company's 2015 Annual Report on Form 10-K, filed with the SEC on March 30, 2016.

Financial statements prepared in accordance with U.S. GAAP require management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities, revenues and expenses and other disclosures. The financial information included herein is unaudited; however, such information reflects all adjustments that are, in the opinion of the Company's management, necessary for a fair statement of results for the interim periods presented.

The results of operations for the three and six month periods ended June 30, 2016 and 2015, are not necessarily indicative of the results to be expected for any other interim period or the full year. See “Management's Discussion and Analysis of Financial Condition and Results of Operations” for additional information.
Discontinued Operations
On September 30, 2013, the Company completed the sale of certain assets comprising its Portamedic service line. During 2014, the Company sold certain assets comprising the Heritage Labs and Hooper Holmes Services businesses. The operating results of these businesses have been segregated and reported as discontinued operations for all periods presented in this Quarterly Report on Form 10-Q.
New Accounting Pronouncements
New Accounting Pronouncements

In May 2014, the Financial Accounting Standards Board ("FASB") issued Accounting Standard Update ("ASU") 2014-09, "Revenue from Contracts with Customers (Topic 606)", which requires an entity to recognize the amount of revenue to which it expects to be entitled for the transfer of promised goods or services to customers. ASU 2014-09 will replace most existing revenue recognition guidance in U.S. GAAP when it becomes effective. This new guidance is effective for the Company in the first quarter of 2018, with early adoption permitted as of the original effective date or first quarter of 2017. The Company is currently evaluating the impact the adoption of ASU 2014-09 will have on the consolidated financial statements and related disclosures.

In August 2014, the FASB issued ASU No. 2014-15, "Presentation of Financial Statements - Going Concern (Subtopic 205-40): Disclosure of Uncertainties about an Entity's Ability to Continue as a Going Concern". This ASU requires management to assess and evaluate whether conditions or events exist, considered in the aggregate, that raise substantial doubt about the entity's ability to continue as a going concern within one year after the financial statements issue date. This standard will be effective for annual periods beginning after December 15, 2016, and for annual and interim periods thereafter; early adoption is permitted. The Company is currently evaluating the impact the adoption of ASU 2014-15 will have on the disclosures in Note 2 of the condensed consolidated financial statements.

In April 2015, the FASB issued ASU 2015-03, "Interest - Imputation of Interest (Subtopic 835-30): Simplifying the Presentation of Debt Issuance Costs", which requires that debt issuance costs be presented in the balance sheet as a direct deduction from the carrying value of the debt liability. The Company adopted the provisions of ASU 2015-03 in the first quarter of 2016. The retrospective application of the new standard resulted in a $0.2 million reduction to both noncurrent assets and current liabilities as of December 31, 2015. The debt issuance costs associated with the revolving credit facilities remain classified in noncurrent assets in accordance with ASU 2015-15.

In February 2016, the FASB issued ASU No. 2016-02, "Leases (Topic 842)", which is intended to improve financial reporting about leasing transactions. This standard requires a lessee to record on the balance sheet the assets and liabilities for the rights and obligations created by lease terms of more than 12 months. This standard will be effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. The Company is currently evaluating the impact the adoption of ASU 2016-02 will have on its consolidated financial position, results of operations or cash flows.

In March 2016, the FASB issued ASU No. 2016-09, "Improvements to Employee Share-Based Payment Accounting (Topic 718)", which is intended to simplify the accounting for share-based compensation. This standard simplifies the accounting for income taxes in relation to share-based compensation, modifies the accounting for forfeitures, and modifies the statutory tax withholding requirements. This standard will be effective for fiscal years beginning after December 15, 2016, including interim periods within those fiscal years. The Company is currently evaluating the impact the adoption of ASU 2016-09 will have on its consolidated financial position, results of operations or cash flows.
Loss Per Share
Loss Per Share

Basic loss per share equals net loss divided by the weighted average common shares outstanding during the period.  Diluted loss per share equals net loss divided by the sum of the weighted average common shares outstanding during the period plus dilutive common stock equivalents.
Fair Value Measurements
Fair Value Measurements

The Company determines the fair value measurements used in our consolidated financial statements based upon the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The fair value hierarchy distinguishes between (1) market participant assumptions developed based on market data obtained from independent sources (observable inputs) and (2) an entity’s own assumptions about market participant assumptions developed based on the best information available in the circumstances (unobservable inputs). The fair value hierarchy consists of three broad levels, which gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). The three levels of the fair value hierarchy are described below:

•
Level 1 - Valuations based on quoted prices in active markets for identical assets or liabilities that the entity has the ability to access.

•
Level 2 - Valuations based on quoted prices for similar assets or liabilities, quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable data for substantially the full term of the assets or liabilities.

•
Level 3 - Valuations based on inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.
XML 34 R21.htm IDEA: XBRL DOCUMENT v3.5.0.2
Acquisition (Tables)
 6 Months Ended
Jun. 30, 2016
Business Combinations [Abstract]  
Allocation of Purchase Price
The allocation of the purchase price was finalized in the first quarter of 2016 and is as follows:
(in thousands)
 
 
Accounts receivable, net of allowance of $2
 
$
918

Inventory and other current assets
 
117

Fixed assets
 
123

Customer portal (existing technologies)
 
4,151

Customer relationships
 
2,097

Goodwill
 
633

Accounts payable and accrued expenses
 
(743
)
Deferred revenue
 
(296
)
           Purchase Price
 
$
7,000
Business Acquisition, Pro Forma Information
The following table provides unaudited pro forma results of operations for the three and six month periods ended June 30, 2015, as if AHS was part of operations on the first day of the 2014 fiscal year.

(in thousands)
 
Three Months Ended
 
Six Months Ended
 
 
June 30,
 
June 30,
 
 
2015
 
2015
Pro forma revenues
 
$
7,662

 
$
15,750

 
 
 
 
 
Pro forma net loss from continuing operations
 
$
(2,749
)
 
$
(5,856
)
XML 35 R22.htm IDEA: XBRL DOCUMENT v3.5.0.2
Share-Based Compensation (Tables)
 6 Months Ended
Jun. 30, 2016
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Schedule of Valuation Assumptions
The fair value of the stock options granted during the three and six month periods ended June 30, 2016, was estimated on the date of grant using the Black-Scholes option pricing model with the following weighted average assumptions:

 
Three Months Ended June 30,
 
Six Months Ended June 30,
 
2016
 
2016
Expected life (years)
5.3
 
5.1
Expected volatility
80.0%
 
81.0%
Expected dividend yield
—%
 
—%
Risk-free interest rate
1.3%
 
1.4%
Weighted average fair value of options granted during the period
$1.27
 
$1.33
Schedule of Stock Option Activity
The following table summarizes stock option activity for the six month period ended June 30, 2016:
 
 
Number of Options
 
Weighted Average Exercise Price Per Option
 
Weighted Average remaining Contractual Life (years)
 
Aggregate Intrinsic Value (in thousands)
Outstanding balance at December 31, 2015
 
286,568

 
$
6.46

 
 
 
 
Granted
 
153,332

 
2.05

 
 
 
 
Exercised
 
—

 
—

 
 
 
 
Forfeited and Expired
 
(34,560
)
 
3.23

 
 
 
 
Outstanding balance at June 30, 2016
 
405,340

 
5.07

 
8.45
 
$0
Options exercisable at June 30, 2016
 
147,113

 
$
7.65

 
7.25
 
$0
XML 36 R23.htm IDEA: XBRL DOCUMENT v3.5.0.2
Goodwill and Other Intangible Assets (Tables)
 6 Months Ended
Jun. 30, 2016
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of Intangible Assets Subject to Amortization
Intangible assets subject to amortization are amortized on a straight-line basis and are summarized in the table below.

 
June 30, 2016
 
December 31, 2015
(in thousands)
Gross Carrying Amount

Accumulated Amortization
 
Intangibles Assets, net
 
Gross Carrying Amount
 
Accumulated Amortization
 
Intangibles Assets, net
Portal
$
4,151

 
$
1,251

 
$
2,900

 
$
4,151

 
$
732

 
$
3,419

Customer relationships
2,097

 
316

 
1,781

 
2,097

 
185

 
1,912

        Total
$
6,248

 
$
1,567

 
$
4,681

 
$
6,248

 
$
917

 
$
5,331
XML 37 R24.htm IDEA: XBRL DOCUMENT v3.5.0.2
Restructuring Charges (Tables)
 6 Months Ended
Jun. 30, 2016
Restructuring Charges [Abstract]  
Activity in the Restructure Accrual
The following table provides a summary of the activity in the restructure accrual for the six month period ended June 30, 2016:

(in thousands)
December 31, 2015
 
Adjustments
 
Payments
 
June 30, 2016
Facility closure obligation
$
657

 
$
134

 
$
(201
)
 
$
590
XML 38 R25.htm IDEA: XBRL DOCUMENT v3.5.0.2
Debt (Tables)
 6 Months Ended
Jun. 30, 2016
Debt Disclosure [Abstract]  
Schedule of Long-term Debt Instruments
The following table summarizes the Company's outstanding borrowings:

(in thousands)
 
June 30, 2016
 
December 31, 2015
 
 
 
 
 
2016 Credit and Security Agreement (2013 Loan and Security Agreement as of December 31, 2015)
 
$
3,277

 
$
3,278

Term Loan
 
4,046

 
5,000

Discount on Term Loan
 
(1,977
)
 
(2,785
)
Unamortized debt issuance costs related to Term Loan
 
(204
)
 
(163
)
Total debt
 
5,142

 
5,330

Short-term portion
 
(5,142
)
 
(5,330
)
Total long-term debt, net
 
$
—

 
$
—
Summary of Components of Interest Expense
The following table summarizes the components of interest expense for the three and six month periods ended June 30, 2016 and 2015:

(in thousands)
 
Three Months Ended
 
Six Months Ended
 
 
June 30,
 
June 30,
 
 
2016
 
2015
 
2016
 
2015
Interest expense on Term Loan (interest at LIBOR, plus 14%)
 
$
161

 
$
154

 
$
341

 
154

Interest expense on 2013 Loan and Security Agreement
 
16

 
4

 
49

 
4

Interest expense on 2016 Credit and Security Agreement
 
48

 
—

 
48

 
—

Accretion of termination fees (over term of Term Loan at rate of 8%)
 
45

 
27

 
91

 
27

Amortization of debt issuance costs
 
62

 
197

 
123

 
280

Write-off of debt issuance costs related to 2013 Loan and Security Agreement
 
282

 
—

 
282

 
—

Amortization of debt discount associated with the warrants
 
397

 
244

 
807

 
244

Mark to market of the Additional Warrant
 
—

 
—

 
59

 
—

Total
 
$
1,011

 
$
626

 
$
1,800

 
$
709
XML 39 R26.htm IDEA: XBRL DOCUMENT v3.5.0.2
Fair Value Measurements (Tables)
 6 Months Ended
Jun. 30, 2016
Fair Value Disclosures [Abstract]  
Fair Value of Term Loan and Derivative Liability
The Company estimated the fair value of the Term Loan and derivative liability using the Black-Scholes valuation model, which is a Level 3 valuation technique.
 
 
June 30, 2016
 
December 31, 2015
(in thousands)
 
Face Value

Fair Value

Carrying Amount
 
Face Value
 
Fair Value
 
Carrying Amount
Term Loan
 
$
5,000

 
$
3,590

 
$
1,953

 
$
5,000

 
$
3,837

 
$
2,052

Derivative liability
 
$
—

 
$
—

 
$
—

 
$
1,250

 
$
828

 
$
828
XML 40 R27.htm IDEA: XBRL DOCUMENT v3.5.0.2
Basis of Presentation (Details)
$ / shares in Units, $ in Thousands
 3 Months Ended 6 Months Ended
Jun. 15, 2016
$ / shares
shares
Jun. 30, 2016
USD ($)
$ / shares
shares
Jun. 30, 2015
USD ($)
Jun. 30, 2016
USD ($)
$ / shares
shares
Jun. 30, 2015
USD ($)
Mar. 28, 2016
$ / shares
Jan. 25, 2016
$ / shares
Dec. 31, 2015
USD ($)
$ / shares
shares
New Accounting Pronouncements or Change in Accounting Principle [Line Items]                
Stock split conversion ratio 0.0667              
Common stock, shares authorized (in shares) | shares 240,000,000 240,000,000   240,000,000       240,000,000
Common stock, par value (in dollars per share) | $ / shares $ 0.04 $ 0.04   $ 0.04   $ 0.04 $ 0.04 $ 0.04
Loss from continuing operations before taxes   $ 2,304 $ 3,337 $ 5,568 $ 5,434      
Adjustments for new accounting pronouncement | Noncurrent assets                
New Accounting Pronouncements or Change in Accounting Principle [Line Items]                
Deferred issuance costs, net               $ (200)
Adjustments for new accounting pronouncement | Current liabilities                
New Accounting Pronouncements or Change in Accounting Principle [Line Items]                
Deferred issuance costs, net               $ 200
Adjustment of Capitalized Costs Related to Modification of Credit Agreement                
New Accounting Pronouncements or Change in Accounting Principle [Line Items]                
Loss from continuing operations before taxes   $ 200            
XML 41 R28.htm IDEA: XBRL DOCUMENT v3.5.0.2
Liquidity (Details) - USD ($)
$ / shares in Units, $ in Thousands
 3 Months Ended 6 Months Ended
Mar. 28, 2016
Jan. 25, 2016
Jun. 30, 2016
Jun. 30, 2015
Jun. 30, 2016
Jun. 30, 2015
Aug. 09, 2016
Jun. 15, 2016
Dec. 31, 2015
Apr. 17, 2015
Dec. 31, 2014
Debt Instrument [Line Items]                      
Stock issued (in shares) 666,667 2,601,789                  
Common stock, par value (in dollars per share) $ 0.04 $ 0.04 $ 0.04   $ 0.04     $ 0.04 $ 0.04    
Issuance of common stock, net of issuance costs $ 1,200 $ 3,400     $ 4,574 $ 0          
Cash and cash equivalents     $ 102 $ 1,242 102 1,242     $ 2,035   $ 5,201
Loss from continuing operations     (2,309) $ (3,342) (5,578) (5,444)          
Net cash used in operating activities of continuing operations         4,848 $ 5,099          
AHS acquisition                      
Debt Instrument [Line Items]                      
Common stock, par value (in dollars per share)                   $ 0.04  
Selling, general and administrative expenses | AHS acquisition                      
Debt Instrument [Line Items]                      
Integration costs         100            
Line of credit | 2016 Credit and Security Agreement                      
Debt Instrument [Line Items]                      
Borrowings outstanding     3,300   3,300            
Available borrowing availability     300   300            
Line of credit | 2016 Credit and Security Agreement | Subsequent event                      
Debt Instrument [Line Items]                      
Borrowings outstanding             $ 2,400        
Available borrowing availability             $ 800        
Loans payable | Credit agreement                      
Debt Instrument [Line Items]                      
Common stock, par value (in dollars per share) $ 0.04                    
Outstanding borrowings under term loan     $ 4,000   $ 4,000            
XML 42 R29.htm IDEA: XBRL DOCUMENT v3.5.0.2
Acquisition - Additional Information (Details) - USD ($)
$ / shares in Units, $ in Thousands
 3 Months Ended 6 Months Ended
Apr. 17, 2015
Jun. 30, 2016
Jun. 30, 2015
Jun. 30, 2016
Jun. 30, 2015
Jun. 15, 2016
Mar. 31, 2016
Mar. 28, 2016
Jan. 25, 2016
Dec. 31, 2015
Business Acquisition [Line Items]                    
Acquisition, cash paid       $ 0 $ 4,000          
Common stock, par value (in dollars per share)   $ 0.04   $ 0.04   $ 0.04   $ 0.04 $ 0.04 $ 0.04
Amortization of intangible assets   $ 300 $ 300 $ 700 300          
Goodwill   633   $ 633           $ 633
AHS acquisition                    
Business Acquisition [Line Items]                    
Acquisition, purchase price $ 7,000                  
Acquisition, cash paid $ 4,000                  
Shared to be issued in acquisition (up to amount) (in shares) 433,333                  
Common stock, par value (in dollars per share) $ 0.04                  
Value of common stock issued in acquisition $ 3,000                  
Acquisition, shares delivered at closing (in shares) 371,739                  
Acquisition, shares held back for working capital adjustment (in shares) 21,739                  
Acquisition, shares held back for indemnification (in shares) 39,855                  
Number of additional shares to be issued (in shares)       0            
Goodwill             $ 633      
Revenues attributable to AHS since the acquisition   2,700   $ 5,200            
AHS acquisition | Amortization of Intangible Assets                    
Business Acquisition [Line Items]                    
Pro forma amortization of intangible assets         300          
AHS acquisition | Acquisition-related costs                    
Business Acquisition [Line Items]                    
Pro forma amortization of intangible assets     600   700          
AHS acquisition | Cost of operations                    
Business Acquisition [Line Items]                    
Amortization of intangible assets   300 200 500 200          
AHS acquisition | Selling, general and administrative expenses                    
Business Acquisition [Line Items]                    
Amortization of intangible assets   $ 100 $ 100 $ 100 $ 100          
AHS acquisition | Customer portal (existing technologies)                    
Business Acquisition [Line Items]                    
Estimated useful life       4 years            
AHS acquisition | Customer relationships                    
Business Acquisition [Line Items]                    
Estimated useful life       8 years            
XML 43 R30.htm IDEA: XBRL DOCUMENT v3.5.0.2
Acquisition - Purchase price allocation (Details) - USD ($)
$ in Thousands
Jun. 30, 2016
Mar. 31, 2016
Dec. 31, 2015
Business Acquisition [Line Items]      
Intangible assets $ 6,248   $ 6,248
Goodwill 633   633
Customer portal (existing technologies)      
Business Acquisition [Line Items]      
Intangible assets 4,151   4,151
Customer relationships      
Business Acquisition [Line Items]      
Intangible assets 2,097   $ 2,097
AHS acquisition      
Business Acquisition [Line Items]      
Accounts receivable, net of allowance of $2   $ 918  
Inventory and other current assets   117  
Fixed assets   123  
Goodwill   633  
Accounts payable and accrued expenses   (743)  
Deferred revenue   (296)  
Purchase Price   7,000  
Accounts receivable, allowance   $ 2  
AHS acquisition | Customer portal (existing technologies)      
Business Acquisition [Line Items]      
Intangible assets 4,151    
AHS acquisition | Customer relationships      
Business Acquisition [Line Items]      
Intangible assets $ 2,097    
XML 44 R31.htm IDEA: XBRL DOCUMENT v3.5.0.2
Acquisition - Pro forma results of operations (Details) - AHS acquisition - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2015
Jun. 30, 2015
Business Acquisition [Line Items]    
Pro forma revenues $ 7,662 $ 15,750
Pro forma net loss from continuing operations $ (2,749) $ (5,856)
XML 45 R32.htm IDEA: XBRL DOCUMENT v3.5.0.2
Loss Per Share (Details) - shares
 6 Months Ended
Jun. 30, 2016
Jun. 30, 2015
Earnings Per Share [Abstract]    
Weighted average options outstanding (in shares) 355,092 274,460
Number of shares to be purchased under warrant (in shares) 543,478  
XML 46 R33.htm IDEA: XBRL DOCUMENT v3.5.0.2
Share-Based Compensation - Employee Share-Based Compensation Plans (Details) - shares
 3 Months Ended 6 Months Ended
Jun. 30, 2016
Jun. 30, 2015
Jun. 30, 2016
Jun. 30, 2015
Share-based Compensation Arrangement by Share-based Payment Award        
Options granted (in shares)     153,332  
2008 Plan        
Share-based Compensation Arrangement by Share-based Payment Award        
Options granted (in shares) 100,000 667 153,332 40,000
Remaining shares available for grant under the plan (in shares) 31,659   31,659  
2011 Plan        
Share-based Compensation Arrangement by Share-based Payment Award        
Options granted (in shares) 0 30,000 0 30,000
Remaining shares available for grant under the plan (in shares) 243,693   243,693  
Non-employee Members Board of Directors | 2011 Plan        
Share-based Compensation Arrangement by Share-based Payment Award        
Options granted (in shares)     166,665 2,778
XML 47 R34.htm IDEA: XBRL DOCUMENT v3.5.0.2
Share-Based Compensation - Stock Option Valuation Assumptions (Details) - $ / shares
 3 Months Ended 6 Months Ended
Jun. 30, 2016
Jun. 30, 2016
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]    
Expected life (years) 5 years 3 months 18 days 5 years 1 month 6 days
Expected volatility (as percent) 80.00% 81.00%
Expected dividend yield (as percent) 0.00% 0.00%
Risk-free interest rate (as percent) 1.30% 1.40%
Weighted average fair value of options granted during the period $ 1.27 $ 1.33
XML 48 R35.htm IDEA: XBRL DOCUMENT v3.5.0.2
Share-Based Compensation - Option Roll-Forward (Details)
$ / shares in Units, $ in Thousands
 6 Months Ended
Jun. 30, 2016
USD ($)
$ / shares
shares
Jun. 30, 2015
$ / shares
shares
Stock Option Activity [Roll Forward]    
Outstanding balance at December 31, 2015 (in shares) | shares 286,568  
Options granted (in shares) | shares 153,332  
Options exercised (in shares) | shares 0 (50,000)
Options forfeited and expired (in shares) | shares (34,560)  
Outstanding balance at June 30, 2016 (in shares) | shares 405,340.00  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]    
Outstanding balance (weighted average exercise price) at December 31, 2015 (in dollars per share) | $ / shares $ 6.46  
Granted (weighted average exercise price) (in dollars per share) | $ / shares 2.05  
Exercised (weighted averaged exercise price) (in dollars per share) | $ / shares 0.00 $ 0.45
Forfeited and Expired (weighted average exercise price) (in dollars per share) | $ / shares 3.23  
Outstanding balance (weighted average exercise price) at June 30, 2016 (in dollars per share) | $ / shares $ 5.07  
Weighted Average Remaining Contractual Life, options outstanding 8 years 5 months 12 days  
Aggregate Intrinsic Value of options | $ $ 0  
Number of options exercisable at March 31, 2016 (in shares) | shares 147,113  
Weighted average exercise price of options exercisable at March 31, 2016 (in dollars per share) | $ / shares $ 7.65  
Weighted Average Remaining Contractual Life, options exercisable 7 years 2 months 29 days  
Aggregate Intrinsic Value of options | $ $ 0  
XML 49 R36.htm IDEA: XBRL DOCUMENT v3.5.0.2
Share-Based Compensation - Award Activity (Details) - USD ($)
$ / shares in Units, $ in Millions
 3 Months Ended 6 Months Ended
Jun. 30, 2016
Jun. 30, 2015
Jun. 30, 2016
Jun. 30, 2015
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]        
Options exercised (in shares)     0 50,000
Exercised (weighted averaged exercise price) (in dollars per share)     $ 0.00 $ 0.45
Options vested in period (in shares)     30,768  
Aggregate fair value of options vested in period     $ 0.1  
Unrecognized compensation cost related to stock options $ 0.4   $ 0.4  
Weighted average period for recognition of compensation cost     1 year 8 months 27 days  
Share-based compensation expense $ 0.4 $ 0.1 $ 0.5 $ 0.2
XML 50 R37.htm IDEA: XBRL DOCUMENT v3.5.0.2
Inventories (Details) - USD ($)
$ in Millions
Jun. 30, 2016
Dec. 31, 2015
Inventory Disclosure [Abstract]    
Finished goods $ 0.4 $ 0.3
Components $ 0.6 $ 0.3
XML 51 R38.htm IDEA: XBRL DOCUMENT v3.5.0.2
Goodwill and Other Intangible Assets (Details) - USD ($)
 3 Months Ended 6 Months Ended
Jun. 30, 2016
Jun. 30, 2015
Jun. 30, 2016
Jun. 30, 2015
Dec. 31, 2015
Goodwill and Intangible Assets Disclosure [Abstract]          
Goodwill $ 633,000   $ 633,000   $ 633,000
Amortization expense 300,000 $ 300,000 700,000 $ 300,000  
Finite-Lived Intangible Assets [Line Items]          
Gross Carrying Amount 6,248,000   6,248,000   6,248,000
Accumulated Amortization 1,567,000   1,567,000   917,000
Intangibles Assets, net 4,681,000   4,681,000   5,331,000
Long-lived assets and goodwill impairment charges     0    
Portal          
Finite-Lived Intangible Assets [Line Items]          
Gross Carrying Amount 4,151,000   4,151,000   4,151,000
Accumulated Amortization 1,251,000   1,251,000   732,000
Intangibles Assets, net 2,900,000   2,900,000   3,419,000
Customer relationships          
Finite-Lived Intangible Assets [Line Items]          
Gross Carrying Amount 2,097,000   2,097,000   2,097,000
Accumulated Amortization 316,000   316,000   185,000
Intangibles Assets, net $ 1,781,000   $ 1,781,000   $ 1,912,000
XML 52 R39.htm IDEA: XBRL DOCUMENT v3.5.0.2
Restructuring Charges (Details)
$ in Thousands
 6 Months Ended
Jun. 30, 2016
USD ($)
Restructuring Charges [Abstract]  
Branch closure obligation $ 600
Facility closure obligation  
Restructuring Reserve [Roll Forward]  
Restructuring reserve, beginning balance 657
Adjustments 134
Payments (201)
Restructuring reserve, ending balance $ 590
XML 53 R40.htm IDEA: XBRL DOCUMENT v3.5.0.2
Debt - Summary of Outstanding Borrowings (Details) - USD ($)
$ in Thousands
Jun. 30, 2016
Dec. 31, 2015
Debt Instrument [Line Items]    
Total debt $ 5,142 $ 5,330
Short-term portion (5,142) (5,330)
Total long-term debt, net 0 0
Line of credit | 2016 Credit and Security Agreement    
Debt Instrument [Line Items]    
Total debt 3,277  
Line of credit | 2013 Loan and Security Agreement    
Debt Instrument [Line Items]    
Total debt   3,278
Loans payable | Credit agreement    
Debt Instrument [Line Items]    
Total debt 4,046 5,000
Discount on Term Loan (1,977) (2,785)
Unamortized debt issuance costs related to Term Loan $ (204) $ (163)
XML 54 R41.htm IDEA: XBRL DOCUMENT v3.5.0.2
Debt - Summary of Interest Expense Components (Details) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2016
Jun. 30, 2015
Jun. 30, 2016
Jun. 30, 2015
Apr. 17, 2015
Debt Instrument [Line Items]          
Amortization of deferred financing costs $ 62 $ 197 $ 123 $ 280  
Write-off of debt issuance costs     282 0  
Amortization of debt discount associated with the warrants 397 244 807 244  
Mark to market of the Additional Warrant 0 0 59 0  
Total 1,011 626 1,800 709  
2013 Loan and Security Agreement          
Debt Instrument [Line Items]          
Write-off of debt issuance costs 282 0 282 0  
Loans payable | Credit agreement          
Debt Instrument [Line Items]          
Interest expense 161 154 341 154  
Accretion of termination fees (over term of Term Loan at rate of 8%) $ 45 27 $ 91 27  
Exit fee as a percent of aggregate principal 8.00%   8.00%   8.00%
Line of credit | 2013 Loan and Security Agreement          
Debt Instrument [Line Items]          
Interest expense $ 16 4 $ 49 4  
Line of credit | 2016 Credit and Security Agreement          
Debt Instrument [Line Items]          
Interest expense $ 48 $ 0 $ 48 $ 0  
XML 55 R42.htm IDEA: XBRL DOCUMENT v3.5.0.2
Debt (Details) - USD ($)
 3 Months Ended 6 Months Ended
Apr. 29, 2016
Mar. 28, 2016
Apr. 17, 2015
Jun. 30, 2016
Jun. 30, 2015
Jun. 30, 2016
Jun. 30, 2015
Aug. 09, 2016
Jun. 15, 2016
Mar. 31, 2016
Jan. 25, 2016
Dec. 31, 2015
Loan and Security Agreements [Line Items]                        
Write-off of debt issuance costs           $ 282,000 $ 0          
Common stock, par value (in dollars per share)   $ 0.04   $ 0.04   $ 0.04     $ 0.04   $ 0.04 $ 0.04
Stock issued           $ 4,723,000            
Number of shares to be purchased under warrant (in shares)       543,478   543,478            
Other Operating Income       $ 887,000 $ 0 $ 887,000 0          
2013 Loan and Security Agreement                        
Loan and Security Agreements [Line Items]                        
Write-off of debt issuance costs       282,000 $ 0 282,000 $ 0          
2013 Loan and Security Agreement | Interest Expense                        
Loan and Security Agreements [Line Items]                        
Write-off of debt issuance costs       300,000                
Loans payable                        
Loan and Security Agreements [Line Items]                        
Amount of term loan       5,000,000   5,000,000           $ 5,000,000
Loans payable | 2013 Loan and Security Agreement | Contingently Issuable Warrant                        
Loan and Security Agreements [Line Items]                        
Value of warrant to be issued is debt instrument is not paid                   $ 1,250,000    
Loans payable | 2013 Loan and Security Agreement | Transaction Cost                        
Loan and Security Agreements [Line Items]                        
Debt extinguishment costs, early termination fees $ 140,000                      
Loans payable | Credit agreement                        
Loan and Security Agreements [Line Items]                        
Facility fee amount     $ 100,000                  
Expected term     7 years                  
Deferred issuance costs, net       $ 204,000   204,000           163,000
Debt covenant, minimum aggregate revenue for twelve month period ending June 30, 2016   $ 34,000,000                    
Debt covenant, minimum aggregate revenue for twelve month period ending September 30, 2016   37,000,000                    
Debt covenant, minimum aggregate revenue for twelve month period ending December 31, 2016   40,000,000                    
Debt covenant, minimum aggregate revenue for twelve month period ending each fiscal quarter thereafter   45,000,000                    
Debt covenant, minimum EBITDA amount for the three month period ending June 30, 2016   2,000,000                    
Debt covenant, minimum EBITDA amount for the six month period ending September 30, 2016   1,100,000                    
Debt covenant, minimum EBITDA amount for the nine month period ending December 31, 2016   800,000                    
Debt covenant, minimum EBITDA amount for the twelve month period ending March 31, 2017   500,000                    
Debt covenant, minimum EBITDA amount for the twelve month period ending June 30, 2017   900,000                    
Debt covenant, minimum EBITDA amount for the twelve month period ending September 30, 2017   2,500,000                    
Amount of term loan     $ 5,000,000                  
Maximum aggregate revenue-based payment     $ 600,000                  
First principal payment           1,000,000            
Interest paid           $ 400,000            
Variable rate floor, percent     1.00%                  
Exit fee as a percent of aggregate principal     8.00% 8.00%   8.00%            
Debt covenant, additional equity required (not less than)   $ 500,000.0                    
Common stock, par value (in dollars per share)   $ 0.04                    
Stock issued   $ 100,000                    
Debt covenant, maximum debt outstanding     $ 250,000.00                  
Number of shares to be purchased under warrant (in shares)     543,478                  
Exercise price of warrant (in dollars per share)     $ 6.90                  
Term loan, fair value       $ 1,977,000   $ 1,977,000           $ 2,785,000
Expected volatility rate (as percent)     85.00%                  
Risk free interest rate (as percent)     1.40%                  
Dividend rate (as percent)     0.00%                  
Loans payable | Credit agreement | Annual Aggregate Revenue Up To And Including $20 million                        
Loan and Security Agreements [Line Items]                        
Percent of aggregate revenue for quarterly payments     8.50%                  
Annual aggregate revenue limit     $ 20,000,000                  
Loans payable | Credit agreement | Annual Aggregate Revenue Greater Than $20 Million Up To And Including $30 Million                        
Loan and Security Agreements [Line Items]                        
Percent of aggregate revenue for quarterly payments     7.00%                  
Loans payable | Credit agreement | Annual Aggregate Revenue Greater Than $20 Million Up To And Including $30 Million | Minimum                        
Loan and Security Agreements [Line Items]                        
Annual aggregate revenue limit     $ 20,000,000                  
Loans payable | Credit agreement | Annual Aggregate Revenue Greater Than $20 Million Up To And Including $30 Million | Maximum                        
Loan and Security Agreements [Line Items]                        
Annual aggregate revenue limit     $ 30,000,000                  
Loans payable | Credit agreement | Annual Aggregate Revenue Greater Than $30 million                        
Loan and Security Agreements [Line Items]                        
Percent of aggregate revenue for quarterly payments     5.00%                  
Annual aggregate revenue limit     $ 30,000,000                  
Loans payable | Credit agreement | LIBOR                        
Loan and Security Agreements [Line Items]                        
Spread on variable rate (as percent)     14.00%     14.00%            
Loans payable | Credit agreement | Contingently Issuable Warrant                        
Loan and Security Agreements [Line Items]                        
Value of warrant to be issued is debt instrument is not paid     $ 1,250,000                  
Expected term     7 years                  
Term loan, fair value     $ 3,600,000                  
Expected volatility rate (as percent)     80.00%                  
Risk free interest rate (as percent)     2.10%                  
Dividend rate (as percent)     0.00%                  
Line of credit | 2013 Loan and Security Agreement | Transaction Cost                        
Loan and Security Agreements [Line Items]                        
Debt extinguishment cost, legal fees 30,000                      
Facility fee amount 107,000                      
Line of credit | 2016 Credit and Security Agreement                        
Loan and Security Agreements [Line Items]                        
Facility fee amount 140,000                      
Maximum borrowing capacity $ 7,000,000                      
Expected term     3 years                  
Borrowings outstanding       3,300,000   $ 3,300,000            
Available borrowing availability       300,000   300,000            
Commitment fee, percentage (as percent) 0.50%                      
Collateral fee (as percent) 0.50%                      
Debt covenant, minimum aggregate revenue for twelve month period ending June 30, 2016 $ 34,000,000                      
Debt covenant, minimum aggregate revenue for twelve month period ending September 30, 2016 37,000,000                      
Debt covenant, minimum aggregate revenue for twelve month period ending December 31, 2016 40,000,000                      
Debt covenant, minimum aggregate revenue for twelve month period ending each fiscal quarter thereafter 45,000,000                      
Debt covenant, minimum EBITDA amount for the three month period ending June 30, 2016 (2,000,000)                      
Debt covenant, minimum EBITDA amount for the six month period ending September 30, 2016 (1,100,000)                      
Debt covenant, minimum EBITDA amount for the nine month period ending December 31, 2016 800,000                      
Debt covenant, minimum EBITDA amount for the twelve month period ending March 31, 2017 500,000                      
Debt covenant, minimum EBITDA amount for the twelve month period ending June 30, 2017 900,000                      
Debt covenant, minimum EBITDA amount for the twelve month period ending September 30, 2017 2,500,000                      
Amount of consolidated unencumbered liquid assets required (not less than) $ 750,000                      
Other Operating Income       900,000                
Line of credit | 2016 Credit and Security Agreement | Other Assets                        
Loan and Security Agreements [Line Items]                        
Deferred issuance costs, net       $ 300,000   $ 300,000            
Line of credit | 2016 Credit and Security Agreement | Prime rate                        
Loan and Security Agreements [Line Items]                        
Spread on variable rate (as percent) 5.50%                      
Line of credit | 2016 Credit and Security Agreement | Subsequent event                        
Loan and Security Agreements [Line Items]                        
Borrowings outstanding               $ 2,400,000        
Available borrowing availability               $ 800,000        
XML 56 R43.htm IDEA: XBRL DOCUMENT v3.5.0.2
Commitments and Contingencies (Details)
$ in Millions
 6 Months Ended
Jun. 30, 2016
USD ($)
branch_office
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]  
Branch closure obligation | $ $ 0.6
Employment agreements, contract term 1 year
Portamedic branch  
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]  
Number of offices | branch_office 2
XML 57 R44.htm IDEA: XBRL DOCUMENT v3.5.0.2
Litigation (Details) - USD ($)
$ in Thousands
 6 Months Ended
Apr. 29, 2016
Jun. 30, 2016
Dec. 31, 2015
Loss Contingencies [Line Items]      
Settlement fund amount $ 450    
Loss from operations | Discontinued operations      
Loss Contingencies [Line Items]      
Loss recognized in period   $ 150  
Accrued expenses      
Loss Contingencies [Line Items]      
Accrual of loss   $ 450 $ 300
XML 58 R45.htm IDEA: XBRL DOCUMENT v3.5.0.2
Income Taxes (Details) - USD ($)
 3 Months Ended 6 Months Ended
Jun. 30, 2016
Jun. 30, 2015
Jun. 30, 2016
Jun. 30, 2015
Dec. 31, 2015
Income Tax Disclosure [Abstract]          
Unrecognized tax benefits $ 0 $ 0 $ 0 $ 0  
Interest and penalty payments $ 0 0 0 $ 0  
Current federal tax benefit   0 0    
Current state tax benefit   $ 0 $ 0    
U.S. Federal          
Operating loss carryforwards, subject to expiration         $ 167,200,000
State          
Operating loss carryforwards, subject to expiration         $ 149,800,000
XML 59 R46.htm IDEA: XBRL DOCUMENT v3.5.0.2
Fair Value Measurements (Details) - USD ($)
$ in Thousands
Jun. 30, 2016
Dec. 31, 2015
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Derivative liability - Face Value $ 0 $ 1,250
Term Loan    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Term Loan - Face Value 5,000 5,000
Carrying Amount    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Derivative liability 0 828
Carrying Amount | Term Loan    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Term Loan, Carrying Amount 1,953 2,052
Level 3 | Fair Value    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Derivative liability 0 828
Level 3 | Fair Value | Term Loan    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Term Loan, Fair Value $ 3,590 $ 3,837
EXCEL 60 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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how.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 62 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 64 FilingSummary.xml IDEA: XBRL DOCUMENT 3.5.0.2 html 131 253 1 false 45 0 false 5 false false R1.htm 0001000 - Document - DEI Document Sheet http://www.hooperholmes.com/role/DeiDocument DEI Document Cover 1 false false R2.htm 1001000 - Statement - Condensed Consolidated Balance Sheets (unaudited) Sheet http://www.hooperholmes.com/role/CondensedConsolidatedBalanceSheetsUnaudited Condensed Consolidated Balance Sheets (unaudited) Statements 2 false false R3.htm 1001501 - Statement - Condensed Consolidated Balance Sheets (unaudited) (Parentheticals) Sheet http://www.hooperholmes.com/role/CondensedConsolidatedBalanceSheetsUnauditedParentheticals Condensed Consolidated Balance Sheets (unaudited) (Parentheticals) Statements 3 false false R4.htm 1002000 - Statement - Condensed Consolidated Statements of Operations (unaudited) Sheet http://www.hooperholmes.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited Condensed Consolidated Statements of Operations (unaudited) Statements 4 false false R5.htm 1003000 - Statement - Condensed Consolidated Statements of Stockholders' (Deficit) Equity (unaudited) Sheet http://www.hooperholmes.com/role/CondensedConsolidatedStatementsOfStockholdersDeficitEquityUnaudited Condensed Consolidated Statements of Stockholders' (Deficit) Equity (unaudited) Statements 5 false false R6.htm 1004000 - Statement - Condensed Consolidated Statements of Cash Flows (unaudited) Sheet http://www.hooperholmes.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited Condensed Consolidated Statements of Cash Flows (unaudited) Statements 6 false false R7.htm 2101100 - Disclosure - Basis of Presentation Sheet http://www.hooperholmes.com/role/BasisOfPresentation Basis of Presentation Notes 7 false false R8.htm 2107100 - Disclosure - Liquidity Sheet http://www.hooperholmes.com/role/Liquidity Liquidity Notes 8 false false R9.htm 2110100 - Disclosure - Acquisition Sheet http://www.hooperholmes.com/role/Acquisition Acquisition Notes 9 false false R10.htm 2122100 - Disclosure - Loss Per Share Sheet http://www.hooperholmes.com/role/LossPerShare Loss Per Share Notes 10 false false R11.htm 2131100 - Disclosure - Share-Based Compensation Sheet http://www.hooperholmes.com/role/ShareBasedCompensation Share-Based Compensation Notes 11 false false R12.htm 2135100 - Disclosure - Inventories Sheet http://www.hooperholmes.com/role/Inventories Inventories Notes 12 false false R13.htm 2136100 - Disclosure - Goodwill and Other Intangible Assets Sheet http://www.hooperholmes.com/role/GoodwillAndOtherIntangibleAssets Goodwill and Other Intangible Assets Notes 13 false false R14.htm 2137100 - Disclosure - Restructuring Charges Sheet http://www.hooperholmes.com/role/RestructuringCharges Restructuring Charges Notes 14 false false R15.htm 2138100 - Disclosure - Debt Sheet http://www.hooperholmes.com/role/Debt Debt Notes 15 false false R16.htm 2139100 - Disclosure - Commitments and Contingencies Sheet http://www.hooperholmes.com/role/CommitmentsAndContingencies Commitments and Contingencies Notes 16 false false R17.htm 2140100 - Disclosure - Litigation Sheet http://www.hooperholmes.com/role/Litigation Litigation Notes 17 false false R18.htm 2141100 - Disclosure - Income Taxes Sheet http://www.hooperholmes.com/role/IncomeTaxes Income Taxes Notes 18 false false R19.htm 2142100 - Disclosure - Fair Value Measurements Sheet http://www.hooperholmes.com/role/FairValueMeasurements Fair Value Measurements Notes 19 false false R20.htm 2201201 - Disclosure - Basis of Presentation (Policies) Sheet http://www.hooperholmes.com/role/BasisOfPresentationPolicies Basis of Presentation (Policies) Policies 20 false false R21.htm 2310301 - Disclosure - Acquisition (Tables) Sheet http://www.hooperholmes.com/role/AcquisitionTables Acquisition (Tables) Tables http://www.hooperholmes.com/role/Acquisition 21 false false R22.htm 2331301 - Disclosure - Share-Based Compensation (Tables) Sheet http://www.hooperholmes.com/role/ShareBasedCompensationTables Share-Based Compensation (Tables) Tables http://www.hooperholmes.com/role/ShareBasedCompensation 22 false false R23.htm 2336301 - Disclosure - Goodwill and Other Intangible Assets (Tables) Sheet http://www.hooperholmes.com/role/GoodwillAndOtherIntangibleAssetsTables Goodwill and Other Intangible Assets (Tables) Tables http://www.hooperholmes.com/role/GoodwillAndOtherIntangibleAssets 23 false false R24.htm 2337301 - Disclosure - Restructuring Charges (Tables) Sheet http://www.hooperholmes.com/role/RestructuringChargesTables Restructuring Charges (Tables) Tables http://www.hooperholmes.com/role/RestructuringCharges 24 false false R25.htm 2338301 - Disclosure - Debt (Tables) Sheet http://www.hooperholmes.com/role/DebtTables Debt (Tables) Tables http://www.hooperholmes.com/role/Debt 25 false false R26.htm 2342301 - Disclosure - Fair Value Measurements (Tables) Sheet http://www.hooperholmes.com/role/FairValueMeasurementsTables Fair Value Measurements (Tables) Tables http://www.hooperholmes.com/role/FairValueMeasurements 26 false false R27.htm 2401402 - Disclosure - Basis of Presentation (Details) Sheet http://www.hooperholmes.com/role/BasisOfPresentationDetails Basis of Presentation (Details) Details http://www.hooperholmes.com/role/BasisOfPresentationPolicies 27 false false R28.htm 2407401 - Disclosure - Liquidity (Details) Sheet http://www.hooperholmes.com/role/LiquidityDetails Liquidity (Details) Details http://www.hooperholmes.com/role/Liquidity 28 false false R29.htm 2410402 - Disclosure - Acquisition - Additional Information (Details) Sheet http://www.hooperholmes.com/role/AcquisitionAdditionalInformationDetails Acquisition - Additional Information (Details) Details 29 false false R30.htm 2410403 - Disclosure - Acquisition - Purchase price allocation (Details) Sheet http://www.hooperholmes.com/role/AcquisitionPurchasePriceAllocationDetails Acquisition - Purchase price allocation (Details) Details 30 false false R31.htm 2410404 - Disclosure - Acquisition - Pro forma results of operations (Details) Sheet http://www.hooperholmes.com/role/AcquisitionProFormaResultsOfOperationsDetails Acquisition - Pro forma results of operations (Details) Details 31 false false R32.htm 2422401 - Disclosure - Loss Per Share (Details) Sheet http://www.hooperholmes.com/role/LossPerShareDetails Loss Per Share (Details) Details http://www.hooperholmes.com/role/LossPerShare 32 false false R33.htm 2431402 - Disclosure - Share-Based Compensation - Employee Share-Based Compensation Plans (Details) Sheet http://www.hooperholmes.com/role/ShareBasedCompensationEmployeeShareBasedCompensationPlansDetails Share-Based Compensation - Employee Share-Based Compensation Plans (Details) Details 33 false false R34.htm 2431403 - Disclosure - Share-Based Compensation - Stock Option Valuation Assumptions (Details) Sheet http://www.hooperholmes.com/role/ShareBasedCompensationStockOptionValuationAssumptionsDetails Share-Based Compensation - Stock Option Valuation Assumptions (Details) Details 34 false false R35.htm 2431404 - Disclosure - Share-Based Compensation - Option Roll-Forward (Details) Sheet http://www.hooperholmes.com/role/ShareBasedCompensationOptionRollForwardDetails Share-Based Compensation - Option Roll-Forward (Details) Details 35 false false R36.htm 2431405 - Disclosure - Share-Based Compensation - Award Activity (Details) Sheet http://www.hooperholmes.com/role/ShareBasedCompensationAwardActivityDetails Share-Based Compensation - Award Activity (Details) Details 36 false false R37.htm 2435401 - Disclosure - Inventories (Details) Sheet http://www.hooperholmes.com/role/InventoriesDetails Inventories (Details) Details http://www.hooperholmes.com/role/Inventories 37 false false R38.htm 2436402 - Disclosure - Goodwill and Other Intangible Assets (Details) Sheet http://www.hooperholmes.com/role/GoodwillAndOtherIntangibleAssetsDetails Goodwill and Other Intangible Assets (Details) Details http://www.hooperholmes.com/role/GoodwillAndOtherIntangibleAssetsTables 38 false false R39.htm 2437402 - Disclosure - Restructuring Charges (Details) Sheet http://www.hooperholmes.com/role/RestructuringChargesDetails Restructuring Charges (Details) Details http://www.hooperholmes.com/role/RestructuringChargesTables 39 false false R40.htm 2438402 - Disclosure - Debt - Summary of Outstanding Borrowings (Details) Sheet http://www.hooperholmes.com/role/DebtSummaryOfOutstandingBorrowingsDetails Debt - Summary of Outstanding Borrowings (Details) Details 40 false false R41.htm 2438403 - Disclosure - Debt - Summary of Interest Expense Components (Details) Sheet http://www.hooperholmes.com/role/DebtSummaryOfInterestExpenseComponentsDetails Debt - Summary of Interest Expense Components (Details) Details 41 false false R42.htm 2438404 - Disclosure - Debt (Details) Sheet http://www.hooperholmes.com/role/DebtDetails Debt (Details) Details http://www.hooperholmes.com/role/DebtTables 42 false false R43.htm 2439401 - Disclosure - Commitments and Contingencies (Details) Sheet http://www.hooperholmes.com/role/CommitmentsAndContingenciesDetails Commitments and Contingencies (Details) Details http://www.hooperholmes.com/role/CommitmentsAndContingencies 43 false false R44.htm 2440401 - Disclosure - Litigation (Details) Sheet http://www.hooperholmes.com/role/LitigationDetails Litigation (Details) Details http://www.hooperholmes.com/role/Litigation 44 false false R45.htm 2441401 - Disclosure - Income Taxes (Details) Sheet http://www.hooperholmes.com/role/IncomeTaxesDetails Income Taxes (Details) Details http://www.hooperholmes.com/role/IncomeTaxes 45 false false R46.htm 2442402 - Disclosure - Fair Value Measurements (Details) Sheet http://www.hooperholmes.com/role/FairValueMeasurementsDetails Fair Value Measurements (Details) Details http://www.hooperholmes.com/role/FairValueMeasurementsTables 46 false false All Reports Book All Reports hh-20160630.xml hh-20160630.xsd hh-20160630_cal.xml hh-20160630_def.xml hh-20160630_lab.xml hh-20160630_pre.xml true true ZIP 66 0000741815-16-000129-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000741815-16-000129-xbrl.zip M4$L#!!0 ( ,^*#TG?Y,-@*^, #U5"P / :&@M,C Q-C V,S N>&UL M['UI=QI)MN#GF5_A\>=15>Q+G>Z:$VNW>^RRVW:_GOKT#H:4Q&L$:D NZ_WZ MN9& !!E)L@@02-1QV1+D=A#[5G!-4%%\PZA5B#;\P>7#?GP;]KJ_I+_? M -3]T2_MP5U_/+S_\]OK\?CVEY]_3E_]-"K:/UT-OO\\_?)G@K"X0/B"XK>S MV^Z&0T!RV7W3;VMN[!3=^GO@BW0Y6[R\^-&^KK\^?5/S_.O'R__XXX^?K@># MVV)X/>C=%*.?VH.;\@XD*)I=W^U_+T;C^E=,ODNWT,67=$<#1K!<>%-YYV!X M!9U<-4?I5 PHL@]0?]_MU-_3LZ MX^'/X_O;XF>XZ *N*H;=]L-]JV]:O&%87"[%1/P,W\XN''7;]2C %S4(C,:W MPR77PSRY;HV\E(-,O:I@#OAD.>L6H]I[RF_J;$AWJ;RJ_ MJ;MI/"RNEM))_PS?SRY-7W0J0O% S\F7"Y>.:R_EDTO'\Y=VFQBT/QJW^NT' MEON1L>@?M+P::ZU_+K]]N'34J;L0'HM__G\?WG]I7Q+NZLOOGB YM?_ M^3_^E-[URZC\XG-Q^:9\]R_7$[Z[OI@)\$\ QMOIEVD5_OQVU+VY[0%"/Z>' M3!1=>] ?%S_&;[H _=^WOR+X3S*L,/_3S]6;RW?\7'W)]!V@E+J#SOQ;@0##L0=K\.N, MFQ">W?[XW=P-1;\S=[FXH.CQ;9W9Q;./'MXW^V!*F7I2O2LI1?]VUP../D): M3=AE/$5=@MP]/'+ZS=:HQX0[_SL[ZH2_GX9. M8,^H$TI2\=-0GWPS]?:U\R@>GG#*@3=3]F M-GA#COAB3WQQ?[]#FVEGW3Z73'0+U6[U.KVWG7 M=ZW;[KC5>Y$+WHCK*]$'6S,*?'PSZ+]<$Y'A]TH88CL#<>:&DS +TU#T[ \^ MIS^XSZ![.^D]+_!)2?#F"WSVZO;NU1V?VC[;Y)-1V9LO[CDB?Q7+?%;UET=O0G7FP_3LJQGWCQ':_V5,+_=M?'_,A1+QE][I$[=TM-Y[_N1N,DC:,X M&/Y6_&':9<83:/%/PT$??FR7&F%1VRV_;B+M#Q?:5B_E-'RY+HKQ^T&[E=1& M^:3KZ__\;="?)$F-S6A4C$_,,FY$N$?=N8IR3>IS ^B6T?WMK]?7O]03_C0] M[L?#ZP>>"\/A8.@&@& [H3TR_.;P4_GDN77[7(QF!L_>S_TRO;#?,3=I MH6;\^GCGX')J\KK_773<8)0>U4M)C./!AT$'.&Q"<+AL6("I-%?#8FZ)3X7# M]T''DO]V1^(#%66D?2FDO(_U)JFT_YX%= M'*T?5M4"\Y[86EK@\?)=I2.:NRND'T35%]_&[V MAF4F_8.=2I>^'[3ZK7[G M2P&6'O"L:,Z')[P?]*_&Q? F/>GK_6VQH#+>0TC_<:IZ*_=]N?LV*OY]ET+% M[_!7=FOE^]/2$CE9)V9K-5UWI CJ5N51&^7+LJ/7+EG4QS?7KNJA GYU@?2. M0T#\H34DZAA5SR+J](*H'>O>XT6]JG7GD5]#Z\Y?OAO?:WXS\. :]ZPSGT%G M'NT^Y51M_:W5)T?I,2VBCB_([G:N_!SJ%T=+@#Q#B&SB,LY??C#E=3OL]K!, M7GYME+VFY@(9'WUJW;>^]8J7H;E6D.4P:BNCZDFJK;KD17LW IT\&IGVO^^Z MH^[\+L,TUDY(_[5H]<;77P:]NW(+ZEV_76Y9?KH;MJ];HV(9J\)U@YOBX3AK M81OC(40I>CT(Y_]2](MAJY=VJ3HWW7X7& &N_5Z$'[>P5J>VP;&$JA..WI:L M.V+UAD69"S$V697#;0 ^>^HO/Z#T_#;H#Y.O-H2%>-PQ6SSN?GSO=,>VW+T] M"\NNA&7Y&LR=PS%#_J@O/FAS)VOL/K?\:#%VO-5H\QO'%]Z(WN"TZ7XOV M=7_0&US=?^Y>79]5[^Y4[P;+\JB+5ZS+*_)4*J?QS^;GI^-*,(WJQ;S61=\^]X\Z[[2?(82]RM_VY>W>?LP)>A-*L'/+OI6#XS!DG MPQE'=RIQ+%O)9_M[MK_'$[ <:)OXS-&O8T?U $KVS$HO7RM5ZZ&.;F?^G-QY MG+OSSY;<><@^AT=SJN.3A&(A$QK.Z4!'* JGG YT#,[Y44C/ M>0?D^67EJ'9 GETR*F=SGWJM_F^MFV*^:PQ.'U:8_&MWW"M2'E6G^[W;N0-= MLQ C=%,_QL'PM#AZ'O>'QC!SR.^(.6M)-^?'+]#N=9R%U6V@U' B4H^+<W;G]3I9 MAVD-:3SKVB.3QK-W^U)MXWK>[5D@3]J[W6R!SSLE+W.GY$@X\1QGO>2=DLTV M9<\+?'*N^_RHG%>WR7"M53@H/I=^"S8OA]<0A";+73;+9[UQN,X,K36OT52#ZN M>"V6K\C!G-<49\YX1L[8MTF8=QK/"WT<"[WWZ&#YA"]ZGO"U9,+7"LKL:,OR M*"=\/1<_GHF?$T//7Y :]G]CVS[\;AQ,YG[F8-B0[+ MC8_59;/2C2_MHM\"+![>W.^G<^ K>-\57/*Y^%[T[XI_W'X=0!CPKM_NW77 MUR?HIMOKP1*>F?QYF'R#U]8N]03O;=;ZD*?$SS<&JE96RXW/CY?_; V'H @^ M#LL][\>R,\"P?P5X]N[?C49W:1VG5U9D[VR ZMAT*7&G!64KJ+LC87DY&N*% MR^)9B,[L>SKL*TKV)7J'&XPKJJ"_@FH]Z=/,CNY*JZZ-I5>7$[ MHWGJ.-$;; ',7_X2C,>V0==?A@7\,OQZW>K3<[SU8N.MY",B_.SBSNUS\W ^6'IE\KS#5,O]#Z4Z!R_G$.*4&O4G[;BG)4A.3FGZMB8^%CV*9;:"7A@9]!_ M!U /O[7Z__IX>5D .FR]^_LQ\\O0Q!.S__9B>E8:VU?Q_["9D=KN]A=>+P& MR%^,QF$R&/1E"-1Q;!4\7E1#XO-QV]E1.CM*IZ&?N?=JGTE M@1]%)\%G[#FTA_YMN_5\7I^!. J6?*5)177#H<[G$"\[ MZM>_/L Z76ZZ"Y M6L^<.B,^39/N5J4]^SSV]AVMY)/--STQQ3$QQ)![;>1OP[+&=M&);CX?/,?,Y9CY=[CW'&^=X MXZAY^+R5?4RNY4EMI)Q=R[-K>;P;*>?-P+-Q?@5Z^%QN<(ZRMGSM:90;'(,Y MJ8AB)95]OOFNZ7=,!Q@%"-WJ^>ZHW1N,[H;%R-[#+[>#4:OWE^'@[G;TT",B M75-F:=X5G8\ 6ID4/YJ)]Z?!<-RZ B/S7OUFW9[<-2?/38N'5K?37QWE_7+/'7O-QTG.&G9G@A)B 7V"RTUJ3 M*A-,=/77U@]S-[X>E!L"66TL>''3[FA3_^O=YR^GM>[U6%;J4Y>C^2J6NC2O MP.])+GI_NQMV1^!PCT^NR^&JI5Z!YNDN];Q]CZWN\#]:O;O"WG\H6BGXFL1H MH^YH8OQ5R0;KU7_ MGT7U>;8L3U!$3F\_>^^A\PO5BTG!]4\]F[4J7MF=S1@!,M?_O'%;_S(,F=H.:"W\./&S_PV;/7; MU_\YN+SLMHNZ9U]?_[)PS3:$^%0,OR0JSC^_T_T.C#J_P.F.W^YN4FK48-XB MK4F\_[$ R.*#YM[@B_[@IMM?^H[F15]\2>59LZ\>4*M2IE-T?S' ^IW$_K'7 MNGHS95"SN#;B8YIM<<7#B-)320N&,F#%,9CZ03A7BF&+&9O?[UL]4:P M+-G#9V]T=\-A^@C4;JOW>]$:ADDFUQHO9P+AX+GA2E'N M<4"\*$5)@Z191Z M^^O%3!2;WC2#Q _:90K\Y()/I8Q&^&RT!BC4..VCDR8HP;502C 55D$8@_;;T0^K >'A+ M%8@)?.LO"=666,8=BDAP1+QF*@BD'&-.4Z+"VP57:.F;JF DW;X. 4+0Q 1/ M:0R<8P!&(<-#^5ZF>1A_!DP=+ MDI+!%V":Q&ST;W<]BM^^Z11M\+=[(_C\MS@'8X@&$RR8IU)R*X$G,*>8!!^# MU,&9MV^2'B@?.+,Y2F(FJ%B N &H1?!CMU<,':SEU6"X#@V%PB%8"?(+2V>= ML\@$:H7SG@F#D'O[ZQ= "Y[Y9N*X)2H -+>M_OT\@ NO783H__O7CQT_A\YN_?GS_(7QY\^XW M-P_*XOL2+*FLIMT>%BF59MKF/WDN9?(M^*!F-!JTNP![YY_=\?6T674.YZ3Z M?GZE+^@@&$,6#./_V\#7 [1>KW M!J22$K78:5,H@K9SQWL#8<$V,<$4R&J#C5 MR&A618IJ>1Q(-:V4Y 1$!JEH!5AAY$&L;5HI&PP*$N2X@I1".T?J*T0$R>^! M3V)1U%C.Y^V^LHQR8+68MYA*+Q%H9^J=8HER# Q'A"\S'E]*N H!GD"F9^Q5 MO8Q,1 KKP5"$R!0Q+( 0(2"38\' #T$>G$S/V_]V&9D4D$=1%P3VB(/<*<2H MTUASZESP05?)Q/C^R72,W!2P#\0:%J4$TPYND2VYB4 DQQ%%53)IO!F9[-VH MVR]&(]/^]UUW5-;[!?AI?#\;]Y-F4Q2=C\/9C H(#0'>CY<3]\H7O>[W5(#Z M=5!^<#WH=8JA&;O>8%3U VNGZ-2\_X'6DS3^]-*_%JW>^/K+H'=7UOV\Z[=! MWQ;C3W?#]G5K5%1;GBQU,IWADO! B'80^VBIHVU;KOC5L]T_NMN-$[D.;;EX +S MP(SUCFN(OYR2!AEOB9>60V#(:I:#[$HRUB#79NLRJ+QH!+2;7 MKK0$!Q8+KR2*F!K,(_?@9J-@-03N5 EF#*Z+@]$F:[ ):2I$AW#VV]2"?"[: M@ZM^][^+SKOI?GE9:94PG@ :BX5:#P67,%W8$D[TTVN^2^656M-[5;%5%>G M6.U[=1:=ED!!2PEM)74<+*TB0B6=Q"#LBRZ8JC66C,[,\3,3<0]+^:[_':X? M#._AVX_CZV(X!6MRZQ&M&HM(..F()U9S[I6!4%8$SQP34@IOJZN&L=S'JC73 MZVD+U&I@D^F5O=[@CU0X"4K6#^Z^C2_O>C.N@3<4W>_IJ4>T:MPPQ)25W"K/ MJ8T&1W /**$XVAAJME2>N&:[(N%T(6NGOY4GN \?/BK:=Y>+X<:[T6^#\:=6 M-S'2S&\O.O;>W8T'EY?Y7O>+&>TWSPQLCAE0$-H+RA''TGOMI-!4:"FM(SQ: MKC(1)BE%@Q+Y^]WK2%@W+L'%BLO+T"9K[,)\7P\O^C[8\,E\M@+ M B;/.VNX M_%/\B)B MS#A5"O[RG <:%,?:8T,)8<$@FBE.:A5 "3GD(;#" M.#N[+7TX]%,].=>@3"--IW8X?=F4,W2T;AJWUGN!(D$NI(A4!>K 6!O$$%(R MWP6)CQ2B@I,);<(::F0 M$MHHC;R3(<\S80VROAYM=DW8XPK?YHF+B,<.<1=E1$(RR2(C@O@ C(J,_#N(ACF%< UT*Q:"0YPL B59"D.3C5J7.KLG[O'R MKC7$Z2B-]YC"HC+@7I9X-Y" 0#UDJ33/3> _!B?#N\0:T+?*$0G* :R6U89( M@85CQH:HLN"$RB>2]H_!K@E[O'SK'"&!8D*DYLZ 4V!I3'QK,2:"D]R@/0]Q MOUX7$#I= L8GP[;.8:0TK[073S$<)M@@,/%/"\. 0@P!+&99O8ZNM M";KVOLKZ)#U>1B5<6J5] $*F4E"!*&=)F5IOE7+L2,AZ0EM5VE*&J200F!*. MC;;@ X!*55A'P42>"'J!\?8D76\G95V"'C&7(A$](MHBK6/$1!JC$I?J2#VG M(C/Y>Z!IPGBQ*&URU\;%U\&H !(GHHN:2HA?L(L"P. N6 N_I56 ?Y3UWEJ2.PI2UB_"1N _I'_-YX1-4\%&9F1@ MV=KPX\?+EYV;L--D'PA)#/8:&8= 286HF?0R2D6,D!AL[-Q*3AL1H9^0K%G) M)R[.><%WFRA$%0'>(4N,U1+;Z*W1FOC:=>7G=3V))*,(H2XGZ0 A M!(XTT5@*X15//5XT)[QV<=6A5K>BS^P-!L-CTT7+2:JD *=24NH8* ^F-8_@ M?KJ(06& T:^W"+B&I$MI,:-<[C&&FJ9=O>H-M,C%2'(CAJ3 $XAQ$4* V M.D%<=H@P7Q>R/8Q3+,/-;6]0&K('T2KI-@3(DE98HU$90C8PA1C'BG%GN)&@ M@0)\B(@D&-.WOW["OY?@KGK9%*:RA W8E[8.6]RFCP@4K0*ZYYY(9'8-%5%O'B4'89]L.$WIO =DN<5H1;RHDO6!8 M&$\"C\9K&@ S9;3S6E&7-;]Z+.7:'J\DW8/II@0 D>IK[]V@UTNN>*L'QF1J M25I7N4,Z&YA^'!LHU0QUB[GVWC"O W.46ZR%MB0@1((ENM8.3$.##6C22,71 M."G=5*/<\8!U_^JW0;_=&ET/AI_ '^VV>M/?OX)HCUKM7/.L(0'_@"@D]2F9[-NO@WW%)'+/*)$F.(DXA)G*>.>DH93HB!F:-XD/+;T0A%,E M_KL%?D:1Y*9,"OT7G)/-&[P2+GE@7BH?/?Q"/'+"60:FD6FFLWX$DS5=]OJ- MH5O!=T1(J86AS&HF4]M)[>,$.HL#-GFWA,< 806(_P1?"MARUC=A>F59.ISQ1&B'D<[,YP2JZFO7AF8%H:P _]T33T$A$\1$?#ZX;1H)9ZZ-1SF5RP;G@M<#6@;(]R$WT==$S M;@B-*( .I<9J!.ZGQMAQI5',0S0JQ;8@+_0'W2) QEPQSY'BJ4^X3J5N.S=F\&UJL,S.*94<$0TUB,*[2KPFVNYN[ M%*:!LKP=%JGC,UP)/_?*6]).V4UJ_O[?Y>>?AH/;8@AFO)?J9?N=5"A[FROX M55Q,M>>*8^$BU9RF%#*G*)7&1BF(LWD.J> 92^P$[,.0HDDZC"/4@2P[ 10! M(ZP,/2D>-D=3WZ!W_6GSRKF-D@TM >(B4O A)0<[ M%;@EDF)CK"?.4YLWVH8 %>L*FBM!>BH"3:N4AFN RG(BZ3"=3DZ9LH098JV" M'S-3A@78$?TD!&9]0D=?!TMNG0R%N 6W>G.O(=)(5<0V>;:,]9U:1:T1 ,^/A:@\-/6&!V M1A_X)"_@OF!*HAX1!9YV:MOJ%140.UFM28D(J"D-850>K#\;(C5S.A:J]J+WX'M[YQD8 M0XZL-CC&**5P",+5S&5DSXE(XXHX;ID2G' :@PR>$R0$TI1'P$BX3(_PG2"R MNJ7G5K&'8CA(Y\ KT0)DPQJ(@@D1E*BH(L1/>88ER9!9&[0=XM1DV(.BR%L* M7C2U/#IJO15$Z8 H 1_59;MX6.@=X33GDWTL.S;.!J]\&A8WW;N:4\@5T8LV M%'P3[ PU$"]8;)52VAML!!9*FPR5V<2>M2%Z(OBK,D(C$4!19"VE2M>)[ 7K% M_"8""BAE0"N((3@$C\KZ ,ZK#DIX+WAFX 0Y#,R-KG:($CED$34J=1?5E*J M0#UD.T?O!9*;&8Q/BT?CCY5\&@\[(I(/Z,OEG!&_I MK*JG$RX&H"BBDJ1B.DS!BE3JY_*?HID:!, MW+KI]LLQ?^/N]V(V#6!5OX(($8K$T0GK>6IB*;R%?W$0'!D;,V[.7/Q]TKO) M@:01%#,RDC$EM:*&@>8#,?00H]BH5.9S'50,]SU39.]B*#1UH)&1\1AL(6AF M$S6(H2 &425K,B%>'75W*X:*I32&:^D(!=_4&BXX9R(->B41'%61[V8?DMY-UE B M*PW'*AI=)J]I"M%M/'5W[)3JX+%*1Y]6$:ZIT3HD,;0IB3R:78IA^N3=S6VK.RP+ MG*];PZOE%13S */Y@WROB+0!0MF4'\$LV&PA4]MQ<)? N\Y.;>=!K04@ [%F MQE;3AB2+SALGJ>0!<1:LP5+@=*(8N6>Q9N-%"E4)KNM)53OK:_DF(F!/5=0N M:(ZXMLA:X;E5X-: OX/SO ',Q#0M- 17*5FK882BTQ+ T+ M#2PSIXKI.FCJ-BV;@6JB$4X[>02@,-AR2X.6$,(0HS#'1C&<=8P34JX)U,:C M&LO!.?"X[E6_,BRQMO)M[S/"%C8&L,>X3.I0 5@(&Y/*@V*:EQA4E'ES8U11 M"D^CQD9T'37/P*P91GD$4T$%!TU%:2 IEY6#0N!61V^8QJ"#W<+HO%E&)Z/I MOPU(O!9A5I!Z]&DXB(/A3>LW4)RE27H_&#W/?LWRW!5PVS5(-3A@A(.? ): M,:ZXL0YYF_?@OR"2Z57<6H_X[JAUR$&HBT=-J2E\,!QY(D',4TO=".8^3:;U M*<4@HQ904NR76G5E\\_.59*1X+R$^(0RX"JA A+T%I/5H.T0H<;L<,)HR@H'%#S' M"14.*A%%#B&JH'E7-R'K->+A$%IQYA9L3&T45; L $+!.-#S%('^8L3@FCU2 M@I\?H>;"'0BWJ#0B6L;!5FD:$&;>,1EA=55>PT3VM$)I@&"W,ZU5+FM?+HM4 M]82?WV=:\$F9X![LE60HS9;22C$5M,/&4I&.4);LNC13;"GN6]*LU@%++52F M'MCFN>!!*J&1 Z^08.)3T1,1")@;PA=/^9(]R>V07@7\P6BR*@]=!T8<"EQ9 M0B3G7I(PH8F)\$53?OSAJ)%NO!JVUE43+VU3*=DVC%49[9X64',)&DP4ZI+KQO'/Z')[X!W5W%S@: MF>"(ER)PP0153@@/[B[CS&CM\EXAO'I*>VCBKS.;W:RAV[X6;*,2K6=:*.59C,@9#C_P M:'G:#+=>,^--1#2O/JVF!QZ$7CM8H'0>^4>WUZM]\6_%,2U)Q,2%H(@%]XDK M&2RR4O$0":V06)YE=A6B=3.H6=[O@N;2M/FV;8N_%O@_'O@'>K M6]/R8$7':#2XKXA7,I>!@ METADCCOA0!5:0"%-W A:A_H 'A5U!"*IJ=3?S=65P*1$+%(=>,*A)LHXJ,!(QJE3V?Q6='+!=5AQ^%,-V M=Y0:HK:+AR]'TV]'>/4A^K'T.K4>"85I- 1B=XU=FGL=?&"*.N5EM6L3D*L\ MLGW[J_A)SQ-W&R*MI/+#*?&DX1_8?M?J]<#8W(=6^WKQVI4R7VDVFE).@@O4 M><>#CD6H'S)B#O#_^CYK@0*)@!X;5-'16UUT92 MGTY_J=!4,'5PT@]N;KJ3\NND'\JFJ5=%O]VMVV%C4*D-LUC+U+&#,TQL MX*D93DSM%+F.54_DS8]1]Y=^M_?GM[ (Q=LW/V\-1LG;C[MQA#@=#%*@[SE' M$8RR35WITE!E:K))'RO!F-:]?VH-/P[++=I.:<-FPK_21ZAHF%A:).EE:I+' ML69,6 +*6S%BP?59IF'03XC-+?EJN)Z,1J/&T%9P+XB&D(?RX(1AD>L0I!$< M=(=U1X'&L^1K5<1;!8<% ;&&Y4[#4#US$,TC&3TXN-5V",]()PBG_];JIQ$ MRU#A6E 60F (%!8(%8V:"P0L*V@$W86/"95RKM-R5) S.'7@IP$ISHW1*H+6 ML!BE2E'"XM&A. LP.5>]?(DZP_^'@S3#M"&!@6K(&5$4F,!I'=( M&6,@RJ$(%+(GHLZ!().&& OQP')XM@:[T8 @K*PUTN"TX^P!JP>,05R9 R1$52&IF-=D)SKL%TJ.R (P>^&:(=H+"*_@$\>@MF M SDIN4388+#8F(+!!D?(DZS.["DH+,9JMC7JCK[<#HM6YV-_-@HKC'E9I'0-N.S]._OQ\\I),A%('<&-L#2%WT)I MFQKW!0A@J*0+&<,/DV3P7*RU+F%WLAC//Y)G]7JDV5WEIZNGBOF K)0ZM9?2 MH(#*&3Y&1(.CUPM[.'/3/?DSD+XNK_"%B8&3@HA4XZT5A)(,PISD*&@6'%/! MH]J!2KL5@]FA[+)IFN"2/R ;6]UAZ:#:^P]%*\W#>WCK8JO8Z3,_%[>#X;CH M3)[]- 4>8\]^.(AK^S FM,=D!+>73M?O,J1NT)3 M>(@JTTA6[Z(0P0%#D,0QP:=D")U5_/#J5LXR\+=#<9Y3=H4B^/,J[=."NP]: M7PIEF&1>8$.1P#:?:;8_%(_Z,#9BH(8F*CA.N95,8TV=1@:GK6X2,@=W)V2: M2O/:VO?AQ[]V(1 8MJ_OWQ??B]X"T@_7O.O?WHU'Y06T0K5UM5 8C8%88W!* M'NXXG KB$1MM(%2BB"KB.38!E;(9O%8Q[T1/%96-*S(%?*L%6:+#7]6"$&>5 M1T*"LVAY<$9Y2Y1%$AQYH07*1(26VP5/6I#B!/3(XOC:H+A0RDBL D_C=U3D M%BL7$0Z6VY5%5DOPWX9$D^BENU;X0M<,7U8TF)H;TY;VAG8WCG1Q1@Q0UW(> MK!5..A<0M4)H&25'GE*9!?(8->J%0]'X %-;%[UAA;A3$-U1:K& N-M:"0&? M5XR" N59PQC,GLB*DQ3";GLZL&Y6IWEDL=WRIEN.1(C'$#:("AUL)#JE;Z2Y M:4F&,WM3'2VP%C'6IM[#A/E3(1\)%+G +)CK: 4C6E$"Y(.(@44J3(U4;D*_ M!W(L)^ _^JU)V[.B,^OOWNQ8/2/A%M09%Q'\3A8ML]PQI"*CCN&(%./>U'3G M!X/;0+@:,CR19O.^SY'0#'OP#%&0E%#-/7>:2G@]1\Q8B/9I37@JFVS 3FE6 MZY[4)FH^]F6_>S6O;IE17Z'8FL*Q92ZS$6A94$HDD+JY#&'S%+@TD$5,\$P1E[5?M=/AGB M/:._XF20PD528T-9])2GQJ]&3M''VONFDZH=8SXI!IV,-I@\K[8@<%ZKSPV1 MBH/A;\4?T]1.>/NGX: //[:+27+Q//,OOZXB0K;52[!\N2Z*O+]J5LZZ0H[2 M$1KP&7@25@&=HU*IUE-C#/Z'H&SE6*8E!#IE&B:.F*_>7N6T4G$H$AZ)H>0X34(1#@G"N544E%EJ!@8LYQ2!@#Z?8E3= MQMT=>>;]B*4L,+O@X_BZ&,ZSP)%$6(NS(X),B6I[;_]5M,=?!^'';7?2LZ99@B=['>G)D^Q,X*=Y M0I017;_5FW8JF&:_O/O\9073>)IJJ)TW0:2:@'2R$C5XL)HYF\:]YA(IE^FL M[; ^$OHM)%/\#>1U!-%>>NH*^H&;#R+FD8W!7$*A4<"U@I$B-@HK.VGTI6=?/CR]<':H7OIXEA MX'R 'DN57)PHD?KJEZ8#TQCJ=HWTFE -N]_+?E5S_M&+./E8WFJ%(>:IEI[A M8 )S",Q#>1[-!(U"96&2JK09J"79[FBZRP/HY7F1J4FD0)Y@S6,D(K4^+VD@ MD";49KL;^Z+!"1[@-.0Y2.:P0U["\A%_G!IL/+8024<< MDX4*)?>#(\Y)32(SX553M0*>)P+?E-Y.)/!6&G[,F.1>6>482[TNX7?A=6Z? MM@4[M(9]8(O1K%@J<4Y[G135^=)?S R*$AN46:_3U'YI.'58R.S MR=E=' RG'Z7KEJ;XSN\[0T0'@5#TJ0A%I*Y<#K2ZDCQ*\!DI>_OK)_R[^@#! MWAR>!T7B(.0K"\(^WI;=!U9;[(5AA$+KI*M59. &XJ"\XRX-)B3.49\/(ZP> M81\$I7D:/CA_CSO.C_UQ-BYT\UA):ZVTC$HO*6%*E>.V-6@JQ%V6_SN'>2,@ M3X.XL>,\]8Y(B 4=-]:#HZ@@7"I/6IQ$)F0]]0X \8HZ-X$YN%,62\X1)]YI MA]*,+8VQD8KE8VXSG($]VBPC M0XC4*_@/&0U!(+@8VG*091.#382AQT:8_;.+!Y.H(1JVB$2.M;)< XV +!I+ M*DS8$[O\QZ '\I[V5UZE:;$X$J>L85*"[P%$!PE-0BK2X$\:98U>_$FMMPJ+ ME-W7>AP+(8G%/F+A//-@I+DU7GM&.;<2.W"F8RTA^3XH^;D[^E<$;&<9LZ^2 MKXE'CG)-).(X*I3F#*5D6@M&7U,G:OD:KFI>CSK*[F"JY!JI=/6I\.% >WR?"WK_N#WN#J?M(8.".O M="1&BDS08."( )9.HP>TM\X2AWG:(&-[(2\0JWUW.>)H?+KYA*R?B>1I= M$1A'/+B@B,$L\HA3_CO)6SF!Z[08BF\,WQZPVY\4+6>=< M&CT1+2@U0O*V[)7R@-.GVDH!65JP:#AEJ9><-!RB-Z-B,"12KE(&$&XAEJ2>&*80U1=FI-L7BA5%M6W$RX(^FCN4>,\RC$(IY'SG'*>LB<)Z= M+F#"\6%(]Y=A-M-[E2V2P1AF7>I]K[B'7Y#3)DI!L<>Z5<2-&QE4AX M <;$3,D2$)59"CT(Q]ILOP.R-)D(C<#>61M5=""+JC:@_, MY L% :ICG$K-J;_CG$\_"*W&%E0FKH:YT*#H (2J(8D#$!HH?,Q7E& M-CPDIVA,%.6.I81LY+QQSI"2+!88A_DLD-H7IRRK'5N>):"8540RYYCG2L$: M$F%3V4":Y@SN;':"3>G:@%<*:K8 ^^#LS:B/-A+B \%PO$>'"CDE&$A)? :#=(<;#0$D2!C)NM$5U+:UB?);,CJ:MV\ MT/ I*F>HQQ I@0ZR3@=P/+3E@AJ(%DP6%%<[(NATD"]P3.-,& MB4.,J% M-!C< )5J,*.@*M\G%)6Y@)M!\FPS>--T4\X),L%+SE*?&5 ::2R ,U&C/!Q[ M*IK+M9>P2+E(H\ 02P7BE,1I?*RA$GB DSU#,L^$6'%J(KQ<:1(_J[;OYK6WF:YSFNPF50H50(+X8))!;2:[90KP9%362D?N$R, M'1B%51G!:12#IB7O37B!:&5DN&#H-#8[P?HC0+1VL." MJ6A,3%D*U$NKHE65ZQ[.@L-"2R:$T])*PX @##2=2S434E$8GP:?. MYP+SJA'8-0JVN!P,BX_?C8N;46KV G<.![T>W+J\ M8>!$#QQF[PI@&J;\&9G7MOZ=ZG^HC1ZE8U!J$@P+E/9RC1IAX8 M!(48G1(*_+;,N]]\?;:F^',N[,%2,QH6-CU_[M3IXV4U5%BQM!0C#'K;^U3> M'XS!!.PZ@J66D8$/E'F"U48PYZ4]4ID%,V") ]<^6LQ!H7I)J4!I:@_U3,DL M_)0GL[ ?NOVR)\OL<:;?67Q*F@T_OO]0C*_36/A4\55V_-K826/(ZJ3*,!*4 M(VLA0 9J*LD2&57>-1JXK$TR7JKJN;40R%I04CH:;H2&($4@ M4//$A8A(KJ>J7;E>Z>(WJRF@8$CIUFGV"/A(H*12;"52LRY<$QIR+C:-JYZ) MJ,"F95.(?/3T&FT?=&KX@;D.EE"(-XF!F+\,^#VBA,1UFY5L".6N$6QH8A!U M9!I6.>V.<^&D $IVTM MMI)"6"P\L )9D9AB-'3?1H\*4)V*87S<.X>R:9V(@S<;T5!$6N(8&@T MWA 6,%/@@0T2R61JEIT+2-'T[QC1EU<08A??DB6S=K+^XO.X^V_%>./ MEZFUYG@\['Z[*^/ZKX-)TS=X3X ;QO<;AY$*HG D*80Y@G&%M)(Z@/VTW+B@ MJ8-[DO)\$/9K8P_)4WX(C"2I0236R9LH> ME%&MLU3NB^8CF6>@QY/\:W"GI1(>>>,81R9-K=8$3#OXV]P)NM2RHY^VI<&: M7LQ3<6XP#ZEA&%*"0@2K00 46(64,DAEFM=M4%/?,(2/%^D5O0FY%)QC\$V# MXU)"G '^'/.86'##"6OR4A$Y:J2;>O YT/!*:6!NPCGXY S05E*DZZ,$+IKDT MRF#A+0>U9AD!*P?"CCE8,=.XW-L+]D$0;Q;N:FC&?>B,<*5JY3%;04MA( M,#Q&*V0!*P(A!Z#%$"%,.YFYEL>#5N-J<8*HBR!C3J7<:Z10H '6B:=)+C*? M-KQSM,KO;-$OMDFX%"%:8KRT-FW:!:(,D> $80Q>D-0ZRT*N"P8S*+8%M#%N ME98*3:/BY1E;,(I:;5(O7A8"DWD-<5V8MAM(5YT&$I_R5Y5RBG+%DS^-B +? MRTK/#,T2JO9'TA6Q'L>12BYLP-B"7G$:(PB%P4 B1"*MMF1^$DF+T:=6=ZV> MT8N%5PH'"S&8)#3U\M5*E_VN=4C%XZ:ZEUPO6Y-7;P35JDDGJ8T=0AZ<9\DQ MN-.!DT5Z5LZEB:LX8<=22 M@VP:Q(WCA 87M*\I4M01N)3*!C"K HP $59(G:5L7A"V:@WFP'D" MW"NH'J@*PDACM3= 9F4)3G/J*%82_!J6\0Y;J1+6!GM18";9DYOS/@D:.<*< M3=T(P;-!B*:R. >1/HA$7H/ ,INV!EB[0&3%0H U\1*Y-!L!^(A'XRF7&B?W M7T=A,J^2K^+^U7AD-6[A1[MWUX&KMRLK4S%Y9U(HXBVW,6KPU!S8&46,P#Z? MXI<5'Z\#TM-1:"K4 E8"9SX=U1L(HY6TG/CH4E(/M][DA5I9F>D6*&P:$B_R M/S.1:>T4(DB"Z(*A$V4C>^&,X?E\94%$%=[E$VBMQDA4N&I, M*2:@@=$%F*N;CRDCMGJPL#UHJPI14AC*C5&!:M#6/!6B8&8!*(FI0S6.,,Z6 M^2FP-6HTX028<@D<%ZB!B)ESE\@& H65SP^H<'5FX?JPI:Z9*TLHEC>0I@<8 MHKJ@(D.J#@3%&!E5E)@(T4RB#&-(JQ@R-[QJJ3+<]T>:0\R779"U$(.@,1D1 M:L'RX2!]21I08M;ZIND0AZ/+H:?*.E"(0@H/'H(A1"MCHRV)0@P)*O=M,-\+ MQ_Q^E,+$1%(GS#!)+6=8&&22FG',L0@N2+8Y]XRD.;0P,>RC2#Z7$\H+A7SR MZA-IO$+6VZ9I=H>CRZ&%"2B2.HI*1!S5(NUU(5T2Q5A%4#41=3_")([5,DG+ M(H2N1H1 >5!>$6E]JDFF\EVG3OJ:WU3:4V>ID MPV/PQ#7U"!Q23I6R+I#4'E1X%IR*3:.(Y]^[/CRKPDSJB23<@3677"K@FQ"5 MXH9@8QC/C]<@=J^E50[49/OO/K53&ET7G;3KL4;'W<4"*X]9FEJE&$3!6%L0 M>\&1DX3B6--Q-R^2KH-A&RB;6NEXCCRV#DF''4^MTS2UX"4IKI55H*Q6C5#< M ,J-^P!:9'S@*<$=F=3:$@@*$2'(!E8.A"$_Y[\.[-V*UL#I,F%NM N$P3 MERWHUD 94CSB?%]A*;O-@[ %C(W,1I4S++)TI,!#620GA$.*(>QU""N;AZV$ M\7UQU>K%HG*$,%4DH,F)WJ&7,#D1_3(KY'P_F!1BSA[U=0@JOU56A::JS7V9 M44$TA15&.++4^#@JT#):1L6XAG XVZZFBQ1](-@"%1^/_4Q_,LOT>M#K%,/1 MI)1P0RE65E"AL5(0HUOBX8\A *S$#-1V7A2)9:K?60!R!3Q/@[UQ)QWT=$3. M.QD,*$=L(I%8>A2Y]E*:O/4F$T3M G9W-QP6=0/LFRAMD&%.&BQ2OE(:F.$= MEP+SP(B*I)H&GJ+;5/6V!-HI!)O"UTA-!'99 G,&#!91A#3W6QJP-D91SZNS MJ1,U>25:6 7?H]@TMW1\7C=X7B7J(*U4P&3 41R!]D;(T@#Z,6CD3;7*">2W MJK?GW[46,2:TH.;N"JVC#?=$D(>OOMQ]&Q7_OH,'AJ3POQ7C<*TDT:9NR5.Q6 ;+ L1S^SY;2=PA=I\66NN"G^M]4-Q@Q8F(U@J'"7-:&:ZCREN49]IK M[EV+E.A??9T"N)E;&^'=6GNCC,%<6J:9YL25C8JD\3(+NCFM!CESK]X(I"/< M4O8&:60@>B;@SA"+M/01,PE>)-@:G+?UI:32N7-OQ#CT/JFR7A!$#6.I";12 MRDD! NTCCSYZE)WE\9Q3MZ%$4X 3L8&0"U%-D.!<.F#;-(P$_N%$(I+I%#!I M9#<@'8GA7FSVS*,3Y>ZUX HQG9C5^. BN)PDSP4$3I6'(<;!S\BP)9YS%SSV M/'4##D 5JKWPJ65X/KF0(28VIL16.P94@[.J3>J=+SEUR9!;(B3H$^P=L7DN M?9-JK8O(UP&P2:(PZ#8PY2I"6V@:5^LI8J1W+=WR11*P!,?2>W(:*0 M 2RET#BJP ,"_1Q9($9XGF94YEMP2Z![?/TV #81T1J;NE&1E,+*'26:!$&FJ3)O'0!'HTE7E:NBW[X/HS& , 8E\0F^2"FD[U=.M[.M7JO?+KY< M%\7B+NKL@KQ. 3X9WA6=N?V@56&$9^"O.@OJ!QP9YPRL#T1IAKD0'*+Y/DMF M+-9 ZS+O!#!-#4B&-TZ";F(/P"M1T<(Q1X1'+AT15W> GTB7] M^JX_:8*X\H2V:<=]=LU#LOAC.7 U&IK=_YA7WAYWOY?4^E)<9:UTIY_5%Q2O M("\Q3!NG11KRPW'4A@E'90!>Y%I(D=?_-9-WGEI5HG[LIPN'\-8DL-.ZS!,_ M!UG?QE*C,";:63"O3H-N1[RSFA:RDX3^;?BK%KC:X_#0?? MNYVB8^__,4IC=B)//Z2V]R:? M@\;TXG;^T^#=)^8KSO61!8N*P5.DR6_R3"/AO<,(2V4YJ_8Y*6L5Q6$QGS32 MW/V:>^0HN#C@]#A0&-HKXQE2(=4YIRK2S$Y=@#.TUJ*O"? ^45^QZ"XJ9!77 MC")8=,"7*@$Q%(:_$-8RVWJXP!H?%O,:@[&316>*:BM3HQ>D.3CB1B N*4Y- M_;0E+F]?E2;HK(/ZF@#O$_55&3R@IUE4A&$K>=)W3#J)E!(.@]#7S/%@JI() M=E*H+QS]2:T!5G51>LNI.Z4]0?_:6-Z[<@%A-* M,BV1(SP(;*R@@6+!#-'"DKK!1()6,7E\_V: -=8CBM36 N)&:J@%&?-@0:9] MX31EN&["LCV\C46$7C&M>0 Y"3C5.J8V;B6\.!H4\KKJ:A7A MKN%=U0M$:6J5U"F#L>P+0S&>BHV4@$QNB:NEA7L N-%KT@09$5.?6.2YCLBD M";D)8(XHK?;?3@!GJG0=@&MBRXUYUXGH M@Y,&Z!$R<4EX2 F\<#\U;C;#/F M@L@*;6N@V ;(1H9-,:K7H',8B8('KB2="ABELF;>!I.5AJN[ '+5-$&%#/@) MT<;4LEMXXW @ =;;4ZZ8J!G$-EGUG0/9&,,1E29O2Z<4X1"86DMH()J(P)2U M-D4G6S#J2G.!_/V;0M=$2%"7(09O0Z(0]\8:B1V6X'>6&Q Y M=)6IVFM#M^U6._AQRD2B+<40**8UEZG_*8+X(8+"RHM&*MMIM2!L 6/SD&]- M373.1E#PDFK@S>3/(TF\4S'O1^JL]:#>P2F68'RP20GZ_,;!P:"69?2KVB4$)5Q$RPXO^ [!H]83;A=G1&_,_(T!I+,&N2HM9P0 M!%X/Q(^T7$-.$2CM3+MLNH:?6O?E&*,X&*9I6L.[]O@NS4-<>8BT<'4ZD3#] M#GQ6#+\O+LA#,FMO,((K5Y5Z,HED "Y-9ZN*&Z61 ,^4@IC1J%R>>(P6=>DR M=.I0_GCYL(]=S@/;6/YA702X'J"A+(2BE&H$$!(6/&! @LLR^&@E,V,9(-L! MNRJVLU8ZAB$: 7MJN3;@)DD=G04.@[@Z\^ZHV!K6KX-R;.:PL-/IG<6HG.Z= MG:+Q\A0-R[V.^UR>HZ=$4$Y9YF7JK&N-8@ 4J,8@(L9Y!+V)\_ZG7ZB>-E:J';F\R)VH-^D<5(EAZC#A$I%P0ZT%- M!>)".40BKV&LGB^M#]JN$%JQ)"R-+H?5\"GK#J>.ID(2&5%(\U:)SOM@Z7K5 MNR%"PT&[*#IEK_%WH]%=RM0 ^SVXN1GTRS*OFJ-W_+=6G_"+\N^ETHU8E(P9 MC@PH9ZJD2I6YKA1T6"679630:@G+2LB>C,:'UI"HY:DVR@-#*80LISP$I06$ M$\HX3#@%(<_7HSI9,Z:2:6DG38"N&5X#(&PQT&US42'$&4>99F@IN(O@#*EO"N:F3MK4F' MQLXHQ6."$604U*0!3R@&4=,IF%?:/FP,<,G['V]+KRW\*(;M[JC8O'L&T-,+ M!_YV@#A;4F8U@T".(B$]BV"\LAB!+H6Z%J G0K_*S%+B+9-$V[3WIK4)4C@- MJA%"4&=SZ)\ >;WUK7'85FUQ:14D9P+\2L-Y:FN!<>ILKQAX!]K%C+55VERJ MT+P!F*> W;BA+0P"&!U)+C*56 MJ#16.!E IVF1*1/%*YZ =@+UQMPYJ?=EQ M#F,O4KFM]0BBX=3J$@>@>A:G$2GQ>D!7FF5L!G)C.X] L93_G[TO;6X<.=+^ M_.ZO0/3:Z^X(M@;WT6T[ @?IF?4<[>[V3O@C"!9%>$" @T-J^=>_F54 ")*@ M1$I%"I1JO3$MDCBJLC*?/"HK$]S(\<0U DQ\#513=TWT1\;N[A$%5=%V].6A M0[X!MS!+P;T/LFI:SJND2=X]'D;LP%),RQWKNF[8BNF!HK$GGN]YOJF/=\O[ MJCO@MW8Y-D"J3=ET504,!->Q3=.VP,/3O8GN M>-X.AIJ&M7^>]7".GV?WL,>)UG/B&;J%IK(7& $H8ZSN8,B6J>*^@;I[P,N1 MCYQG&0)6S,9ACJ>W"\#D:EDE84EF 9G'45\AEON,"!BD'>BV[X#!0RM$!3#( MP%0G@>VISNX)RO<*C'BKY,[#8WKJ#.ZS*33=,D'!*;;B8=,PF %,2+?'OFK; M8]?NF8&)!UB?-(,;DE9[VGW!YME80% U@B!P92S #>P_ML"8V,5@ M<&;5K7&R-Q\\FOO=4,7R-3!E5=LW3&5B8W=SU[,=\$YU6=MU0S5-UYXPG ?V M(!7#'&N:K7G8RT(##T*=*)KMVEA935?4'?T/0/G$T=R[8QNX8(O(Z#WBSK+O MV;+JPOOLB:\X8W_W')%NV]O(O#N<+R1)L*4#24D>)GA\;+;$,GXE;KK=/#H] MTQ]CRP\=3Z[HQL2V'-]0 MM20;6/?+=EA;R46'#8N3C.Y-P\.&XT!9FI8 M 5E35#"H5!W,%FH'.NK.1IFI6\\UDP?8V0YD4W44IJAJ#8V MF-_=1;-4_?EFZ'O 9.)P[@FD83UX3[!'J MA069^=D2?]T]6W>0XP;&KF[9LF4;$\.S30RNR<%DC,G^EK];&0BK*F\,O'<8 MCQGH R3&YJN@L!SL,6!HED6M0=WT/'#OQSW'KV@7* X#=?,\3*_I%JAWM[ZD MWJ!Q;\-\-@GC_/_"I,+.--6R"2.M2(2Z,<9C$& V@:(\1$ VZS8IOBL;8U@C MT(6&-I;= -8&*:![JNQO'.-N*F$]-&..\WE^XMW;3G2,E8!<+; G0,1 =3Q9 ME5734 /9,"U_X]C 2R3>_V5@G+%"1@?RWH8=!AX7J!90Z%B"5QT[8]MV/,LV M-4US )S[:K#9#\L;USD-@83_VD]"1PX4TX.K=-W7 LM2+-4W94<&NTFUC8W@ M])J$R@LAX>>X^&V2$])4LWX,#P:![OF:8HWUB64H8&#*8PV+8OF6,YEHO0)\ M)2O:B0C8-Z/G)]\]_!=X@:_X3F!- LMTK;$;V KRGVF-33"E>D585O1+(]_/ M%48;?IG37POW)HP3#&9-LOQO<.\#U7@P2/YSN"2=U$G9QB\?JJBHCTVL1NEC MV!A,\8FC@:[&%L43&9O =BV^@@X,,]--P^% W0Y8R!?37-]Q1'[2&JJF,OZPNAZN86(SZ>O?7!:,XFF<"MP.K]$P6< M/P-;M@4J.H*T!;$U<9P>,F')(B[(N&\*)Z+/KR2^7H#6;LISR. M^F.77:JI75]3"3#LZ(\=33<4Q?%,'^.0"C@/&C;7W'0?/I&96%A+ #!"#T!1N6J@R1-E MC)'*7OOHD(#-Q5'S7SPX4[/D0-4,$TAIF(H&A)5-,.5M>R(;[F:_BH::^FND MYF&\J5F![?MCH*>JCRW-M4U;,V77]$&%Z;8W$;RY2\WVNJ]QF9!?YC^D,PQF M56&RL1,VS\RW+ M?EGT-SEIK;%AZKJG.H:K@]:R94_5'#=033FP@,9!G].DR"^/G1\FYV'@8'IC MTS/ B1\KKC&6/=O1Y2 P/<8_&$6&X2J@DS3-T+ >CS'! M6K@33;=\8^,L16/9M738,8^SI&"8&>,1>P!M- M)U\W.0^37^Q='_B:Y^O6V#!4S]/!]1R#X :JHBGN^+7([[,H=D7')I>:-0D M,G77G6B>@XH=["Q8BG%O9,J$_^,88CGK"FRYP?3'("Q)&P _9,M#W8C9@]+V M/$L-W+$1>+9GZ9KFT2P)3W=D99_[KURI)W-$'YSDT.A[3WC%D;& I6T9NF+# M_P(7#QC)CNSYFHY'=_;35^,87GE&^OY2E449@HQC_8(RC],BCGHH^5!&(3;P MT/"@O@I$4[$ L D6@0X^/YY)W"T)RQ%B]\[@1&3:%Z+?2AG=VLDP-=O#='*L MGAJHKF?XP7@LCY5 ]; (?Y^'8YN&R=''V9G"F>ES[Q8&:&C3=5S#&>M@\NAC M1]4]VY!=3?%T,">]WH &&)O8Z.WR2'3<+L868W7A"TSLP-<=;!PH&V:@V98/ MG&9X 1!3W>GCMH8O\THW3T*V<\6!'TW,>[:$ L7'+FZ*;@%@@4%M@R)0U, ! M1O1T=;N/QYJ8QI7,4=>>@IC%8=M0Y)$[&+LIA5VRCAW=KIB^ M;LJ^&HP=WP=R[R.K?*4?8P9RG>.0J'N_ 6.JFH==V_4Q(*=K@:D8J+;KX!D% M#;[8:\ <"9S#I>Z]MM.32.NI@>*HBJS@%O'$&GO:.)"U0'-5 %AMNYC;FK3J ME\V M$]E&L)-,X42$VA+DMKEHT]ZE"I-#^8HUXI9EU= ]PPJP[YAJJO3,H#=Q#1/X MROJ7^I/J\&"LQ\^$)R'W6TG[7J\>0$@7*]\ZKC7QW,# XCI8S\#S L\R VR/ M#(2T_V7\!$8A/T(^8B8\"?E_I"BQ'P/3+BUJW,-V>RHJC3U#,P.07WDR,5S7 M=US?5L:NB67')K*V>RJW;\_I!!/9(5:!=6NV:XMLG^AM.T5AM03:+'R5I:BL M-X*@G:)##^:'8BU%5W?\8&*;8%@ N6S#=W058,[Q#+?'P35@3-9.F*D>_BFG M]34G85'E=P=-S+?QB*8RMB>*:HWML>Y-FHDID['=M]UHJMO.Y]&3ZJ:7:(0I&8;G;.1<-5,"4T8UE%K90+GJ?)X+ /S M83(X]ANI)Z;:LMZ7-K(MH7U3PE>SKP-Z!IN)(+O\9W)+?]JM3[F_U-Q6=N'$ MM2>.[_BV)VL35U?P?+ALV*8>P$>C+PM+-;$+5S>W^J A\IG43N&YK603>X(Q M?-#/#E9FU,'6D5W3M":J#Y+3FZR+.R(;>67GF$W?UA%W21O;CCRV7-T*+-.3 MU;&G>%[-D('M!WUA44T#0=O(_>!+#3R#G!>$7O-EE<3["\F<$(!\6;=L5P;T M]QS/U'Q3U@PLDF>;LJWW;IOIMGD@278G>#!M^GW9\],' $$)7-5TP)GT%!G; M[B) 3WQ3-S1KHX;@WFW%X^=Y.)D>6XEMP3X+A6K[K&4[@F%C5Q<$"X@]HI%/, MCYJ-#R/\ !IX;RD6554<5=5=[*/LN:HKRZ &Q]BL4,6V6 \:X(>0XVGT.^1< M]V0#I-/80S> MBA^NXC),'JB08RL3TW!M+;#!<+,4/V76/'Q\24J]/1X3AMN)_A#461QPI8/[+LFY:I MN^!FL$G!_\:[G8&V"QDN MJO8RB'6XB)@Z=I>V=0QA:1/3\12=$L@$_M+D7:@X1@L<2*!%ELS PF03.JZT MEJ'ZLFEZ@3GV3,,"Y>59]L3$H[0:N./R3BT;=:L$X^[['S&ZLS"R*^NJ8AL3 M"RPZL'0 Q+W:%==]S1GO5I(R3,7I ?4S3_9P1@3C5;5D'9?.<":F!<+9P)JM M:3T%EA15>?;I;1V".BN[)CARHCA\ =[(^$?4/XF-TCC4 _T#%-41X'CC]1$"=KPU@',UG= MJ82G(#F<9Y_LX8CAC3WP_TQ#![S7/!U M0-'/4@PQ L)]1@M1Z8FAJ/];I8KQGOZW.S.]NV4&;I&&-/A-?[S6, 3&69L:_[$=GT[D%T'&XY3 M6NB!LELN=,NN&# ]CD%+5U8T70D <7Q#TR>VKMIN3070W\&N <.3#"Q0>F0J MNV&JLJF!,XG];5W+=%6P/H"GX7^@V+R^ Y$;&[X](SAZ@/?FDGN!BS5P-= W MFF$&)M8T#FS9&YN:,1E[?3O2^PAZT/!JJI]_&T13'7N,\0_P/$#)@M,LHZ9U M+4VVL-7C(U:BGLM99WS4%K;E*H&ARZ;LPA^!YP>!JK Y*\Y$,:3MI8X?4ONX> MR@P"7U-=VXX.\Y%#Y#V[?^V?W1A; M]IB![DW U=*= '22[>K:6)5EW50"NV=VNJ/KMJH/8W:[YT&[LY,U6PW&$_!6 M'-NP4;79D\!5;' 2@\G$[DN&L4U9-1QY,+.[9^U4R"#XJ@T.L>VY M"KC(MN79IMF;>*6A[VR?RZ"X;CY8O+XZ<<'Y]&W MW3% B"R/%7!"^ZK-J):NFP^OX ,#/<54[U]/#VMDJ/[8G=BJ$3B!9UO@NQF! MI[N>K 1]I_JPDZNCGFNJQ?8CCL527_$<3_?&VD0+#%6;>(H9V-A7$10#*((^ M8_A0+.T?(-^9W;-V>J#98S"T &,,0]>Q"H6KJ::A&YJGZTI?4;]#&;6B6I@>V:1AJH(/:4RW7<67=<8%+^\SF0S'T'#.[9\T,534UQY?M"9;^ M\73;=+'GFFI:AJ=;=I]Q?"A^'C"S/"[)+_,Y8"V9DSS'/C#3LFD2BC[I@]7E M]J32P(4:9L+ B[^0J(+WW-W7AGPC8\#67&.B>OH8^Y(XGN6#&PB@&SBVCGF7 M]QAJ#\^'P^SO[:>B3A1+@]7!3L6.-@$+QC,QB5R=6);KWV<(GVOL)UPY"P#4 MFG@38VQ:MA*8SGALPLH%R@1-G=W>-F>=O7EROO6TR<13%<_T# N#H&J L_<] M>ZSJ$V=G]U2U-[L>70X)VB?\D$;9DK0A@Q^SB)T Z88*FF+A=?^3'B)VCZ2H M#BA:50LFIFWYNFCKZ/ M(\%B\>''^/3>UN8= Q=,(\Q%-B=@2I@!()9KN;!0JF>[OJ.] M^>O_).7'67PC%>5=0O[R9@Z/?#\/EW%R]^%KO"2%]#.YE3YGRS#]2'\KXO^0 M#XJ\*C^^^9_K\N/6[4F!XSN!YZTJ_B= :\^D'55]^X3N#K@DAA!,"W"M,[])CG,4A) M%(<)/*E&PD):A#=$FA*22JN(MW&24)9-TXK M>'@AA=)U5COC$EK65S? .!=X/,2K.X MB!;8)Q._3^)PBOU"8K@M3NF=:9:#Z,(3J[R@UTRK KNS%M(\R^D5N)]8$$+; MF\XK+"1])4DX^0K'A'OHP%(YN0[S&9M4.Y\_P1#H^^ZD,I.N:4.LDDA%-<=@\5V?!AMKT+-LN )O"X-$JJ&=P.RQ+.D*'8SW3-ELAU,.>B2DII MGF=+.FL8!:I!)&*YB(LN?:X>+W/G9NL7(9>-0"U@] Q5"I.$W,3 9S7_[O(8778"2A%8X#8N%S7#(Z?M9?A[6/##"^>'DC5# M)DFR"F<("]39Q<_%*HR:SP:/ B[.D^;L=;3GK/.#PB[_KO+AG".!YEW$4)O4*E=GJP9$ MZ:\[@_:E0YJ(DD 9K@\<"2EI$35$M?V+] 7P&B$>CQLDS@D MPO+&IG?T.D0<+F]71Z:LC"S;X?(TB46PZ&SH_AUNF\-#P' ?<2*_?"7K?,8* M-IMT@]NER"YY5ETO ,QSY%N< /@E5&D VE?@H>#S<6YUXE)MKH$M,"5X684' M[1K3YC;+?Z,J@:7<'"R"'03ZCN+L(Z5K TPH: JU(=2&4!O;:N.G, <95NTS M* WE2GU!2L,TS9%I6J];963 -;+T\\_?CZ0??_1'1VF$^YT$H1*$2A J88 J M(27761F'F'2!6+6.,D79#4FQ(F03?&/E!:0VH"Z]#0MI1N9X+ 4 (LENWR$X MY C0>1V?HD6T) _^NP,-%!8E-(RFY&D^(A1M'.#QNN&"%M A("('HB@140D MU>F#"$*W0@$=4A#N$&RTVP8), C>;+-U8(%&'+_X/TE?5@21!'Z<4%0ATB^K M59:7N)&&0?T)F!%@:%Q]NNJ#DIRL$BH0=#2XLR?AUMZ^M^X^X4J2/N-6'((2 M'L>1G"8 &F48?JSKR!19$L\H_O5&V'%CH6-]X@Y%5>!)GBMA[PPJ]-N-I!-: M@+;8B&O#WV"%QR6L)RJC]>Y-!+;ZO$J2NQ&U:9D.FU7 KML;(R/*?+ ,.6XY M4=,>MX120F9%)]X"]OX46*G9WP)22O#2)6@_MMO2$]OG&V(?(*<(RUBHO6&I MO:][M[)1SUU?HXS'-R2YDPI"?J-Z#Z4_)V65IYV-9]Q012B@^VW4(8;!9DL, MJ.+U $7X#UZQPJUI5(.U0?T] >6XH%?]"H) '[<,\]](B9J/B!BK@ T!&Q<% M&_%RE3!S=%[E(.(Y#6&V&_@4#^ITDN@.K\[!R:9VYMF%78BV$&TAVL=Z$*VO M (HZ#:\)VU-9K=/7IIB91B5Z5&=E42N?'H]G%Y4QIM.-@&LCM"&N,3I&_0W\ M>Q;>%?4^#8I'@6E:[2$WO)N^MKURQ2IV;EQV=K_TM D]E/\44W[HKPMT4_^$ M)F&\Q"R/(JORB.T8K1U3X#7F8.+"TS\PM'H3)C0P$1;2+8 ES=>Z">.DR>6J M8. Y>*'W!VG>H@'Z!J,]]U_XYMWCXCEOX(8W&()Q2SX[7O];I62]W)K,0E5< M'KT9[UJ$O#9(Y2N%ZP8I^@WW\ -\R6_LVI7&=^Q=(&,L6H?U'F# $>._FL7! M8IAF>Z!H1:"X%S 3*@XQJ/(K)^)?-EFUHKINLP M#=9"EQ+<47C[!B>&'8_H#L.;=YW$AVMPT'*ZIW!'IX]WT=4*I:B&K;5.?=.W M3=IJT%__3C4DOOO''WU4D;_^'7Y$V+L%);Z17$%W*1#AHZ:431,Z=B/ _()N M1P#GC$,8)ONE(.NAL#(C(>H+%KONV]?M&J@W81YG%2@1\$YS6,GXAM"!I>2: M?>CN!C7:[:0>XOI< M$3,6('F*DC+6=?5MOA(-NR6,6M:!Q;AK&HCHM MQI M1R$"CG;V<$%6+99C@%7,(\H/!RWX#WG6+=8#*.B.6Y>$#PDR"*98)?A MP1*ZL3DEY2VISR^N<8FP(@K%.FX194E"HB9! J\&&S"+6!IB;42N&9!@1A+@ M6X:?R.XK^GQ\>U&M5@DR?&VJSEJ<73^?7@B#HB*X8",'_VA.:-(0>$WL23$8 M9$Q8:P,N29 4K=\QPZP1FOA^0R-M-9G::4+PU:.(V7?<3+/V :?QS528%T]]*'Y8YGS<+S&#UN2UT-<&<*!'P3Y8V4D6G<4 M66<1KYC#3D&U,VH H2\A[F A\-*9=29$3RRRA+D*\+&H$#4QHZ[JX!F 40+X M11_2_+9&XX84VV.FZ)7-2X"_-GPQ8T/,*.LWIR6+MF0"D&_G*3!JW,./L?8" M?"C1>0;$HYJM]K9AMN]!&>1PF5W7]'397%F"M M]^UCIH7+-4'65G:5@[) !X:J#Z!^&Z-M%JAS&X)[)R)7MW=9 MV3Y-'L+BP@)E4QA44S^J#N3#,JX=Z01MN#J-<+E*,N;Y-H\HVGI;58+R2[MO M X>"3D'F:,-!8J7/$)#9B-EVRBQA*\MB?K<5H&,G2&A^%R%E7;BLN^=6;%J$ MU_7N=ATJP:T\FDM:QP/ JJ]?R>R'O7&\MKC8QDT;B:D=J&NJC-&4]J(3O.F; M\Y')[JVA3HV??1[!"-/OPSAE4:7M?/MZNY&=1X__4^?6L5A4-T^)#:UDF[KT M%,^66;\%LS1(!)//J0O5.A>CKDU71WHZIAUNZV[9@74PA$;M\QD[F8:+G-=' M;[_1+;D"^:X&?.:3L>7 5<=GT:4JVJ7;6*QE> =^'4V20)\$UF?M\6TL#P6- M#)2;],-\TP+"$T\TB8)I$#;I9N19WMS9@:6Z3,.:G>M1;$,0$4KFE-!#LP53 M)'R:T;*-S(^GWF.G="&U1[K1/'9VF M*)ST$@Q=IG7>:[>&(@U:L(=TF(X>N6N"IDBB*3 +BUQD^3HL31WS+=1\@(.[ MR0)[SK:W4<4:J1!3RYYRETC@]8.7V0P6M=Y/;S?;X17,7=O<[D\0NG,V&UH9 MLF]+9>-E5(=/Z5X]C< Q2WU&YF&5E(TASZZ"^](N4>N7T6!-% %$T3J6+!S3 M1,LQ@05S1^N\Y.TL8_*-Y!$.$],Q9HB9=1G!8FUG)FB@@+>P.1@:^@G71F>- M 8A28*(T>+R.?311K@>RENN___Q=;P'=;G%A+!=?_#)WHPBGAGVELR2.[MA_ MCRFY:QOZQ/ 5Q]%MT_ F$]>P9=GT@K$JJZ9O*,]1%5:971L\=/B]$[]O?F'+@6A"P:TKG$SM8J-.!-EO.L0=[U"0+QL&9=X._B=6#R)RBC&&OMIV-;$ M?_Y=I6P_KXU#=![]P -IB"NKJP.#@9=M$'X3+[ C@.2F M*?I+GPG:58@I#>O\'1$XZ49#@ 'P E8#I0D4O.Z-HY."R.18,6EYN]E4[>X4 MHIX-?R-M%F.3ZUOO=6!IZE5=&Q?5=>WIUJH.> .WP!L5MU%HNE-;>M1Z4^SXW?]J=C8UTD)[B;@J1):NT*:AW&^7@V\E]6"7F<)8:@0 MO+PZ4-=QD(2@G%3;-NN VU;K%#^NN5LL#LM2#C:#_,60HOQ@3F;YA_^F?3%D M1O@91J@I23[@\IX\\$N)Q.5)J*,XQ:(Q5(\!WD:F61AF%D#Z^04M,<8BFT*N91U-E;O0(AP(Q8XI3WO*7_\J<44 )B@K7M#Z>2"XW(' MAC:.8 WY/E@1<6M;?5YS]R\M=[?/5SYNE];I0.*AWL!Q1O^&FU#['9V]O4]Y MAG9$^,-Z',?X"[IO!F//"F1-,0W?#3S3M

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�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end